UNITED
STATES SECURITIES AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
10-K
x
ANNUAL REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE
SECURITIES EXCHANGE ACT OF 1934
For the
fiscal year ended December 31, 2007
o
TRANSITION REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE
SECURITIES EXCHANGE ACT OF 1934 [NO FEE REQUIRED]
For the
transition period from
to
Commission
File Number: 000-26392
CICERO
INC.
(Exact
name of registrant as specified in its charter)
Delaware
|
11-2920559
|
(State
of incorporation)
|
(I.R.S.
Employer Identification No.)
|
8000
Regency Parkway, Suite 542, Cary, NC 27518
|
(Address
of principal executive offices, including Zip Code)
|
|
(919)
380-5000
|
(
Registrant’s telephone number,
including area code)
|
_____________
Securities
registered pursuant to Section 12(b) of the Act:
|
NONE
|
Securities
registered pursuant to Section 12(g) of the Act:
|
Common Stock, $.001
par value
|
_____________
Indicate
by check mark if the registrant is a well-known seasoned issuer, as defined in
Rule 405 of the Securities Act. Yes
o
No
x
Indicate
by check mark if the registrant is not required to file reports pursuant to
Section 13 or Section 15(d) of the above Act. Yes
o
No
x
Indicate
by check mark whether the registrant (1) has filed all reports required to be
filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the
preceding 12 months (or for such shorter period that the registrant was required
to file such reports), and (2) has been subject to such filing requirements for
the past 90 days.
Yes
x
No
o
Indicate
by check mark if disclosure of delinquent filers pursuant to Item 405 of
Regulation S-K is not contained herein, and will not be contained, to the best
of the Registrant’s knowledge, in definitive proxy or information statements
incorporated by reference in Part III of this Form 10-K or any amendment to this
Form 10-K.
o
Indicate
by check mark whether the registrant is a shell
company. Yes
o
No
x
Indicate
by check mark whether the registrant is a large accelerated filer, an
accelerated filer, or a non-accelerated filer. See definition of
“accelerated filer and large accelerated filer” in Rule 12b-2 of the Exchange
Act. (Check one):
Large
accelerated filer
o
|
Accelerated
filer
o
|
Non -
accelerated filer
x
|
Aggregate
market value of the outstanding shares of common stock held by non-affiliates of
the Registrant as of June 30, 2007 was approximately $5,765,578 based upon the
closing price quoted on the Over The Counter Bulletin Board.
There
were 43,805,508 shares of Common Stock outstanding as of March 11,
2008.
Documents
Incorporated by reference: None
CICERO
INC.
(Formerly
Level 8 Systems, Inc.)
Annual
Report on Form 10-K
Item
Number
|
|
Page
Number
|
|
PART
I
|
|
1.
|
|
1
|
1A.
|
|
9
|
1B
|
|
14
|
2.
|
|
14
|
3.
|
|
14
|
4.
|
|
14
|
|
PART
II
|
|
5.
|
|
15
|
6.
|
|
16
|
7.
|
|
17
|
7A.
|
|
26
|
8.
|
|
26
|
9.
|
|
26
|
9A.
|
|
26
|
9B.
|
|
28
|
|
PART
III
|
|
10.
|
|
29
|
11.
|
|
33
|
12.
|
|
39
|
13.
|
|
41
|
14.
|
|
46
|
|
PART
IV
|
|
15.
|
|
47
|
|
|
|
|
53
|
|
F-1
|
PART
I
Overview
Cicero Inc, formerly known as Level
8 Systems, Inc. (the “Company”)
is a
provider of business
integration software, which enables organizations to integrate new and existing
information and processes at the desktop. Our business integration software
addresses the emerging need for companies’ information systems to deliver
enterprise-wide views of their business information processes.
In addition to software
products, the Company also provides technical support, training and consulting
services as part of its commitment to providing its customers with
industry-leading integration solutions. The Company’s consulting team
has in-depth experience in developing successful enterprise-class solutions as
well as valuable insight into the business information needs of customers in the
largest 500 corporations worldwide (the “Global 500”).
The
Company’s focus is on the desktop integration and business process automation
market with our Cicero
®
product.
Cicero® is a business application integration platform that enhances end-user
productivity, streamlines business operations and integrates systems and
applications that would not otherwise work together. Cicero® software
offers a proven, innovative departure from traditional, costly and
labor-intensive enterprise application integration, which occurs at the server
level. Cicero® provides non-invasive application integration at the
desktop level. Desktop level integration provides the user with a
single environment with a consistent look and feel for diverse applications
across multiple operating environments, reduces enterprise integration
implementation cost and time, and supports a Service-Oriented Architecture
(“SOA”). Cicero®’s desktop level integration also enables clients to transform
applications, business processes and human expertise into a seamless, cost
effective business solution that provides a cohesive, task-oriented and
role-centric interface that works the way people think.
By using
Cicero® software, companies can decrease their customer management costs,
improve their customer service and more efficiently cross-sell the full range of
their products and services resulting in an overall increase in return on their
information technology investments. In addition, Cicero® software
enables organizations to reduce the business risks inherent in replacement or
re-engineering of mission-critical applications and extend the productive life
and functional reach of their application portfolio.
Cicero®
software is engineered to integrate diverse business applications and shape them
to more effectively serve the people who use them. Cicero® provides
an intuitive integration and development environment, which simplifies the
integration of complex multi-platform applications. Cicero® provides a unique
approach that allows companies to organize components of their existing
applications to better align them with tasks and operational
processes. In addition, Cicero® can streamline end-user tasks by
providing a single, seamless user interface for simple access to multiple
systems or be configured to display one or more composite applications to
enhance productivity. Cicero® software enables automatic information
sharing among line-of-business applications and tools. It is ideal for
deployment in contact centers where its highly productive, task-oriented user
interface promotes user efficiency. Finally, Cicero® software, by
integrating diverse applications across multiple operating systems, is ideal for
the financial services, for which Cicero® was initially developed, insurance,
telecommunications, intelligence, security, law enforcement, governmental and
other industries requiring a cost-effective, proven application integration
solution. Cicero® is also an integration solution for merger and
acquisition events where the sharing of data and combining of systems is
imperative.
Some of
the companies and other users that have implemented or are implementing our
Cicero® software product include Merrill Lynch Pierce Fenner & Smith
Incorporated, Nationwide Financial Services, IBM and N.E.W. Customer Service
Companies. We have also sold to intelligence, security, law enforcement and
other government users.
In
addition to our Cicero® product, our Ensuredmail email encryption products
address information and security compliance requirements from the individual to
the enterprise. The Ensuredmail suite of products includes the
Enterprise Email Encryption Server, and Email Encryption Desktop for individual
use. All of the Ensuredmail products use 3-DES or AES encryption
technology and are tested and federally certified FIPS
140-1. Ensuredmail products are easy to install, use and administer.
They also use rules and other utilities that allow users to flag messages
including attachments for encryption. Unlike other secure email
encryption software applications, Ensuredmail products do not require the
recipient to install software or use special secure keys to open and read
messages and attachments. In conjunction with Cicero® software,
Ensuredmail email encryption technology has been used to secure information
shared in Cicero® integration projects.
Some of
the companies using Ensuredmail server products include the United Postal
Service, ITX, Physicians Plus, the U.S. Bureau of Alcohol, Tobacco, Firearms and
Explosives, UFCW, Select Benefit, Delta Dental, Truog-Ryding Company, and
hundreds of individual users with the Ensuredmail Email Desktop
product. Ensuredmail customers use email encryption primarily to
secure outbound messages with confidential information for compliance (e.g.,
HIPAA) and security purposes.
Cicero
Inc. was incorporated in New York in 1988 as Level 8 Systems, Inc. and
re-incorporated in Delaware in 1999. Our principal executive offices are located
at 8000 Regency Parkway, Suite 542, Cary, NC 27518 and our telephone number is
(919) 380-5000. Our web site is www.ciceroinc.com.
Strategic
Realignment
Historically,
the Company has been a global provider of software solutions designed to help
companies integrate new and existing applications as well as extend those
applications to the Internet. This market segment is commonly known as
Enterprise Application Integration or EAI. Historically, EAI solutions work
directly at the server or back-office level allowing disparate applications to
communicate with each other.
Until
early 2001, we focused primarily on the development, sale and support of EAI
solutions through our Geneva product suite. After extensive strategic
consultation with outside advisors and an internal analysis of our products and
services, we recognized that a new market opportunity had
emerged. This opportunity was represented by the increasing need to
integrate applications that are physically resident on different platforms, a
typical situation in larger companies. In most cases, companies with
large customer bases utilize numerous different, or "disparate," applications
that were not designed to effectively communicate and pass
information. In addition, traditional EAI is often times too costly
and time-consuming to implement. It also requires a group of
programmers with the necessary skills and ongoing invasive changes to
application software code throughout the enterprise. With Cicero® software,
which non-invasively integrates the functionality of these disparate
applications at the desktop, we believe that we have found a unique solution to
this disparate application problem. We believe that our existing experience in
and understanding of the EAI marketplace coupled with the unique Cicero®
software solution, which approaches traditional EAI needs in a more effective
manner, position us to be a competitive provider of business integration
solutions to the financial services and other industries with large deployed
contact centers, as well as our other target markets.
We
originally licensed the Cicero® technology and related patents on a worldwide
basis from Merrill Lynch, Pierce, Fenner & Smith Incorporated in August of
2000 under a license agreement containing standard provisions and a two-year
exclusivity period. On January 3, 2002, the license agreement was amended to
extend our exclusive worldwide marketing, sales and development rights to
Cicero® in perpetuity (subject to Merrill Lynch's rights to terminate in the
event of bankruptcy or a change in control of the Company) and to grant
ownership rights in the Cicero® trademark. Merrill Lynch indemnifies us with
regard to the rights granted to us by them. Consideration for the original
Cicero® license we issued to Merrill Lynch consisted of 10,000 shares of our
common stock. In consideration for the amendment, we issued an additional 2,500
shares of common stock to MLBC, Inc., a Merrill Lynch affiliate and entered into
a royalty sharing agreement. Under the royalty sharing agreement, we pay a
royalty of 3% of the sales price for each sale of Cicero® or related maintenance
services. The royalties over the life of the agreement are not payable in excess
of $20 million. We have completely re-engineered the Cicero® software to provide
increased functionality and much more powerful integration
capabilities.
The
Company’s future revenues are entirely dependent on acceptance of Cicero® which
has had limited success in commercial markets to date. The Company has
experienced negative cash flows from operations for the past three years. As of
December 31, 2007, the Company had a working capital deficiency of approximately
$6,132,000. Accordingly, there is substantial doubt that the Company
can continue as a going concern, as is expressed in the independent auditor’s
report accompanying our financial statements. In order to address
these issues and to obtain adequate financing for the Company’s operations for
the next twelve months, the Company is actively promoting and expanding its
product line and continues to negotiate with significant customers who have
demonstrated interest in the Cicero® technology. The Company is experiencing
difficulty increasing sales revenue largely because of the inimitable nature of
the product as well as customer concerns about the Company’s financial
viability. Cicero® software is a new “category defining” product in that most
EAI projects are performed at the server level and Cicero®’s integration occurs
at the desktop level without the need to open and modify the underlying code for
those applications being integrated. Many companies are not aware of this new
technology or tend to look toward more traditional and accepted approaches. The
Company is attempting to solve the former problem by improving the market’s
knowledge and understanding of Cicero® through increased marketing and
leveraging its limited number of reference accounts while enhancing its list of
resellers and system integrators to assist in the sales and marketing process.
In addition, emerging competition in the marketplace has aided in the awareness
of this new technology.
Additionally,
the Company is seeking additional equity capital or other strategic transactions
in the near term to provide additional liquidity.
Recent
Developments
In December 2007, the Company entered into an OEM agreement with Merrill Lynch,
Pierce Fenner and Smith. Under the terms of the agreement, the Company has
allowed Merrill to embed the Cicero framework in a product it is building for
resale in the financial services arena. Merrill has agreed to purchase licenses
for Cicero on an as needed basis with an initial license purchase of $500,000 in
December 2007. At the same time, the Company and Merrill agreed to an enterprise
wide three year support agreement with a total value of $3,000,000 to be
recognized over the next three years.
Plan
of Recapitalization
In
December 2006, the Company completed its Plan of Recapitalization which was
approved by shareholders at a Special Shareholder Meeting held on November 16,
2006. The Plan provided the Company’s Board of Directors with discretionary
authority to affect a reverse stock split ratio from 20:1 to 100:1 and on
November 20, 2006, the Board of Directors set that reverse stock ratio to be
100:1. In addition, the Company’s shareholders approved an amendment to change
the name of the Company from Level 8 Systems, Inc. to Cicero Inc., to increase
the authorized common stock of the Company from 85 million shares to 215 million
shares and to convert existing preferred shares into a new Series A-1 preferred
stock. Senior Reorganization Notes in the aggregate principal amount of
$2,309,000, were cancelled and converted into 3,438,473 shares of common
stock. Senior Reorganization Notes were issued pursuant to a Note and
Warrant Offering in 2004 wherein warrant holders of the Company’s common stock
were offered a one-time conversion of their existing warrants at a conversion
price of $0.10 per share. Those warrant holders who elected to convert, tendered
their conversion price in cash and received a Note Payable in exchange. In
addition, holders of Senior Reorganization Notes were granted additional
warrants to acquire the Company’s common stock. The Company also converted
$3,915,000 of Convertible Bridge Notes into 30,508,448 shares of common stock.
The Plan of Recapitalization also included an exchange of existing preferred
shares into a new Series A-1 preferred shares for Cicero Inc. As part of that
exchange and part of the plan of recapitalization, $992,000 of Convertible
Promissory Notes were converted into 1,591 Series A-1 preferred shares and
$1,061,000 of Series D preferred stock recorded as mezzanine financing was
converted into 53 shares of Series A-1 preferred shares.
The
Company expects that increased revenues will reduce its operating losses in
future periods; however, there can be no assurance that management will be
successful in executing its strategy as anticipated or in a timely
manner. If these strategies are unsuccessful, the Company may have to
pursue other means of financing that may not be on terms favorable to the
Company or its stockholders. If the Company is unable to increase
cash flow or obtain financing, it may not be able to generate enough capital to
fund operations for the next twelve months. At our current rate of
expenses and assuming revenues for the next twelve months at an annualized rate
of our revenue for the year ended 2007, we will be able to fund planned
operations with existing capital resources for a minimum of seven months and
experience negative cash flow of approximately $1,250,000 during the next twelve
months to maintain planned operations. The accompanying financial statements
have been prepared on a going concern basis, which contemplates the realization
of assets and the satisfaction of liabilities in the normal course of business.
The financial statements presented herein do not include any adjustments
relating to the recoverability of assets and classification of liabilities that
might be necessary should the Company be unable to continue as a going
concern.
Products
Desktop
Integration
Cicero
®.
Cicero® software integrates disparate applications regardless of the platform,
enables rapid development of effective, simple-to-maintain composite
applications, accelerates time to value and deploys cost-effective,
"best-of-breed" business solutions by leveraging existing IT
investments. Cicero® software helps the architect maintain consistent
integration project design and implementation by providing extensible,
standardized software methods for interacting with Windows applications, COM
objects, web pages, commercial software packages, legacy applications, and Java
applications among others. Cicero® software can integrate applications running
on the server or desktop, giving the architect complete flexibility in
determining where, when, and how application integration occurs. Cicero®
software can also be used to capture and aggregate data from many different
applications, apply business rules as needed, such as data transformation rules,
and share that data bi-directionally via a composite view. An event in one
application can cause processing in another unrelated application, even if these
were implemented using differing technologies, such as Windows and
Java.
The
patented Cicero® software technology, as exclusively licensed from Merrill
Lynch, consists of several components, including the following: The Resource
Manager, which manages the starting, stopping, and status of applications; the
Event Manager, a Component Object Model (COM)-based messaging service; the
Context Manager which administers the “publish and subscribe” protocols; and a
Graphical User Interface (GUI) manager which allows applications to be presented
to the user in one or more flexible formats selected by the user
organization. In 2004, we released a version of the Cicero® product
which included our newly developed Cicero® Studio integration tool, to allow
applications to be integrated using point-and-click methods. Cicero® software
incorporates an Application Bus with code modules to handle the
inter-application connections. There are additional tools that provide ancillary
functions for the integrator including toolset to debug, view history and trace
logs.
Cicero® Studio provides a
nontraditional approach to application integration. By providing a high level of
object-oriented integration, Cicero® Studio eliminates the need for source code
modification. It includes high-level integration objects called genes (which
translate disparate application interface protocols to one common interface used
by Cicero® software), an event processor, a context manager and a
publish-subscribe information bus that enables applications to share data. It
also includes a set of integration wizards that greatly simplify the task of
application integration.
Cicero® Studio is a powerful
integration tool that eliminates most of the technical complexity associated
with application integration. Integrators avoid the high cost and complexity of
invasive code modifications and extend the scope of their integration
capabilities into new and legacy environments. Cicero® Studio provides an open
architecture that can be extended to incorporate new behaviors by adding genes
and communicating with COM objects. This enables Cicero® software to be extended
to accommodate new platforms and interface requirements as needed and provides a
rich paradigm for evolving integration behaviors over time. It also means that
Cicero® software can be implemented in both the desktop and n-tier server of a
service-oriented architecture.
Cicero® software runs on Vista,
Windows XP, and Windows 2000 to organize applications in a flexible graphical
configuration that keeps all the application functionality that the user needs
within easy reach. For instance, selecting the “memo” tab might cause a
Microsoft Word memo-template to be created within the Cicero® desktop. The
end-user need not even know that they are using Microsoft
Word. Moreover, a customer-tracking database can be linked with a
customer relationship management software package.
Cicero®
technology provides non-intrusive integration of desktop and web applications,
portals, third-party business tools, and even legacy mainframe and client server
applications, so all co-exist and share their information
seamlessly. Cicero®’s non-invasive technology means that clients
don’t risk modifying either fragile source code or sensitive application program
interfaces - and they can easily integrate off-the-shelf products and emerging
technologies.
Cicero®
software allows end-users to access applications in the most efficient way
possible, by only allowing them to use the relevant portions of that
application. For instance, a contact center customer service representative may
not use 90% of the functionality of Microsoft Word, but might need access to a
memorandum and other custom designed forms as well as basic editing
functionality. Cicero® can be set to control access to only those templates and,
in a sense, turn-off the unused functionality by not allowing the end-user
direct access to the underlying application. Under the same Cicero®
implementation, however, a different Cicero® configuration could allow the
employees in the Marketing department full access to Word because they have need
of the full functionality. The functionality of the applications that
Cicero® integrates can be modulated by the business goals of the ultimate
client, the parent company. This ability to limit user access to
certain functions within applications enables companies to reduce their training
burden by limiting the portions of the applications on which they are required
to train their customer service representatives.
Messaging
Ensuredmail
.
Our Ensuredmail products
provide encrypted email capabilities such as security, proof-of-delivery and
non-repudiation of origination. The recipient of an Ensuredmail message does not
need to be an Ensuredmail licensee or install software. When an Ensuredmail user
sends a message to another user, the recipient receives an email message with an
attached encrypted message. The recipient opens the attached, which
starts their web browser, enters a password, and can read the message and
attachments. If the recipient replies to the message, the message is
fully encrypted and sent back securely to the original sender. Organizations
typically use our server-based Ensuredmail products, whereas individuals can use
a person-to-person desktop variation.
Ensuredmail
is FIPS140-1 certified, and in use by agencies of the Federal Government, in
addition to private sector organizations.
Services
We
provide a full spectrum of technical support, training and consulting services
across all of our operating segments as part of our commitment to providing our
customers industry-leading business integration solutions. Experts in
the field of systems integration with backgrounds in development, consulting,
and business process reengineering staff our services
organization. In addition, our services professionals have
substantial industry specific backgrounds with extraordinary depth in our focus
marketplace of financial services.
Maintenance
and Support
We offer
customers varying levels of technical support tailored to their needs, including
periodic software upgrades, and telephone support. Cicero® is
frequently used in mission-critical business situations, and our maintenance and
support services are accustomed to the critical demands that must be met to
deliver world-class service to our clients. Many of the members of
our staff have expertise in mission critical environments and are ready to
deliver service commensurate with those unique client needs.
Training
Services
Our
training organization offers a full curriculum of courses and labs designed to
help customers become proficient in the use of our products and related
technology as well as enabling customers to take full advantage of our
field-tested best practices and methodologies. Our training
organization seeks to enable client organizations to gain the proficiency needed
in our products for full client self-sufficiency but retains the flexibility to
tailor their curriculum to meet specific needs of our clients.
Consulting
Services
We offer
consulting services around our product offerings in project management,
applications and platform integration, application design and development and
application renewal, along with expertise in a wide variety of development
environments and programming languages. We also have an active partner program
in which we recruit leading IT consulting and system integration firms to
provide services for the design, implementation and deployment of our solutions.
Our consulting organization supports third party consultants by providing
architectural and enabling services.
Customers
Our
customers include both end-users to whom we sell our products and services
directly and distributors and other intermediaries who either resell our
products to end-users or incorporate our products into their own product
offerings. Typical end-users of our products and services are large businesses
with sophisticated technology requirements for contact centers, in the financial
services, insurance and telecommunications industries, and intelligence,
security, law enforcement and other governmental organizations.
Our
customers are using our solutions to rapidly deploy applications. Some examples
of customers' uses of our products include:
·
Business Process Outsourcers
- use our Cicero
®
solution in
contact centers to provide real time integration among existing back-office
systems, eliminate redundant data entry, shorten call times, provide real-time
data access and enhance customer service and service levels.
·
A financial institution
-
uses our Cicero
®
solution to
provide real-time integration among market data, customer account information,
existing back-office systems and other legacy applications, eliminate redundant
data entry, provide real-time data access and processing, and enhance customer
service and service levels.
·
An insurance company
- uses
our Cicero
®
solution to integrate their customer information systems with over thirty
software applications including a CRM application.
·
A law enforcement
organization
- uses our Cicero
®
solution to
streamline and automate support for arrests and investigations while merging
federal, state and local systems within a unified process.
Other
customers are systems integrators, which use our Cicero® product to develop
integration solutions for their customers.
In 2007,
Merrill Lynch accounted for more then ten percent (10%) of our operating
revenues. Merrill Lynch, N.E.W. Customer Service Companies, IBM, and
Pilar Services, Inc. each accounted for more than ten percent (10%) of our
operating revenues in 2006. In 2005, N.E.W. Customer Service Companies and
Innovative System Solutions Corporation accounted for more than ten percent
(10%) of our operating revenue.
Sales
and Marketing
Sales
An
important element of our sales strategy is to supplement our direct sales force
by expanding our relationships with third parties to increase market awareness
and acceptance of our business integration software solutions. As part of these
relationships, we continue to jointly sell and implement Cicero® software
solutions with strategic partners such as systems integrators and embed Cicero®
along with other products through reseller relationships. We provide
training and other support necessary to systems integrators and Resellers to aid
in the promotion of our products. To date we have entered into
strategic partnerships with the following resellers, for integrated business
solutions: BluePhoenix Solutions, ThinkCentric, Hewlett Packard and House of
Code. In addition, we have entered into strategic partnerships with
TrySynergy Consulting, Innovative Solutions Group, Piercetech, Silent Systems,
Inc., ADPI LLC, and Pilar Services, Inc. These organizations have
relationships with existing customers or have access to organizations requiring
top secret or classified access. In addition, several of these
partners can bundle Cicero® with other software to provide a comprehensive
solution to customers. We are not materially dependent on any of
these organizations. Generally, our agreements with such partners provide for
price discounts based on their sales volume, with no minimum required
volume.
Marketing
The
target market for our products and services are large companies operating
contact centers and in the financial services, insurance and telecommunications
industries, as well as users in the intelligence, security and law enforcement
communities and other governmental organizations. Increasing competitiveness and
consolidation is driving companies in such businesses to increase the efficiency
and quality of their customer contact centers. As a result, customer contact
centers are compelled by both economic necessity and internal mandates to find
ways to increase internal efficiency, increase customer satisfaction, increase
effective cross-selling, decrease staff turnover cost and leverage their
investment in current information technology.
Our
marketing staff has an in-depth understanding of the customer contact center
software marketplace and the needs of these customers, as well as experience in
all of the key marketing disciplines. They also have knowledge of the
financial services industry and government organizations that have focused on
application integration solutions to address needs in mergers and acquisitions
and homeland security.
Core
marketing functions include product marketing, marketing communications and
strategic alliances. We utilize focused marketing programs that are
intended to attract potential customers in our target vertical industries and to
promote our company and our brands. Our marketing programs are specifically
directed at our target markets, and include speaking engagements, public
relations campaigns, focused trade shows and web site marketing, while devoting
substantial resources to supporting the field sales team with high quality sales
tools and ancillary material. As product acceptance grows and our
target markets increase, we will shift to broader marketing
programs.
The
marketing department also produces ancillary material for presentation or
distribution to prospects, including demonstrations, presentation materials,
white papers, case studies, articles, brochures, and data sheets.
Research
and Product Development
In
connection with the narrowing of our strategic focus, we have experienced an
overall reduction in research and development costs. Since Cicero® is a new
product in a relatively untapped market, it is imperative to constantly enhance
the feature sets and functionality of the product.
We
incurred research and development expense of approximately $569,000, $533,000,
and $891,000 in 2007, 2006, and 2005, respectively. The increase in costs in
2007 as compared to 2006 reflects a charge for stock compensation expense of
approximately $103,000 offset by general decreases in overhead costs and
employee benefits. The decrease in costs in 2006 as compared to 2005 reflects
the reduction in the number of employees by two plus associated overheads in
2006.
Our
budgets for research and development are based on planned product introductions
and enhancements. Actual expenditures, however, may significantly differ from
budgeted expenditures. Inherent in the product development process are a number
of risks. The development of new, technologically advanced software products is
a complex and uncertain process requiring high levels of innovation, as well as
the accurate anticipation of technological and market trends.
Competition
The
markets in which we compete are highly competitive and subject to rapid change.
These markets are highly fragmented and served by numerous firms. We believe
that the competitive factors affecting the markets for our products and services
include:
|
·
|
Product
functionality and features;
|
|
·
|
Availability
and quality of support services;
|
|
·
|
Ease
of product implementation;
|
|
·
|
Product
reputation; and
|
|
·
|
Our
financial stability.
|
The
relative importance of each of these factors depends upon the specific customer
environment. Although we believe that our products and services can compete
favorably, we may not be able to increase our competitive position against
current and potential competitors. In addition, many companies choose to deploy
their own information technology personnel or utilize system integrators to
write new code or rewrite existing applications in an effort to develop
integration solutions. As a result, prospective customers may decide against
purchasing and implementing externally developed and produced solutions such as
ours.
We
compete with companies that utilize varying approaches to modernize, web-enable
and integrate existing software applications:
·
|
Portal
software offers the ability to aggregate information at a single point,
but not the ability to integrate transactions from a myriad of information
systems on the desktop. Plumtree is a representative company in
the market.
|
·
|
Middleware
software provides integration of applications through messages and data
exchange implemented typically in the middle tier of the application
architecture. This approach requires modification of the
application source code and substantial infrastructure investments and
operational expense. Reuters, TIBCO and IBM MQSeries are
competitors in the middleware
market.
|
·
|
CRM
software offers application tools that allow developers to build product
specific interfaces and custom applications. This approach is
not designed to be product neutral and is often dependent on deep
integration with our technology. Siebel is a representative
product in the CRM software
category.
|
·
|
Recently,
there have been several companies that offer capabilities similar to our
Cicero® software in that these companies advertise that they integrate
applications without modifying the underlying code for those applications.
OpenSpan is one company who advertises that they can non-invasively
integrate at the point of contact or on the
desktop.
|
Other
competitors include Above All Software, Attachmate Corporation, Seagull Software
Ltd. and Oracle. Our Cicero® product competes directly with other contact center
solutions offered by Microsoft, Corizon and Jacada. We expect additional
competition from other established and emerging companies. Furthermore, our
competitors may combine with each other, or other companies may enter our
markets by acquiring or entering into strategic relationships with our
competitors. Many of our current and possible future competitors have greater
name recognition, a larger installed customer base and greater financial,
technical, marketing and other resources than we have.
Intellectual
Property
Our
success is dependent upon developing, protecting and maintaining our
intellectual property assets. We rely upon combinations of copyright, trademark
and trade secrecy protections, along with contractual provisions, to protect our
intellectual property rights in software, documentation, data models,
methodologies, data processing systems and related written materials in the
international marketplace. In addition, Merrill Lynch holds a patent with
respect to the Cicero® technology. Copyright protection is generally available
under United States laws and international treaties for our software and printed
materials. The effectiveness of these various types of protection can be
limited, however, by variations in laws and enforcement procedures from country
to country. We use the registered trademarks “Cicero®”
and “Ensuredmail”
All other
product and company names mentioned herein are for identification purposes only
and are the property of, and may be trademarks of, their respective
owners.
Employees
As of
December 31, 2007, we employed 19 employees, of which 16 are full time
employees. Our employees are not represented by a union or a
collective bargaining agreement.
We
believe that to fully implement our business plan we will be required to enhance
our ability to work with the Microsoft Vista, Windows XP, and Windows 2000
operating systems as well as the Linux operating system by adding additional
development personnel as well as additional direct sales personnel to complement
our sales plan. Although we believe that we will be successful in attracting and
retaining qualified employees to fill these positions, no assurance can be given
that we will be successful in attracting and retaining these employees now or in
the future.
Available
Information
Our web
address is www.ciceroinc.com. We make available free of charge
through our web site our annual report on Form 10-K, quarterly reports on Form
10-Q, current reports on Form 8-K, and all amendments to those reports as soon
as reasonably practicable after such material is electronically filed with or
furnished to the Securities and Exchange Commission. Also, the public
may read and copy such material at the Security and Exchange Commission’s Public
Reference Room at 450 Fifth Street, N.W., Washington, D.C. 20549. The
public may obtain information on the operation of the Public Reference Room by
calling the Security and Exchange Commission at 1-800-SEC-0330. The
Security and Exchange Commission also maintains an internet site that contains
reports, proxy and information statements, and other information at
www.sec.gov.
Forward
Looking and Cautionary Statements
Certain statements
contained in this Annual Report may constitute "forward looking statements"
within the meaning of the Private Securities Litigation Reform Act of 1995
("Reform Act"). We may also make forward looking statements in other reports
filed with the Securities and Exchange Commission, in materials delivered to
shareholders, in press releases and in other public statements. In addition, our
representatives may from time to time
make oral
forward-looking statements. Forward looking statements provide current
expectations of future events based on certain assumptions and include any
statement that does not directly relate to any historical or current fact. Words
such as "anticipates," "believes," "expects," "estimates," "intends," "plans,"
"projects," and similar expressions, may identify such forward looking
statements. In accordance with the Reform Act, set forth below are cautionary
statements that accompany those forward looking statements. Readers should
carefully review these cautionary statements as they identify certain important
factors that could cause actual results to differ materially from those in the
forward-looking statements and from historical trends. The following cautionary
statements are not exclusive and are in addition to other factors discussed
elsewhere in our filings with the Securities and Exchange Commission and in
materials incorporated therein by reference: there may be a question as to our
ability to operate as a going concern, our future success depends on the market
acceptance of the Cicero® product and successful execution of the new strategic
direction; general economic or business conditions may be less favorable than
expected, resulting in, among other things, lower than expected revenues; an
unexpected revenue shortfall may adversely affect our business because our
expenses are largely fixed; our quarterly operating results may vary
significantly because we are not able to accurately predict the amount and
timing of individual sales and this may adversely impact our stock price; trends
in sales of our products and general economic conditions may affect investors'
expectations regarding our financial performance and may adversely affect our
stock price; our future results may depend upon the continued growth and
business use of the Internet; we may lose market share and be required to reduce
prices as a result of competition from our existing competitors, other vendors
and information systems departments of customers; we may not have the ability to
recruit, train and retain qualified personnel; rapid technological change could
render the Company's products obsolete; loss of any one of our major customers
could adversely affect our business; our products may contain undetected
software errors, which could adversely affect our business; because our
technology is complex, we may be exposed to liability claims; we may be unable
to enforce or defend our ownership and use of proprietary technology; because we
are a technology company, our common stock may be subject to erratic price
fluctuations; and we may not have sufficient liquidity and capital resources to
meet changing business conditions.
There is
substantial doubt as to whether we can continue as a going
concern
.
Because
we incurred net operating losses of approximately $2.0 million for the year
ended December 31, 2007 in addition to losses from continuing operations of
approximately $6.7 million for the previous two fiscal years we experienced
negative cash flows from operations, had significant working capital
deficiencies at December 31, 2007, and because we are relying on acceptance of a
newly developed and marketed product, there is substantial doubt that we can
continue to operate as a going concern. While we have attracted some additional
capital to continue to fund operations, there can be no assurance that we can
obtain additional financing and if we do obtain financing that it will be on
terms that are favorable to us or our stockholders.
We have a history
of losses and expect that we will continue to experience losses at least through
the first quarter of 2008
.
We
experienced operating losses and net losses for each of the years from 1998
through 2007. We incurred a net loss of $3.68 million in 2005, $3.0 million in
2006 and $2.0 million for 2007. As of December 31, 2007, we had a
working capital deficit of $6.1 million and an accumulated deficit of $236
million. Our ability to generate positive cash flow is dependent upon sustaining
certain cost reductions and generating sufficient revenues.
Therefore,
due to these and other factors, we expect that we will continue to experience
net losses through the first quarter of 2008. We have not generated sufficient
revenues to pay for all of our operating costs or other expenses and have relied
on financing transactions over the last several fiscal years to pay our
operating costs and other expenses. We cannot predict with accuracy our future
results of operations and believe that any period-to-period comparisons of our
results of operations are not meaningful. Furthermore, there can be
no assurance that if we are unable to generate sufficient revenue from
operations that we will be able to continue to access the capital markets to
fund our operations, or that if we are able to do so that it will be on
satisfactory terms.
As the
number of software products in the industry increases and the functionality of
these products further overlaps, we believe that software developers and
licensors may become increasingly subject to infringement claims. Any such
claims, with or without merit, could be time consuming and expensive to defend
and could adversely affect our business, operating results and financial
condition.
We
develop new and unproven technology and products.
To date,
our products have not been widely accepted in the market place and therefore may
be considered unproven. The markets for our products are characterized by
rapidly changing technologies, evolving industry standards, frequent new product
introductions and short product life cycles. Our future success will depend to a
substantial degree upon our ability to market and enhance our existing products
and to develop and introduce, on a timely and cost-effective basis, new products
and features that meet changing customer requirements and emerging and evolving
industry standards.
We
depend on an unproven strategy for ongoing revenue; going concern
qualification.
The
Company’s future revenues are entirely dependent on acceptance of Cicero® which
had limited success in commercial markets to date. The Company has experienced
negative cash flows from operations for the past three years. At December 31,
2007, the Company had a working capital deficiency of approximately
$6,132,000. Accordingly, there is substantial doubt that the Company
can continue as a going concern, and the independent auditor’s report
accompanying our financial statements raises doubt about our ability to continue
as a going concern. In order to address these issues and to obtain
adequate financing for the Company’s operations for the next twelve months, the
Company is actively promoting and expanding its product line and continues to
negotiate with significant customers who have demonstrated interest in the
Cicero® technology. The Company is experiencing difficulty increasing sales
revenue largely because of the inimitable nature of the product as well as
customer concerns about the Company’s financial viability. Cicero® software is a
new “category defining” product in that most EAI projects are performed at the
server level and Cicero®’s integration occurs at the desktop level without the
need to open and modify the underlying code for those applications being
integrated. Many companies are not aware of this new technology or tend to look
toward more traditional and accepted approaches although emerging competition
has increased the public awareness of this new form of technology. The Company
is attempting to solve the former problem by improving the market’s knowledge
and understanding of Cicero® through increased marketing and leveraging its
limited number of reference accounts while enhancing its list of resellers and
system integrators to assist in the sales and marketing process. Additionally,
the Company is seeking additional equity capital or other strategic transactions
in the near term to provide additional liquidity, however, there is no assurance
that the Company will be able to obtain any additional funding.
Our new
strategy is subject to the following specialized risks that may adversely affect
our long-term revenue and profitability prospects:
|
·
|
Cicero®
was originally developed internally by Merrill Lynch and has no track
record of successful sales to organizations within the financial services
industry and may not gain market
acceptance;
|
|
·
|
We
are approaching a different segment of the financial services industry,
the customer contact center, compared to our sales and marketing efforts
in the past and there can be no assurance that we can successfully sell
and market into this industry; and
|
|
·
|
We
have had very limited success because the financial condition of the
Company has caused concern for enterprise customers that would be
dependent on Cicero® for their long-term
needs.
|
Economic
conditions could adversely affect our revenue growth and cause us not to achieve
desired revenue.
Our
ability to generate revenue depends on the overall demand for desktop
integration software and services. Our business depends on overall economic
conditions, the economic and business conditions in our target markets and the
spending environment for information technology projects, and specifically for
desktop integration in those markets. A weakening of the economy in one or more
of our geographic regions, unanticipated major events and economic uncertainties
may make more challenging the spending environment for our software and
services, reduce capital spending on information technology projects by our
customers and prospective customers, result in longer sales cycles for our
software and services or cause customers or prospective customers to be more
cautious in undertaking larger transactions. Those situations may cause a
decrease in our revenue. A decrease in demand for our software and services
caused, in part, by an actual or anticipated weakening of the economy, may
result in a decrease in our revenue rates.
The
so-called “penny stock rule” could make it cumbersome for brokers and dealers to
trade in our common stock, making the market for our common stock less liquid
which could cause the price of our stock to decline.
The
Company ’s common stock is quoted on the Over-the-Counter Bulletin
Board.
Trading of our common
stock on the OTCBB may be subject to certain provisions of the Securities
Exchange Act of 1934, as amended, commonly referred to as the "penny stock"
rule. A penny stock is generally defined to be
any
equity security that has a market price less than $5.00 per share, subject to
certain exceptions. If our stock is deemed to be a penny stock, trading in our
stock will be subject to additional sales practice requirements on broker-
dealers.
These may require a broker-dealer to:
|
·
|
make
a special suitability determination for purchasers of our
shares;
|
|
·
|
receive
the purchaser's written consent to the transaction prior to the purchase;
and
|
|
·
|
deliver
to a prospective purchaser of our stock, prior to the first transaction, a
risk disclosure document relating to the penny stock
market.
|
Consequently,
penny stock rules may restrict the ability of broker-dealers to trade and/or
maintain a market in our common stock. Also, prospective investors may not want
to get involved with the additional administrative requirements, which may have
a material adverse effect on the trading of our shares.
Because we cannot
accurately predict the amount and timing of individual sales, our quarterly
operating results may vary significantly, which could adversely impact our stock
price
.
Our
quarterly operating results have varied significantly in the past, and we expect
they will continue to do so in the future. We have derived, and expect to
continue to derive in the near term, a significant portion of our revenue from
relatively large customer contracts or arrangements. The timing of revenue
recognition from those contracts and arrangements has caused and may continue to
cause fluctuations in our operating results, particularly on a quarterly basis.
Our quarterly revenues and operating results typically depend upon the volume
and timing of customer contracts received during a given quarter and the
percentage of each contract, which we are able to recognize as revenue during
the quarter. Each of these factors is difficult to forecast. As is common in the
software industry, the largest portion of software license revenues are
typically recognized in the last month of each fiscal quarter and the third and
fourth quarters of each fiscal year. We believe these patterns are partly
attributable to budgeting and purchasing cycles of our customers and our sales
commission policies, which compensate sales personnel for meeting or exceeding
periodic quotas.
Furthermore,
individual Cicero® sales are large and each sale can or will account for a large
percentage of our revenue and a single sale may have a significant impact on the
results of a quarter. The sales of both our historical products and Cicero® can
be classified as generally large in size to a small discrete number of
customers. In addition, the substantial commitment of executive time and
financial resources that have historically been required in connection with a
customer’s decision to purchase Cicero® and our historical products increases
the risk of quarter-to-quarter fluctuations. Cicero® sales require a significant
commitment of time and financial resources because it is an enterprise product.
Typically, the purchase of our products involves a significant technical
evaluation by the customer and the delays frequently associated with customers’
internal procedures to approve large capital expenditures and to test, implement
and accept new technologies that affect key operations. This evaluation process
frequently results in a lengthy sales process of several months. It also
subjects the sales cycle for our products to a number of significant risks,
including our customers’ budgetary constraints and internal acceptance reviews.
The length of our sales cycle may vary substantially from customer to
customer.
Our
product revenue may fluctuate from quarter to quarter due to the completion or
commencement of significant assignments, the number of working days in a quarter
and the utilization rate of services personnel. As a result of these factors, we
believe that a period-to-period comparison of our historical results of
operations is not necessarily meaningful and should not be relied upon as
indications of future performance. In particular, our revenues in the third and
fourth quarters of our fiscal years may not be indicative of the revenues for
the first and second quarters. Moreover, if our quarterly results do not meet
the expectations of our securities analysts and investors, the trading price of
our common stock would likely decline.
Loss of key
personnel associated with Cicero
®
development
could adversely affect our business
.
Loss of
key executive personnel or the software engineers we have hired with specialized
knowledge of the Cicero® technology could have a significant impact on our
execution of our new strategy given that they have specialized knowledge
developed over a long period of time with respect to the Cicero®
technology. Furthermore, because of our restructuring and reduction
in the number of employees, we may find it difficult to recruit new employees in
the future.
Different
competitive approaches or internally developed solutions to the same business
problem could delay or prevent adoption of Cicero
®.
Cicero®
is designed to address in a novel way the problems that large companies face
integrating the functionality of different software applications by integrating
these applications at the desktop. To effectively penetrate the market for
solutions to this disparate application problem, Cicero® will compete with
traditional Enterprise Application Integration, or EAI, solutions that attempt
to solve this business problem at the server or back-office level. Server level
EAI solutions are currently sold and marketed by companies such as NEON,
Mercator, Vitria, and BEA. There can be no assurance that our potential
customers will determine that Cicero®’s desktop integration methodology is
superior to traditional middleware EAI solutions provided by the competitors
described above in addressing this business problem. Moreover, the information
systems departments of our target customers, large financial institutions, are
large and may elect to attempt to internally develop an internal solution to
this business problem rather than to purchase the Cicero® product. Cicero®
itself was originally developed internally by Merrill Lynch to solve these
integration needs.
Accordingly,
we may not be able to provide products and services that compare favorably with
the products and services of our competitors or the internally developed
solutions of our customers. These competitive pressures could delay or prevent
adoption of Cicero® or require us to reduce the price of our products, either of
which could have a material adverse effect on our business, operating results
and financial condition.
Our
ability to compete may be subject to factors outside our control.
We
believe that our ability to compete depends in part on a number of competitive
factors outside our control, including the ability of our competitors to hire,
retain and motivate senior project managers, the ownership by competitors of
software used by potential clients, the development by others of software that
is competitive with our products and services, the price at which others offer
comparable services and the extent of our competitors’ responsiveness to
customer needs.
The
markets for our products are characterized by rapidly changing technologies,
evolving industry standards, frequent new product introductions and short
product life cycles.
Our
future success will depend to a substantial degree upon our ability to enhance
our existing products and to develop and introduce, on a timely and
cost-effective basis, new products and features that meet changing customer
requirements and emerging and evolving industry standards.
The
introduction of new or enhanced products also requires us to manage the
transition from older products in order to minimize disruption in customer
ordering patterns, as well as ensure that adequate supplies of new products can
be delivered to meet customer demand. There can be no assurance that we will
successfully develop, introduce or manage the transition to new
products.
We have
in the past, and may in the future, experience delays in the introduction of our
products, due to factors internal and external to our business. Any future
delays in the introduction or shipment of new or enhanced products, the
inability of such products to gain market acceptance or problems associated with
new product transitions could adversely affect our results of operations,
particularly on a quarterly basis.
We
may face damage to the reputation of our software and a loss of revenue if our
software products fail to perform as intended or contain significant
defects.
Our
software products are complex, and significant defects may be found following
introduction of new software or enhancements to existing software or in product
implementations in varied information technology environments. Internal quality
assurance testing and customer testing may reveal product performance issues or
desirable feature enhancements that could lead us to reallocate product
development resources or postpone the release of new versions of our software.
The reallocation of resources or any postponement could cause delays in the
development and release of future enhancements to our currently available
software, require significant additional professional services work to address
operational issues, damage the reputation of our software in the marketplace and
result in potential loss of revenue. Although we attempt to resolve all errors
that we believe would be considered serious by our partners and customers, our
software is not error-free. Undetected errors or performance problems may be
discovered in the future, and known errors that we consider minor may be
considered serious by our partners and customers. This could result in lost
revenue, delays in customer deployment or legal claims and would be detrimental
to our reputation. If our software experiences performance problems or ceases to
demonstrate
technology
leadership, we may have to increase our product development costs and divert our
product development resources to address the problems.
We may be unable
to enforce or defend our ownership and use of proprietary and licensed
technology
.
We
originally licensed the Cicero® technology and related patents on a worldwide
basis from Merrill Lynch, Pierce, Fenner & Smith Incorporated in August of
2000 under a license agreement containing standard provisions and a two-year
exclusivity period. On January 3, 2002, the license agreement was amended to
extend our exclusive worldwide marketing, sales and development rights to
Cicero® in perpetuity (subject to Merrill Lynch's rights to terminate in the
event of bankruptcy or a change in control of the Company) and to grant
ownership rights in the Cicero® trademark. Merrill Lynch indemnifies us with
regard to the rights granted to us by them. Consideration for the original
Cicero® license consisted of 10,000 shares of our common stock. In exchange for
the amendment, we granted an additional 2,500 shares of common stock to MLBC,
Inc., a Merrill Lynch affiliate and entered into a royalty sharing agreement.
Under the royalty sharing agreement, we pay a royalty of 3% of the sales price
for each sale of Cicero® or related maintenance services. The royalties over the
life of the agreement are not payable in excess of $20 million. We have
completely re-engineered the Cicero® software to provide increased functionality
and much more powerful integration capabilities.
Our
success depends to a significant degree upon our proprietary and licensed
technology. We rely on a combination of patent, trademark, trade secret and
copyright law, contractual restrictions and passwords to protect our proprietary
technology. However, these measures provide only limited protection, and there
is no guarantee that our protection of our proprietary rights will be adequate.
Furthermore, the laws of some jurisdictions outside the United States do not
protect proprietary rights as fully as in the United States. In addition, our
competitors may independently develop similar technology; duplicate our products
or design around our patents or our other intellectual property rights. We may
not be able to detect or police the unauthorized use of our products or
technology, and litigation may be required in the future to enforce our
intellectual property rights, to protect our trade secrets or to determine the
validity and scope of our proprietary rights. Additionally, with respect to the
Cicero® line of products, there can be no assurance that Merrill Lynch will
protect its patents or that we will have the resources to successfully pursue
infringers. Any litigation to enforce our intellectual property rights would be
expensive and time-consuming, would divert management resources and may not be
adequate to protect our business.
We do not
believe that any of our products infringe the proprietary rights of third
parties. However, companies in the software industry have experienced
substantial litigation regarding intellectual property and third parties could
assert claims that we have infringed their intellectual property rights. In
addition, we may be required to indemnify our distribution partners and end-
users for similar claims made against them. Any claims against us would divert
management resources, and could require us to spend significant time and money
in litigation, pay damages, develop new intellectual property or acquire
licenses to intellectual property that is the subject of the infringement
claims. These licenses, if required, may not be available on acceptable terms.
As a result, intellectual property claims against us could have a material
adverse effect on our business, operating results and financial
condition.
Our
business may be adversely impacted if we do not provide professional services to
implement our solutions.
Customers
that license our software typically engage our professional services staff or
third-party consultants to assist with product implementation, training and
other professional consulting services. We believe that many of our software
sales depend, in part, on our ability to provide our customers with these
services and to attract and educate third-party consultants to provide similar
services. New professional services personnel and service providers require
training and education and take time and significant resources to reach full
productivity. Competition for qualified personnel and service providers is
intense within our industry. Our business may be harmed if we are unable to
provide professional services to our customers to effectively implement our
solutions of if we are unable to establish and maintain relationships with
third-party implementation providers.
Because
our software could interfere with the operations of customers, we may be subject
to potential product liability and warranty claims by these
customers.
Our
software enables customers’ software applications to
integrate and is often used for mission critical functions or
applications. Errors, defects or other performance problems in our software or
failure to provide technical support could result in financial or other damages
to our customers. Customers could seek damages for losses from us. In addition,
the failure of our software and solutions to perform to customers’ expectations
could give rise to warranty claims. The integration of our software
with our customer’s applications, increase the risk that a customer may bring a
lawsuit us. Even if our software is not at fault, a product liability claim
brought against us, even if not successful, could be time consuming and costly
to defend and could harm our reputation.
We
have not paid any dividends on our common stock and it is likely that no
dividends will be paid in the future.
We have
never declared or paid cash dividends on our common stock and we do not
anticipate paying any cash dividends on our common stock in the foreseeable
future.
Provisions
of our charter and Bylaws and Delaware law could deter takeover
attempts.
Section
203 of the Delaware General Corporation Law, which prohibits certain persons
from engaging in business combinations with the Company, may have anti-takeover
effects and may delay, defer or prevent a takeover attempt that a stockholder
may consider to be in the holder’s best interests. These provisions of Delaware
law also may adversely affect the market price of our common stock. Our
certificate of incorporation authorizes the issuance, without stockholder
approval, of preferred stock, with such designations, rights and preferences as
the board of directors may determine preferences as from time to time. Such
designations, rights and preferences established by the board may adversely
affect our stockholders. In the event of issuance, the preferred stock could be
used, under certain circumstances, as a means of discouraging, delaying or
preventing a change of control of the Company. Although we have no present
intention to issue any shares of preferred stock in addition to the currently
outstanding preferred stock, we may issue preferred stock in the
future.
Not
Applicable
Our
corporate headquarters and United States operations group and administrative
functions are based in offices of approximately 5,038 square feet in our Cary,
North Carolina office pursuant to a lease expiring in 2010.
Various
lawsuits and claims have been brought against us in the normal course of our
business. In October 2003, we were served with a summons and complaint in the
Superior Court of North Carolina regarding unpaid invoices for services rendered
by one of our subcontractors. The amount in dispute was approximately
$200,000 and is recorded as part of our accounts payable. Subsequent to March
31, 2004, we settled this litigation. Under the terms of the
settlement agreement, we agreed to pay a total of $189,000 plus interest over a
19-month period ending November 15, 2005. The Company is in the process of
negotiating a series of payments for the remaining liability of approximately
$80,000.
Under the
indemnification clause of the Company’s standard reseller agreements and
software license agreements, the Company agrees to defend the reseller/licensee
against third party claims asserting infringement by the Company’s products of
certain intellectual property rights, which may include patents, copyrights,
trademarks or trade secrets, and to pay any judgments entered on such claims
against the reseller/licensee.
Item
4. Submission of Matters to a
Vot
e of Security Holders
None
PART
II
Item
5. Market Fo
r
Registrant's
Common Stock, Related Shareholder Matters and Issuer Purchases of Equity
Securities.
Our common is currently quoted on the Over-The-Counter Bulletin Board. In
January 2007 we formally changed our name to Cicero Inc. and now trade under the
ticker CICN. The chart below sets forth the high and low stock prices
for the quarters of the fiscal years ended December 31, 2007 and 2006 as
retroactively adjusted for the 100:1 reverse stock split.
|
|
2007
|
|
|
2006
|
|
Quarter
|
|
High
|
|
|
Low
|
|
|
High
|
|
|
Low
|
|
First
|
|
|
$2.60
|
|
|
|
$1.02
|
|
|
|
$3.00
|
|
|
|
$1.80
|
|
Second
|
|
|
$1.13
|
|
|
|
$0.16
|
|
|
|
$2.50
|
|
|
|
$1.00
|
|
Third
|
|
|
$0.75
|
|
|
|
$0.24
|
|
|
|
$2.10
|
|
|
|
$1.10
|
|
Fourth
|
|
|
$0.29
|
|
|
|
$0.15
|
|
|
|
$4.50
|
|
|
|
$1.30
|
|
The
closing price of the common stock on December 31, 2007 was $0.25 per share, and
as of March 11, 2008, the closing price of the common stock was $0.15 per
share.
Dividends
and Record Stockholders
We have
never declared or paid any cash dividends on our common stock. We anticipate
that all of our earnings will be retained for the operation and expansion of our
business and do not anticipate paying any cash dividends on our common stock in
the foreseeable future As of March 11, 2008 we had 224
registered stockholders of record.
Recent
Sales of Unregistered Securities
In
October 2007, the Company agreed to restructure the Note payable to Bank
Hapoalim and guaranty by BluePhoenix Solutions. Under a new agreement with
BluePhoenix, the Company made a principal reduction payment to Bank Hapoalim in
the amount of $300,000. Simultaneously, BluePhoenix paid $1,671,000 to Bank
Hapoalim, thereby discharging that indebtedness. The Company and BluePhoenix
entered into a new Note in the amount of $1,021,000, bearing interest at LIBOR
plus 1.0% and maturing on December 31, 2011. In addition, BluePhoenix acquired
2,546,149 shares of the Company’s common stock in exchange for $650,000 paid to
Bank Hapoalim to retire that indebtedness.
In August
2007, the Company issued 2,756,173 options of which 977,449 were vested
immediately. The Company recognized $650,000 in stock-based
compensation expense in fiscal 2007. The Company also recognized
$36,000 in stock-based compensation expense for the 549,360 restricted shares of
stock reserved for Mr. John Broderick, the Company’s CEO, in accordance with his
2007 employment agreement.
These
securities were issued pursuant to an exemption from registration under Rule 506
of Regulation D promulgated under Section UW of the Securities Act of 1933 as
amended.
The
Company has not repurchased any shares of its stock.
Equity
Compensation Plan Information
The
following table sets forth certain information as of December 31, 2007, about
shares of Common Stock outstanding and available for issuance under the
Company’s existing equity compensation plans: the 2007 Cicero Stock Option Plan,
the Level 8 Systems, Inc. 1997 Stock Option Incentive Plan, the 1995
Non-Qualified Option Plan and the Outside Director Stock Option
Plan.
Plan
Category
|
|
Number
of Securities to
be
issued upon exercise of
outstanding options
|
|
|
Weighted-average
exercise
price of
outstanding options
|
|
|
Number
of securities
remaining
available under
equity
compensation plans
(excluding
securities reflected
in the first column)
|
|
Equity
compensation plans approved by stockholders
|
|
|
28,265
|
|
|
$
|
76.09
|
|
|
|
1,200
|
|
Equity
compensation plans not approved by stockholders
|
|
|
2,500,760
|
|
|
$
|
0.51
|
|
|
|
1,999,240
|
|
Total
|
|
|
2,529,025
|
|
|
$
|
1.35
|
|
|
|
2,000,440
|
|
Item
6. Selected Fina
n
cial
Data.
The
following selected financial data is derived from the consolidated financial
statements of the Company. The data should be read in conjunction with the
consolidated financial statements, related notes, and other financial
information included herein.
See Item
7 for a discussion of the entities included in operations (in thousands).
Weighted average shares outstanding have been restated retroactively to reflect
the 100:1 reverse stock split.
|
|
Year Ended December 31,
(in thousands, except per share
data)
|
|
|
|
2003
|
|
|
2004
|
|
|
2005
|
|
|
2006
|
|
|
2007
|
|
SELECTED
STATEMENT OF OPERATIONS DATA
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenue
|
|
$
|
530
|
|
|
$
|
775
|
|
|
$
|
785
|
|
|
$
|
972
|
|
|
$
|
1,808
|
|
Loss
from continuing operations
|
|
$
|
(9,874
|
)
|
|
$
|
(9,731
|
)
|
|
$
|
(3,681
|
)
|
|
$
|
(2,997
|
)
|
|
$
|
(1,975
|
)
|
Loss
from continuing operations per common share – basic and
diluted
|
|
$
|
(54.00
|
)
|
|
$
|
(27.05
|
)
|
|
$
|
(8.27
|
)
|
|
$
|
(0.25
|
)
|
|
$
|
(0.05
|
)
|
Weighted
average common and common equivalent shares outstanding– basic and
diluted
|
|
|
215
|
|
|
|
360
|
|
|
|
445
|
|
|
|
35,182
|
|
|
|
36,771
|
|
|
|
December 31,
|
|
|
|
2003
|
|
|
2004
|
|
|
2005
|
|
|
2006
|
|
|
2007
|
|
SELECTED
BALANCE SHEET DATA
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Working capital
(deficiency)
|
|
$
|
(6,555
|
)
|
|
$
|
(10,255
|
)
|
|
$
|
(13,894
|
)
|
|
$
|
(7,894
|
)
|
|
$
|
(6,132
|
)
|
Total assets
|
|
|
5,362
|
|
|
|
530
|
|
|
|
241
|
|
|
|
597
|
|
|
|
1,251
|
|
Long-term debt, including current
maturities
|
|
|
2,756
|
|
|
|
5,444
|
|
|
|
7,931
|
|
|
|
2,932
|
|
|
|
2,558
|
|
Senior convertible redeemable
preferred stock
|
|
|
3,355
|
|
|
|
1,367
|
|
|
|
1,061
|
|
|
|
--
|
|
|
|
--
|
|
Stockholders'
deficiency
|
|
|
(6,103
|
)
|
|
|
(11,857
|
)
|
|
|
(15,076
|
)
|
|
|
(7,912
|
)
|
|
|
(7,433
|
)
|
Item
7.
Management's Di
scu
ssion and Analysis of Financial Condition and Results of
Operations
General
Information
Cicero
Inc. is a global provider of business integration software that enables
organizations to integrate new and existing information and processes at the
desktop with our Cicero® software product. Business integration
software addresses the emerging need for a company's information systems to
deliver enterprise-wide views of the company's
business
information processes. The Company also provides email encryption products that
address information and security compliance from the individual to the
enterprise.
In addition to software products, the Company also provides technical support,
training and consulting services as part of its commitment to providing its
customers industry-leading integration solutions. The Company’s
consulting team has in-depth experience in developing successful
enterprise-class solutions as well as valuable insight into the business
information needs of customers in the Global 5000. Cicero offers
services around our integration and encryption software
products.
This
discussion contains forward-looking statements relating to such matters as
anticipated financial performance, business prospects, technological
developments, new products, research and development activities, liquidity and
capital resources and similar matters. The Private Securities Litigation Reform
Act of 1995 provides a safe harbor for forward-looking statements. In order to
comply with the terms of the safe harbor, the Company notes that a variety of
factors could cause its actual results to differ materially from the anticipated
results or other expectations expressed in the Company's forward-looking
statements. See ''Item 1. Business—Forward Looking and Cautionary
Statements.''
Business
Strategy
Based upon the current business environment in which the Company operates, the
economic characteristics of its operating segment and managements view of the
business, a revision in terms of aggregation of its segments was appropriate.
Therefore the segment discussion outlined below clarifies the adjusted segment
structure as determined by management under SFAS No. 131. All prior year amounts
have been restated to conform to the new reporting segment
structure.
Management
makes operating decisions and assesses performance of the Company’s operations
based on one reportable segment, the Software product segment. Prior
to this change the Company had two separate segments: Desktop Integration and
Messaging. The Messaging business has always been an immaterial part of the
Company’s overall business and generally all its sales efforts are focused on
the Cicero product. As such, the Company has elected to combine the two products
into one reportable segment.
The Software product segment is comprised of the Cicero® product and the
Ensuredmail product. Cicero® is a business integration software
product that maximizes end-user productivity, streamlines business operations
and integrates disparate systems and applications, while renovating or
rejuvenating older legacy systems by making them usable in the business
processes. Ensuredmail is an encrypted email technology that can reside on
either the server or the desktop.
Results
of Operations
The
following table sets forth, for the years indicated, the Company's results of
continuing operations expressed as a percentage of revenue and presents
information for the three categories of revenue.
|
|
Year
Ended December 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
Revenue:
|
|
|
|
|
|
|
|
|
|
Software
|
|
|
27.7
|
%
|
|
|
21.4
|
%
|
|
|
51.9
|
%
|
Maintenance
|
|
|
16.6
|
%
|
|
|
12.3
|
%
|
|
|
18.7
|
%
|
Services
|
|
|
55.7
|
%
|
|
|
66.3
|
%
|
|
|
29.4
|
%
|
Total
|
|
|
100.0
|
%
|
|
|
100.0
|
%
|
|
|
100.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost
of revenue:
|
|
|
|
|
|
|
|
|
|
|
|
|
Software
|
|
|
1.0
|
%
|
|
|
0.9
|
%
|
|
|
2.0
|
%
|
Maintenance
|
|
|
14.6
|
%
|
|
|
21.8
|
%
|
|
|
44.6
|
%
|
Services
|
|
|
36.2
|
%
|
|
|
56.2
|
%
|
|
|
104.7
|
%
|
Total
|
|
|
51.8
|
%
|
|
|
78.9
|
%
|
|
|
151.3
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross
margin (loss)
|
|
|
48.2
|
%
|
|
|
21.1
|
%
|
|
|
(51.3
|
)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating
expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales
and marketing
|
|
|
43.5
|
%
|
|
|
35.6
|
%
|
|
|
79.9
|
%
|
Research
and product development
|
|
|
31.5
|
%
|
|
|
54.8
|
%
|
|
|
113.5
|
%
|
General
and administrative
|
|
|
75.0
|
%
|
|
|
124.1
|
%
|
|
|
144.8
|
%
|
(Gain)
on disposal of assets
|
|
|
0.0
|
%
|
|
|
(2.5
|
)%
|
|
|
0.0
|
%
|
Total
|
|
|
150.0
|
%
|
|
|
212.0
|
%
|
|
|
338.2
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss
from operations
|
|
|
(101.8
|
)%
|
|
|
(190.9
|
)%
|
|
|
(389.5
|
)%
|
Other (expense),
net
|
|
|
(7.5
|
)%
|
|
|
(117.5
|
)%
|
|
|
(79.4
|
)%
|
Loss
before taxes
|
|
|
(109.3
|
)%
|
|
|
(308.4
|
)%
|
|
|
(468.9
|
)%
|
Income
tax provision (benefit)
|
|
|
0.0
|
%
|
|
|
0.0
|
%
|
|
|
0.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net
loss
|
|
|
(109.3
|
)%
|
|
|
(308.4
|
)%
|
|
|
(468.9
|
)%
|
The
following table sets forth data for total revenue for continuing operations by
geographic origin as a percentage of total revenue for the periods
indicated:
|
2007
|
|
2006
|
|
2005
|
United
States
|
100%
|
|
100
%
|
|
100
%
|
The
table below presents information about reported segments for the years ended
December 31, 2007, 2006, and 2005 (in thousands):
|
|
For
the year ended December 31,
|
|
|
2007
|
|
|
2006
|
|
2005
|
|
Total
revenue
|
|
$
|
1,808
|
|
|
$
|
972
|
|
|
$
|
785
|
|
Total
cost of revenue
|
|
|
937
|
|
|
|
767
|
|
|
|
1,188
|
|
Gross
margin (loss)
|
|
|
871
|
|
|
|
205
|
|
|
|
(403
|
)
|
Total
operating expenses
|
|
|
2,711
|
|
|
|
2,085
|
|
|
|
2,655
|
|
Segment
loss
|
|
$
|
(1,840
|
)
|
|
$
|
(1,880
|
)
|
|
$
|
(3,058
|
)
|
A
reconciliation of segment operating expenses to total operating expense follows
(in thousands):
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
Segment
operating expenses
|
|
$
|
2,711
|
|
|
$
|
2,085
|
|
|
$
|
2,655
|
|
(Gain)
on disposal of assets
|
|
|
--
|
|
|
|
(24
|
)
|
|
|
--
|
|
Total
operating expenses
|
|
$
|
2,711
|
|
|
$
|
2,061
|
|
|
$
|
2,655
|
|
A
reconciliation of total segment profitability to net loss follows for the fiscal
years ended December 31 (in thousands):
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
Total
segment profitability (loss)
|
|
$
|
(1,840
|
)
|
|
$
|
(1,880
|
)
|
|
$
|
(3,058
|
)
|
Gain
on disposal of assets
|
|
|
--
|
|
|
|
24
|
|
|
|
--
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest
and other income/(expense), net
|
|
|
(135
|
)
|
|
|
(1,141
|
)
|
|
|
(623
|
)
|
Net
loss
|
|
$
|
(1,975
|
)
|
|
$
|
(2,997
|
)
|
|
$
|
(3,681
|
)
|
Years
Ended December 31, 2007, 2006, and 2005
Revenue and Gross
Margin.
The Company has three categories of revenue:
software products, maintenance, and services. Software products revenue is
comprised primarily of fees from licensing the Company's proprietary software
products. Maintenance revenue is comprised of fees for maintaining, supporting,
and providing periodic upgrades to the Company's software products. Services
revenue is comprised of fees for consulting and training services related to the
Company's software products.
The
Company's revenues vary from quarter to quarter, due to market conditions, the
budgeting and purchasing cycles of customers and the effectiveness of the
Company’s sales force. The Company does not have any material backlog
of unfilled software orders and product revenue in any period is substantially
dependent upon orders received in that quarter. Because the Company's operating
expenses are based on anticipated revenue levels and are relatively fixed over
the short term, variations in the timing of the recognition of revenue can cause
significant variations in operating results from period to period. Fluctuations
in operating results may result in volatility of the price of the Company's
common stock.
Total
revenues increased 86% from $972,000 in 2006 to $1,808,000 in 2007. Revenues
increased 24% from $785,000 in 2005 to $972,000 in
2006. The increase in revenues in 2007 is primarily due to
increased labor billings from integration contracts with the Company’s
professional services staff (approximately $366,000) and software license
revenue generated under an OEM contract with Merrill Lynch in December 2007
($500,000). The increase in revenues in 2006 over 2005 reflects a change in the
mix of revenues, wherein license revenues decreased and professional service
revenues from consulting contracts increased. Gross profit margin (loss) was
48%, 21% and (51%) for 2007, 2006, and 2005,
respectively. Under the terms of the OEM agreement with Merrill
Lynch, the Company will recognize two components of software revenue. The first
component will be runtime licenses, and once those licenses are deployed by
Merrill Lynch; the second component will be a monthly subscription fee for each
license deployed. The Company may or may not incur additional license revenues
under this OEM agreement.
Software Products
.
Software product revenue
increased from $208,000 in 2006 to $501,000 in 2007 or approximately 141%.
Software product revenue decreased approximately 49% in 2006 from those results
achieved in 2005. The increase in software revenues in 2007 is attributed the
Company entering into an OEM agreement with Merrill Lynch in December
2007. In 2005, the Company was able to successfully deploy its
software to several smaller integration engagements.
The gross
margin (loss) on software products was 96% for each of the years ended December
31, 2007, 2006 and 2005. Cost of software is composed primarily of
royalties to third parties, and to a lesser extent, production and distribution
costs. The Cicero® software technology and related patents was licensed by the
Company on a worldwide basis from Merrill Lynch in August of 2000 under a
license agreement containing standard provisions and a two-year exclusivity
period. On January 3, 2002, the license agreement was amended to extend the
Company’s exclusive worldwide marketing, sales and development rights to Cicero®
in perpetuity (subject to Merrill Lynch’s rights to terminate in the event of
bankruptcy or a change in control of the Company) and to grant ownership rights
in the Cicero® trademark. The Company is indemnified by Merrill Lynch with
regard to the rights granted to Cicero® by them. In consideration for the
original Cicero® license we issued to Merrill Lynch 10,000 shares of the
Company’s common stock. In consideration for the amendment, the Company issued
an additional 250,000 shares of common stock to MLBC, Inc., a Merrill Lynch
affiliate and entered into a royalty sharing agreement pursuant to which, the
Company pays a royalty of 3% of the sales price for each sale of Cicero®
software or related maintenance services. The royalties over the life of the
agreement are not payable in excess of $20,000,000.
The
Company expects to see significant increases in software sales coupled with
improving margins on software products as Cicero® gains acceptance in the
marketplace. The Company’s expectations are based on its review of the sales
cycle that has developed around the Cicero® product since being released by the
Company, its review of the pipeline of prospective customers and their
anticipated capital expenditure commitments and budgeting cycles, as well as the
status of in-process proof of concepts or beta sites with select
corporations.
Maintenance.
Maintenance
revenues for the year ended December 31, 2007 increased by approximately 150% or
$180,000 from 2006. Maintenance revenues for the year ended December 31,
2006
decreased by
approximately 18% or $27,000 from 2005. The increase in maintenance revenues for
2007 is primarily attributed to one significant new maintenance customer during
the year. The decline in maintenance revenues in 2006 reflects the non-renewal
of one maintenance contract for the Cicero® product.
Cost of
maintenance is comprised of personnel costs and related overhead and the cost of
third-party contracts for the maintenance and support of the Company’s software
products. The Company experienced a gross margin on maintenance products of 12%
for 2007. Gross margin (loss) on maintenance products for 2006 and 2005 were
(76%) and (138%), respectively.
Maintenance
revenues are expected to increase as a result of our expected increase in sales
of the Cicero® product. The cost of maintenance should increase
slightly.
Services.
Services
revenue for the year ended December 31, 2007 increased by approximately 56% or
$363,000 over the same period in 2006. Services revenue for the year ended
December 31, 2006 increased by approximately 178% or $413,000 over the same
period in 2005. The increase in service revenues in each of the past
two years are attributable to consulting engagements that were earned during the
past two years.
Cost of
services primarily includes personnel and travel costs related to the delivery
of services. Services gross margin (loss) was 35%, 15%, and (256%)
for the years ended 2007, 2006, and 2005 respectively.
Services
revenues are expected to increase as the Cicero® product gains
acceptance.
Sales and
Marketing.
Sales and marketing expenses primarily include
personnel costs for salespeople, marketing personnel, travel and related
overhead, as well as trade show participation and promotional expenses. Sales
and marketing expenses increased 127% or approximately $440,000 in 2007 and
decreased by 45% or approximately $281,000 in 2006. The increase in sales and
marketing expenses in 2007 is attributable to the establishment of a sales team
and several marketing campaigns as well as a charge for stock compensation
expense of approximately $97,000. In 2006, the Company had reduced its sales and
marketing workforce, decreased promotional activities
and changed the sales compensation structure.
Specifically, the Company changed the compensation structure to lower fixed
costs and increase variable success-based costs.
Sales and
marketing expenses are expected to increase as the Company adds additional
direct sales personnel and supports the sales function with collateral marketing
materials and marketing events.
Research and
Development.
Research and development expenses primarily
include personnel costs for product authors, product developers and product
documentation and related overhead. Research and development expense
increased by 7% or $36,000 in 2007 as compared to 2006 and decreased by 40% or
$358,000 in 2006 as compared to 2005. The increase in costs in 2007 as compared
to 2006 reflects a charge for stock compensation expense of approximately
$103,000 offset by general decreases in overhead costs and employee benefits.
The decrease in costs in 2006 as compared to 2005 reflects the reduction in the
number of employees by two plus associated overheads in 2006.
The
Company intends to continue to make a significant investment in research and
development while enhancing efficiencies in this area.
General and Administrative.
General and administrative expenses consist of personnel costs for the
executive, legal, financial, human resources, investor relations and
administrative staff, related overhead, and all non-allocable corporate costs of
operating the Company. General and administrative expenses for the year ended
December 31, 2007 increased by 12% or $150,000 over the prior year. The increase
in general administrative costs reflects a charge for stock based compensation
of approximately $363,000, net of reductions in general overheads and salary
from its former Chief Information Officer who left the company in July 2007. In
fiscal 2006, general and administrative expenses increased by 6% or $69,000 as
compared to 2005. The increase in general administrative costs is primarily due
to costs associated with the Company’s recapitalization plan in
2006.
General
and administrative expenses are expected to slightly increase going forward as
the Company’s revenues increase.
Provision for Taxes.
The
Company’s effective income tax rate for continuing operations differs from the
statutory rate primarily because an income tax benefit was not recorded for the
net loss incurred in 2007, 2006, or 2005. Because of the Company’s inconsistent
earnings history, the deferred tax assets have been fully offset by a valuation
allowance.
Impact of
Inflation.
Inflation has not had a significant effect on the
Company’s operating results during the periods presented.
Liquidity and Capital
Resources
Operating
and Investing Activities
The
Company utilized $60,000 of cash for the year ended December 31,
2007
Operating
activities utilized approximately $1,384,000 in cash, which was primarily
comprised of the loss from operations of $1,975,000, offset by non-cash charges
for depreciation and amortization of approximately $10,000, and stock
compensation expense of $720,000 and a provision for doubtful accounts of
$50,000. In addition, the Company had an increase in accounts receivable of
$622,000, and prepaid expenses and other assets of $136,000. The Company
generated approximately $478,000 in cash through an increase in the amount owing
its creditors.
The
Company utilized approximately $17,000 in cash in the purchase of updating the
Company’s network equipment.
The
Company generated approximately $1,347,000 of cash during the year from
financing activities from increases in issuance of common stock in private
placement of $1,040,000 and from approximately $307,000 resulting from net
borrowings of notes payable.
The
Company generated $281,000 of cash for the year ended December 31,
2006
Operating
activities utilized approximately $2,224,000 in cash, which was primarily
comprised of the loss from operations of $2,997,000, offset by non-cash charges
for depreciation and amortization of approximately $12,000, and stock
compensation expense of $614,000 and a provision for doubtful accounts of
$60,000. In addition, the Company had an increase in accounts receivable of
$212,000, offset by a reduction of prepaid expenses and other assets of $31,000.
The Company generated approximately $311,000 in cash through an increase in the
amount owing its creditors.
The
Company utilized approximately $17,000 in cash in the purchase of updating the
Company’s network equipment.
The
Company generated approximately $2,528,000 of cash during the year from
financing activities from increases in Convertible Bridge notes of $2,148,000
and from approximately $380,000 resulting from the issuance of common
stock.
Financing
Activities
The
Company funded its cash needs during the year ended December 31, 2007 with cash
on hand from December 31, 2006, as well as through the use of proceeds from the
private sale of its common stock and from short term borrowings.
The
Company had a term loan in the principal amount of $1,971,000 from Bank Hapoalim
bearing interest at LIBOR plus 1.5%). In October 2007, the Company agreed to
restructure the Note payable to Bank Hapoalim and guaranty by BluePhoenix
Solutions (formerly Liraz Systems Ltd.). Under a new agreement with BluePhoenix,
the Company made a principal reduction payment to Bank Hapoalim in the amount of
$300,000. Simultaneously, BluePhoenix paid $1,671,000 to Bank Hapoalim, thereby
discharging that indebtedness. The Company and BluePhoenix entered into a new
Note in the amount of $1,021,000, bearing interest at LIBOR plus 1.0% and
maturing on December 31, 2011. In addition, BluePhoenix acquired 2,546,149
shares of the Company’s common stock in exchange for $650,000 paid to Bank
Hapoalim to retire that indebtedness. Of the new note payable to
BluePhoenix, approximately $350,000 is due on January 31, 2009 and the balance
is due on December 31, 2011. In November 2006, The Company and Liraz
Systems Ltd. agreed to extend its guaranty on the term loan with Bank Hapoalim,
and to extend the maturity date on the loan to October 31, 2007. Under the terms
of the agreement with Liraz, the Company agreed to issue 60,000 shares of its
common stock. Based upon fair market value at the time of issuance, the Company
recognized $240,000 as loan amortization costs in the Statement of Operations
for the year ended December 31, 2006. In addition, since the contingency
surrounding the warrants granted in the prior years’ debt extension was removed,
the Company also recognized $72,000 as the value of these warrants and as loan
amortization costs in the Statement of Operations for the year ended December
31, 2006. In November 2005, The Company and Liraz Systems Ltd. agreed to extend
its guaranty on the term loan with Bank Hapoalim, and to extend the maturity
date on the loan to November 15, 2006. Under the terms of the agreement with
Liraz, the Company agreed to issue 24,000 shares of its common stock and granted
a warrant to purchase an additional 36,000 shares of our common stock at an
exercise price of $0.20 per share. Based upon fair market value at the time of
issuance, the Company recognized $48,000 as loan amortization costs in the
Statement of Operations for the year ended December 31, 2005. Because the
warrants are contingently issuable upon an event outside the control of the
Company (the proposed Plan of Recapitalization), the Company did not recognize
any value to these warrants until the contingency is removed.
In
October 2007, the Company completed a private sale of shares of its common stock
to a group of investors, four of which are members of our Board of Directors.
Under the terms of that agreement, the Company sold 2,169,311 shares of its
common stock for $0.2457 per share for a total of $533,000. Participating in
this consortium were Mr. John L. (Launny) Steffens, the Company’s Chairman, and
Messrs. Bruce Miller, Don Peppers, and Bruce Percelay, members of the
Board. Mr. Steffens converted the principal amount of his short term
notes with the Company of $250,000 for 1,017,501 shares of common
stock. Mr. Miller invested $20,000 for 81,400 shares of common stock,
Mr. Peppers acquired 101,750 shares for a $25,000 investment and Mr. Bruce
Percelay acquired 40,700 shares for a $10,000 investment.
In
February 2007, the
Company completed a private sale of shares of its common stock to a group of
investors, three of which are members of our Board of Directors. Under the terms
of that agreement, the Company sold 3,723,007 shares of its common stock for
$0.1343 per share for a total of $500,000. Participating in this offering were
Mr. Mark Landis, who was the Company’s Chairman at that time and Mr. Bruce
Miller, who is a Board member. Mr. Landis acquired 74,460 shares for a $10,000
investment and Mr. Miller acquired 148,920 shares for a $20,000 investment. In
May 2007, Mr. John L. (Launny) Steffens was elected Chairman of the Board of
Directors. Prior to his election, Mr. Steffens had participated in
the private purchase of shares acquiring 1,006,379 shares for an investment of
$135,157.
In
October 2007, the Company entered into a Long Term Promissory Note in the amount
of $300,000 with Mr. John L Steffens, our chairman. The Note bears interest at
3% per annum and matures on October 30, 2009. In order to bring the interest
rate on the Note in compliance with arm’s length regulations, the Company also
issued 188,285 warrants to purchase the Company’s common stock at $0.18 each.
The warrants were valued using the Black Scholes method and a fair value of
$34,230 was charged to stock compensation expense in the fourth quarter of 2007.
The warrants expire in 10 years. The Company used the proceeds from that loan to
pay down the debt to Bank Hapoalim as noted above.
In 2004,
the Company announced a Note and Warrant Offering in which warrant holders of
the Company’s common stock were offered a one-time conversion of their existing
warrants at a conversion price of $0.10 per share as part of a recapitalization
plan. Under the terms of the Offer, which expired on December 31, 2004, warrant
holders who elected to convert, would tender their conversion price in cash and
receive a Note Payable in exchange. As of December 31, 2004 the
Company had raised $1,615,000. Upon approval of the plan of
recapitalization at a Shareholders meeting, these Notes would convert into
common shares of Cicero Inc. In addition, those warrant holders who elected to
convert the first $1 million of warrants would receive additional replacement
warrants at a ratio of 2:1 for each warrant converted, with a strike price of
$10.00 per share. In addition, upon approval of the plan of recapitalization,
each warrant holder would be entitled to additional warrants to purchase common
stock in Cicero Inc. In early 2005, the Company announced an extension to the
Note and Warrant offering and as of December 31, 2005, the Company has raised an
additional $944,000 for a total of approximately $2,559,000. Upon effectiveness
of the plan of recapitalization, $2,309,000 of the Note and Warrant holders
agreed to convert their notes into 3,438,473 shares of the Company’s common
stock.
From July
through December 2006, the Company issued several Convertible Bridge Notes with
a consortium of investors. The Company had raised a total of $3,915,000 of
Convertible Bridge Notes of which $746,000 was from various members of the
Company’s Board of Directors. Under the terms of these Notes, holders have
converted their Notes into 30,508,448 shares of Cicero Inc. common stock upon
effectiveness of the plan of recapitalization approved by stockholders on
November 16, 2006.
The
Company believes that the plan of recapitalization will have a positive impact
on the future operations of the Company and its ability to raise additional
capital that it will need to continue operations, however, there can be no
assurance that management will be successful in executing as anticipated or in a
timely enough manner. If these strategies are unsuccessful, the
Company may have to pursue other means of financing that may not be on terms
favorable to the Company or its stockholders. If the Company is
unable to increase cash flow or obtain financing, it may not be able to generate
enough capital to fund operations for the next twelve months. We do
not believe that we currently have sufficient cash on hand to finance operations
for the next twelve months. At our current rates of expense and assuming
revenues for the next twelve months at the annualized rate of revenue for the
year ended 2007, we will be able to fund planned operations with existing
capital resources for a minimum of seven months and experience negative cash
flow of approximately $1.25 million during the next twelve months to maintain
planned operations. The accompanying financial statements have been prepared on
a going concern basis, which contemplates the realization of assets and the
satisfaction of liabilities in the normal course of business. The financial
statements presented herein do not include any adjustments relating to the
recoverability of assets and classification of liabilities that might be
necessary should the Company be unable to continue as a going
concern.
In April
2005, the Company borrowed $30,000 from a director of the Company pursuant to a
convertible loan agreement. Under the term of this agreement, the loan bears
interest at 1% per month and is convertible upon the option of the director into
4,285 shares of our common stock at a conversion price of $7.00 per share which
was the fair market value of the Company’s stock at the time the loan was made.
As part of the Plan of Recapitalization, this debt together with all other
convertible promissory notes totaling $992,000 was converted into 1,591 shares
of preferred stock designated Series A-1.
The
Company incurred a net loss of approximately $1,975,000 for the year ended
December 31, 2007 in addition to net losses of approximately $6,678,000 for the
previous two fiscal years. The Company has experienced negative cash flows from
operations for the past three years. At December 31, 2007, the Company had a
working capital deficiency of approximately $6,132,000. The Company’s
future revenues are entirely dependent on acceptance of Cicero®, which has had
limited success in commercial markets to date. Accordingly, there is substantial
doubt that the Company can continue as a going concern and the independent
auditor’s report accompanying our financial statements raises doubts about our
ability to continue as a going concern. In order to address these issues and to
obtain adequate financing for the Company’s operations for the next twelve
months, the Company is actively promoting and expanding its product line and
continues to negotiate with significant customers that have expressed interest
in the Cicero® technology. The Company is experiencing difficulty increasing
sales revenue largely because of the inimitable nature of the product as well as
customer concerns about the financial viability of the Company. Cicero® software
is a new “category defining” product in that most Enterprise Application
Integration (EAI) projects are performed at the server level and Cicero®’s
integration occurs at the desktop level without the need to open and modify the
underlying code for those applications being integrated. Many companies are not
aware of this new technology or tend to look toward more traditional and
accepted approaches. The Company is attempting to solve the former problem by
improving the market’s knowledge and understanding of Cicero® software through
increased marketing and leveraging our limited number of reference accounts,
while enhancing our list of resellers and systems integrators to assist in the
sales and marketing process.
The
emergence of competing technologies has also increased the awareness of this new
technology. Additionally, we must seek additional equity capital or other
strategic transactions in the near term to provide additional
liquidity.
Contractual
Obligations
Future
minimum payments for all contractual obligations for years subsequent to
December 31, 2007 are as follows (in thousands):
|
|
2008
|
|
|
2009
|
|
|
2010
|
|
|
2011
|
|
|
Total
|
|
Short
and long-term debt, including interest payments
|
|
$
|
1,647
|
|
|
$
|
699
|
|
|
$
|
40
|
|
|
$
|
711
|
|
|
$
|
3,097
|
|
Service
purchase commitments
|
|
|
175
|
|
|
|
--
|
|
|
|
--
|
|
|
|
--
|
|
|
|
175
|
|
Operating
leases
|
|
|
103
|
|
|
|
97
|
|
|
|
101
|
|
|
|
--
|
|
|
|
301
|
|
Capital
leases
|
|
|
2
|
|
|
|
--
|
|
|
|
--
|
|
|
|
--
|
|
|
|
2
|
|
Total
|
|
$
|
1,927
|
|
|
$
|
796
|
|
|
$
|
141
|
|
|
$
|
711
|
|
|
$
|
3,575
|
|
Short and
long-term debt, including interest payments, includes an outstanding
indebtedness of approximately $1,021,000 term loan with BluePhoenix Solutions, a
long term promissory note of $300,000 with the Company’s Chairman, Mr. John L.
Steffens, and a $250,000 short-term note with SDS Merchant Fund.
Under the
employment agreement between the Company and Mr. Broderick effective January 1,
2008, the Company will pay Mr. Broderick a base salary of $175,000 and
performance bonuses in cash of up to $100,000 per annum based upon certain
revenue goals and operating metrics as determined by the Compensation Committee
of the Board of Directors of the Company. In addition, Mr. Broderick is eligible
for additional bonuses should the targeted pre tax income be exceeded by 150%.
Upon termination of Mr. Broderick's employment by the Company without cause, the
Company has agreed to provide Mr. Broderick with a lump sum payment of one year
of Mr. Broderick’s then current base salary and payment of all deferred salaries
and bonuses within thirty (30) days of termination. In addition, all then
outstanding but unvested stock options shall vest one hundred percent
(100%).
Off Balance Sheet
Arrangements
The
Company does not have any off balance sheet arrangements. We have no
subsidiaries or other unconsolidated limited purpose entities, and we have not
guaranteed or otherwise supported the obligations of any other
entity.
Significant Accounting
Policies and Estimates
The
policies discussed below are considered by us to be critical to an understanding
of our financial statements because they require us to apply the most judgment
and make estimates regarding matters that are inherently
uncertain. Specific risks for these critical accounting policies are
described in the following paragraphs. With respect to the policies
discussed below, we note that because of the uncertainties inherent in
forecasting, the estimates frequently require adjustment.
Our
financial statements and related disclosures, which are prepared to conform to
accounting principles generally accepted in the United States of America,
require us to make estimates and assumptions that affect the reported amounts of
assets, liabilities, revenues and accounts receivable and expenses during the
period reported. We are also required to disclose amounts of
contingent assets and liabilities at the date of the financial
statements. Our actual results in future periods could differ from
those estimates. Estimates and assumptions are reviewed periodically,
and the effects of revisions are reflected in the Consolidated Financial
Statements in the period they are determined to be necessary.
We
consider the most significant accounting policies and estimates in our financial
statements to be those surrounding: (1) revenue recognition; (2) allowance for
doubtful trade accounts receivable; and (3) valuation of deferred tax
assets. These accounting policies, the basis for any estimates and
potential impact to our Consolidated Financial Statements, should any of the
estimates change, are further described as follows:
Revenue
Recognition.
Our revenues are derived principally from three
sources: (i) license fees for the use of our software products; (ii)
fees for consulting services and training; and (iii) fees for maintenance and
technical support. We generally recognize revenue from software
license fees when a license agreement has been signed by both parties, the fee
is fixed or determinable, collection of the fee is probable, delivery of our
products has occurred
and no other significant obligations
remain. For multiple-element arrangements, we apply the “residual
method”. According to the residual method, revenue allocated to the
undelivered elements is allocated based on vendor specific objective evidence
(“VSOE”) of fair value of those elements. VSOE is determined by
reference to the price the customer would be required to pay when the element is
sold separately. Revenue applicable to the delivered elements is
deemed equal to the remainder of the contract price. The revenue
recognition rules pertaining to software arrangements are complicated and
certain assumptions are made in determining whether the fee is fixed and
determinable and whether collectability is probable. For instance, in
our license arrangements with resellers, estimates are made regarding the
reseller’s ability and intent to pay the license fee. Our estimates
may prove incorrect if, for instance, subsequent sales by the reseller do not
materialize. Should our actual experience with respect to collections
differ from our initial assessment, there could be adjustments to future
results.
Revenues
from services include fees for consulting services and
training. Revenues from services are recognized on either a time and
materials or percentage of completion basis as the services are performed and
amounts due from customers are deemed collectible and
non-refundable. Revenues from fixed price service agreements are
recognized on a percentage of completion basis in direct proportion to the
services provided. To the extent the actual time to complete such
services varies from the estimates made at any reporting date, our revenue and
the related gross margins may be impacted in the following period.
Allowance for Doubtful Trade Accounts
Receivable
. In addition to assessing the probability of
collection in conjunction with revenue arrangements, we continually assess the
collectability of outstanding invoices. Assumptions are made
regarding the customer’s ability and intent to pay and are based on historical
trends, general economic conditions, and current customer
data. Should our actual experience with respect to collections differ
from our initial assessment, there could be adjustments to bad debt
expense.
Capitalization and Valuation of
Software Product Technology.
Our policy on capitalized
software costs determines the timing of our recognition of certain development
costs. In addition, this policy determines whether the cost is
classified as development expense or cost of software
revenue. Management is required to use professional judgment in
determining whether development costs meet the criteria for immediate expense or
capitalization. Additionally, we review software product technology
assets for net realizable value at each balance sheet date. Should we
experience reductions in revenues because our business or market conditions vary
from our current expectations, we may not be able to realize the carrying value
of these assets and will record a write down at that time. As of December 31,
2007 and 2006 the Company had $0 in capitalized software product
technology.
Valuation of Deferred Tax
Assets.
Income taxes are accounted for under the asset and
liability method. Deferred tax assets and liabilities are recognized
for the future tax consequences attributable to differences between the
financial statement carrying amounts of existing assets and liabilities and
their respective tax bases and operating loss and tax credit carry
forwards. Deferred income tax assets and liabilities are measured
using enacted tax rates expected to apply to taxable income in the years in
which those temporary differences are expected to be recovered or
settled. The effect on deferred income tax assets and liabilities of
a change in tax rates is recognized in income in the period that includes the
enactment date. A valuation allowance is established to the extent
that it is more likely than not, that we will be unable to utilize deferred
income tax assets in the future. At December 31, 2007, we had a
valuation allowance of $98,053,000 against $98,053,000 of gross deferred tax
assets. We considered all of the available evidence to arrive at our
position on the net deferred tax asset; however, should circumstances change and
alter our judgment in this regard, it may have an impact on future operating
results.
At
December 31, 2007, the Company has net operating loss carryforwards of
approximately $230,847,000, which may be applied against future taxable income.
These carryforwards will expire at various times between 2008 and 2027. A
substantial portion of these carryforwards is restricted to future taxable
income of certain of the Company’s subsidiaries or limited by Internal Revenue
Code Section 382. Thus, the utilization of these carryforwards cannot be
assured.
Recent
Accounting Pronouncements:
In
February 2007, the FASB issued SFAS 159, “The Fair Value Option for Financial
Assets and Financial Liabilities – an amendment of FASB Statement
115”. The statement permits entities to choose to measure many
financial instruments and certain other items at fair value. The
objective is to improve financial reporting by providing entities with the
opportunity to mitigate volatility in reported earnings caused by measuring
related assets and liabilities differently without having to apply complex hedge
provisions. Most of the provisions of this statement apply only to
entities that elect the fair value option; however, the amendment to FASB
Statement 115, “Accounting for Certain Investment in Debt and Equity Services,”
applies to all entities with available-for-sale and trading
securities. The Company does not believe adoption of this statement
will have a material impact on the Company’s financial statements.
In July
2006, the FASB issued FIN No. 48, “Accounting for Uncertainty in Income Taxes –
An Interpretation of SFAS No. 109”. FIN No. 48 clarifies the
accounting for uncertainty in income taxes recognized in an enterprise’s
financial statements in accordance with SFAS No. 109, “Accounting for Income
Taxes.” FIN No. 48 also prescribes a recognition threshold and
measurement attribute for financial statement recognition and measurement of a
tax position taken or expected to be taken in a tax return. In
addition, FIN No. 48 provides guidance on derecognition, classification,
interest and penalties, accounting in interim periods, disclosure and
transition. The provisions of FIN No. 48 are to be applied to all tax
positions upon initial adoption of this standard. Only tax positions
that meet the more-likely-than-not recognition threshold at the effective date
may be recognized or continue to be recognized as an adjustment to the opening
balance of accumulated deficit (or other appropriate components of equity) for
that fiscal year. The provisions of FIN No. 48 are effective for
fiscal years beginning after December 15, 2006. The adoption of this
new standard did not have a material impact on our financial position, results
of operations, or cash flows.
In
September 2006, the Securities and Exchange Commission (“SEC”) issued Staff
Accounting Bulleting (“SAB”) 108, to address diversity in practice in
quantifying financial statement misstatements. SAB 108 requires that
the Company quantify misstatements based on their impact on each of its
financial statements and related disclosures. SAB 108 is effective
for fiscal years ending after November 15, 2006. The Company has
adopted SAB 108 effective as of December 31, 2006. The adoption of
this bulletin did not have a material impact on our financial position, results
of operations, or cash flows.
In
September 2006, the FASB issued SFAS No. 157, “Fair Value
Measurements”. SFAS No. 157 provides guidance for using fair value to
measure assets and liabilities. It also responds to investors’
requests for expanded information about the extent to which companies measure
assets and liabilities at fair value, the information used to measure fair
value, and the effect of fair value measurements on earnings. SFAS
No. 157 applies whenever other standards require (or permit) assets or
liabilities to be measured at fair value, and does not expand the use of fair
value in any new circumstances. SFAS No. 157 is effective for
financial statements issued for fiscal years beginning after November 15, 2007
and is required to be adopted by the Company in the first quarter of
2008. The Company is currently evaluating the effect that the
adoption of SFAS No. 157 will have on our financial position, results of
operations, or cash flows.
Item
7A. Quantitative and Qu
ali
tative Disclosures about Market Risk
As the
Company has disposed of or closed most of its European offices and operations,
the majority of revenues are generated from US sources. The Company expects that
trend to continue for the next year. As such, there is minimal foreign currency
risk at present. Should the Company continue to develop a reseller
presence in Europe and Asia, that risk will be increased.
Item
8. Financial Statements and Sup
ple
mentary Data
The
information required by this item appears beginning on page F-1 of this
report.
Item
9. Changes in
and
Disagreements with Accountants on Accounting and Financial
Disclosure
During
the two most recent fiscal years there were no changes in or disagreements with
the Company’s independent public accountants.
Item
9A. Controls and Pro
ce
dures
(a)
Evaluation of Disclosure Controls
Our Chief
Executive Officer and Chief Financial Officer, evaluated the effectiveness of
our disclosure controls and procedures as of December 31, 2007. The term
“disclosure controls and procedures,” as defined in Rules 13a-15(e) and
15d-15(e) under the Securities and Exchange Act of 1934, means controls and
other procedures of a company that are designed to ensure that information
required to be disclosed by a company in the reports that it files or submits
under the Exchange Act is recorded, processed, summarized, and reported, within
the time periods specified
in the SEC’s rules and forms. Disclosure
controls and procedures include, without limitation, controls and procedures
designed to ensure that information required to be disclosed by a company in the
reports that it files and submits under the Exchange Act is accumulated and
communicated to the company’s management, including its principal executive and
principal financial officers, as appropriate to allow timely decisions regarding
required disclosure. Based on the evaluation of our disclosure controls and
procedures as of December 31, 2007, our Chief Executive Officer and Chief
Financial Officer concluded that, as of such date, our disclosure controls and
procedures were effective.
The Audit
Committee of the Board of Directors, which is composed solely of independent
directors, meets regularly with our independent registered public accounting
firm, Margolis & Company P.C., and representatives of management to review
accounting, financial reporting, internal control and audit matters, as well as
the nature and extent of the audit effort. The Audit Committee is responsible
for the engagement of the independent auditors. The independent auditors have
free access to the Audit Committee.
(b)
Management’s Responsibility for Financial Statements
Our
management is responsible for the integrity and objectivity of all information
presented in this report. The consolidated financial statements were prepared in
conformity with accounting principles generally accepted in the United States of
America and include amounts based on management’s best estimates and judgments.
Management believes the consolidated financial statements fairly reflect the
form and substance of transactions and that the financial statements fairly
represent the Company’s condensed consolidated financial position and results of
operations for the periods and as of the dates stated therein.
(c)
Management’s Assessment of Internal Control over Financial
Reporting
The
management of Cicero Inc. is responsible for establishing and maintaining
adequate internal control over financial reporting as defined by Rules 13a–15(f)
and 15(d)-15(f) under the Securities and Exchange Act of 1934. This
system is designed to provide reasonable assurance regarding the reliability of
financial reporting and the preparation of financial statements for external
purposes in accordance with accounting principals generally accepted in the
United States of America.
Our
internal control over financial reporting includes those policies and procedures
that: (1) pertain to the maintenance of records that, in reasonable detail,
accurately and fairly reflect the transactions and dispositions of the assets of
the Company; (2) provide reasonable assurance that transactions are
recorded as necessary to permit preparation of financial statements in
accordance with generally accepted accounting principles, and that receipts and
expenditures of the Company are being made only in accordance with
authorizations of management and directors of the Company; and (3) provide
reasonable assurance regarding prevention or timely detection of unauthorized
acquisition, use or disposition of the Company’s assets that could have a
material effect on the financial statements.
Because
of its inherent limitations, a system of internal control over financial
reporting can only provide reasonable assurance and may not prevent or detect
misstatements. Further, because of changes in conditions,
effectiveness of internal control over financial reporting may vary over
time.
Under the
direction of Chief Executive Officer and Chief Financial Officer, management
began an evaluation of the effectiveness of the system of internal control over
financial reporting based on the framework in
Internal Control-Integrated
Framework
, published by the Committee of Sponsoring Organizations of the
Treadway Commission (COSO). Management was not able to complete its
testing to determine that the identified controls were effective. Management is
aware that there is a lack of segregation of duties due to the small number of
employees dealing with general administrative and financial
matters. Management has discussed the controls and procedures issues
with the Audit Committee. However, at this time, with the
consideration of the Audit Committee, management has decided that
taking into account the abilities of the employees now involved, the control
procedures in place and its awareness of the issues presented, the risks
associated with such lack of segregation are low and the potential benefits of
adding employees to clearly segregate duties do not justify the substantial
expenses associated with such increases. Management will periodically
reevaluate this situation, and report to the Audit Committee and the registered
public accounting firm to the Company about this condition. Based on
our overall controls, and taking into account the reporting and interaction by
our Audit Committee and Board of Directors, management determined that the
Company’s system of internal control over financial reporting was effective as
of December 31, 2007.
(d)
Report of Independent Registered Public Accounting Firm
This
annual report does not include an attestation report of the Company’s registered
public accounting firm regarding internal control over financial reporting.
Management’s report was not subject to attestation by the Company’s registered
public accounting firm pursuant to temporary rules of the Securities and
Exchange Commission that permit the Company to provide only management’s report
in this annual report.
Item
9B. Other In
fo
rmation
None
PART
III
Item
10. Directors and E
xec
utive Officers of the
Registrant
Name
|
Age
|
Position(s)
|
John
L Steffens
|
66
|
Director
and Chairman
|
John
Broderick
|
58
|
Director
and Chief Executive Officer/Chief Financial Officer
|
Anthony
C. Pizi
|
48
|
Director
|
Mark
Landis
|
66
|
Director
|
Bruce
W. Hasenyager
|
66
|
Director
|
Jay
R. Kingley
|
46
|
Director
|
Charles
B. Porciello
|
72
|
Director
|
Bruce
D. Miller
|
57
|
Director
|
Bruce
A. Percelay
|
52
|
Director
|
John
W. Atherton
|
65
|
Director
|
Don
Peppers
|
57
|
Director
|
John
L. Steffens
Director
since May, 2007.
Mr.
Steffens was appointed to our Board of Directors on May 16, 2007 and is the
Founder and Managing Director of Spring Mountain Capital, L. P. Prior
to establishing Spring Mountain Capital, Mr. Steffens spent 38 years at Merrill
Lynch & Co., where he held numerous senior management positions, including
President of Merrill Lynch Consumer Markets, which was later named the Private
Client Group, from July 1985 until April 1997, and both Vice Chairman of Merrill
Lynch & Co., Inc. (the parent company) and Chairman of its U.S. Private
Client Group from April 1997 until July 2001. Mr. Steffens was elected a member
of the Board of Directors of Merrill Lynch & Co., Inc. in April 1986 and
served on the board until July 2001. Mr. Steffens was Chairman of the Securities
Industry Association during 1994 and 1995, and is currently a Trustee of the
Committee for Economic Development. He is the National Chairman Emeritus of the
Alliance for Aging Research and serves on the Board of Aozora Bank in
Japan. Mr. Steffens graduated from Dartmouth University in 1963
with a B.A. degree in Economics. He also attended the Advanced
Management Program of the Harvard Business School in
1979.
John
P. Broderick
Director
since July 2005.
Mr.
Broderick is currently the Chief Executive Officer and Chief Financial Officer
of the Company and is also a director. Mr. Broderick has served as the Chief
Operating Officer of the Company since June 2002, as the Chief Financial Officer
of the Company since April 2001, and as Corporate Secretary since August 2001.
Prior to joining our Company, Mr. Broderick was Executive Vice President of
Swell Inc., a sports media e-commerce company where he oversaw the development
of all commerce operations and served as the organization's interim Chief
Financial Officer. Previously, Mr. Broderick served as Chief Financial Officer
and Senior Vice President of North American Operations for Programmer's
Paradise, a publicly held (NASDAQ: PROG) international software
marketer. Mr. Broderick received his B.S. in accounting from
Villanova University.
Anthony
C. Pizi
Director
since August 2000.
Mr. Pizi
is presently the CIO of the Asset Management Platform Services Group of Deutsche
Bank AG. Mr. Pizi was the Company’s Chief Information Officer until August 2007
and served as Chief Executive Officer and Chief Technology Officer from February
2001 to July 2005. Mr. Pizi also served as Chairman of the Board of Directors
from December 1, 2000 until March 7, 2005 and from June 1, 2005 until July 22,
2005. Mr. Pizi has been a director since August 2000. Until December 2000, he
was First Vice President and Chief Technology Officer of Merrill Lynch’s Private
Client Technology Architecture and Service Quality Group. Mr. Pizi’s
16 years with Merrill Lynch included assignments in Corporate MIS, Investment
Banking and Private Client. Mr. Pizi earned his B.S. in Engineering from West
Virginia University.
Mark
Landis
Director
since July 2005.
Mr. Mark Landis is the
Senior Managing Member of the Security Growth Fund, a newly established private
equity firm focused on the electronic security industry. Prior to joining the
Security Growth Fund and since 2003,
Mr.
Landis was the Executive in Residence of The Jordan Company, a private equity
firm based in New York. Mr. Landis retired from being President of the North
American Security Division of Siemens Building Technologies, Inc. in July of
2003, having joined that company in 1988. Mr. Landis earned his B.A.
from Cornell University and his Juris Doctorate from the University of
Pennsylvania. Mr. Landis received his CPCU - Chartered Property and
Casualty Underwriter from the American Institute for Property and Liability
Underwriters.
Bruce
W. Hasenyager
Director
since October 2002.
Mr.
Hasenyager has been a director of the Company since October
2002. Since November 2004, Mr. Hasenyager has served as Principal of
Bergen & Webster Executive Communications. Prior to that, he
served as Director of Business and Technology Development at the Hart eCenter at
Southern Methodist University (SMU) and Chief Operating Officer of the Guildhall
at SMU. From April 1996 to April 2002, Mr. Hasenyager was a founder and served
as Senior Vice President of Technology and Operations and Chief Technology
Officer at MobilStar Network Corporation. Prior to April 1996, Mr. Hasenyager
held executive and senior management positions in information technology at
Chemical Bank, Merrill Lynch, Kidder Peabody, and Citibank.
Jay
R. Kingley
Director
since November 2002.
Mr.
Kingley has been a director of the Company since November 2002. Mr.
Kingley is currently the Chief Executive Officer of Kingley Institute LLC, a
medical wellness company. Prior to that, Mr. Kingley has served as CEO of Warren
Partners, LLC, a software development and consultancy company. Mr. Kingley was
Managing Director of a business development function of Zurich Financial
Services Group from 1999-2001. Prior to joining Zurich Financial
Services Group, Mr. Kingley was Vice President of Diamond Technology Partners,
Inc., a management-consulting firm.
Charles
B. Porciello
Director
since June 2005.
Mr.
Porciello has been a director since June 6, 2005. Since 2003, Mr.
Porciello is the Chief Executive Officer of Pilar Services, Inc. From 2001 until
2003, he served as Chief Operating Officer of Enterprise Integration
Corporation, a minority-owned IT services company. Prior to that Mr.
Porciello worked for various IT companies, developing and facilitating in their
growth. Mr. Porciello retired from the U.S. Air Force in 1982
after serving his country for twenty five years. Mr. Porciello graduated from
the U.S. Military Academy with a B.S. in Engineering and received his Masters
Degree in Management from the University of Nebraska.
Bruce
D. Miller
Director
since July 2005.
Mr. Bruce
D. Miller has been a General Partner of Delphi Partners, Ltd. a privately-owned
investment partnership since 1989. He is the treasurer and a director
of American Season Corporation. Mr. Miller is a board member of Cape
Air/Nantucket Airlines, Inc. Mr. Miller is a trustee of the Egan
Maritime Foundation and is involved in other non-profit
activities. Mr. Miller received his B.S. in Finance from
Lehigh University and subsequently earned an M.B.A. from
Lehigh.
Bruce
A. Percelay
Director
since January 2006.
Mr.
Percelay has been a director since January 10, 2006. Mr. Percelay is
the Founder and Chairman of the Mount Vernon Company, a real estate investment
company specializing in the acquisition and renovation of multi-family and
commercial properties in Greater Boston Communities. Since 2000, Mr. Percelay
has been President of the Board of Habitat for Humanity in Greater
Boston. Mr. Percelay is currently Chairman of the Board of
Make-A-Wish Foundation of Greater Boston and Eastern
Massachusetts. Since 2002, Mr. Percelay has been a Board Member of
the Nantucket Historic Association. Mr. Percelay received his B.S. from Boston
University School of Management, and a B.A. in Business and Economics from City
of London Polytechnic, Special Studies in Economics.
John
W. Atherton
Director
since May 2006.
Mr.
Atherton has been a director since May 12, 2006. Since 2005, Mr. Atherton has
been the Vice President and Chief Financial Officer of CityFed Financial, a
publicly held financial holding company, based in Nantucket, Massachusetts. He
served as Chairman of CityFed Financial from 1991 until 2005. Mr. Atherton
received his B.A. degree from Wesleyan University (Middletown, Connecticut) and
an M.B.A. with Distinction from Babson College (Wellesley,
Massachusetts).
Don
Peppers
Director
since June 2007.
Mr.
Peppers has been a director since June 20, 2007. Mr. Peppers formed
Marketing 1:1, Inc. in January 1992 which became Peppers & Rogers Group, a
customer-centered management consulting firm with offices located in the United
States, Europe, Latin America and South Africa. In August 2003,
Peppers & Rogers Group joined Carlson Marketing. From October 1990 to
January 1992, Mr. Peppers was the Chief Executive Officer of Perkins/Butler
Direct Marketing, a top-20 U.S.-direct-marketing agency. Prior to
marketing and advertising, he worked as an economist in the oil business and as
the director of accounting for a regional airline. Mr. Peppers holds a
Bachelor's Degree in astronautical engineering from the U.S. Air Force Academy,
and a Master's Degree in public affairs from Princeton University's
Woodrow Wilson School.
Board
Meetings
The Board
met eight (8) times during the year ended December 31, 2007. The
standing committees of the Board include the Compensation Committee, the Audit
Committee and the Nominating Committee. Stockholders are encouraged to
communicate with Board members via our investor relations department, and such
communications are either responded to immediately or referred to our chief
executive officer for a response. During fiscal 2007, each of the incumbent
directors, during his period of service, attended at least 75% of the total
number of meetings held by the Board.
Corporate
Governance Guidelines
Our Board
has long believed that good corporate governance is important to ensure that we
are managed for the long-term benefit of our stockholders. Our common stock is
currently quoted on the OTC Bulletin Board. The OTC Bulletin Board currently
does not have any corporate governance rules similar to the NASDAQ Stock Market,
Inc. or any other national securities exchange or national securities
association. However, our Board believes that the corporate governance rules of
NASDAQ represent good governance standards and, accordingly, during the past
year, our Board has continued to review our governance practices in light of the
Sarbanes-Oxley Act of 2002, the new rules and regulations of the Securities and
Exchange Commission and the new listing standards of NASDAQ and it has
implemented certain of the foregoing rules and listing standards during this
past fiscal year.
Director
Compensation
In 2007,
the Board of Directors approved the 2007 Cicero Employee Stock Option Plan which
permits the issuance of incentive and nonqualified stock options, stock
appreciation rights, performance shares, and restricted and unrestricted stock
to employees, officers, directors, consultants, and advisors. The aggregate
number of shares of common stock which may be issued under this Plan shall not
exceed 4,500,000 shares upon the exercise of awards and provide that the term of
each award be determined by the Board of Directors
.
In August 2007, outside
directors were each granted an option to purchase 5,000 shares of common stock
at a price equal to the fair market value on the date of grant. The value of
these awards was $2,609. These options vest on the one year
anniversary of the date of grant provided that the director is still an active
member of the Board of Directors. In addition, each outside director who serves
on either the Audit Committee, the Compensation Committee or as the Chairman of
the Board, were each granted an additional option to purchase 3,000 shares of
common stock at a price equal to the fair value on the date of grant. The value
of these awards was $1,565. These options also vest on the one year
anniversary of the date of grant and carry the same service
requirements.
In May 1999, stockholders
of the Company approved the Outside Director Stock Incentive Plan of the
Company. Under this plan, the outside directors may be granted an option to
purchase 120 shares of common stock at a price equal to the fair market value of
the common stock as of the grant date. In January 2002, the board of directors
approved an amendment to the Outside Director Stock Incentive Plan to provide an
increase in the number of options to be granted to outside directors to
240. These options vest over a three-year period in equal increments
upon the
eligible director’s election to the Board, with the initial increment vesting on
the date of grant. The Outside Director Stock Incentive Plan also
permits eligible directors to receive partial payment of director fees in common
stock in lieu of cash, subject to approval by the board of directors. In
addition, the plan permits the board of directors to grant discretionary awards
to eligible directors under the plan. None of the Company’s directors
received additional monetary compensation for serving on the Board of Directors
of the Company in 2007.
In
October 2002, the Board of Directors approved an amendment to the stock
incentive plan for all non-management directors. Under the amendment, each
non-management director will receive 1,000 options to purchase common stock of
the Company at the fair market value of the common stock on the date of grant.
These shares will vest in three equal increments with the initial increment
vesting on the date of grant. The option grant contains an acceleration of
vesting provision should the Company incur a change in control. A change in
control is defined as a merger or consolidation of the Company with or into
another unaffiliated entity, or the merger of an unaffiliated entity into the
Company or another subsidiary thereof with the effect that immediately after
such transaction the stockholders of the Company immediately prior to the
transaction hold less than fifty percent (50%) of the total voting power of all
securities generally entitled to vote in the election of directors, managers or
trustees of the entity surviving such merger or consolidation. Under
the amendment, there will be no additional compensation awarded for committee
participation. The shares allocated to the Board of Directors were
issued out of the Level 8 Systems, Inc. 1997 Employee Stock Plan.
Audit
Committee
The Audit
Committee is composed of Mr. Bruce Miller, Mr. Bruce Hasenyager and Mr. John W.
Atherton. The responsibilities of the Audit Committee include the appointment
of, retention, replacement, compensation and overseeing the work of the
Company’s independent accountants and tax professionals. The Audit Committee
reviews with the independent accountants the results of the audit engagement,
approves professional services provided by the accountants including the scope
of non-audit services, if any, and reviews the adequacy of our internal
accounting controls. The Audit Committee met formally six times during our
fiscal year ended December 31, 2007. Each member attended every meeting while
they were appointed to the Audit Committee. The Board of Directors has
determined that the members of the Audit Committee are independent as defined in
Rule 4200(a)(15) of the National Association of Securities Dealers’ listing
standards. Mr. John W. Atherton was designated the “audit committee financial
expert” as defined in Item 401(h) of Regulation S-K.
Code
of Ethics and Conduct
Our Board
of Directors has adopted a code of ethics and a code of conduct that applies to
all of our directors, Chief Executive Officer, Chief Financial Officer, and
employees. We will provide copies of our code of conduct and code of
ethics without charge upon request. To obtain a copy of the code of ethics or
code of conduct, please send your written request to Cicero Inc., Suite 542,
8000 Regency Pkwy, Cary, North Carolina 27518, Attn: Corporate
Secretary. The code of ethics is also available on the Company’s
website at www.ciceroinc.com.
Section
16(a) Beneficial Ownership Reporting Compliance
Section
16(a) of the Securities Exchange Act of 1934, as amended, requires the Company’s
officers, directors and persons who own more than ten percent of the Company’s
Common Stock (collectively, “Reporting Persons”) to file reports of ownership
and changes in ownership with the SEC and Nasdaq. Reporting Persons
are required by SEC regulations to furnish the Company with copies of all
Section 16(a) reports they file. Based solely on its review of the copies of
such reports received by it and written representations all Section 16(a)
reports were filed in a timely manner.
Compensation
Discussion and Analysis
Compensation Committee Membership and
Organization
The
Compensation Committee of the Board of Directors has responsibility for
establishing, implementing and monitoring adherence with the Company’s
compensation philosophy. It’s duties include:
|
·
Setting
the total compensation of our Chief Executive Officer and evaluating his
performance based on corporate goals and
objectives;
|
|
·
Reviewing
and approving the Chief executives Officer’s decisions relevant to the
total compensation of the Company’s other executive
officer;
|
|
·
Making
recommendations to the Board of Directors with respect to equity-based
plans in order to allow us to attract and retain qualified personnel;
and
|
|
·
Reviewing
director compensation levels and practices, and recommending, from time to
time, changes in such compensation levels and practices of the Board of
Directors.
|
The
members of the Compensation Committee are Messrs. Kingley and Porciello. None of
the current members of the Compensation Committee has served as an executive
officer of the Company, and no executive officer of the Company has served as a
member of the Compensation Committee of any other entity of which Messrs.
Kingley and Porciello have served as executive officers. Mr. Porciello is the
Chief Executive Office of Pilar Services Inc., a reseller partner. We
have recognized approximately $1,000 and $100,000 in revenues with Pilar
Services Inc. during 2007 and 2006, respectively. There were no
interlocking relationships between us and other entities that might affect the
determination of the compensation of the directors and executive officers of the
Company. The Compensation Committee meets on an as necessary basis during the
year.
General
Compensation Philosophy
As a
technology company, we operate in an extremely competitive and rapidly changing
industry. We believe that the skill, talent, judgment and dedication of our
executive officers are critical factors affecting the long term value of our
company. The Compensation Committee’s philosophy and objectives in setting
compensation policies for executive officers are to align pay with performance,
while at the same time providing fair, reasonable and competitive compensation
that will allow us to retain and attract superior executive talent. The
Compensation Committee strongly believes that executive compensation should
align executives’ interests with those of shareholders by rewarding achievement
of specific annual, long-term and strategic goals by the Company, with an
ultimate objective of providing long-term stockholder value. The specific goals
that our current executive compensation program rewards are focused primarily on
revenue growth and profitability. To that end, the Compensation Committee
believes executive compensation packages provided by the Company to its
executive officers should include a mix of both cash and equity based
compensation that reward performance as measured against established goals. As a
result, the principal elements of our executive compensation are base salary,
non-equity incentive plan compensation, long-term equity incentives generally in
the form of stock options and/or restricted stock and post-termination severance
and acceleration of stock option vesting upon termination and/or a change in
control.
Our goal
is to maintain an executive compensation program that will fairly compensate our
executives, attract and retain qualified executives who are able to contribute
to our long-term success, induce performance consistent with clearly defined
corporate goals and align our executives long-term interests with those of our
shareholders. The decision on the total compensation for our executive officers
is based primarily on an assessment of each individual’s performance and the
potential to enhance long-term stockholder value. Often, judgment is utilized in
lieu of total reliance upon rigid guidelines or formulas in determining the
amount and mix of compensation for each executive officer. Factors affecting
such judgment include performance compared to strategic goals established for
the individual and the Company at the beginning of the year, the nature and
scope of the executive’s responsibilities and effectiveness in leading
initiatives to achieve corporate goals.
Role
of Chief Executive Officer in Compensation Decisions
The
Compensation Committee of our Board of Directors determines the base salary (and
any bonus and equity-based compensation) for each executive officer annually.
John Broderick, our Chief Executive Officer, confers with members of the
Compensation Committee, and makes recommendations, regarding the compensation of
all executive officers other than himself. He does not participate in the
Compensation Committee's deliberations regarding his own compensation. In
determining the compensation of our executive officers, the Compensation
Committee does not engage in any benchmarking of total compensation or any
material element of compensation.
Components
of Executive Compensation
The
compensation program for our Named Executive Officers consists of:
|
·
Non-equity
incentive plan compensation;
|
|
·
Long-term
incentive compensation; and
|
Base
Salary
The
Company provides our executive officers and other employees with base salary to
compensate them for services rendered during the fiscal year. The Compensation
Committee considered the scope and accountability associated with each executive
officer’s position and such factors as the performance and experience of each
executive officer, individual leadership and level of responsibility when
approving the base salary levels for fiscal year 2008.
Non-Equity
Incentive Plan Compensation
Non-equity
incentive plan compensation for our executive officers is designed to reward
performance against key corporate goals and for certain of our executives for
performance against individual business development goals. Our chief executive
officer incentive targets are designed to motivate management to exceed specific
goals related to profitability objectives. We believe that these metrics closely
correlate to stockholder value. Our other executive officer’s non-equity
incentive plan is based upon revenues generated through his individual business
development activities and subject to final approval by our chief executive
officer. We believe that these metrics also correlate to stockholder value and
individual performance. None of our executives have achieved a non-equity
incentive bonus in either of the past two years.
Our Chief
Executive Officer, Mr. Broderick, is eligible for non-equity incentive plan
compensation with a target bonus of $100,000 for achieving targeted pre tax
income for fiscal 2008. In addition, Mr. Broderick is eligible for additional
bonuses should the targeted pre tax income be exceeded by 150%.
Long-Term
Equity Incentive Awards
The
Company presently has one equity-based compensation plan, entitled Cicero Inc.
2007 Employee Stock Option Plan, which will require stockholder approval. The
Plan provides for the grant of incentive and non-qualified stock options to
employees, and the grant of non-qualified options to consultants and to
directors and advisory board members. In addition, various other types of
stock-based awards, such a stock appreciation rights, may be granted under the
Plan. The Plan is administered by the Compensation Committee of our Board of
Directors, which determines the individuals eligible to receive options or other
awards under the Plan, the terms and conditions of those awards, the applicable
vesting schedule, the option price and term for any granted options, and all
other terms and conditions governing the option grants and other awards made
under the Plan. Under the 2007 Plan, 4,500,000 shares of our common stock were
reserved for issuance pursuant to options or restricted stock awards; at
December 31, 2007, 1,999,240 shares were available for future option grants and
awards. The Company’s previous equity-based compensation plan, entitled Level 8
Systems 1997 Employee Stock Option Plan, expired during fiscal 2007. There are
28,265 options outstanding under that plan.
To date,
awards have been solely in the form of non-qualified stock options granted under
the Plans. The Compensation Committee grant these stock-based incentive awards
from time to time for the purpose of attracting and retaining key executives,
motivating them to attain the Company's long-range financial objectives, and
closely aligning their financial interests with long-term stockholder interests
and share value.
In August
2007, the Board of Directors approved a stock option grant to Mr. Broderick, our
CEO, for 549,360 shares of common stock at the fair market value on the date of
grant. The Company has also agreed to grant Mr. Pizi a stock option grant of
122,080 shares of the Company at the fair market value on the date of grant.
Vesting of Mr. Broderick’s grant will be over 2 years with one third being
vested immediately upon the date of grant and one third on each of the next two
anniversaries of the date of grant. Mr. Pizi’s grant was vested immediately
however, he failed to exercise his options within 90 days of his separation from
the Company and those shares were forfeited.
Coincidental
with the grant of stock options to our named executives, the Company granted a
restricted stock award to Mr. Broderick. Mr. Broderick will receive a restricted
stock award equal to 1.35% of the fully diluted shares of the Company. The
restricted stock award will vest upon the termination or resignation of the
named executive or upon a change in control of the Company.
The
grants to our named executives during fiscal 2007 reflect the absence of any
grants since 2004. Our focus as a Company and for our Chief Executive Officer
was to complete the Plan of Recapitalization that was approved by shareholders
in November 2006 and effective with our filing our Amended and Restated
Certificate with the State of Delaware in January 2007. The 2007 grant is
intended to satisfy three fiscal years of equity incentive awards and to bring
our named executive ownership in the Company up to competitive
levels.
Grants to
other employees are typically made upon initial employment and then periodically
as the Compensation Committee so determines. During 2007, the Compensation
Committee approved grants totaling 2,084,733 shares to employees and directors
of the Company. These were the first grants made in the past two
years. The Compensation Committee has empowered our Chief Executive
Officer to issue grants of up to 75,000 options to new employees at the fair
market value of the stock on the date of employment. Any proposed option grants
in excess of that amount require Compensation Committee approval. Our stock
options typically vest over two years with one third being immediately vested
upon the date of grant and one third vesting on each of the next two
anniversaries of the date of grant.
We
account for equity compensation paid to all of our employees under the rules of
SFAS No. 123(R), which requires us to estimate and record compensation expense
over the service period of the award. All equity awards to our employees,
including executive officers, and to our directors have been granted and
reflected in our consolidated financial statements, based upon the applicable
accounting guidance, at fair market value on the date of grant. Generally, the
granting of a non-qualified stock option to our executive officers is not a
taxable event to those employees, provided, however, that the exercise of such
stock would result in taxable income to the optionee equal to the difference
between the fair market value of the stock on the exercise date and the exercise
price paid for such stock. Similarly, a restricted stock award subject to a
vesting requirement is also not taxable to our executive officers unless such
individual makes an election under section 83(b) of the Internal Revenue Code of
1986, as amended. In the absence of a section 83(b) election, the value of the
restricted stock award becomes taxable to the recipient as the restriction
lapses.
Other
Benefits
Our
executive officers participate in benefit programs that are substantially the
same as all other eligible employees of the Company.
Compensation
Committee Report
The
Compensation Committee has reviewed and discussed the Compensation Discussion
and Analysis required by Item 402(b) of Regulation S-K with management and,
based on such review and discussions, the Compensation Committee recommended to
the Board that the Compensation Discussion and Analysis be included in this
report.
Submitted
by the Compensation Committee of the Board
Jay Kingley
Charles Porciello
The
following summary compensation table sets forth the compensation earned by all
persons serving as the Company’s executive officers during fiscal year
2007.
Summary
Compensation Table
Name
and
Principal
Position
|
|
Fiscal
Year
|
|
Salary
|
|
|
Stock
Awards
(1)
|
|
|
Option
Awards
(2)
|
|
|
Non-
Equity
Incentive
Plan
Compensation
(3)
|
|
|
Nonqualified
Deferred Compensation
Earnings
(4)
|
|
|
All
Other
Compensation
(5)
|
|
|
Total
|
|
John
P. Broderick
Chief
Executive Officer
Chief /Financial Officer,
Corporate
Secretary
|
|
2007
|
|
$
|
175,000
|
|
|
$
|
37,396
|
|
|
$
|
125,838
|
|
|
|
--
|
|
|
|
--
|
|
|
$
|
6,862
|
|
|
$
|
345,096
|
|
Anthony
C. Pizi
Chief
Information Officer (6)
|
|
2007
|
|
$
|
78,840
|
|
|
|
--
|
|
|
$
|
63,543
|
|
|
$
|
15,289
|
|
|
|
--
|
|
|
$
|
504
|
|
|
$
|
158,176
|
|
(1)
|
In
August 2007, the Company issued Mr. Broderick a restricted stock award in
the amount of 549,360 shares which will vest to him upon his resignation
or termination or a change of control. The Company used the Black-Scholes
method to value these shares and assumed a life of 10
years.
|
(2)
|
The
Company issued 549,360 options to Mr. Broderick in August 2007. The fair
market on the date of grant was $0.51 each. The options vested one-third
immediately and the balance on each of the next two anniversaries of the
date of grant. The Company issued 122,080 options to Mr. Pizi in August
2007. The fair market value on the date of grant was $0.51 each. Mr.
Pizi’s options vested immediately however he failed to exercise these
options within 90 days of separation from the Company and therefore they
were cancelled on November 30,
2007.
|
(3)
|
Non-equity
incentive plan compensation includes commission on revenue for named
executive earned during fiscal year ended December 31,
2007.
|
(4)
|
The
Company had no nonqualified deferred compensation arrangements with named
executive officers in the fiscal year ended December 31,
2007.
|
(5)
|
Other
compensation includes the Company’s portion of major medical insurance
premiums and long term disability premiums for named executives during
fiscal year ended December 31,
2007.
|
(6)
|
Mr.
Pizi resigned as the Company’s Chief Information Officer effective July
31, 2007.
|
Grants
of Plan Based Awards
The
Company awarded 549,360 stock options to the named executive during fiscal
2007. The Company did not award any stock appreciation rights
(“SARs”) during fiscal 2007.
The
following table presents the number and values of exercisable options as of
December 31, 2007 by the named executive.
Outstanding
Equity Awards at December 31, 2007
Option
Awards
|
|
Stock
Awards
|
Name
|
|
Number
of Securities Underlying Unexercised Options # Exercisable
(Vested)
|
|
Number
of Securities Underlying Unexercised Unearned Options# Unexercisable
(Unvested)
|
|
Option Exercise price ($)
|
|
Option Expiration date
|
|
Number of Shares of Stock That Have Not Vested
(8)
|
|
Market Value of Shares of Stock That Have Not
Vested
|
John
P. Broderick
|
|
500
(1)
|
|
--
|
|
$
|
400.00
|
|
05/17/2011
|
|
|
|
|
|
|
250
(2)
|
|
--
|
|
$
|
175.00
|
|
09/25/2011
|
|
|
|
|
|
|
909
(3)
|
|
--
|
|
$
|
174.00
|
|
12/03/2011
|
|
|
|
|
|
|
1,000
(4)
|
|
--
|
|
$
|
39.00
|
|
07/08/2012
|
|
|
|
|
|
|
4,950
(5)
|
|
--
|
|
$
|
26.00
|
|
04/24/2013
|
|
|
|
|
|
|
5,000
(6)
|
|
--
|
|
$
|
31.00
|
|
02/18/2014
|
|
|
|
|
|
|
183,120
(7)
|
|
366,240
(7)
|
|
$
|
0.51
|
|
08/17/2017
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
549,630
|
|
$
126,415
|
(1)
|
These
options were granted on May 17, 2001. This stock option vested and became
exercisable in four equal installments with the first installment vesting
on May 17, 2002.
|
(2)
|
These
options were granted on September 25, 2001. This stock option vested and
became exercisable in four equal annual installments with the first
installment vesting on September 25,
2002.
|
(3)
|
These
options were granted on December 3, 2001. This stock option vested and
became exercisable in three equal annual installments with the first
installment vesting on December 3,
2001.
|
(4)
|
These
options were granted on July 8, 2002. This stock option vested
and became exercisable in three equal annual installments with the first
installment vesting on July 8,
2002.
|
(5)
|
These
options were granted on April 24, 2003. This stock option vested and
became exercisable in three equal annual installments with the first
installment vesting on April 24,
2003.
|
(6)
|
These
options were granted on February 18, 2004. This stock option vested and
became exercisable in three equal annual installments with the first
installment vesting on February 18,
2004.
|
(7)
|
These
options were granted on August 17, 2007. This stock option vests in three
equal installments with the first installment vesting on August 17,
2007.
|
(8)
|
These
are restricted stock granted on August 17, 2007. The shares
will vest to him upon his resignation or termination or a change of
control.
|
Options
Exercised and Stock Vested
The named
executive did not exercise any options during the year ended December 31, 2007.
All of Mr. Broderick’s outstanding options are fully vested except for those
identified in the table above.
Employment
Agreements, Termination of Employment and Change-In-Control
Arrangements
Under the
employment agreement between the Company and Mr. Broderick effective January 1,
2008, we agreed to pay Mr. Broderick an annual base salary of $175,000 and
performance bonuses in cash of up to $300,000 per annum based upon certain
revenue goals and operating metrics, as determined by the Compensation
Committee,
in its discretion. Upon termination of Mr.
Broderick’s employment by the Company without cause, we agreed to pay Mr.
Broderick a lump sum payment of one year of Mr. Broderick’s then current base
salary within 30 days of termination and any unpaid deferred salaries and
bonuses. In the event there occurs a substantial change in Mr. Broderick’s job
duties, there is a decrease in or failure to provide the compensation or vested
benefits under the employment agreement or there is a change in control of the
Company, we agreed to pay Mr. Broderick a lump sum payment of one year of Mr.
Broderick’s then current base salary within thirty (30) days of termination. Mr.
Broderick will have thirty (30) days from the date written notice is given about
either a change in his duties or the announcement and closing of a transaction
resulting in a change in control of the Company to resign and execute his rights
under this agreement. If Mr. Broderick’s employment is terminated for any
reason, Mr. Broderick has agreed that, for one (1) year after such termination,
he will not directly or indirectly solicit or divert business from us or assist
any business in attempting to do so or solicit or hire any person who was our
employee during the term of his employment agreement or assist any business in
attempting to do so.
Estimated
Payments and Benefits Upon Termination
The
amount of compensation and benefits payable to named executive has been
estimated in the table below. Since all options held by the executive are
out-of-the-money, and fully vested, we have not estimated any value for option
acceleration. Deferred compensation reflects amounts voluntarily deferred from
salaries during fiscal 2004 and 2005 plus accrued but unpaid bonuses from
2003.
|
|
Compensation
|
|
|
|
|
|
|
|
|
|
Base
Salary
|
|
|
Non-equity
Compensation Plan
|
|
|
Restricted
Shares Award
|
|
|
Unvested
Option Shares Accelerated
|
|
|
Deferred
Compensation
|
|
|
Continua-tion
of Medical Benefits
|
|
|
Total
Compensation and Benefits
|
|
John
P. Broderick
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Death
|
|
$
|
--
|
|
|
$
|
--
|
|
|
$
|
252,951
|
|
|
$
|
--
|
|
|
$
|
175,000
|
|
|
$
|
--
|
|
|
$
|
427,951
|
|
Disability
|
|
|
--
|
|
|
|
--
|
|
|
|
252,951
|
|
|
|
--
|
|
|
|
175,000
|
|
|
|
--
|
|
|
|
427,951
|
|
Involuntary
termination without cause
|
|
|
175,000
|
|
|
|
--
|
|
|
|
252,951
|
|
|
|
--
|
|
|
|
175,000
|
|
|
|
--
|
|
|
|
602,951
|
|
Change
in Control
|
|
|
175,000
|
|
|
|
--
|
|
|
|
252,951
|
|
|
|
--
|
|
|
|
175,000
|
|
|
|
--
|
|
|
|
602,951
|
|
The
amounts shown in the table above do not include payments and benefits to the
extent they are provided on a non-discriminatory basis to salaried employees
generally upon termination, such as unreimbursed business expenses
payable.
Item
12. Security Ownership of
C
ertain Beneficial Owners
and Management.
The
following table sets forth information as of December 31, 2007 with respect to
beneficial ownership of shares by (i) each person known to the Company to
be the beneficial owner of more than 5% of the outstanding common stock,
(ii) each of the Company’s directors, (iii) the executive officers of
the Company named in the Summary Compensation Table (the “Named Executives”) and
(iv) all current directors and executive officers of the Company as a
group. Unless otherwise indicated, the address for each person listed is c/o
Cicero Inc., 8000 Regency Parkway, Suite 542, Cary, North Carolina
27518.
The named
person has furnished stock ownership information to the Company. Beneficial
ownership as reported in this section was determined in accordance with
Securities and Exchange Commission regulations and includes shares as to which a
person possesses sole or shared voting and/or investment power and shares that
may be acquired on or before December 31, 2007 upon the exercise of stock
options as well as exercise of warrants. The chart is based on 43,805,508 common
shares outstanding as of December 31, 2007. Except as otherwise
stated in the footnotes below, the named persons have sole voting and investment
power with regard to the shares shown as beneficially owned by such
persons.
|
|
Common
Stock
|
|
Name of Beneficial
Owner
|
|
No. of Shares
|
|
|
Percent of Class
|
|
Ahab
International Ltd. (1)
|
|
|
4,559,927
|
(2)
|
|
|
10.5
|
%
|
Ahab
Partners LP (1)
|
|
|
3,833,723
|
(3)
|
|
|
8.77
|
%
|
John
L. Steffens (4)
|
|
|
4,515,831
|
(5)
|
|
|
10.3
|
%
|
Mark
and Carolyn P. Landis (6)
|
|
|
5,104,863
|
(7)
|
|
|
11.6
|
%
|
BluePhoenix
Solutions (8)
|
|
|
2,546,149
|
(9)
|
|
|
5.81
|
%
|
Anthony
C. Pizi
|
|
|
1,397,634
|
(10)
|
|
|
3.2
|
%
|
Bruce
Miller
|
|
|
1,567,246
|
(11)
|
|
|
3.6
|
%
|
Bruce
Percelay
|
|
|
1,073,486
|
(12)
|
|
|
2.5
|
%
|
John
P. Broderick
|
|
|
748,337
|
(13)
|
|
|
1.7
|
%
|
John
W. Atherton
|
|
|
148,884
|
(14)
|
|
|
*
|
|
Bruce
W. Hasenyager
|
|
|
33,652
|
(15)
|
|
|
*
|
|
Don
Peppers
|
|
|
101,750
|
(16)
|
|
|
*
|
|
Charles
Porciello
|
|
|
80,286
|
(17)
|
|
|
*
|
|
Jay
R. Kingley
|
|
|
1,000
|
(18)
|
|
|
*
|
|
All
current directors and executive officers as a group (11
persons)
|
|
|
14,027,780
|
(19)
|
|
|
32.0
|
%
|
*
|
Represents
less than one percent of the outstanding
shares.
|
1.
|
The
address of Ahab International Ltd. and Ahab Partners LP is 299 Park Avenue
New York, New York 10171.
|
2.
|
As
of December 31, 2007, Ahab International Ltd. owns 4,587,415 shares of
common stock and 13,347 shares issuable upon the exercise of
warrants. The exercise prices of the warrants are as follows:
3,194 at $40.00 per share, and 9,318 at $10.00 per
share.
|
3.
|
As
of December 31, 2007, Ahab Partners LP. owns 3,833,723 shares of common
stock and 6,738 shares issuable upon the exercise of
warrants. The exercise prices of the warrants are as follows:
1,720 at $40.00 per share, and 5,018 at $10.00 per
share.
|
4.
|
The
address of John L. Steffens is 65 East 55th Street, New York, N.Y.
10022.
|
5.
|
Includes
4,293,470 shares of common stock, 14,832 shares of the Series A-1
Convertible Preferred Stock and 207,529 shares issuable upon the exercise
of warrants. The exercise prices of the warrants are as follows: 4,912 at
$40.00 per share, 14,332 at $10.00 per share and 188,285 at $0.18 per
share.
|
6.
|
The
address of Mark and Carolyn P. Landis is 503 Lake Drive, Princeton, New
Jersey 08540.
|
7.
|
Includes
3,748,155 shares of common stock, 1,326,136 shares of the Series A-1
Convertible Preferred Stock, and 30,572 shares issuable upon
the exercise of warrants. The exercise prices of the stock options and
warrants are at $0.51 and $10.00 per share
respectively. Disclaims beneficial ownership
of 35,572 shares because they are
anti-dilutive.
|
8.
|
The
address of BluePhoenix Solutions is 8 Maskit Street, PO Box 2062, Herzlia,
Israel 46120.
|
9.
|
Includes
2,546,149 shares of common stock
|
10.
|
Includes
1,274,951 shares of common stock, 111.016 shares of the Series A-1
Convertible Preferred Stock, and 11,667 shares of common stock issuable
upon the exercise of warrants. The exercise price of warrants
is $10.00 per share of common
stock.
|
11.
|
Consists
of 996,813 shares of common stock, 42.000 shares of the Series A-1
Convertible Preferred Stock, and 15,652 shares of common stock issuable
upon the exercise of warrants. The exercise prices of the
warrants are as follows: 2,457 at $40.00 per share, and 13,195
at $10.00 per share. Mr. Miller has sole or shared voting or
dispositive power with respect to the securities held by Delphi Partners,
Ltd., which holds 491,267 shares of common stock, 18.000 shares of the
Series A-1 Convertible Preferred Stock, and 3,514 shares of common stock
issuable upon the exercise of warrants at $10.00 per
share.
|
12.
|
Consists
of 1,073,486 shares of common
stock.
|
13.
|
Includes
3,248 shares of common stock, 195,729 shares subject to stock
options exercisable within sixty (60) days and 549,360 shares of
restricted stock that is awarded upon resignation or termination and
change of control.
|
14.
|
Includes
148,784 shares of common stock, and 100 shares of common stock held in a
self-directed IRA.
|
15.
|
Consists
of 32,652 shares of common stock and 1,000 shares subject to stock options
exercisable within sixty (60) days. Disclaims beneficial
ownership of 1,000 shares of common stock because they are
anti-dilutive.
|
16.
|
Includes
101,750 shares of common stock
|
17.
|
Consists
of 80,286 shares of common stock.
|
18.
|
Consists
of 1,000 shares subject to stock options exercisable within sixty (60)
days.
|
19.
|
Includes
shares issuable upon exercise of options and warrants exercisable within
sixty (60) days as described in Notes 7-14 to our financial
statements.
|
Item
13. Certain Re
lat
ionships and
Related Transactions.
Sale
of Common Stock
In
October 2007, the Company completed a private sale of shares of its common stock
to a group of investors, four of which are members of our Board of Directors.
Under the terms of that agreement, the Company sold 2,169,311 shares of its
common stock for $0.2457 per share for a total of $533,000. Participating in
this consortium were Mr. John L. (Launny) Steffens, the Company’s Chairman, and
Messrs. Bruce Miller, Don Peppers, and Bruce Percelay, members of the
Board. Mr. Steffens converted the principal amount of his short term
notes with the Company of $250,000 for 1,017,501 shares of common
stock. Mr. Miller invested $20,000 for 81,400 shares of common stock,
Mr. Peppers acquired 101,750 shares for a $25,000 investment and Mr. Bruce
Percelay acquired 40,700 shares for a $10,000 investment.
In
February 2007, the
Company completed a private sale of shares of its common stock to a group of
investors, three of which are members of our Board of Directors. Under the terms
of that agreement, the Company sold 3,723,007 shares of its common stock for
$0.1343 per share for a total of $500,000. Participating in this offering were
Mr. Mark Landis, who was the Company’s Chairman at that time and Mr. Bruce
Miller, who is a Board member. Mr. Landis acquired 74,460 shares for a $10,000
investment and Mr. Miller acquired 148,920 shares for a $20,000 investment. In
May 2007, Mr. John L. (Launny) Steffens was elected Chairman of the Board of
Directors. Prior to his election, Mr. Steffens had participated in
the private purchase of shares acquiring 1,006,379 shares for an investment of
$135,157.
In March
2008, the Company was notified that a group of investors including two members
of the Board of Directors acquired a short term promissory note due SDS Merchant
Fund in the principal amount of $250,000. The note is unsecured and bears
interest at 10% per annum. Also in March, our Board of Directors approved a
resolution to convert this debt plus accrued interest into common stock of the
Company. The total principal and interest amounted to $361,827 and is being
converted into 1,417,264 shares of common stock. Mr. John Steffens, the
Company’s Chairman, will acquire 472,516 shares and Mr. Bruce Miller, also a
member of our Board of Directors, will acquire 472,374 shares.
Loans
from Related Parties
In
October 2007, the Company entered into a long-term promissory note with John L.
(Launny) Steffens, the Chairman on the Board of Directors, as part of the
restructuring of the Note payable to Bank Hapoalim. The Note bears
interest of 3% and matures in October 2009. The Company also granted Mr.
Steffens 188,285 warrants to purchase common stock at $0.18 each. The Company
used the Black Scholes method to value the warrants and recorded a stock
compensation charge and additional paid-in capital in the amount of $34,230. At
December 31, 2007, the Company was indebted to Mr. Steffens in the amount of
$300,000.
In
November 2007, the Company entered into a short term note
payable with John L.
(Launny) Steffens, the Chairman of the Board of Directors, for various working
capital needs. The Note bears interest at 6% per year and is unsecured. At
December 31, 2007, the Company was indebted to Mr. Steffens in the amount of
$40,000.
During
2005, the Company entered into short term notes
payable with Anthony
Pizi, the Company’s former Chief Information Officer, for various working
capital needs. The Notes bear interest at 1% per month and are unsecured. At
December 31, 2007, the Company was indebted to Mr. Pizi in the amount of
$9,000.
Convertible Promissory
Notes
. Directors and executive officers made several loans to
us in exchange for convertible promissory notes. As part of the Plan of
Recapitalization which was approved by our shareholders, the Company offered to
adjust the conversion rates and terms on these notes. As a result of the Plan of
Recapitalization, these notes were automatically converted into shares of the
preferred stock designated as Series A-1 Preferred stock. Each share of Series
A-1 Preferred Stock is convertible into 1,000 shares of the Company’s common
stock. Because the conversion rates were adjusted, the Company calculated the
amount of the beneficial conversion resulting from the adjusted conversion rate
and recorded that amount as a deemed dividend and additional paid in capital.
See Note 2 to the Consolidated Financial Statements.
In June,
2004, the Company entered into a convertible promissory note with Mr. Pizi in
the face amount of $100,000, bearing interest at 1% per month which was
converted into 14 shares of the Company’s Series A-1 Preferred Stock. In
addition, Mr. Pizi was granted 270,270 warrants to purchase the Company’s common
stock at $0.37 per share. As part of the Note and Warrant Offering, Mr. Pizi
elected to convert these warrants by loaning the Company the reduced exercise
price.
In
July 2004, the Company entered into a convertible promissory note with Mr. Pizi
in the face amount of $112,000, bearing interest at 1% per month which was
converted into 78.4 shares of the Company’s Series A-1 Preferred Stock upon
approval of the Plan of Recapitalization. In addition, at the time of the loan,
Mr. Pizi was granted warrants to purchase 560,000 shares of our common stock at
$0.20 per share. As part of the Note and Warrant Offering, Mr. Pizi
elected to convert 289,376 of these warrants by loaning the Company the reduced
exercise price. Mr. Pizi elected not to exercise 270,624 warrants and after the
reverse stock ratio now total 2,706 warrants with an exercise price of $20 per
share. Also in July 2004, Mr. Pizi entered into a second convertible promissory
note in the face amount of $15,000 which was converted into 12.62 shares of the
Company’s Series A-1 Preferred Stock. In addition, at the time of the loan, Mr.
Pizi was granted warrants to purchase 90,118 shares of the Company’s common
stock at $0.17 per share. Mr. Pizi has not elected to exercise these warrants
and after the reverse stock ratio now total 901 warrants with an exercise price
of $17.
In March
2004, the Company entered into a convertible promissory note with Mr. and Mrs.
Landis in the amount of $125,000. Under the terms of the note, the loan bore
interest at 1% per month, and was converted into 62.5 shares of Series A-1
Preferred stock. In addition, Mr. and Mrs. Landis were granted warrants to
purchase 446,429 shares of the Company’s common stock exercisable at $0.28 per
share. As part of the Note and Warrant Offering, Mr. and Mrs. Landis elected to
convert these warrants by loaning the Company the reduced exercise
price.
In June
2004, the Company entered into a convertible promissory note with Mr. and Mrs.
Landis in the amount of $125,000. Under the terms of the note, the loan bore
interest at 1% per month and was converted into 113.64 shares of Series A-1
Preferred stock. In addition, Mr. and Mrs. Landis were granted warrants to
purchase 781,250 shares of the Company’s common stock exercisable at $0.16 per
share. As part of the Note and Warrant Offering, Mr. and Mrs. Landis elected to
convert these warrants by loaning the Company the reduced exercise
price.
In
October 2004, the Company entered into a convertible promissory note with Mr.
and Mrs. Landis in the amount of $100,000. Under the terms of the agreement, the
loan bore interest at 1% per month and was converted into 400 shares of Series
A-1 Preferred stock. In addition, Mr. and Mrs. Landis were granted 2,000,000
warrants to purchase the Company’s common stock exercisable at $0.10 per share.
Mr. and Mrs. Landis elected not to exercise these warrants as part of the Note
and Warrant Offering and after the reverse stock split ratio these warrants
total 20,000 with an exercise price of $10.00.
In
November 2004, the Company entered into a convertible promissory note with Mr.
and Mrs. Landis in the amount of $150,000. Under the terms of the agreement, the
loan bore interest at 1% per month and was converted into 18,750 shares of
common stock after the reverse stock split ratio. In addition, Mr. and Mrs.
Landis were granted 1,875,000 warrants to purchase the Company’s common stock
exercisable at $0.08 per share. Mr. and Mrs. Landis elected not to
exercise these warrants as part of the Note and Warrant Offering and after the
reverse stock split ratio these warrants total 18,750 with an exercise price of
$8.00.
In June
2004, the Company entered into a convertible promissory note with Fredric Mack,
a former director of the Company, in the amount of $125,000. Under the terms of
the note, the loan bore interest at 1% per month, and was converted into 54.69
shares of Series A-1 Preferred stock. In addition, Mr. Mack was granted warrants
to purchase 390,625 shares of the Company’s common stock exercisable at $0.32
per share. As part of the Note and Warrant Offering, Mr. Mack elected
to convert these warrants by loaning the Company the reduced exercise
price.
In April
2005, the Company entered into a convertible promissory note with Bruce Miller,
a director of the Company, in the amount of $30,000. Under the terms of the
note, the loan bore interest at 1% per month and was converted into 60 shares of
Series A-1 Preferred stock.
In July
2004, the Company entered into a convertible promissory note with Nicholas
Hatalski, who until July 22, 2005 (during the period when the terms of the
recapitalization plan were being negotiated and at the time of approval of the
plan by our board of directors), was a director of the Company, in the amount of
$25,000. Under the terms of the note, the loan bore interest at 1% per month and
was converted into 10.94 shares of Series A-1 Preferred stock. In addition, Mr.
Hatalski was granted warrants to purchase 78,125 shares of the Company’s common
stock exercisable at $0.32 per share. Mr. Hatalski elected not to exercise these
warrants as part of the Note and Warrant Offering and after the reverse stock
split ratio these warrants total 781 with an exercise price of $32.
All of
such warrants expire three years from date of grant.
Senior Reorganization
Notes. From March 2004 to April 2005, directors and executive
officers made the following loans to the Company evidenced by Senior
Reorganization Notes: Mr. Pizi held $423,333 of Senior Reorganization
Notes, which were converted into warrants to purchase an additional 571,659
shares of Cicero common stock at a purchase price of $0.20 per
share.
Mr.
Landis held $327,860 of Senior Reorganization Notes, which were converted into
warrants to purchase an additional 442,345 shares of Cicero common stock at an
exercise price of $0.20 per share.
Mr. Mack
held, together with his affiliates, $88,122 of Senior Reorganization Notes,
which were converted into warrants to purchase an additional 112,205 shares of
Cicero common stock at a purchase price of $0.20 per share.
Mr.
Miller held, together with his affiliates, $77,706 of Senior Reorganization
Notes, which were converted into warrants to purchase an additional 114,597
shares of Cicero common stock at a purchase price of $0.20.
Mr.
Atherton holds $20,000 of Senior Reorganization Notes which were converted into
warrants to purchase an additional 289,856 shares of Cicero common stock at a
purchase price of $0.20.
Mr.
Broderick, Chief Executive Officer and Chief Financial Officer of the Company,
held $2,300 of Senior Reorganization Notes, which were converted into warrants
to purchase 3,222 shares of Cicero Inc. common stock at a purchase price of
$0.20 per share, and options to purchase 12,609 shares of common stock under the
Company’s stock option plan that will convert into options to purchase Cicero
common stock.
Convertible Bridge
Notes
. From July 2005 to November 2006, directors and
executive officers made the following loans to us for Convertible Bridge
Notes:
Mr. Pizi
held $85,000 of Convertible Bridge Notes which bear interest at 10% and matured
on September 15, 2005. These notes automatically converted into
680,000 shares of Cicero common stock upon approval of the recapitalization plan
by stockholders.
Mr.
Landis held $395,000 of Convertible Bridge Notes which bear interest at 10% and
matured on various dates in 2005 and 2006. These notes automatically
converted into 3,160,000 shares of Cicero common stock upon approval of the
recapitalization plan by stockholders.
Mr. Mack
held, together with his affiliates, $114,000 of Convertible Bridge Notes which
bear interest at 10% and matured on various dates in 2005 and
2006. These notes automatically converted into 897,564 shares of
Cicero common stock upon approval of the recapitalization plan by
stockholders.
Mr.
Miller held, together with his affiliates, $120,000 of Convertible Bridge Notes
which bear interest at 10% and matured on various dates in 2005 and
2006. These notes automatically converted into 947,273 shares of
Cicero common stock upon approval of the recapitalization plan by
stockholders.
Mr.
Hasenyager, a member of our Board of Directors, held $4,061 of Convertible
Bridge Notes which bear interest at 10% and matured on September 15, 2005. These
notes automatically converted into 32,485 shares of Cicero common stock upon
approval of the recapitalization plan by stockholders.
Mr.
Percelay, a member of our Board of Directors, held $130,000 of Convertible
Bridge Notes which bear interest at 10% and matured on various dates in 2005 and
2006. These notes automatically converted into 1,027,273 shares of Cicero common
stock upon approval of the recapitalization plan by stockholders.
Mr.
Atherton, a member of our Board of Directors, held $15,000 of convertible Bridge
Notes which bear interest at 10% and matured during 2006. These notes
automatically converted into 120,000 shares of Cicero common stock upon approval
of the recapitalization plan by stockholders.
Mr.
Porciello, a member of our Board of Directors, held $10,000 of Convertible
Bridge Notes which bear interest at 10% and matured during 2006. These notes
automatically converted into 80,000 shares of Cicero common stock upon approval
of the recapitalization plan by stockholders.
Transactions
with Merrill Lynch
On
January 3, 2002, the Company entered into a Purchase Agreement with MLBC, Inc.,
an affiliate of Merrill Lynch. Pursuant to the Purchase Agreement, the Company
issued 2,500 shares of its common stock to MLBC and entered into a royalty
sharing agreement for sales of Cicero
®
.
Under the royalty sharing agreement, the Company is obligated to pay a royalty
of 3% of the sales price for each sale of Cicero
®
or related maintenance services. The royalties are not payable in excess of $20
million. As consideration for the issuance of the shares and the royalty
payments, Merrill Lynch has entered into an amendment to the Cicero
®
license agreement, which extends our exclusive worldwide marketing, sales, and
development rights to Cicero
®
and granted us certain ownership rights in the Cicero
®
trademark. Pursuant to the Purchase Agreement, the Company also entered into a
Registration Rights Agreement granting MLBC certain rights to have the shares of
common stock it received under the Purchase Agreement registered under the
Securities Act of 1933, as amended.
Preferred
Stock Exchange
As part
of the Company’s plan of recapitalization presented to shareholders for
approval, the Company proposed to amend the conversion prices of the existing
Series A-3, B-3, C and D preferred shareholders and convert each of those shares
into Series A-1 Preferred stock. The new conversion prices with
respect to the Series A-3, B-3 and D preferred stock were negotiated with the
holders of each series based upon such factors as the current conversion price
in relation to the market, the dollar amount represented by such series and,
waiver of anti-dilution, liquidation preferences, seniority and other senior
rights. The conversion price for the Series C preferred stock was
determined in relation to the conversion price for the Series D preferred
stock. The board of directors determined the new conversion price of
each series of Level 8 preferred stock after discussion and review of those
rights, ranks and privileges that were being waived by the present holders of
preferred stock. Among those rights being waived are anti-dilution
protection, liquidation preferences and seniority.
The
holders of the Series A-1 preferred stock shall have the rights and preferences
set forth in the Certificate of Designations filed with the Secretary of State
of the State of Delaware upon the approval of the
Recapitalization. The rights and interests of the Series A-1
preferred stock of the Company will be substantially similar to the rights
interests of each of the series of Level 8 preferred stock other than for (i)
anti-dilution protections that have been permanently waived and (ii) certain
voting, redemption and other rights that holders of Series A-1 preferred stock
will not be entitled to. All shares of Series A-1 preferred stock
will have a liquidation preference
pari passu
with all other
Series A-1 preferred stock.
The
Series A-1 preferred stock is convertible at any time at the option of the
holder into an initial conversion ratio of 1,000 shares of Common Stock for each
share of Series A-1 preferred stock. The initial conversion ratio
shall be adjusted in the event of any stock splits, stock dividends and other
recapitalizations. The Series A-1 preferred stock is also convertible
on a automatic basis in the event that (i) the Company closes on an additional
$5,000,000 equity financing from strategic or institutional investors, or (ii)
the Company has four consecutive quarters of positive cash flow as reflected on
the Company’s financial statements prepared in accordance with generally
accepted accounting principals (“GAAP”) and filed with the
Commission. The holders of Series A-1 preferred stock are entitled to
receive equivalent dividends on an as-converted basis whenever the Company
declares a dividend on its Common Stock, other than dividends payable in shares
of Common Stock. The holders of the Series A-1 preferred stock are
entitled to a liquidation preference of $500 per share of Series A-1 preferred
stock upon the liquidation of the Company. The Series A-1 preferred
stock is not redeemable.
The
holders of Series A-1 preferred stock also possess the following voting
rights. Each share of Series A-1 preferred stock shall represent that
number of votes equal to the number of shares of Common Stock issuable upon
conversion of a share of Series A-1 preferred stock. The holders of
Series A-1 preferred stock and the holders of Common Stock shall vote together
as a class on all matters except: (i) regarding the election of the board
of directors of the Company (as set forth below); (ii) as required by law; or
(iii) regarding certain corporate actions to be taken by the Company (as
set forth below).
The
approval of at least two-thirds of the holders of Series A-1 preferred stock
voting together as a class, shall be required in order for the Company to: (i)
merge or sell all or substantially all of its assets or to recapitalize or
reorganize; (ii) authorize the issuance of any equity security having any right,
preference or priority superior to or on parity with the Series A-1 preferred
stock; (iii) redeem, repurchase or acquire indirectly or directly any of its
equity securities, or to pay any dividends on the Company’s equity securities;
(iv) amend or repeal any provisions of its certificate of incorporation or
bylaws that would adversely affect the rights, preferences or privileges of the
Series A-1 preferred stock; (v) effectuate a significant change in the principal
business of the Company as conducted at the effective time of the
Recapitalization; (vi) make any loan or advance to any entity other than in the
ordinary course of business unless such entity is wholly owned by the Company;
(vii) make any loan or advance to any person, including any employees or
directors of the Company or any subsidiary, except in the ordinary course of
business or pursuant to an approved employee stock or option plan; and (viii)
guarantee, directly or indirectly any indebtedness or obligations, except for
trade accounts of any subsidiary arising in the ordinary course of
business. In addition, the unanimous vote of the board of
directors is required for any liquidation, dissolution, recapitalization or
reorganization of the Company. The voting rights of the holders
of Series A-1 preferred stock set forth in this paragraph shall be terminated
immediately upon the closing by the Company of at least an additional $5,000,000
equity financing from strategic or institutional investors.
In
addition to the voting rights described above, the holders of a majority of the
shares of Series A-1 preferred stock are entitled to appoint two observers to
the Company’s board of directors who shall be entitled to receive all
information received by members of the board of directors, and shall attend and
participate without a vote at all meetings of the Company’s board of directors
and any committees thereof. At the option of a majority of the
holders of Series A-1 preferred stock, such holders may elect to temporarily or
permanently exchange their board observer rights for two seats on the Company’s
board of directors, each having all voting and other rights attendant to any
member of the Company’s board of directors. As part of the
Recapitalization, the right of the holders of Series A-1 preferred stock to
elect a majority of the voting members of the Company’s board of directors shall
be terminated.
As a
result of the reduced conversion prices and exchange of the Series A-3, B-3, C
and D preferred stock into Series A-1 preferred stock and using Black-Scholes,
we calculated a beneficial conversion in the exchange of the Series A-3, B-3, C
and D shares for Series A-1 preferred stock. The beneficial conversion of
$21,000 is treated as a deemed dividend in the Statement of Operations for the
year ended December 31, 2006.
Borrowings
and Commitments from BluePhoenix Solutions
BluePhoenix
Solutions guaranteed certain debt obligations of the Company. In October 2007,
the Company agreed to restructure the Note payable to Bank Hapoalim and guaranty
by BluePhoenix Solutions. Under a new agreement with BluePhoenix, the Company
made a principal reduction payment to Bank Hapoalim in the amount of $300,000.
Simultaneously, BluePhoenix paid $1,671,000 to Bank Hapoalim, thereby
discharging that indebtedness. The Company and BluePhoenix entered into a new
Note in the amount of $1,021,000, bearing interest at LIBOR plus 1.0% and
maturing on December 31, 2011. In addition, BluePhoenix acquired 2,546,149
shares of the Company’s common stock in exchange for $650,000 paid to Bank
Hapoalim to retire that indebtedness. Of the new note payable to
BluePhoenix, approximately $350,000 is due on January 31, 2009 and the balance
is due on December 31, 2011. In November 2006, the Company and
BluePhoenix (formerly Liraz Systems Ltd.) agreed to extend its guaranty on the
term loan and with Bank Hapoalim, to extend the maturity date on the loan until
October 31, 2007. Under the terms of the agreement with Liraz, the Company
agreed to issue 60,000 shares of its common stock. Based upon the fair market
value at the time of issuance, the Company recognized $240,000 as loan
amortization costs in the Statement of Operations for the year ended December
31, 2006. In November 2005, the Company and Liraz Systems Ltd. agreed
to extend its guaranty on the term loan and with Bank Hapoalim, to extend the
maturity date on the loan to October 30, 2006. Under the terms of the agreement
with Liraz, the Company agreed to issue 24,000 shares of its common stock and
granted a warrant to purchase an additional 36,000 shares of our common stock at
an exercise price of $0.20 per share. Based upon fair market value at the time
of issuance, the Company recognized $48,000 as loan amortization costs in the
Statement of Operations for the year ended December 31, 2005.
Transactions
with Board Members
During
2006, under an existing reseller agreement, the Company recognized $100,000 of
software revenue with Pilar Services, Inc. Pilar Services is presently owned and
managed by Charles Porciello who is a member of our Board of Directors. As of
December 31, 2007, the receivable was still outstanding and the Company has
reserved for possible doubtful accounts.
Director
Independence
Our board
of directors currently consists of eleven members. They are John L.
Steffens, John P. Broderick, Mark Landis, Anthony C. Pizi, Bruce Hasenyager, Jay
Kingley, Bruce D. Miller, Charles Porciello, Bruce Percelay, John W. Atherton,
and Don Peppers. Mr. Steffens is the Company’s Chairman of the Board
and Mr. Broderick is the Chief Executive Officer and Chief Financial
Officer. The Company’s stock is quoted on the Over The Counter
Bulletin Board, which does not have director independence requirements. Under
Item 407(a) of Regulation S-B, the Company has chosen to measure the
independence of its directors under the definition of independence used by the
American Stock Exchange, which can be found in the AMEX Company Guide,
§121(A)(2) (2007). Under such definition, Messrs. Steffens,
Hasenyager, Kingley, Miller, Porciello, Percelay, Atherton and Peppers are
independent directors.
Item
14. Principal Ac
coun
tant Fees and
Services
Independent
Registered Public Accounting Firm
Margolis
& Company P.C. audited our financial statements for each of the years ended
December 31, 2007 and 2006.
Audit
Fees
Audit
fees include fees for the audit of the Company’s annual financial statements,
fees for the review of the Company’s interim financial statements, and fees for
services that are normally provided by the Independent Registered Public
Accounting Firm in connection with statutory and regulatory filings or
engagements. The aggregate fees billed by Margolis & Company P.C. for
professional services rendered to our company for the audit of the Company's
annual financial statements for fiscal years 2007 and 2006 (and reviews of
quarterly financial statements on form 10-Q), were $44,000 and $36,000
respectively.
Audit-Related
Fees
Audit-related
fees include fees for assurance and related services that are reasonably related
to the performance of the audit or review of the Company’s financial statements.
There were no audit-related fees paid to Margolis & Company P.C. for fiscal
years 2007 and 2006.
Tax
Fees
Tax fees
include fees for tax compliance, tax advice and tax planning. There were no fees
billed by Margolis & Company P.C. for these services in 2007 and
2006.
Other
Fees
All other
fees include fees for all services except those described above. There were no
other fees paid to Margolis & Company P.C. for fiscal year
2006.
Determination
of Auditor Independence
The Audit
Committee considered the provision of non-audit services by Margolis &
Company P.C. and determined that the provision of such services was consistent
with maintaining the independence of Margolis & Company P.C.
Audit
Committee’s Pre-Approval Policies
The Audit
Committee has adopted a policy that all audit, audit-related, tax and any other
non-audit service to be performed by the Company’s Independent Registered Public
Accounting Firm must be pre-approved by the Audit Committee. It is the Company’s
policy that all such services be pre-approved prior to commencement of the
engagement. The Audit Committee is also required to pre-approve the estimated
fees for such services, as well as any subsequent changes to the terms of the
engagement.
PART
IV
(A) Financial
Statements
The
following financial statements of the Company and the related reports of
Independent Registered Public Accounting Firms thereon are set forth immediately
following the Index of Financial Statements which appears on page F-1 of this
report:
Independent
Registered Public Accounting Firm Report
Consolidated
Balance Sheets as of December 31, 2007 and 2006
Consolidated
Statements of Operations for the years ended December 31, 2007, 2006 and
2005
Consolidated
Statements of Stockholders' Equity for the years ended December 31, 2007, 2006
and 2005
Consolidated
Statements of Comprehensive Loss for the years ended December 31, 2007, 2006 and
2005
Consolidated
Statements of Cash Flows for the years ended December 31, 2007, 2006 and
2005
Notes to
Consolidated Financial Statements
Financial
Statement Schedules
All other
schedules for which provision is made in the applicable accounting regulations
of the Securities and Exchange Commission are not required under the related
instructions or are inapplicable and therefore have been omitted.
Exhibits
The
exhibits listed under Item 15(c) hereof are filed as part of this Annual Report
on Form 10-K.
On July
26, 2007, the Company filed a Form 8-K announcing the resignation of Mr. Anthony
Pizi, the Company’s Chief Information Officer.
On June
20, 2007, the Company filed a Form 8-K reporting the election of Mr. Don Peppers
to the Board of Directors
On May
16, 2007, the Company filed a Form 8-K reporting the election of Mr.
John L Steffens as a member and Chairman of the Board of Directors
On
November 21, 2006, the Company filed a Form 8-K reporting that shareholders
approved an amendment to the Certificate of Incorporation to provide the
Company’s Board of Directors with discretionary authority to effect a reverse
stock split ratio from 20:1 to 100:1 and that on November 20, 2006, the Board of
directors set that reverse stock ratio to be 100:1. In addition, the Company
also reported that shareholders approved an amendment to change the name of the
Company from Level 8 Systems, Inc. to Cicero Inc., to increase the authorized
common stock of the Company from 85 million shares to 215 million shares and to
convert existing preferred shares into a new Series A-1 preferred stock of
Cicero Inc The proposals at the Special Meeting of Stockholders of Level 8
comprised a proposed recapitalization of Level 8 which is also subject to the
receipt of amendments to outstanding convertible promissory notes, senior
reorganization notes and the convertible bridge notes.
On May
15, 2006, the Company filed a Form 8-K reporting the election of Mr. John W.
Atherton to the Board of Directors.
On March
9, 2006, the Company filed a Form 8-K reporting the resignation of Frederic Mack
as a member of the Board of Directors.
On
January 13, 2006, the Company filed a Form 8-K reporting the election of Mr.
Bruce Percelay to the Board of Directors.
(C)
Exhibits
Exhibit
Number
|
Description
|
|
|
3.1
|
Certificate of
Incorporation of Level 8 Systems, Inc., a Delaware corporation, as amended
and restated December 29, 2006 (incorporated by reference to
exhibit 3.1 to Level 8’s Form 8-K filed
January
17, 2007).
|
3.2
|
Certificate
of Designation relating to Series A1 Convertible Redeemable Preferred
Stock (incorporated by reference to exhibit 3.2 to Level 8’s Form 8-K
filed January 17, 2007).
|
3.3
|
Certificate
of Designation relating to Series A3 Convertible Redeemable Preferred
Stock, as amended December 29, 2006 (incorporated by reference to exhibit
3.3 to Level 8’s Level 8’s Form 8-K filed January 17,
2007).
|
3.4
|
Certificate
of Designation relating to Series B3 Convertible Redeemable Preferred as
amended December 29, 2006 (incorporated by reference to exhibit 3.4 to
Level 8’s Level 8’s Form 8-K filed January 17,
2007).
|
3.5
|
Certificate
of designation relating to Series C Convertible Redeemable Preferred Stock
as amended December 29, 2006 (incorporated by reference to exhibit 3.5 to
Level 8’s Level 8’s Form 8-K filed January 17,
2007).
|
3.6
|
Certificate
of designation relating to Series C Convertible Redeemable Preferred Stock
as amended December 29, 2006 (incorporated by reference to exhibit 3.5 to
Level 8’s Level 8’s Form 8-K filed January 17,
2007).
|
3.7
|
Certificate
of designation relating to Series D Convertible Redeemable Preferred Stock
as amended December 29, 2006 (incorporated by reference to exhibit 3.5 to
Level 8’s Level 8’s Form 8-K filed January 17,
2007).
|
3.8
|
Certificate
of Incorporation of Level 8 Systems, Inc., a Delaware corporation, as
amended August 4, 2003 (incorporated by reference to exhibit 3.1 to Level
8’s Form 10-K filed March 31,
2004).
|
3.9
|
Bylaws
of Level 8 Systems, Inc., a Delaware corporation (incorporated by
reference to exhibit 3.2 to Level 8’s Form 10-K filed April 2,
2002).
|
3.10
|
Certificate
of Designations, Preferences and Rights dated March 19, 2003 relating to
Series D Convertible Redeemable Preferred Stock (incorporated by reference
to exhibit 3.1 to Level 8's Form 8-K, filed March 31,
2003).
|
3.11
|
Certificate
of Designation relating to Series A3 Convertible Redeemable Preferred
Stock (incorporated by reference to exhibit 3.1 to Level 8’s Form 10-Q
filed November 15, 2002).
|
3.12
|
Certificate
of Designation relating to Series B3 Convertible Redeemable Preferred
Stock (incorporated by reference to exhibit 3.1 to Level 8’s Form 10-Q
filed November 15, 2002).
|
3.13
|
Certificate
of designation relating to Series C Convertible Redeemable Preferred Stock
(incorporated by reference to exhibit 3.1 to Level 8’d Form 8-K filed
August 27, 2002).
|
4.1
|
Registration
Rights Agreement dated July 2006, by and among Level 8 Systems, Inc. and
the Purchasers in the Senior Placement listed on Schedule I
thereto relating to the Security Purchasers Agreement (filed
herewith).
|
4.2
|
Registration
Rights Agreement, dated January 2004, by and among Level 8 Systems, Inc.
and the Purchasers in the January 2004 Private Placement listed on
Schedule I thereto relating to the Security Purchasers
Agreement (incorporated by reference to exhibit 4.1 to Level
8’s Form 10-K/A filed
April
21, 2004).
|
4.3
|
Registration
Rights Agreement dated as of March 19, 2003 by and among Level 8 Systems,
Inc. and the Purchasers listed on Schedule I thereto relating to the
Series D Convertible Redeemable Preferred Stock (incorporated by reference
to exhibit 4.1 to Level 8’s Form 8-K, filed March 31,
2003).
|
4.4
|
Registration
Rights Agreement dated as of October 15, 2003 by and among Level 8
Systems, Inc. and the Purchasers in the October Private Placement listed
on schedule I thereto (incorporated by reference to exhibit 4.2 to Level
8’s Form 10-K, filed March 31,
2004).
|
4.5
|
Registration
Rights Agreement, dated as of January 16, 2002, by and among Level 8
Systems, Inc. and the Purchasers in the January Private Placement listed
on Schedule I thereto (incorporated by reference to exhibit 4.1 to Level
8's Report on Form 8-K, filed January 25,
2002).
|
4.6
|
Registration
Rights Agreement, dated as of January 3, 2002, between Level 8 Systems,
Inc. and MLBC, Inc. (incorporated by reference to exhibit 4.1 to Level 8's
Report on Form 8-K, filed January 11,
2002).
|
4.7
|
Registration
Rights Agreement, dated as of August 29, 2002, entered into by and between
Level 8 Systems, Inc. and the holders of Series A2/A3 Preferred Stock and
Series B2/B3 Preferred Stock (incorporated by reference to exhibit 10.4 to
Level 8’s Form 8-K filed August 30,
2002).
|
4.7A
|
First
Amendment to Registration Rights Agreement, dated as of October 25, 2002,
entered into by and between Level 8 Systems, Inc. and the holders of
Series A2/A3 Preferred Stock and Series B2/B3 Preferred Stock
(incorporated by reference to exhibit 10.4 to Level 8’s Form 10-Q filed
November 15, 2002).
|
4.8
|
Registration
Rights Agreement, dated as of June 13, 1995, between Level 8 Systems, Inc.
and Liraz Systems Ltd. (incorporated by reference to exhibit 10.24 to
Across Data Systems, Inc.'s (Level 8's predecessor) Registration Statement
on Form S-1, filed May 12, 1995, File No.
33-92230).
|
4.8A
|
First
Amendment to Registration Rights Agreement, dated as of August 8, 2001, to
the Registration Rights Agreement dated as of June 13, 1995, by and
between Across Data Systems, Inc. (Level 8's predecessor) and Liraz
Systems Ltd. (incorporated by reference to exhibit 4.1 to Level 8's Report
on Form 8-K, filed August 14,
2001).
|
4.9
|
Registration
Rights Agreement, dated as of August 14, 2002, entered into by and between
Level 8 Systems, Inc. and the investors in Series C Preferred Stock
(incorporated by reference to exhibit 4.1 to Level 8’s Form 8-K filed
August 27, 2002).
|
4.10
|
Form
of Registration Rights Agreement, dated January 2004, by and among Level 8
Systems, Inc. and the Purchasers of Convertible Promissory Note
(incorporated by reference to exhibit 4.2 to Level 8's Report on Form
10-Q, filed May 12, 2004).
|
4.13
|
Form
of Warrant issued to the Purchasers in the Series D Preferred Stock
transaction dated as of March 19, 2003 (incorporated by reference to
exhibit 4.2 to Level 8's Form 8-K, filed March 31,
2003).
|
|
4.13A
|
Form
of Warrant issued to the Purchasers in the Series D Preferred Stock
transaction dated as of March 19, 2003 (incorporated by reference to
exhibit 4.2 to Level 8's Form 8-K, filed March 31,
2003).
|
4.14
|
Form
of Stock Purchase Warrant issued to Purchasers in the October 2003 Private
Placement (incorporated by reference to exhibit 4.9 to Level 8’s Form
10-K, filed March31, 2004).
|
4.16
|
Form
of Series A3 Stock Purchase Warrant (incorporated by reference to exhibit
10.2 of Level 8’s Form 10-Q filed November 15,
2002).
|
4.17
|
Form
of Series B3 Stock Purchase Warrant (incorporated by reference to exhibit
10.3 of Level 8’s Form 10-Q filed November 15,
2002).
|
4.18
|
Form
of Series C Stock Purchase Warrant (incorporated by reference to exhibit
10.2 to Level 8’s Form 8-K filed August 27,
2002)
|
|
Form
of Long term Promissory Note Stock Purchase Warrant (filed
herewith)
|
10.1
|
Securities
Purchase Agreement for Consortium IV (incorporated by reference to exhibit
10.1 to Cicero Inc.’s Form 10-K/A filed July 11,
2007).
|
10.2
|
Securities
Purchase Agreement dated January 2004 by and among Level 8 Systems, Inc.
and the Purchasers in the January 2004 Private Placement (incorporated by
reference to exhibit 10.1 to Level 8’s Form 10-K/A filed April 21,
2004).
|
10.3
|
Securities
Purchase Agreement dated March 2004 by and among Level 8 Systems, Inc. and
the Purchasers of Convertible Promissory Note (incorporated by reference
to exhibit 10.2 to Level 8's Form 10-Q, filed May 12,
2004).
|
10.3
|
Form
of Convertible Promissory Note dated March 2004 by and among Level 8
Systems, Inc. and the Purchasers of Convertible Promissory Note
(incorporated by reference to exhibit 10.3 to Level 8's Form 10-Q, filed
May 12, 2004).
|
10.4
|
Securities
Purchase Agreement dated as of March 19, 2003 by and among Level 8
Systems, Inc. and the Purchasers (incorporated by reference to exhibit
10.1 to Level 8's Form 8-K, filed March 31,
2003).
|
10.5
|
Securities
Purchase Agreement dated as of October 15, 2003 by and among Level 8
Systems, Inc. and the Purchasers in the October Private Placement
(incorporated by reference to exhibit 10.2 to Level 8’s Form 10-K, filed
March 31, 2004).
|
10.6
|
Securities
Purchase Agreement, dated as of January 16, 2002, by and among Level 8
Systems, Inc. and the Purchasers in the January Private Placement
(incorporated by reference to exhibit 10.1 to Level 8's Report on Form
8-K, filed January 25, 2002).
|
10.7
|
Purchase
Agreement, dated as of January 3, 2002, between Level 8 Systems, Inc. and
MLBC, Inc. (incorporated by reference to exhibit 10.1 to Level
8's Report on Form 8-K, filed January 11,
2002).
|
|
10.7A
|
Purchase
Agreement, dated as of July 31, 2000, between Level 8 Systems, Inc. and
Merrill Lynch, Pierce, Fenner & Smith Incorporated (incorporated by
reference to Exhibit 10.1 to Level 8's Report on Form 8-K, filed August
11, 2000).
|
10.8
|
Securities
Purchase Agreement, dated as of August 14, 2002, by and among Level 8
Systems, Inc. and the purchasers of the Series C Preferred Stock
(incorporated by reference to exhibit 10.1 to Level 8’s Form 8-K filed
August 27, 2002).
|
10.9
|
Agreement
by and among Level 8 Systems, Inc. and the holders of Series A1/A2/A3 and
B1/B2/B3 Preferred Stock, dated as of August 14, 2002 (incorporated by
reference to exhibit 10.3 to Level 8’s Form 8-K filed August 27,
2002).
|
10.10
|
Exchange
Agreement among Level 8 Systems, Inc., and the various stockholders
identified and listed on Schedule I, dated as of August 29, 2002
(incorporated by reference to exhibit 10.1 to Level 8’s Form 8-K filed
August 30, 2002).
|
|
10.11A
|
First
Amendment to Exchange Agreement, dated as of October 25, 2002, among Level
8 Systems, Inc., and the various stockholders identified and listed on
Schedule I to that certain Exchange Agreement, dated as of August 29, 2002
(incorporated by reference to exhibit 10.1 to Level 8’s Form 10-Q filed
November 15, 2002).
|
|
10.11B
|
Securities
Purchase Agreement, dated as of June 29, 1999, among Level 8 Systems, Inc.
and the investors named on the signature pages thereof for the purchase of
Series A Preferred Stock (incorporated by reference to exhibit 10.1 to
Level 8's Form 8-K filed July 23,
1999).
|
|
10.11C
|
Securities
Purchase Agreement, dated as of July 20, 2000, among Level 8 Systems, Inc.
and the investors named on the signature pages thereof for the purchase of
Series B Preferred Stock (incorporated by reference to Exhibit 10.1 to
Level 8's Report on Form 8-K filed July 31,
2000).
|
10.12
|
Amended
PCA Shell License Agreement, dated as of January 3, 2002, between Level 8
Systems, Inc. and Merrill Lynch, Pierce, Fenner & Smith Incorporated
(incorporated by reference to exhibit 10.2 to Level 8's Form 8-K, filed
January 11, 2002).
|
|
10.12A
|
PCA
Shell License Agreement between Level 8 Systems, Inc. and Merrill Lynch,
Pierce, Fenner & Smith Incorporated (incorporated by reference to
exhibit 10.2 to Level 8’s Report on Form 8-K, filed September 11,
2000).
|
|
10.12A
|
OEM
License Agreement between Cicero Inc. and Merrill Lynch, Pierce, Fenner
& Smith Incorporated (filed
herewith).
|
|
10.12A
|
Software
Support and Maintenance Schedule between Cicero Inc. and Merrill Lynch,
Pierce, Fenner & Smith Incorporated (filed
herewith).
|
|
Employment
Agreement between Anthony Pizi and the Company effective January 1, 2007
(filed herewith).*
|
|
Employment
Agreement between John P. Broderick and the Company effective January 1,
2007 (filed herewith).*
|
10.17
|
Lease
Agreement for Cary, N.C. offices, dated November 7, 2003, between Level 8
Systems, Inc. and Regency Park Corporation (incorporated by reference to
exhibit 10.17 to Level 8’s Form 10-K, filed March 31,
2004).
|
10.18
|
Level
8 Systems Inc. 1997 Stock Option Plan, as Amended and Restated
(incorporated by reference to exhibit 10.2 to Level 8’s Registration
Statement of Form S-1/A, filed September 22, 2000, File No.
333-44588).*
|
|
10.18A
|
Fifth
Amendment to Level 8 Systems Inc. 1997 Stock Option Plan (incorporated by
reference to exhibit 10.9A to Level 8’s Form 10-K filed April 2,
2002).*
|
|
10.18B
|
Seventh
Amendment to Level 8 Systems Inc. 1997 Stock Option Plan (incorporated by
reference to exhibit 10.14 B to Level 8’s Form 10-K, filed March 31,
2004).*
|
10.20
|
Lease
Agreement for Cary, N.C. offices, dated March 31, 1997, between Seer
Technologies, Inc. and Regency Park Corporation (incorporated by reference
to exhibit 10.47 to Seer Technologies, Inc.'s Quarterly Report on Form
10-Q for the period ended March 31, 1997, File No.
000-26194).
|
|
10.20A
|
Addendum
#1 to the Lease Agreement for Cary, N.C. offices, dated July 6, 1998
(incorporated by reference to exhibit 10.58 to Seer Technology Inc.'s
Quarterly Report on Form 10-Q for the period ended June 30, 1998, File No.
000-26194).
|
|
10.20B
|
Amendment
to Lease Agreement for Cary, N.C. offices, dated January 21, 1999
(incorporated by reference to exhibit 10.21A to Level 8's Annual Report on
Form 10-K for the fiscal year ended December 31,
1998).
|
|
Lease
Agreement for Cary, N.C. offices, dated August 16
,
2007, between Cicero Inc. and Regency Park Corporation (filed
herewith).
|
|
Cicero
Inc. 2007 Employee Stock Option Plan (filed
herewith).
|
|
Agreement
and Promissory Note of Cicero Inc,, dated October 30, 2007 among Cicero
Inc. and BluePhoenix Solutions Ltd. (filed
herewith).
|
|
Promissory
Note of Cicero Inc., dated October 29, 2007 among Cicero Inc. and John L.
Steffens (filed herewith).
|
|
Securities
Purchase Agreement, dated as of February 26, 2007, by and among Cicero
Inc. and the Purchasers in the February Private Placement (filed
herewith).
|
|
Securities
Purchase Agreement, dated as of August 15, 2007, by and among Cicero Inc.
and the Purchasers in the August Private Placement (filed
herewith).
|
14.1
|
Code
of Ethics (incorporated by reference to exhibit 14.1 to Level 8’s Form
10-K/A, filed
March
31, 2004).
|
|
List
of subsidiaries of the Company (filed
herewith).
|
|
Consent
of Margolis & Company P.C. (filed
herewith).
|
|
Certification
of Chief Executive pursuant to Rule 13a-14(a) (filed
herewith).
|
|
Certification
of Chief Financial Officer pursuant to Rule 13a-14(a) (filed
herewith).
|
|
Certification
of John P. Broderick pursuant to 18 USC § 1350, as adopted pursuant to
§906 of the Sarbanes-Oxley Act of 2002 (filed
herewith).
|
* Management
contract or compensatory agreement.
Pursuant
to the requirements of Section 13 or 15(d) of the Securities Exchange Act of
1934, the Registrant has duly caused this Report to be signed on its behalf by
the undersigned, thereunto duly authorized.
|
CICERO
INC.
|
|
|
|
|
|
By:
/s/
John P. Broderick
|
|
John
P. Broderick
|
|
Chief
Executive Officer
|
|
Date:
March 31, 2008
|
Pursuant
to the requirements of the Securities Exchange Act of 1934, the following
persons on behalf of the Registrant and in the capacities and on the dates
indicated have signed this Report below.
Signature
/s/ John L. Steffens
|
|
Title
|
|
|
John
L. Steffens
/s/ John P.
Broderick
|
|
Chief Executive Officer/Chief Financial
Officer
|
|
|
John
P. Broderick
/s/ Mark
Landis
|
|
(Principal
Executive Officer)
|
|
|
Mark
Landis
/s/ Anthony C.
Pizi
|
|
Director
|
|
|
Anthony
C. Pizi
/s/ Bruce
Hasenyager
|
|
|
|
|
Bruce
Hasenyager
/s/ Jay
Kingley
|
|
|
|
|
Jay
Kingley
/s/ Bruce D.
Miller
|
|
|
|
|
Bruce
D. Miller
/s/ Charles
Porciello
|
|
|
|
|
Charles
Porciello
/s/ Bruce
Percelay
|
|
|
|
|
Bruce
Percelay
/s/ John W.
Atherton
|
|
|
|
|
John
W. Atherton
/s/ Don Peppers
|
|
|
|
|
Don
Peppers
|
|
|
|
|
INDEX TO
FI
NANCIAL STATEMENTS
Report
of Independent Registered Public Accounting Firm
|
F-2
|
Financial
Statements:
|
|
|
|
Consolidated
Balance Sheets
|
F-3
|
|
|
Consolidated
Statements of Operations
|
F-4
|
|
|
Consolidated
Statements of Stockholders' Equity (Deficit)
|
F-5
|
|
|
Consolidated
Statements of Comprehensive Loss
|
F-6
|
|
|
Consolidated
Statements of Cash Flows
|
F-7
|
|
|
Notes
to Consolidated Financial Statements
|
F-9
|
REPORT OF
INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the
Board of Directors and Stockholders of
Cicero
Inc.
Cary,
North Carolina
We have
audited the accompanying consolidated balance sheet of Cicero Inc. and
subsidiaries (the "Company") as of December 31, 2007 and 2006, and the related
consolidated statements of operations, stockholders' equity (deficit),
comprehensive loss and cash flows for each of the years in the three-year period
ended December 31, 2007. Cicero Inc’s management is responsible for
these financial statements. Our responsibility is to express an opinion on these
financial statements based on our audits.
We
conducted our audits in accordance with the standards of the Public Company
Accounting Oversight Board (United States). Those standards require
that we plan and perform the audit to obtain reasonable assurance about whether
the financial statements are free of material misstatement. The
Company is not required to have, nor were we engaged to perform, an audit of its
internal control over financial reporting. Our audit included
consideration of internal control over financial reporting as a basis for
designing audit procedures that are appropriate in the circumstances, but not
for the purpose of expressing an opinion on the effectiveness of the Company’s
internal control over financial reporting. Accordingly, we express no
such opinion. An audit also includes examining, on a test basis,
evidence supporting the amounts and disclosures in the financial statements,
assessing the accounting principles used and significant estimates made by
management, as well as evaluating the overall financial statement
presentation. We believe that our audits provide a reasonable basis
for our opinion.
In our
opinion, the consolidated financial statements referred to above present fairly,
in all material respects, the financial position of Cicero Inc. and subsidiaries
as of December 31, 2007 and 2006, and the results of their operations and their
cash flows for each of the years in the three-year period ended December 31,
2007, in conformity with accounting principles generally accepted in the United
States of America.
The
accompanying consolidated financial statements have been prepared assuming that
the Company will continue as a going concern. As discussed in Note 1
to the consolidated financial statements, the Company's recurring losses from
operations and working capital deficiency raise substantial doubt about its
ability to continue as a going concern. Management's plans concerning
these matters are also described in Note 1. The consolidated
financial statements do not include any adjustments that might result from the
outcome of this uncertainty.
/s/
Margolis & Company P.C.
Certified
Public Accountants
Bala
Cynwyd, PA
March 10,
2008
CICERO
INC.
CONSOLIDATED
BALANCE SHEETS
(in
thousands, except share and per share amounts)
|
|
December
31, 2007
|
|
|
December
31, 2006
|
|
ASSETS
|
|
|
|
|
|
|
Current
assets:
|
|
|
|
|
|
|
Cash
and cash equivalents
|
|
$
|
250
|
|
|
$
|
310
|
|
Assets
of operations to be abandoned
|
|
|
79
|
|
|
|
80
|
|
Trade
accounts receivable, net
|
|
|
692
|
|
|
|
170
|
|
Prepaid
expenses and other current assets
|
|
|
208
|
|
|
|
22
|
|
Total
current assets
|
|
|
1,229
|
|
|
|
582
|
|
Property
and equipment, net
|
|
|
22
|
|
|
|
15
|
|
Total
assets
|
|
$
|
1,251
|
|
|
$
|
597
|
|
LIABILITIES
AND STOCKHOLDERS' DEFICIT
|
|
|
|
|
|
|
|
|
Current
liabilities:
|
|
|
|
|
|
|
|
|
Short-term
debt
(Note
5)
|
|
$
|
1,235
|
|
|
$
|
2,899
|
|
Accounts
payable
|
|
|
2,489
|
|
|
|
2,360
|
|
Accrued
expenses:
|
|
|
|
|
|
|
|
|
Salaries,
wages, and related items
|
|
|
1,002
|
|
|
|
1,012
|
|
Other
|
|
|
2,072
|
|
|
|
1,732
|
|
Liabilities
of operations to be abandoned
|
|
|
455
|
|
|
|
435
|
|
Deferred
revenue
|
|
|
108
|
|
|
|
38
|
|
Total
current liabilities
|
|
|
7,361
|
|
|
|
8,476
|
|
Long-term
debt (Note 6)
|
|
|
1,323
|
|
|
|
33
|
|
Total
liabilities
|
|
|
8,684
|
|
|
|
8,509
|
|
Commitments
and contingencies (Notes 14 and 15)
|
|
|
|
|
|
|
|
|
Stockholders'
deficit:
|
|
|
|
|
|
|
|
|
Convertible
preferred stock, $0.001 par value, 10,000,000 shares
authorized
Series
A-1 – 1,603.6 shares issued and outstanding at December 31, 2007, $500 per
share liquidation preference (aggregate liquidation value of $802) and
1,763.5 shares issued and outstanding at December 31, 2006, $500 per share
liquidation preference (aggregate liquidation value of
$880)
|
|
|
--
|
|
|
|
--
|
|
Common
stock, $0.001 par value, 215,000,000 shares authorized at December 31,
2007 and 2006, respectively; 43,805,508 and 35,182,406 issued and
outstanding at December 31, 2007 and 2006, respectively (Note
2)
|
|
|
44
|
|
|
|
35
|
|
Additional
paid-in-capital
|
|
|
228,858
|
|
|
|
226,407
|
|
|
|
|
|
|
|
|
|
|
Accumulated
deficit
|
|
|
(236,320
|
)
|
|
|
(234,345
|
)
|
Accumulated
other comprehensive loss
|
|
|
(15
|
)
|
|
|
(9
|
)
|
Total
stockholders' deficit
|
|
|
(7,433
|
)
|
|
|
(7,912
|
)
|
Total
liabilities and stockholders' deficit
|
|
$
|
1,251
|
|
|
$
|
597
|
|
The
accompanying notes are an integral part of the consolidated financial
statements.
CICERO
INC.
CONSOLIDATED
STATEMENTS OF OPERATIONS
(in
thousands, except per share amounts)
|
|
Years
Ended December 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
Revenue:
|
|
|
|
|
|
|
|
|
|
Software
|
|
$
|
501
|
|
|
$
|
208
|
|
|
$
|
407
|
|
Maintenance
|
|
|
300
|
|
|
|
120
|
|
|
|
147
|
|
Services
|
|
|
1,007
|
|
|
|
644
|
|
|
|
231
|
|
Total
operating revenue
|
|
|
1,808
|
|
|
|
972
|
|
|
|
785
|
|
Cost
of revenue:
|
|
|
|
|
|
|
|
|
|
|
|
|
Software
|
|
|
19
|
|
|
|
9
|
|
|
|
16
|
|
Maintenance
|
|
|
264
|
|
|
|
212
|
|
|
|
350
|
|
Services
|
|
|
654
|
|
|
|
546
|
|
|
|
822
|
|
Total
cost of revenue
|
|
|
937
|
|
|
|
767
|
|
|
|
1,188
|
|
Gross
margin (loss)
|
|
|
871
|
|
|
|
205
|
|
|
|
(403
|
)
|
Operating
expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales
and marketing
|
|
|
786
|
|
|
|
346
|
|
|
|
627
|
|
Research
and product development
|
|
|
569
|
|
|
|
533
|
|
|
|
891
|
|
General
and administrative
|
|
|
1,356
|
|
|
|
1,206
|
|
|
|
1,137
|
|
(Gain)
on disposal of assets
|
|
|
-
|
|
|
|
(24
|
)
|
|
|
-
|
|
Total
operating expenses
|
|
|
2,711
|
|
|
|
2,061
|
|
|
|
2,655
|
|
Loss
from operations
|
|
|
(1,840
|
)
|
|
|
(1,856
|
)
|
|
|
(3,058
|
)
|
Other
income (charges):
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest
expense
|
|
|
(257
|
)
|
|
|
(853
|
)
|
|
|
(593
|
)
|
Other
|
|
|
122
|
|
|
|
(288
|
)
|
|
|
(30
|
)
|
|
|
|
(135
|
)
|
|
|
(1,141
|
)
|
|
|
(623
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net
loss
|
|
$
|
(1,975
|
)
|
|
$
|
(2,997
|
)
|
|
$
|
(3,681
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accretion
of preferred stock and deemed dividends
|
|
|
-
|
|
|
|
5,633
|
|
|
|
-
|
|
Net
loss applicable to common stockholders
|
|
$
|
(1,975
|
)
|
|
$
|
(8,630
|
)
|
|
$
|
(3,681
|
)
|
Loss
per share:
|
|
|
|
|
|
|
|
|
|
|
|
|
Net
loss applicable to common stockholders - basic and diluted
|
|
$
|
(0.05
|
)
|
|
$
|
(0.25
|
)
|
|
$
|
(8.27
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted
average common shares outstanding - basic and diluted
|
|
|
36,771
|
|
|
|
35,182
|
|
|
|
445
|
|
The
accompanying notes are an integral part of the consolidated financial
statements.
CICERO
INC.
CONSOLIDATED
STATEMENTS OF STOCKHOLDERS' DEFICIT
(in
thousands)
|
|
Common
Stock
|
|
|
Preferred
Stock
|
|
|
Additional
Paid-in
|
|
|
Accumulated
|
|
|
Accumulated
Other
Comprehensive
|
|
|
|
|
|
|
Shares
|
|
|
Amount
|
|
|
Shares
|
|
|
Amount
|
|
|
Capital
|
|
|
(Deficit)
|
|
|
Income
(Loss)
|
|
|
Total
|
|
Balance
at December 31, 2004
|
|
|
43,304
|
|
|
$
|
43
|
|
|
|
33
|
|
|
|
--
|
|
|
$
|
210,142
|
|
|
$
|
(222,034
|
)
|
|
$
|
(8
|
)
|
|
$
|
(11,857
|
)
|
Conversion
of preferred shares to common
|
|
|
395
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
--
|
|
|
|
|
|
|
|
|
|
|
|
--
|
|
Shares
issued as compensation
|
|
|
961
|
|
|
|
2
|
|
|
|
|
|
|
|
|
|
|
|
101
|
|
|
|
|
|
|
|
|
|
|
|
103
|
|
Shares
issued for bank guarantee
|
|
|
2,400
|
|
|
|
2
|
|
|
|
|
|
|
|
|
|
|
|
45
|
|
|
|
|
|
|
|
|
|
|
|
47
|
|
Conversion
of senior convertible redeemable preferred stock
|
|
|
957
|
|
|
|
1
|
|
|
|
|
|
|
|
|
|
|
|
306
|
|
|
|
|
|
|
|
|
|
|
|
307
|
|
Foreign
currency translation adjustment
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5
|
|
|
|
5
|
|
Net
loss
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
_
|
|
|
|
(3,681
|
)
|
|
|
|
|
|
|
(3,681
|
)
|
Balance
at December 31, 2005
|
|
|
48,017
|
|
|
|
48
|
|
|
|
33
|
|
|
|
--
|
|
|
|
210,594
|
|
|
|
(225,715
|
)
|
|
|
(3
|
)
|
|
|
(15,076
|
)
|
Reversed
stock split 100:1
|
|
|
(47,536
|
)
|
|
|
(48
|
)
|
|
|
(33
|
)
|
|
|
|
|
|
|
48
|
|
|
|
|
|
|
|
|
|
|
|
--
|
|
Balance
at December 31, 2005 as adjusted for stock split
|
|
|
481
|
|
|
|
--
|
|
|
|
--
|
|
|
|
--
|
|
|
|
210,642
|
|
|
|
(225,715
|
)
|
|
|
(3
|
)
|
|
|
(15,076
|
)
|
Shares
issued from conversion of senior reorganization debt
|
|
|
3,438
|
|
|
|
3
|
|
|
|
|
|
|
|
|
|
|
|
1,705
|
|
|
|
|
|
|
|
|
|
|
|
1,708
|
|
Shares
issued from conversion of convertible bridge notes
|
|
|
30,508
|
|
|
|
32
|
|
|
|
|
|
|
|
|
|
|
|
3,877
|
|
|
|
|
|
|
|
|
|
|
|
3,909
|
|
Shares
issued for bank guarantee
|
|
|
96
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
312
|
|
|
|
|
|
|
|
|
|
|
|
312
|
|
Shares
issued from short term debt conversion
|
|
|
224
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
190
|
|
|
|
|
|
|
|
|
|
|
|
190
|
|
Shares
issued from conversion of convertible promissory notes
|
|
|
|
|
|
|
|
|
|
|
2
|
|
|
|
|
|
|
|
992
|
|
|
|
|
|
|
|
|
|
|
|
992
|
|
Conversion
of senior convertible redeemable preferred stock
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,061
|
|
|
|
|
|
|
|
|
|
|
|
1,061
|
|
Conversion
of warrants
|
|
|
99
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,086
|
|
|
|
|
|
|
|
|
|
|
|
1,086
|
|
Shares
issued for interest conversion
|
|
|
211
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
629
|
|
|
|
|
|
|
|
|
|
|
|
629
|
|
Shares
issued as compensation
|
|
|
125
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
280
|
|
|
|
|
|
|
|
|
|
|
|
280
|
|
Accretion
of preferred stock
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
529
|
|
|
|
(529
|
)
|
|
|
|
|
|
|
--
|
|
Deemed
dividend
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5,104
|
|
|
|
(5,104
|
)
|
|
|
|
|
|
|
--
|
|
Foreign
currency translation adjustment
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(6
|
)
|
|
|
(6
|
)
|
Net
loss
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(2,997
|
)
|
|
|
|
|
|
|
(2,997
|
)
|
Balance
at December 31, 2006
|
|
|
35,182
|
|
|
|
35
|
|
|
|
2
|
|
|
|
--
|
|
|
|
226,407
|
|
|
|
(234,345
|
)
|
|
|
(9
|
)
|
|
|
(7,912
|
)
|
Shares
issued for private placement
|
|
|
5,892
|
|
|
|
6
|
|
|
|
|
|
|
|
|
|
|
|
1,034
|
|
|
|
|
|
|
|
|
|
|
|
1,040
|
|
Shares
issued for litigation settlement
|
|
|
25
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
50
|
|
|
|
|
|
|
|
|
|
|
|
50
|
|
Conversion
of preferred shares to common
|
|
|
160
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
--
|
|
Options
issued as compensation
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
650
|
|
|
|
|
|
|
|
|
|
|
|
650
|
|
Restricted
shares issued as compensation
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
36
|
|
|
|
|
|
|
|
|
|
|
|
36
|
|
Warrant
issued
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
34
|
|
|
|
|
|
|
|
|
|
|
|
34
|
|
Shares
issued with refinancing of debt
|
|
|
2,546
|
|
|
|
3
|
|
|
|
|
|
|
|
|
|
|
|
647
|
|
|
|
|
|
|
|
|
|
|
|
650
|
|
Foreign
currency translation adjustment
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(6
|
)
|
|
|
(6
|
)
|
Net
loss
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1,975
|
)
|
|
|
|
|
|
|
(1,975
|
)
|
Balance
at December 31, 2007
|
|
|
43,805
|
|
|
$
|
44
|
|
|
|
2
|
|
|
|
--
|
|
|
$
|
228,858
|
|
|
$
|
(236,320
|
)
|
|
$
|
(15
|
)
|
|
$
|
(7,433
|
)
|
The
accompanying notes are an integral part of the consolidated financial
statements.
CICERO
INC.
CONSOLIDATED
STATEMENTS OF COMPREHENSIVE LOSS
(in
thousands)
|
|
Years
Ended December 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
|
|
|
|
|
|
|
|
|
Net
loss
|
|
$
|
(1,975
|
)
|
|
$
|
(2,997
|
)
|
|
$
|
(3,681
|
)
|
Other
comprehensive income (loss), net of tax:
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign
currency translation adjustment
|
|
|
(6
|
)
|
|
|
(6
|
)
|
|
|
5
|
|
Comprehensive
loss
|
|
$
|
(1,981
|
)
|
|
$
|
(3,003
|
)
|
|
$
|
(3,676
|
)
|
The
accompanying notes are an integral part of the consolidated financial
statements.
CICERO
INC.
CONSOLIDATED
STATEMENTS OF CASH FLOWS
(in
thousands)
|
|
Years
Ended December 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
Cash
flows from operating activities:
|
|
|
|
|
|
|
|
|
|
Net
loss
|
|
$
|
(1,975
|
)
|
|
$
|
(2,997
|
)
|
|
$
|
(3,681
|
)
|
Adjustments
to reconcile net loss to net cash (used in) operating
activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation
and amortization
|
|
|
10
|
|
|
|
12
|
|
|
|
11
|
|
Stock
compensation expense
|
|
|
720
|
|
|
|
614
|
|
|
|
149
|
|
Provision
(credit) for doubtful accounts
|
|
|
50
|
|
|
|
60
|
|
|
|
(12
|
)
|
Gain on
disposal of assets
|
|
|
--
|
|
|
|
24
|
|
|
|
--
|
|
Changes
in assets and liabilities, net of assets acquired and liabilities
assumed:
|
|
|
|
|
|
|
|
|
|
|
|
|
Trade
accounts receivable and related party receivables
|
|
|
(622
|
)
|
|
|
(212
|
)
|
|
|
146
|
|
Assets
and liabilities of operations to be abandoned
|
|
|
21
|
|
|
|
(27
|
)
|
|
|
(29
|
)
|
Prepaid
expenses and other assets
|
|
|
(136
|
)
|
|
|
31
|
|
|
|
55
|
|
Accounts
payable and accrued expenses
|
|
|
478
|
|
|
|
311
|
|
|
|
804
|
|
Deferred
revenue
|
|
|
70
|
|
|
|
(40
|
)
|
|
|
(7
|
)
|
Net
cash (used in) operating activities
|
|
|
(1,384
|
)
|
|
|
(2,224
|
)
|
|
|
(2,564
|
)
|
Cash
flows from investing activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Purchases
of property and equipment
|
|
|
(17
|
)
|
|
|
(17
|
)
|
|
|
(6
|
)
|
Net
cash (used in) investing activities
|
|
|
(17
|
)
|
|
|
(17
|
)
|
|
|
(6
|
)
|
Cash
flows from financing activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds
from issuance of common shares, net of issuance costs
|
|
|
1,040
|
|
|
|
380
|
|
|
|
--
|
|
Borrowings
under credit facility, term loans and notes payable
|
|
|
984
|
|
|
|
2,148
|
|
|
|
2,542
|
|
Repayments
of term loans, credit facility and notes payable
|
|
|
(677
|
)
|
|
|
--
|
|
|
|
(55
|
)
|
Net
cash provided by financing activities
|
|
|
1,347
|
|
|
|
2,528
|
|
|
|
2,487
|
|
Effect
of exchange rate changes on cash
|
|
|
(6
|
)
|
|
|
(6
|
)
|
|
|
5
|
|
Net
increase (decrease) in cash and cash equivalents
|
|
|
(60
|
)
|
|
|
281
|
|
|
|
(78
|
)
|
Cash
and cash equivalents at beginning of year
|
|
|
310
|
|
|
|
29
|
|
|
|
107
|
|
Cash
and cash equivalents at end of year
|
|
$
|
250
|
|
|
$
|
310
|
|
|
$
|
29
|
|
|
|
|
|
|
|
SUPPLEMENTAL
DISCLOSURES OF CASH FLOW INFORMATION
|
|
|
|
|
|
Cash
paid during the year for:
|
|
|
|
|
|
|
|
|
|
|
|
|
Income
taxes
|
|
$
|
5
|
|
|
$
|
20
|
|
|
$
|
1
|
|
Interest
|
|
$
|
264
|
|
|
$
|
865
|
|
|
$
|
645
|
|
The
accompanying notes are an integral part of the consolidated financial
statements.
CICERO
INC.
CONSOLIDATED
STATEMENTS OF CASH FLOWS - CONTINUED
Non-Cash Investing and
Financing Activities
2007
During
2007, the Company issued 24,793 shares of common stock to Critical Mass Mail as
part of a litigation settlement valued at $50,000.
In
October 2007, the Company issued 2,546,149 shares of common stock to BluePhoenix
(formerly Liraz Systems Ltd.) in exchange for $650,000 paid to Bank Hapoalim to
retire a portion of that indebtedness.
2006
During
2006, the Company issued 111,000 shares of common stock to vendors for
outstanding liabilities valued at $237,000.
In
November 2006, the Company issued 60,000 shares of common stock to Liraz Systems
Ltd. as compensation for extension of a bank debt guaranty valued at
$240,000.
In
December 2006, the Company issued 224,000 shares of common stock to Liraz
Systems Ltd. for its short term debt and interest of $191,000.
In
December 2006, the Company issued 50,000 shares of common stock to Brown Simpson
Partners I, Ltd. as compensation for assisting in its
recapitalization.
2005
During
2005, the Company issued 9,613 shares of common stock to vendors for outstanding
liabilities valued at $103,000.
In
November 2005, the Company issued 24,000 shares of common stock to a designated
subsidiary of Liraz Systems Ltd. as compensation for extension of a bank debt
guarantee valued at $48,000.
During
2005, the Company issued 9,564 shares of Level 8 Systems common stock upon
conversion of 1,367 shares of Series D Convertible Redeemable Preferred
Stock.
During
2005, 150 shares of Series C Convertible Redeemable Preferred Stock were
converted into 3,947 shares of Level 8 Systems common stock.
NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS
NOTE
1.
|
SUMMARY
OF OPERATIONS, SIGNIFICANT ACCOUNTING POLICIES AND RECENT ACCOUNTING
PRONOUNCEMENTS
|
Cicero
Inc., formerly Level 8 Systems, Inc. (''Cicero'' or the ''Company''), is a
provider of business integration software which enables organizations to
integrate new and existing information and processes at the
desktop. Business integration software addresses the emerging need
for a company's information systems to deliver enterprise-wide views of the
company's business information processes.
Going
Concern:
The
accompanying financial statements have been prepared on a going concern basis,
which contemplates the realization of assets and the satisfaction of liabilities
in the normal course of business. The Company has incurred an
operating loss of approximately $1,975,000 for the year ended
December 31, 2007 and has experienced negative cash flows from operations for
each of the years ended December 31, 2007, 2006 and 2005. At December
31, 2007, the Company had a working capital deficiency of approximately
$6,132,000. The Company’s future revenues are entirely dependent on acceptance
of a newly developed and marketed product, Cicero®, which has had limited
success in commercial markets to date. These factors among others raise
substantial doubt about the Company’s ability to continue as a going concern for
a reasonable period of time.
The
financial statements presented herein do not include any adjustments relating to
the recoverability of assets and classification of liabilities that might be
necessary should the Company be unable to continue as a going
concern. In order to address these issues and to obtain adequate
financing for the Company’s operations for the next twelve months, the Company
is actively promoting and expanding its Cicero®-related product line and
continues to negotiate with significant customers who have expressed interest in
the Cicero® software technology. The Company is experiencing difficulty
increasing sales revenue largely because of the inimitable nature of the product
as well as customer concerns about the financial viability of the Company.
Cicero® software is a new “category defining” product in that most Enterprise
Application Integration (EAI) projects are performed at the server level and
Cicero®’s integration occurs at the desktop without the need to open and modify
the underlying code for those applications being integrated. Many companies are
not aware of this new technology or tend to look toward more traditional and
accepted approaches. The Company is attempting to solve the former problem by
improving the market’s knowledge and understanding of Cicero® software through
increased marketing and leveraging its limited number of reference accounts
while enhancing its list of resellers and system integrators to assist in the
sales and marketing process. Additionally, the Company is seeking additional
equity capital or other strategic transactions in the near term to provide
additional liquidity. Management expects that it will be able to
raise additional capital and to continue to fund operations and also expects
that increased revenues will reduce its operating losses in future periods,
however, there can be no assurance that management’s plan will be executed as
anticipated.
Principles
of Consolidation:
The
accompanying consolidated financial statements include the accounts of the
Company and its subsidiaries. All of the Company's subsidiaries are wholly-owned
for the periods presented.
All
significant inter-company accounts and transactions are eliminated in
consolidation.
Use
of Estimates:
The
preparation of financial statements in conformity with accounting principals
generally accepted in the United States of America requires management to make
estimates and assumptions that affect the reported amounts of assets and
liabilities and disclosure of contingent assets and liabilities at the date of
the financial statements and the reported amounts of revenues and expenses
during the reporting period. Actual amounts could differ from these
estimates.
Financial
Instruments:
The
carrying amount of the Company’s financial instruments, representing accounts
receivable, notes receivable, accounts payable and debt approximate their fair
value.
Foreign
Currency Translation:
The
assets and liabilities of foreign subsidiaries are translated to U.S. dollars at
the current exchange rate as of the balance sheet date. The resulting
translation adjustment is recorded in other comprehensive income as a component
of stockholders' equity. Statements of operations items are translated at
average rates of exchange during each reporting period.
Transaction
gains and losses that arise from exchange rate fluctuations on transactions
denominated in a currency other than the functional currency are included in the
results of operations as incurred.
Cash
and Cash Equivalents:
Cash and
cash equivalents include all cash balances and highly liquid investments with
maturity of three months or less from the date of purchase. For these
instruments, the carrying amount is considered to be a reasonable estimate of
fair value. The Company places substantially all cash and cash equivalents with
various financial institutions. At times, such cash and cash equivalents may be
in excess of FDIC insurance limits.
Trade
Accounts Receivable:
Trade
accounts receivable are stated in the amount management expects to collect from
outstanding balances. Management provides for probable uncollectible
amounts through a charge to earnings and a credit to a valuation allowance based
on its assessment of the current status of individual
accounts. Balances that are still outstanding after management has
used reasonable collection efforts are written off through a charge to the
valuation allowance and a credit to trade accounts
receivable. Changes in the valuation allowance have not been material
to the financial statements.
Property
and Equipment:
Property
and equipment purchased in the normal course of business is stated at cost, and
property and equipment acquired in business combinations is stated at its fair
market value at the acquisition date. All property and equipment is
depreciated using the straight-line method over estimated useful
lives.
Expenditures
for repairs and maintenance are charged to expense as incurred. The cost and
related accumulated depreciation of property and equipment are removed from the
accounts upon retirement or other disposition and any resulting gain or loss is
reflected in the Consolidated Statements of Operations.
Software
Development Costs:
The
Company capitalizes certain software costs after technological feasibility of
the product has been established. Generally, an original estimated economic life
of three years is assigned to capitalized software costs, once the product is
available for general release to customers. Costs incurred prior to the
establishment of technological feasibility are charged to research and product
development expense.
Capitalized
software costs are amortized over related sales on a product-by-product basis
using the straight-line method over the remaining estimated economic life of the
product. (See Note 5.)
The
establishment of technological feasibility and the ongoing assessment of
recoverability of capitalized software development costs require considerable
judgment by management with respect to certain external factors, including, but
not limited to, technological feasibility, anticipated future gross revenue,
estimated economic life and changes in software and hardware
technologies.
Long-Lived
Assets:
The
Company reviews the recoverability of long-lived intangible assets when
circumstances indicate that the carrying amount of assets may not be
recoverable. This evaluation is based on various analyses including undiscounted
cash flow projections. In the event undiscounted cash flow projections indicate
impairment, the Company would record an impairment based on the fair value of
the assets at the date of the impairment. The Company accounts for impairments
under the Financial Accounting Standards Board ("FASB") Statement of Financial
Accounting Standards ("SFAS") No. 144, “Accounting for the Impairment or
Disposal of Long-Lived Assets”.
Revenue
Recognition:
The
Company recognizes license revenue from end-users and third party resellers in
accordance with the American Institute of Certified Public Accountants ("AICPA")
Statement of Position ("SOP") 97-2, “Software Revenue Recognition”, as amended
by SOP 98-9, ''Modification of SOP 97-2, 'Software Revenue Recognition,' with
Respect to Certain Transactions''. The Company reviews each contract
to identify elements included in the software arrangement. SOP 97-2
and SOP 98-9 require that an entity recognize revenue for multiple element
arrangements by means of the ''residual method'' when (1) there is
vendor-specific objective evidence (''VSOE'') of the fair values of all of the
undelivered elements that are not accounted for by means of long-term contract
accounting, (2) VSOE of fair value does not exist for one or more of the
delivered elements, and (3) all revenue recognition criteria of SOP 97-2 (other
than the requirement for VSOE of the fair value of each delivered element) are
satisfied. VSOE of the fair value of undelivered elements is
established on the price charged for that element when sold
separately. Software customers are given no rights of return and a
short-term warranty that the products will comply with the written
documentation. The Company has not experienced any product warranty
returns.
Revenue
from recurring maintenance contracts is recognized ratably over the maintenance
contract period, which is typically twelve months. Maintenance revenue that is
not yet earned is included in deferred revenue.
Revenue
from consulting and training services is recognized as services are performed.
Any unearned receipts from service contracts result in deferred
revenue.
Cost
of Revenue:
The
primary components of the Company's cost of revenue for its software products
are software amortization on internally developed and acquired technology,
royalties on certain products, and packaging and distribution costs. The primary
component of the Company's cost of revenue for maintenance and services is
compensation expense.
Advertising
Expenses:
The
Company expenses advertising costs as incurred. Advertising expenses
were approximately $104,000, $88,000, and $16,000 for the years ended December
31, 2007, 2006 and 2005, respectively.
Research
and Product Development:
Research
and product development costs are expensed as incurred.
Income
Taxes:
The Company uses SFAS No.
109, ''Accounting for Income Taxes'', to account for income taxes. This
statement requires an asset and liability approach that recognizes deferred tax
assets and liabilities for the expected future tax consequences of events that
have been recognized in the Company's financial statements or tax returns. In
estimating future tax consequences,
all
expected future events, other than enactments of changes in the tax law or
rates, are generally considered. A valuation allowance is recorded when it is
''more likely than not'' that recorded deferred tax assets will not be
realized. (See Note 8.)
Stock
Split:
As
discussed in Note 2, the Company’s stockholders approved a 100 to 1 reverse
stock split in November 2006. The Company retained the current par
value of $.001 per share for all common shares. All references in the
financial statements and notes to the number of shares outstanding, per share
amounts, and stock option data of the Company’s common shares have been restated
to reflect the effect of the reverse stock split for the periods
presented.
Loss
Per Share:
Basic
loss per share is computed based upon the weighted average number of common
shares outstanding. Diluted loss per share is computed based upon the weighted
average number of common shares outstanding and any potentially dilutive
securities. During 2007, 2006, and 2005, potentially dilutive securities
included stock options, warrants to purchase common stock, and preferred
stock.
The
following table sets forth the potential shares that are not included in the
diluted net loss per share calculation because to do so would be anti-dilutive
for the periods presented. The amounts have been restated in accordance with SAB
Topic 4 (c ) to reflect the adjustment to the Company’s capitalization as a
result of the 100:1 reverse stock split which was approved by the Company in
November 2006:
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
Stock
options
|
|
|
2,529,025
|
|
|
|
45,315
|
|
|
|
59,009
|
|
Warrants
|
|
|
445,387
|
|
|
|
323,623
|
|
|
|
193,761
|
|
Preferred
stock
|
|
|
1,603,618
|
|
|
|
1,763,478
|
|
|
|
85,046
|
|
|
|
|
4,578,030
|
|
|
|
2,132,416
|
|
|
|
337,816
|
|
In 2007,
2006 and 2005, no dividends were declared on preferred stock.
Stock-Based
Compensation:
During
2006, the Company adopted SFAS No. 123 (revised 2004) (SFAS No. 123R”),
“Share-Based Payment”, which addresses the accounting for stock-based payment
transactions in which an enterprise receives employee services in exchange for
(a) equity instruments of the enterprise or (b) liabilities that are based on
the fair value of the enterprise’s equity instruments or that may be settled by
the issuance of such equity instruments. In January 2005, the SEC
issued SAB No. 107, which provides supplemental implementation guidance for SFAS
No. 123R. SFAS No. 123R eliminates the ability to account for
stock-based compensation transactions using the intrinsic value method under
Accounting Principles Board (“APB”) Opinion No. 25, “Accounting for Stock Issued
to Employees”, and instead generally requires that such transactions be
accounted for using a fair-value-based method. The Company uses the
Black-Scholes option-pricing model to determine the fair-value of stock-based
awards under SFAS No. 123R, consistent with that used for pro forma disclosures
under SFAS No. 123, “Accounting for Stock-Based Compensation”. The
Company has elected to use the modified prospective transition method as
permitted by SFAS No. 123R and, accordingly, prior periods have not been
restated to reflect the impact of SFAS No. 123R. The modified
prospective transition method requires that stock-based compensation expense be
recorded for all new and unvested stock options that are ultimately expected to
vest as the requisite service is rendered beginning on the first day of the
Company’s year ended December 31, 2006. Stock-based compensation
expense for awards granted prior to 2006 is based on the grant-date fair-value
as determined under the pro forma provisions of SFAS No. 123. The
Company granted 2,756,173 options in August 2007 at an exercise price of $0.51
per share. The Company recognized $650,000 of stock-based
compensation. The Company did not grant options during 2006.
Prior to
the adoption of SFAS No. 123R, the Company measured compensation expense for its
employee stock-based compensation plans using the intrinsic value method
prescribed by APB Opinion No. 25. The Company applied the disclosure
provisions of SFAS No. 123 as amended by SFAS No. 148, “Accounting for
Stock-Based Compensation – Transition and Disclosure”, as if the
fair-value-based method had been applied in measuring compensation
expense. Under
APB
Opinion No. 25, when the exercise price of the Company’s employee stock options
was equal to the market price of the underlying stock on the date of the grant,
no compensation expense was recognized.
The
following table illustrates the effect on net loss and net loss per common share
as if the Company had applied the fair value recognition provisions of SFAS No.
123 to stock-based compensation during 2005 (in thousands):
|
|
Years
Ended
December 31,
|
|
|
|
2005
|
|
Net
loss applicable to common stockholders, as reported
|
|
$
|
(3,681
|
)
|
Less: Total
stock-based employee compensation expense under
fair
value based method for all awards, net of related tax effects
|
|
|
(180
|
)
|
|
|
|
|
|
Pro
forma loss applicable to common stockholders
|
|
$
|
(3,861
|
)
|
|
|
|
|
|
Loss
per share:
|
|
|
|
|
Basic
and diluted, as reported
|
|
$
|
(8.27
|
)
|
Basic
and diluted, pro forma
|
|
$
|
(8.68
|
)
|
The fair
value of the Company's stock-based awards to employees was estimated as of the
date of the grant using the Black-Scholes option-pricing model, using the
following weighted-average assumptions:
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
|
|
|
|
|
|
|
|
|
Expected
life (in years)
|
|
10.0
years
|
|
|
3.6
years
|
|
|
6.0
years
|
|
Expected
volatility
|
|
|
166
|
%
|
|
|
140
|
%
|
|
|
149
|
%
|
Risk
free interest rate
|
|
|
5.25
|
%
|
|
|
4.93
|
%
|
|
|
4.48
|
%
|
Expected
dividend yield
|
|
|
0
|
%
|
|
|
0
|
%
|
|
|
0
|
%
|
Reclassifications:
Certain
prior year amounts in the accompanying financial statements have been
reclassified to conform to the 2007 presentation. Such reclassifications had no
effect on previously reported net loss or stockholders’ deficit.
Recent
Accounting Pronouncements:
In
February 2007, the FASB issued SFAS 159, “The Fair Value Option for Financial
Assets and Financial Liabilities – an amendment of FASB Statement
115”. The statement permits entities to choose to measure many
financial instruments and certain other items at fair value. The
objective is to improve financial reporting by providing entities with the
opportunity to mitigate volatility in reported earnings caused by measuring
related assets and liabilities differently without having to apply complex hedge
provisions. Most of the provisions of this statement apply only to
entities that elect the fair value option; however , the amendment to FASB
Statement 115, “Accounting for Certain Investment in Debt and Equity Services,”
applies to all entities with available-for-sale and trading
securities. The Company does not believe adoption of this statement
will have a material impact on the Company’s financial statements.
In July
2006, the FASB issued FIN No. 48, “Accounting for Uncertainty in Income Taxes –
An Interpretation of SFAS No. 109”. FIN No. 48 clarifies the
accounting for uncertainty in income taxes recognized in an enterprise’s
financial statements in accordance with SFAS No. 109, “Accounting for Income
Taxes.” FIN No. 48 also prescribes a recognition threshold and
measurement attribute for financial statement recognition and measurement of a
tax position taken or expected to be taken in a tax return. In
addition, FIN No. 48 provides guidance on derecognition, classification,
interest and penalties, accounting in interim periods, disclosure and
transition. The provisions of FIN No. 48 are to be applied to all tax
positions upon initial adoption of this standard. Only tax positions
that meet the more-likely-than-not recognition threshold at the effective date
may be recognized or continue to be recognized as an adjustment to the opening
balance of accumulated deficit (or other appropriate components of equity) for
that fiscal year. The provisions of FIN No. 48 are effective for
fiscal years beginning after December 15, 2006. The adoption of this
new standard did not have a material impact on our financial position, results
of operations, or cash flows.
In
September 2006, the Securities and Exchange Commission (“SEC”) issued Staff
Accounting Bulleting (“SAB”) 108, to address diversity in practice in
quantifying financial statement misstatements. SAB 108 requires that
the Company quantify
misstatements
based on their impact on each of its financial statements and related
disclosures. SAB 108 is effective for fiscal years ending after
November 15, 2006. The Company has adopted SAB 108 effective as of
December 31, 2006. The adoption of this bulletin did not have a
material impact on our financial position, results of operations, or cash
flows.
In
September 2006, the FASB issued SFAS No. 157, “Fair Value
Measurements”. SFAS No. 157 provides guidance for using fair value to
measure assets and liabilities. It also responds to investors’
requests for expanded information about the extent to which companies measure
assets and liabilities at fair value, the information used to measure fair
value, and the effect of fair value measurements on earnings. SFAS
No. 157 applies whenever other standards require (or permit) assets or
liabilities to be measured at fair value, and does not expand the use of fair
value in any new circumstances. SFAS No. 157 is effective for
financial statements issued for fiscal years beginning after November 15, 2007
and is required to be adopted by the Company in the first quarter of
2008. The Company is currently evaluating the effect that the
adoption of SFAS No. 157 will have on our financial position, results of
operations, or cash flows.
NOTE
2. RECAPITALIZATION
In
November 2006, the Company’s stockholders approved an amendment to the
Certificate of Incorporation to provide the Company’s Board of Directors with
discretionary authority to effect a reverse stock split ratio from 20:1 to 100:1
and on November 20, 2006, the Board of Directors set that reverse stock ratio to
be 100:1. In addition, the Company’s stockholders approved an amendment to
change the name of the Company from Level 8 Systems, Inc. to Cicero Inc., to
increase the authorized common stock of the Company from 85 million shares to
215 million shares and to convert existing preferred shares into a new Series
A-1 preferred stock of Cicero Inc. The proposals at the Special
Meeting of Stockholders of Level 8 comprised a proposed recapitalization of
Level 8 which was also subject to the receipt of amendments to outstanding
convertible promissory notes, senior reorganization notes and the convertible
bridge notes.
As part
of the plan of recapitalization, Senior Reorganization Notes in the aggregate
principal amount of $2,559,000 to Senior Reorganization Noteholders who had
loaned funds to the Company in exchange for Senior Reorganization Notes and
Additional Warrants at a special one-time exercise price of $0.10 per share, (i)
will receive and have automatically exercised Additional Warrants exercisable
into shares of Common Stock, by applying the accrued interest on their Senior
Reorganization Notes and by cashless exercise to the extent of the balance of
the exercise price, (ii) if a holder of existing warrants who advanced the
exercise price of their warrants to the Company, will have their existing
warrants automatically exercised and (iii) those Senior Reorganization
Noteholders who loaned the Company the first $1,000,000 in respect of the
exercise price of their existing warrants will receive Early Adopter Warrants of
the Company at a ratio of 2:1 for shares issuable upon exercise of each existing
warrant exercised at the special exercise price of $10.00 per share. At the time
of issuance of the Senior Reorganization Notes, the trigger for conversion into
exercisable warrants was an anticipated recapitalization merger. Since the
recapitalization plan was amended, the Company solicited Senior Noteholders for
their consent to convert upon approval of the plan of recapitalization by
stockholders. Approximately $2,309,000 of the Senior Reorganization
Noteholders have consented to the change in the “trigger” and have cancelled
their notes and converted into 3,438,473 shares of the Company’s common
stock.
In
accordance with EITF 98-5, “Accounting for Convertible Securities with
Beneficial Conversion Features or Contingently Adjustable Conversion Ratios”,
the Company has allocated the proceeds received from the Note and Warrant
Offering between the warrants exercised and the future warrants granted and has
employed the Black-Scholes valuation method to determine the fair value of the
warrants exercised and the additional warrants issued. The Senior Reorganization
Noteholders who have consented to convert their debt amounted to approximately
$2,309,000. Of that amount, approximately $979,000 represents the exercise price
of existing warrants that was loaned to the Company for which the warrant
holders will receive both additional warrants and early adopter warrants. Using
the Black-Scholes formula, the Company has determined that the fair value of the
warrants granted to this tranche was approximately $440,000. The difference
between the fair value of the additional warrants and the total invested in this
tranche, or $539,000, was treated as a beneficial conversion and fully
amortizable. The second tranche of investment that consisted of those warrant
holders who loaned the exercise price of their existing warrants,
and received additional warrants but no early adopter warrants, amounted to
approximately $107,000. Using Black-Scholes, the Company has determined that the
fair value of the warrants granted to this tranche was
approximately $32,000 and the beneficial conversion amount was $75,000. The
third tranche consisted of investors who had no existing warrants and will only
receive additional warrants upon consummation of the Recapitalization. The total
investment in this tranche was $1,223,000. Using Black-Scholes, the Company has
determined that the fair value of the warrants granted to this tranche was
approximately $570,000 and the beneficial conversion amount was $653,000. Since
this beneficial conversion feature was immediately convertible upon
issuance, the Company has fully amortized this beneficial conversion feature in
the Statement of Operations for the year ended December 31,
2006.
Also as
part of the recapitalization plan, Convertible Bridge Notes in the principal
amount of $3,915,000 are automatically cancelled and converted into 30,508,448
shares of the Company’s common stock. Also in accordance with EITF 98-5, using
the Black-Scholes formula, the Company has calculated the fair value of the
common stock resulting from conversion of the Convertible Bridge Notes. Based
upon that calculation, the fair value of the stock received was $195,000. The
difference between the total of the Convertible Bridge Notes and the fair value
of the stock ($3,720,000) is treated as a beneficial conversion. Since this
beneficial conversion feature is immediately convertible upon issuance, the
Company has fully amortized this beneficial conversion feature in the Statement
of Operations for the year ended December 31, 2006.
The
Company had issued $992,000 aggregate principal amount of Convertible Promissory
Notes. As part of the recapitalization plan, these Noteholders were
offered reduced conversion prices to convert their notes into shares of the
Company’s new series A-1 preferred stock. All Noteholders have agreed to convert
their notes into shares of Series A-1 preferred stock. The Company has cancelled
these notes and issued 1,591 shares of its Series A-1 preferred stock. In
accordance with EITF 98-5 and specifically paragraph 8, the Company has utilized
the Black-Scholes formula to determine the fair value of the stock received. The
Company has calculated the fair value of the stock received to be $484,000
resulting in a beneficial conversion of $508,000. Since this beneficial
conversion is immediately recognizable by the holders, the Company has fully
amortized this conversion and recorded an accretion to preferred stock in the
Statement of Operations for the year ended December 31, 2006.
Holders
of the Company’s Series A-3, B-3, C and D preferred stock were offered reduced
conversion rates on their existing preferred stock in exchange for shares in a
new Series A-1 preferred stock for Cicero Inc. as part of the recapitalization
plan. As a result of stockholder approval, the Company affected an exchange of
existing preferred shares into 172.15 Series A-1 preferred shares. In exchange
for the reduced conversion prices, holders of the series A-3, B-3 and D shares
forfeited their anti-dilution protection along with certain other rights, ranks
and privileges. The Company’s Series D preferred stock contained a redemption
feature which required that the Company account for same as a liability. The
Company’s Series A-1 preferred stock contains no redemption features and
accordingly, upon exchange, the fair value of these shares were converted to
equity. The Company employed the Black-Scholes formula to value the shares
exchanged and have determined that the reduced conversion prices and exchange
has created a beneficial conversion of $21,000. As the new Series A-1 preferred
shares are immediately convertible, the Company has recorded this beneficial
conversion as a deemed dividend in the Statement of Operations for the year
ended December 31, 2006.
NOTE
3. ACCOUNTS
RECEIVABLE
Trade
accounts receivable was composed of the following at December 31 (in
thousands):
|
|
2007
|
|
|
2006
|
|
Current
trade accounts receivable
|
|
$
|
792
|
|
|
$
|
230
|
|
Less:
allowance for doubtful accounts
|
|
|
100
|
|
|
|
60
|
|
|
|
$
|
692
|
|
|
$
|
170
|
|
The
(credit) provision for uncollectible amounts was $50,000, $60,000, and
($12,000), for the years ended December 31, 2007, 2006, and 2005,
respectively. Write-offs (net of recoveries) of accounts receivable
were ($0) for the years ended December 31, 2007, 2006 and
2005.
NOTE
4. PROPERTY AND
EQUIPMENT
Property
and equipment was composed of the following at December 31 (in
thousands):
|
|
2007
|
|
|
2006
|
|
Computer
equipment
|
|
$
|
263
|
|
|
$
|
252
|
|
Furniture
and fixtures
|
|
|
8
|
|
|
|
8
|
|
Office
equipment
|
|
|
154
|
|
|
|
149
|
|
|
|
|
425
|
|
|
|
409
|
|
Less:
accumulated depreciation and amortization
|
|
|
(403
|
)
|
|
|
(394
|
)
|
|
|
|
|
|
|
|
|
|
|
|
$
|
22
|
|
|
$
|
15
|
|
Depreciation
and amortization expense of property and equipment was $10,000, $12,000, and
$11,000, for the years ended December 31, 2007, 2006, and 2005,
respectively.
NOTE
5. SHORT-TERM
DEBT
Term
loan, notes payable, and notes payable to related party consist of the following
at December 31(in thousands):
|
|
2007
|
|
|
2006
|
|
Term
loan (a)
|
|
$
|
--
|
|
|
$
|
1,971
|
|
Note
payable related party (b)
|
|
|
49
|
|
|
|
9
|
|
Notes
payable (c)
|
|
|
1,186
|
|
|
|
919
|
|
|
|
$
|
1,235
|
|
|
$
|
2,899
|
|
(a)
|
The
Company had a $1,971 term loan bearing interest at LIBOR plus
1.5%. Interest was payable quarterly. There are no
financial covenants and the term loan was guaranteed by Liraz Systems Ltd.
(now known as BluePhoenix Solutions), the Company’s former principal
stockholder. The loan matured on October 31,
2007. In October 2007, the Company, in conjunction with Blue
Phoenix Solutions, retired the term loan. (See Note
14.)
|
(b)
|
In
November 2007, the Company entered into a short term note payable with
John L. (Launny) Steffens, the Chairman of the Board of Directors, for
various working capital needs. The Note bears interest at 6% per year and
is unsecured. At December 31, 2007, the Company was indebted to Mr.
Steffens in the amount of $40,000.
|
From time
to time the Company entered into promissory notes with one of the Company’s
directors and the former Chief Information Officer, Anthony Pizi. The
notes bear interest at 12% per annum. As of December 31, 2007 and 2006, the
Company was indebted to Anthony Pizi in the amount of $9,000.
(c)
|
The
Company does not have a revolving credit facility and from time to time
has issued a series of short term promissory notes with private lenders,
which provide for short term borrowings, both secured by accounts
receivable and unsecured. In addition, the Company has settled
certain litigation and agreed to issue a series of promissory notes to
support its obligations in the aggregate principal amount of
$88,000. The notes bear interest between 10% and 36% per
annum.
|
Long-term
loan and notes payable to related party consist of the following at December
31(in thousands):
|
|
2007
|
|
|
2006
|
|
Term
loan (a)
|
|
$
|
1,021
|
|
|
$
|
--
|
|
Note
payable; related party (b)
|
|
|
300
|
|
|
|
--
|
|
Other
long-term debt
|
|
|
2
|
|
|
|
33
|
|
|
|
$
|
1,323
|
|
|
$
|
33
|
|
(a)
|
In
October 2007, the Company, in conjunction with Blue Phoenix Solutions,
retired the note payable to Bank Hapoalim and entered into a new note with
Blue Phoenix Solutions in the principal amount of $1,021,000 with interest
at Libor plus 1% (approximately 5.86% at December 31, 2007) maturing in
December 2011. Interest is payable
quarterly.
|
(b)
|
In
October 2007, the Company entered into a long-term note with John L.
(Launny) Steffens, the Chairman on the Board of Directors, as part of the
restructuring of the Note payable to Bank Hapoalim. The Note
bears interest of 3% and matures in October 2009. At December
31, 2007, the Company was indebted to Mr. Steffens in the amount of
$300,000.
|
Scheduled
maturities of the above debt are as follows:
Year
|
|
|
|
2008
|
|
$
|
2
|
|
2009
|
|
$
|
300
|
|
2011
|
|
$
|
1,021
|
|
NOTE
7. INCOME
TAXES
A
reconciliation of expected income tax at the statutory federal rate with the
actual income tax provision is as follows for the years ended December 31 (in
thousands):
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
Expected
income tax benefit at statutory rate (34%)
|
|
$
|
(672
|
)
|
|
$
|
(1,019
|
)
|
|
$
|
(1,251
|
)
|
State
taxes, net of federal tax benefit.
|
|
|
(118
|
)
|
|
|
(180
|
)
|
|
|
(308
|
)
|
Effect
of change in valuation allowance
|
|
|
788
|
|
|
|
1,073
|
|
|
|
1,537
|
|
Non-deductible
expenses
|
|
|
2
|
|
|
|
126
|
|
|
|
22
|
|
Total
|
|
$
|
--
|
|
|
$
|
--
|
|
|
$
|
--
|
|
Significant
components of the net deferred tax asset (liability) at December 31 were as
follows:
|
|
2007
|
|
|
2006
|
|
Current
assets:
|
|
|
|
|
|
|
Allowance
for doubtful accounts
|
|
$
|
44
|
|
|
$
|
24
|
|
Accrued
expenses, non-tax deductible
|
|
|
222
|
|
|
|
279
|
|
Deferred
revenue
|
|
|
44
|
|
|
|
15
|
|
Noncurrent
assets:
|
|
|
|
|
|
|
|
|
Stock
Compensation Expense
|
|
|
287
|
|
|
|
--
|
|
Loss
carryforwards
|
|
|
92,337
|
|
|
|
91,016
|
|
Depreciation
and amortization
|
|
|
5,119
|
|
|
|
5,931
|
|
|
|
|
98,053
|
|
|
|
97,265
|
|
|
|
|
|
|
|
|
|
|
Less:
valuation allowance
|
|
|
(98,053
|
)
|
|
|
(97,265
|
)
|
|
|
|
|
|
|
|
|
|
|
|
$
|
--
|
|
|
$
|
--
|
|
At
December 31, 2007, the Company had net operating loss carryforwards of
approximately $230,847,000, which may be applied against future taxable income.
These carryforwards will expire at various times between 2008 and 2027. A
substantial portion of these carryforwards are restricted to future taxable
income of certain of the Company's subsidiaries or limited by Internal Revenue
Code Section 382. Thus, the utilization of these carryforwards cannot be
assured. Net operating loss carryforwards include tax deductions for the
disqualifying dispositions of incentive stock options. When the Company utilizes
the net operating loss related to these deductions, the tax benefit will be
reflected in additional paid-in capital and not as a reduction of tax expense.
The total amount of these deductions included in the net operating loss
carryforwards is $21,177,000.
The
undistributed earnings of certain foreign subsidiaries are not subject to
additional foreign income taxes nor considered to be subject to U.S. income
taxes unless remitted as dividends. The Company intends to reinvest such
undistributed earnings indefinitely; accordingly, no provision has been made for
U.S. taxes on those earnings. The determination of the amount of the
unrecognized deferred tax liability related to the undistributed earnings is not
practicable.
The
Company provided a full valuation allowance on the total amount of its deferred
tax assets at December 31, 2007 and 2006 since management does not believe
that it is more likely than not that these assets will be realized.
NOTE
8. STOCKHOLDERS’
EQUITY
Common Stock
:
During
2007, the Company completed two common stock financing rounds wherein it raised
a total of $1,033,000 of capital from several new investors as well as certain
members of its Board of Directors. In February 2007, the Company sold 3,723,007
shares of its common stock for $0.1343 per share for a total of
$500,000. In October 2007, the Company completed a private sale of
shares of its common stock to a group of investors, four of which are members of
our Board of Directors. Under the terms of that agreement, the Company sold
2,169,311 shares of its common stock for $0.2457 per share for a total of
$533,000.
These
shares were issued in reliance upon the exemption from registration under Rule
506 of Regulation D and on the exemption from registration provided by Section
4(2) of the Securities Act of 1933 for transactions by an issuer not involving a
public offering.
As part
of the recapitalization plan described in Note 2, the Company converted
outstanding convertible promissory notes, senior reorganization notes and
convertible bridge notes. Senior reorganization debt amounting to $2,309,000 was
cancelled and converted into 3,438,473 shares of the Company’s common stock. The
Company also converted $3,915,000 of Convertible Bridge Notes into 30,508,448
shares of Cicero common stock. These shares were issued in reliance upon the
exemption
from registration under Rule 506 of Regulation D and on the exemption from
registration provided by Section 4(2) of the Securities Act of 1933 for
transactions by an issuer not involving a public offering.
In August
2007, the Company issued Mr. John P. Broderick, our Chief Executive Officer, a
restricted stock award in the amount of 549,360 shares which will vest to him
upon his resignation or termination. The Company used the
Black-Scholes method to value these shares and assumed a life of 10
years. The Company recorded compensation expense of approximately
$36,000 for fiscal 2007.
Stock Options
:
In 2007,
the Board of Directors approved the 2007 Cicero Employee Stock Option Plan which
permits the issuance of incentive and nonqualified stock options, stock
appreciation rights, performance shares, and restricted and unrestricted stock
to employees, officers, directors, consultants, and advisors. The aggregate
number of shares of common stock which may be issued under this Plan shall not
exceed 4,500,000 shares upon the exercise of awards and provide that the term of
each award be determined by the Board of Directors. The Company also
has a stock incentive plan for outside directors and the Company has set aside
1,200 shares of common stock for issuance under this plan. The Company's 1997
Employee Stock Option Plan expired during 2007.
Under the
terms of the Plans, the exercise price of the incentive stock options may not be
less than the fair market value of the stock on the date of the award and the
options are exercisable for a period not to exceed ten years from date of grant.
Stock appreciation rights entitle the recipients to receive the excess of the
fair market value of the Company's stock on the exercise date, as determined by
the Board of Directors, over the fair market value on the date of grant.
Performance shares entitle recipients to acquire Company stock upon the
attainment of specific performance goals set by the Board of Directors.
Restricted stock entitles recipients to acquire Company stock subject to the
right of the Company to repurchase the shares in the event conditions specified
by the Board are not satisfied prior to the end of the restriction period. The
Board may also grant unrestricted stock to participants at a cost not less than
85% of fair market value on the date of sale. Options granted vest at varying
periods up to five years and expire in ten years.
Activity
for stock options issued under these plans for the fiscal years ending December
31, 2007, 2006 and 2005 was as follows:
|
|
Plan Activity
|
|
|
Option Price
Per Share
|
|
|
Weighted Average
Exercise Price
|
|
Balance
at December 31, 2004
|
|
|
74,887
|
|
|
|
12.00
– 3,931.00
|
|
|
|
111.00
|
|
Granted
|
|
|
2,529
|
|
|
|
7.00
– 12.00
|
|
|
|
9.00
|
|
Exercised
|
|
|
(2,529
|
)
|
|
|
7.00
– 12.00
|
|
|
|
9.00
|
|
Forfeited
|
|
|
(15,877
|
)
|
|
|
22.00
– 3,931.00
|
|
|
|
75.00
|
|
Balance
at December 31, 2005
|
|
|
59,010
|
|
|
|
12.00
– 3,931.00
|
|
|
|
124.00
|
|
Forfeited
|
|
|
(13,695
|
)
|
|
|
22.00
– 3,931.00
|
|
|
|
137.14
|
|
Balance
at December 31, 2006
|
|
|
45,315
|
|
|
|
12.00
– 3,931.00
|
|
|
|
120.61
|
|
Granted
|
|
|
2,756,173
|
|
|
|
0.51
|
|
|
|
0.51
|
|
Forfeited
|
|
|
(270,413
|
)
|
|
|
0.51
– 612.50
|
|
|
|
12.21
|
|
Expired
|
|
|
(2,050
|
)
|
|
|
1,473.00
|
|
|
|
1,473.00
|
|
Balance
at December 31, 2007
|
|
|
2,529,025
|
|
|
|
0.51
– 3,931.00
|
|
|
|
1.35
|
|
There
were 2,756,173 options granted during 2007 and none during 2006. The weighted
average grant date fair value of options issued during the years ended December
31, 2007 and 2005 was equal to $0.51 and $9.00 per share, respectively. There
were no option grants issued below fair market value during 2007 and
2005.
At
December 31, 2007, 2006, and 2005, options to purchase 888,634, 45,315, and
5,237 shares of common stock were exercisable, respectively, pursuant to the
plans at prices ranging from $0.51 to $3,931.25. The following table summarizes
information about stock options outstanding at December 31, 2007:
EXERCISE PRICE
|
|
|
NUMBER
OUTSTANDING
|
|
|
REMAINING
CONTRACTUAL
LIFE
FOR OPTIONS
OUTSTANDING
|
|
|
NUMBER
EXERCISABLE
|
|
|
WEIGHTED
AVERAGE
EXERCISE
PRICE
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$0.51-0.51
|
|
|
|
2,500,760
|
|
|
|
9.6
|
|
|
|
860,369
|
|
|
$
|
0.51
|
|
|
0.52-393.12
|
|
|
|
26,680
|
|
|
|
5.5
|
|
|
|
26,680
|
|
|
|
40.60
|
|
|
393.13-786.25
|
|
|
|
1,350
|
|
|
|
3.2
|
|
|
|
1,350
|
|
|
|
532.20
|
|
|
786.26-1,179.37
|
|
|
|
165
|
|
|
|
2.0
|
|
|
|
165
|
|
|
|
944.41
|
|
|
1,179.38-3,538.12
|
|
|
|
40
|
|
|
|
2.6
|
|
|
|
40
|
|
|
|
1,881.25
|
|
|
3,538.13-3,931.25
|
|
|
|
30
|
|
|
|
2.2
|
|
|
|
30
|
|
|
|
3,931.25
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,529,025
|
|
|
|
9.6
|
|
|
|
888,634
|
|
|
$
|
2.91
|
|
Preferred Stock
:
As part
of the recapitalization plan approved by shareholders in November 2006, the
Company offered to exchange its existing Series A-3, B-3, C and D preferred
shares at reduced conversion rates in exchange for shares of a new Series A-1
preferred stock in Cicero Inc. This proposal also required approval by existing
preferred shareholders as a class. The new conversion prices with respect to the
Series A-3, B-3 and D preferred stock were negotiated with the holders of each
series based upon such factors as the current conversion price in relation to
the market, the dollar amount represented by such series and, waiver of
anti-dilution, liquidation preferences, seniority and other senior
rights. The conversion price for the Series C preferred stock was
determined in relation to the conversion price for the Series D preferred
stock. The Board of Directors determined the new conversion price of
each series of Level 8 preferred stock after discussion and review of those
rights, ranks and privileges that were being waived by the present holders of
preferred stock. Among those rights being waived are anti-dilution
protection, liquidation preferences and seniority.
The
holders of the Series A-1 preferred stock shall have the rights and preferences
set forth in the Certificate of Designations filed with the Secretary of State
of the State of Delaware upon the approval of the
Recapitalization. The rights and interests of the Series A-1
preferred stock of the Company will be substantially similar to the rights
interests of each of the series of the former Level 8 preferred stock
other than for (i) anti-dilution protections that have been permanently waived
and (ii) certain voting, redemption and other rights that holders of Series A-1
preferred stock will not be entitled to. All shares of Series A-1
preferred stock will have a liquidation preference
pari passu
with all other
Series A-1 preferred stock.
The
Series A-1 preferred stock is convertible at any time at the option of the
holder into an initial conversion ratio of 1,000 shares of Common Stock for each
share of Series A-1 preferred stock. The initial conversion ratio
shall be adjusted in the event of any stock splits, stock dividends and other
recapitalizations. The Series A-1 preferred stock is also convertible
on an automatic basis in the event that (i) the Company closes on an additional
$5,000,000 equity financing from strategic or institutional investors, or (ii)
the Company has four consecutive quarters of positive cash flow as reflected on
the Company’s financial statements prepared in accordance with generally
accepted accounting principals (“GAAP”) and filed with the
Commission. The holders of Series A-1 preferred stock are entitled to
receive equivalent dividends on an as-converted basis whenever the Company
declares a dividend on its Common Stock, other than dividends payable in shares
of Common Stock. The holders of the Series A-1 preferred stock are
entitled to a liquidation preference of $500 per share of Series A-1 preferred
stock upon the liquidation of the Company. The Series A-1 preferred
stock is not redeemable.
The
holders of Series A-1 preferred stock also possess the following voting
rights. Each share of Series A-1 preferred stock shall represent that
number of votes equal to the number of shares of Common Stock issuable upon
conversion of a share of Series A-1 preferred stock. The holders of
Series A-1 preferred stock and the holders of Common Stock shall vote together
as a class on all matters except: (i) regarding the election of the Board
of Directors of the Company (as set forth below); (ii) as required by law; or
(iii) regarding certain corporate actions to be taken by the Company (as
set forth below).
The
approval of at least two-thirds of the holders of Series A-1 preferred stock
voting together as a class, shall be required in order for the Company to: (i)
merge or sell all or substantially all of its assets or to recapitalize or
reorganize; (ii) authorize the issuance of any equity security having any right,
preference or priority superior to or on parity with the Series A-1 preferred
stock; (iii) redeem, repurchase or acquire indirectly or directly any of its
equity securities, or to pay any dividends on the Company’s equity securities;
(iv) amend or repeal any provisions of its certificate of incorporation or
bylaws that would adversely affect the rights, preferences or privileges of the
Series A-1 preferred stock; (v) effectuate a significant change in the principal
business of the Company as conducted at the effective time of the
Recapitalization; (vi) make any loan or advance to any entity other than in the
ordinary course of business unless such entity is wholly owned by the Company;
(vii) make any loan or advance to any person, including any employees or
directors of the Company or any subsidiary, except in the ordinary course of
business or pursuant to an approved employee stock or option plan; and (viii)
guarantee, directly or indirectly any indebtedness or obligations, except for
trade accounts of any subsidiary arising in the ordinary course of
business. In addition, the unanimous vote of the Board of
Directors is required for any liquidation, dissolution, recapitalization or
reorganization of the Company. The voting rights of the holders
of Series A-1 preferred stock set forth in this paragraph shall be terminated
immediately upon the closing by the Company of at least an additional $5,000,000
equity financing from strategic or institutional investors.
In
addition to the voting rights described above, the holders of a majority of the
shares of Series A-1 preferred stock are entitled to appoint two observers to
the Company’s Board of Directors who shall be entitled to receive all
information received by members of the Board of Directors, and shall attend and
participate without a vote at all meetings of the Company’s Board of Directors
and any committees thereof. At the option of a majority of the
holders of Series A-1 preferred stock, such holders may elect to temporarily or
permanently exchange their board observer rights for two seats on the Company’s
Board of Directors, each having all voting and other rights attendant to any
member of the Company’s Board of Directors. As part of the
Recapitalization, the right of the holders of Series A-1 preferred stock to
elect a majority of the voting members of the Company’s Board of Directors shall
be terminated.
As a
result of the reduced conversion prices the Company exchanged all of the Series
A-3, B-3, C and D preferred stock into 172 shares of Series A-1 preferred stock
and using Black-Scholes, we calculated a beneficial conversion in the exchange
of the Series A-3, B-3, C and D shares for Series A-1 preferred stock. The
beneficial conversion of $21,000 is treated as a deemed dividend in the
Statement of Operations for the year ended December 31, 2006.
As part
of the recapitalization plan, Noteholders of $992,000 of Convertible Promissory
Notes were offered reduced conversion prices to convert their notes into shares
of the Company’s new series A-1 preferred stock. All Noteholders have agreed to
convert their notes into shares of Series A-1 preferred stock. The Company has
cancelled these notes and issued 1,591 shares of its Series A-1 preferred stock.
In accordance with EITF 98-5 and specifically paragraph 8, the Company has
utilized the Black-Scholes formula to determine the fair value of the stock
received. The Company has calculated the fair value of the stock received to be
$484,000 resulting in a beneficial conversion of $508,000. Since this beneficial
conversion is immediately recognizable by the holders, the Company has fully
amortized this conversion and recorded an accretion to preferred stock in the
Statement of Operations for the year ended December 31, 2006.
During
2005 and 2004, there were 456 shares of preferred stock converted into 13,511
shares of the Company's common stock and 4,686 shares of preferred stock
converted into 70,375 shares of the Company’s common stock,
respectively. There were 1,571 shares of the Series A3 Preferred
Stock and 30,000 shares of Series B3 Preferred Stock, 991 shares of Series C
Preferred Stock, and 1,061 shares of Series D Preferred Stock
outstanding at December 31, 2005.
Stock
Warrants:
The
Company values warrants based on the Black-Scholes pricing
model. Warrants granted in 2007, 2006 and 2005 were valued using the
following assumptions:
|
|
Expected
Life in
Years
|
|
|
Expected
Volatility
|
|
|
Risk
Free Interest
Rate
|
|
Expected
Dividend
|
|
Fair
Value of Common
Stock
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred
Series D-1 Warrants
|
|
|
5
|
|
|
|
117
|
%
|
|
|
3
|
%
|
None
|
|
$
|
7.00
|
|
Preferred
Series D-2 Warrants
|
|
|
5
|
|
|
|
102
|
%
|
|
|
3
|
%
|
None
|
|
$
|
20.00
|
|
Early
Adopter Warrants
|
|
|
4
|
|
|
|
104
|
%
|
|
|
4
|
%
|
None
|
|
$
|
1.50
|
|
Long
Term Promissory Note Warrants
|
|
|
10
|
|
|
|
168
|
%
|
|
|
5.25
|
%
|
None
|
|
$
|
0.18
|
|
Increase
in Capital Stock:
In
November 2006, the stockholders approved a proposal to amend the Amended and
Restated Certificate of Incorporation to increase the aggregate number of shares
of Common Stock that the Company is authorized to issue from 85,000,000 to
215,000,000.
NOTE
9. EMPLOYEE BENEFIT
PLANS
The
Company sponsors one defined contribution plan for its U.S. employees - the
Cicero Inc 401(K) Plan. Under the terms of the Plan, the Company, at
its discretion, provides a 50% matching contribution up to 6% of an employee’s
salary. Participants must be eligible company plan participants and
employed at December 31 of each calendar year to be eligible for employer
matching contributions. Matching contributions to the Plan included in the
Consolidated Statements of Operations totaled $0, $0 and $30,000, for the years
ended December 31, 2007, 2006, and 2005, respectively. On December 1, 2005,
the Company suspended further contributions to the defined contribution
plan.
The
Company also had employee benefit plans for each of its foreign subsidiaries, as
mandated by each country's laws and regulations. The Company’s
foreign subsidiaries are no longer active.
NOTE
10. SIGNIFICANT CUSTOMERS AND
CONCENTRATION OF CREDIT RISK
In 2007,
one customer accounted for 87.2% of operating revenues and represented 100% of
accounts receivable at December 31, 2007. In 2006, four customers
accounted for 50.0%, 18.7%, 13.3% and 10.0% of operating revenue. In 2005, two
customers accounted for 52.4% and 13.0% of operating revenues.
NOTE
11. FOREIGN CURRENCIES
The
Company’s net foreign currency transaction losses/ (gains) were $15,000,
$14,000, and $(23,000), for the years ended 2007, 2006, and 2005,
respectively.
NOTE
12. SEGMENT INFORMATION AND GEOGRAPHIC
INFORMATION
Based
upon the current business environment in which the Company operates, the
economic characteristics of its operating segments and management’s view of the
business, a revision in terms of aggregation of its segments was appropriate.
Therefore the segment discussion outlined below clarifies the adjusted segment
structure as determined by management under SFAS No. 131. All prior year amounts
have been restated to conform to the new reporting segment
structure.
Management
makes operating decisions and assesses performance of the Company’s operations
based on one reportable segment, it’s the Software product
segment. Prior to this change the Company had segregated into two
separate segments: Desktop Integration and Messaging. The Messaging business has
always been an immaterial part of the Company’s overall business and generally
all its sales efforts are focused on the Cicero product. As such, the Company
has elected to combine the two products into one reportable
segment.
The
Software product segment is comprised of the Cicero® product and the Ensuredmail
product. Cicero® is a business integration software product that
maximizes end-user productivity, streamlines business operations and integrates
disparate systems and applications, while renovating or rejuvenating older
legacy systems by making them usable in the business processes.Ensuredmail is an
encrypted email technology that can reside on either the server or the
desktop.
The table
below presents information about reported segments for the year ended December
31, 2007, 2006 and 2005 (in thousands):
|
|
For
the year ended December 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
Total
revenue
|
|
$
|
1,808
|
|
|
$
|
972
|
|
|
$
|
785
|
|
Total
cost of revenue
|
|
|
937
|
|
|
|
767
|
|
|
|
1,188
|
|
Gross
margin (loss)
|
|
|
871
|
|
|
|
205
|
|
|
|
(403
|
)
|
Total
operating expenses
|
|
|
2,711
|
|
|
|
2,085
|
|
|
|
2,655
|
|
Segment
loss
|
|
$
|
(1,840
|
)
|
|
$
|
(1,880
|
)
|
|
$
|
(3,058
|
)
|
A
reconciliation of segment operating expenses to total operating expense follows
(numbers are in thousands):
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
Segment
operating expenses
|
|
$
|
2,711
|
|
|
$
|
2,085
|
|
|
$
|
2,655
|
|
(Gain)
on disposal of assets
|
|
|
--
|
|
|
|
(24
|
)
|
|
|
--
|
|
Total
operating expenses
|
|
$
|
2,711
|
|
|
$
|
2,061
|
|
|
$
|
2,655
|
|
A
reconciliation of total segment profitability to net loss for the fiscal years
ended December 31(in thousands):
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
Total
segment profitability (loss)
|
|
$
|
(1,840
|
)
|
|
$
|
(1,880
|
)
|
|
$
|
(3,058
|
)
|
Gain
on disposal of assets
|
|
|
--
|
|
|
|
24
|
|
|
|
--
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest
and other income/(expense), net
|
|
|
(135
|
)
|
|
|
(1,141
|
)
|
|
|
(623
|
)
|
Net
loss
|
|
$
|
(1,975
|
)
|
|
$
|
(2,997
|
)
|
|
$
|
(3,681
|
)
|
The
following table presents a summary of revenue by geographic region for the years
ended December 31(in thousands):
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
|
|
|
|
|
|
|
|
|
USA
|
|
|
1,808
|
|
|
|
972
|
|
|
|
783
|
|
Italy
|
|
|
-
|
|
|
|
-
|
|
|
|
2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
1,808
|
|
|
$
|
972
|
|
|
$
|
785
|
|
Presentation
of revenue by region is based on the country in which the customer is domiciled.
As of December 31, 2007, 2006 and 2005, all of the long-lived assets of the
Company are located in the United States.
NOTE
13. RELATED PARTY
INFORMATION
BluePhoenix
Solutions, formerly Liraz Systems Ltd., the Company’s former principal
stockholder, guaranteed certain debt obligations of the Company. In October
2007, the Company agreed to restructure the note payable to Bank Hapoalim and
guaranty by BluePhoenix Solutions. Under a new agreement with BluePhoenix, the
Company made a principal reduction payment to Bank Hapoalim in the amount of
$300,000. Simultaneously, BluePhoenix paid $1,671,000 to Bank Hapoalim, thereby
discharging that indebtedness. The Company and BluePhoenix entered into a new
Note in the amount of $1,021,000, bearing interest at LIBOR plus 1.0% and
maturing on December 31, 2011. In addition, BluePhoenix acquired 2,546,149
shares of the Company’s common stock in exchange for $650,000 paid to Bank
Hapoalim to retire that indebtedness. Of the new note payable to
BluePhoenix, approximately $350,000 is due on January 31, 2009 and the balance
is due on December 31, 2011. In November 2006, the Company and Liraz
agreed to extend the guaranty and with the approval of the lender, agreed to
extend the maturity of the debt obligation until October 31, 2007. The Company
issued 60,000 shares of common stock to Liraz in exchange for this debt
extension.
In
October 2007, the Company entered into a long-term note with John L. (Launny)
Steffens, the Chairman on the Board of Directors, as part of the restructuring
of the Note payable to Bank Hapoalim. The Note bears interest of 3%
and matures in October 2009. At December 31, 2007, the Company was
indebted to Mr. Steffens in the amount of $300,000.
In
November 2007, the Company entered into a short term note
payable with John L.
(Launny) Steffens, the Chairman of the Board of Directors, for various working
capital needs. The Note bears interest at 6% per year and is unsecured. At
December 31, 2007, the Company was indebted to Mr. Steffens in the amount of
$40,000.
During
2006, under an existing reseller agreement, the Company recognized $100,000 of
software revenue with Pilar Services, Inc. Pilar Services is presently owned and
managed by Charles Porciello who is a member of our Board of Directors. As of
December 31, 2007, the receivable was still outstanding and the Company has
reserved 100% of the balance as doubtful.
From time
to time during 2005 and 2004, the Company entered into short term notes payable
with Anthony Pizi, the Company’s former Chief Information Officer. The Notes
bear interest at 1% per month and are unsecured. At December 31, 2007, the
Company was indebted to Mr. Pizi in the amount of $9,000.
Convertible Promissory Notes:
Directors and executive officers made the following loans to the Company for
convertible promissory notes: In June 2004, the Company entered into
a convertible loan agreement with Mr. Pizi in the amount of $100,000. Under the
terms of the agreement, the loan bears interest at 1% per month and is
convertible upon the option of the Note holder into 270,270 shares of our common
stock and warrants to purchase 270,270 shares of our common stock exercisable at
$0.37. The warrants expire in three years from the date of grant. As part of the
recapitalization plan, the Company has offered to lower that conversion rate and
exchange the Note for 14 shares of Series A-1 preferred stock.
In November 2006, the
Noteholder consented to the amended conversion rate and the Note has been
cancelled.
In July
2004, the Company entered into a convertible promissory note with Mr. Pizi in
the face amount of $112,000. Under the terms of the agreement, the
loan bears interest at 1% per month and is convertible upon the option of the
Note holder into 560,000 shares of our common stock and warrants to purchase
560,000 shares of our common stock at $0.20 per share. As part of the
recapitalization plan, the Company has offered to lower that conversion rate and
exchange the Note for 78.4 shares of Series A-1 preferred stock.
In November 2006, the
Noteholder consented to the amended conversion rate and the Note has been
cancelled. Also in July 2004, Mr. Pizi entered into a second convertible
promissory note in the face amount of $15,000 which bears interest at 1% per
month and is convertible into 90,118 shares of our common stock and warrants to
purchase 90,118 shares of our common stock at $0.17 per share. All
such warrants expire three years from the date of grant. As part of the
recapitalization plan, the Company has offered to lower that conversion rate and
exchange the note for 12.62 shares of Series A-1 preferred stock
.
In November 2006, the
Noteholder consented to the amended conversion rate and the Note has been
cancelled.
In March
2004, the Company entered into a convertible promissory note with Mr. and Mrs.
Mark Landis in the amount of $125,000. Mr. Landis is a director and
the Company’s former Chairman of the Board and Mr. and Mrs. Landis are
parents-in-law to Mr. Pizi, the Company’s former Chief Information Officer.
Under
the terms of the agreement, the loan bears interest at 1% per month and is
convertible upon the option of the note holder into 446,429 shares of our common
stock and warrants to purchase 446,429 shares of our common stock exercisable at
$0.28. The warrants expire in three years from the date of grant. As part of the
recapitalization plan, the Company has offered to lower that conversion rate and
exchange the note for 62.5 shares of Series A-1 preferred stock.
In
November 2006, the Noteholder consented to the amended conversion rate and the
Note has been cancelled.
In June
2004, the Company entered into a convertible promissory note with Mr. and Mrs.
Landis in the amount of $125,000. Under the terms of the note, the loan bears
interest at 1% per month and is convertible into 781,250 shares of the Company’s
common stock and warrants to purchase 781,250 shares of Level 8 common stock
exercisable at $0.16 per share. The warrants expire in three years from the date
of grant. As part of the recapitalization plan, the Company has offered to lower
that conversion rate and exchange the note for 113.64 shares of Series A-1
preferred stock. In November 2006, the Noteholder consented to the amended
conversion rate and the Note has been cancelled.
In
October 2004, the Company entered into a convertible promissory note with Mr.
and Mrs. Landis in the amount of $100,000. Under the terms of the agreement, the
loan bears interest at 1% per month and is convertible into 1,000,000 shares of
our common stock and warrants to purchase 2,000,000 shares of the Company’s
common stock exercisable at $0.10 per share. The warrants expire in three
years. As part of the recapitalization plan, the Company has offered
to lower that conversion rate and exchange the note for 400 shares of Series A-1
preferred stock
.
In November 2006,
the Noteholder consented to the amended conversion rate and the Note has been
cancelled.
In
November 2004, the Company entered into a convertible promissory note with Mr.
and Mrs. Landis, in the amount of $150,000. Under the terms of the agreement,
the loan bears interest at 1% per month and is convertible into 1,875,000 shares
of our common stock and warrants to purchase 1,875,000 shares of the Company’s
common stock exercisable at $0.08 per share. All such warrants expire three
years from the date of grant. As part of the recapitalization plan, the Company
has offered to lower that conversion rate and exchange the note for 750 shares
of Series A-1 preferred stock. In November 2006, the Noteholder
consented to the amended conversion rate and the Note has been
cancelled.
In June
2004, the Company entered into a convertible promissory note with Fredric Mack,
a former director of the Company, in the amount of $125,000. Under the terms of
the note, the loan bears interest at 1% per month, and is convertible into
390,625 shares of the Company’s common stock and warrants to purchase 390,625
shares of the Company’s common stock exercisable at $0.32 per
share. As part of the recapitalization plan, the Company has offered
to lower that conversion rate and exchange the note for 54.69 shares of Series
A-1 preferred stock. In November 2006, the Noteholder consented
to the amended conversion rate and the Note has been cancelled.
In April
2005, the Company entered into a convertible promissory note with Bruce Miller,
a director of the Company, in the amount of $30,000. Under the terms of the
note, the loan bears interest at 1% per month and is convertible into 428,571
shares of the Company’s common stock. As part of the recapitalization plan, the
Company has offered to lower that conversion rate and exchange the note for 60
shares of Series A-1 preferred stock.
In November 2006, the
Noteholder consented to the amended conversion rate and the Note has been
cancelled.
In July
2004, the Company entered into a convertible promissory note with Nicholas
Hatalski, who until July 22, 2005 (during the period when the terms of the
recapitalization merger were being negotiated and at the time of approval of the
recapitalization merger by our board of directors), was a director of the
Company, in the amount of $25,000. Under the terms of the note, the loan bears
interest at 1% per month and is convertible into 78,125 shares of the Company’s
common stock and warrants to purchase 78,125 shares of the Company’s common
stock exercisable at $0.32 per share. As part of the recapitalization plan, the
Company has offered to lower that conversion rate and exchange the note for
10.94 shares of Series A-1 preferred stock.
In November 2006, the
Noteholder consented to the amended conversion rate and the Note has been
cancelled.
All of
such warrants expire three years from date of grant.
Senior Reorganization
Notes. From March 2004 to April 2005, directors and executive
officers made the following loans to us for Senior Reorganization
Notes: Mr. Pizi held $423,333 of Senior Reorganization Notes, which
were converted into warrants to purchase an additional 5,716 shares of Cicero
common stock at a purchase price of $0.20 per share.
Mr.
Landis held $327,860 of Senior Reorganization Notes, which were converted into
warrants to purchase an additional 4,423 shares of Cicero common stock at an
exercise price of $0.20 per share.
Mr. Mack
held, together with his affiliates, $88,122 of Senior Reorganization Notes,
which were converted into warrants to purchase an additional 1,122 shares of
Cicero common stock at a purchase price of $0.20 per share.
Mr.
Miller held, together with his affiliates, $77,706 of Senior Reorganization
Notes, which were converted into warrants to purchase an additional 1,145 shares
of Cicero common stock at a purchase price of $0.20.
Mr.
Atherton held, together with his affiliates, $20,000 of Senior Reorganization
Notes which were converted into warrants to purchase an additional 2,898 shares
of Cicero common stock at a purchase price of $0.20.
Mr.
Broderick, Chief Executive Officer and Chief Financial Officer of the Company,
held $2,300 of Senior Reorganization Notes, which were converted into warrants
to purchase 3,222 shares of the Cicero Inc. common stock at a purchase price of
$0.20 per share, and options to purchase 12,609 shares of common stock under the
Company’s stock option plan that will convert into options to purchase Cicero
common stock.
Such
warrants are only issuable upon approval of the recapitalization merger, and
were automatically exercised in connection with the consummation of the
recapitalization plan.
Convertible Bridge
Notes
. From July 2005 to December 2006, directors and
executive officers made the following loans to the Company for Convertible
Bridge Notes:
Mr. Pizi
held $85,000 of Convertible Bridge Notes which bore interest at 10% and matured
on September 15, 2005. These notes automatically converted into
680,000 shares of Cicero common stock upon approval of the recapitalization plan
by stockholders.
Mr.
Landis held $395,000 of Convertible Bridge Notes which bore interest at 10% and
matured on various dates in 2005 and 2006. These notes automatically
converted into 3,160,000 shares of Cicero common stock upon approval of the
recapitalization plan by stockholders.
Mr. Mack
held, together with his affiliates, $114,000 of Convertible Bridge Notes which
bear interest at 10% and matured on various dates in 2005 and
2006. These notes automatically converted into 897,564 shares of
Cicero common stock upon approval of the recapitalization plan by
stockholders.
Mr.
Miller held, together with his affiliates, $120,000 of Convertible Bridge Notes
which bear interest at 10% and matured on various dates in 2005 and
2006. These notes automatically converted into 947,273 shares of
Cicero common stock upon approval of the recapitalization plan by
stockholders.
Mr. Bruce
Hasenyager, a member of our Board of Directors, held $4,061 of Convertible
Bridge Notes which bear interest at 10% and matured on September 15, 2005. These
notes automatically converted into 32,485 shares of Cicero common stock upon
approval of the recapitalization plan by stockholders.
Mr. Bruce
Percelay, a member of our Board of Directors, held $130,000 of Convertible
Bridge Notes which bear interest at 10% and matured on various dates in 2005 and
2006. These notes automatically converted into 1,027,273 shares of Cicero common
stock upon approval of the recapitalization plan by stockholders.
Mr. John
W. Atherton, a member of our Board of Directors, held $15,000 of convertible
Bridge Notes which bear interest at 10% and matured during 2006. These notes
automatically converted into 120,000 shares of Cicero common stock upon approval
of the recapitalization plan by stockholders.
Mr.
Charles Porciello, a member of our Board of Directors, held $10,000 of
Convertible Bridge Notes which bear interest at 10% and matured during 2006.
These notes automatically converted into 80,000 shares of Cicero common stock
upon approval of the recapitalization plan by stockholders.
NOTE
14. LEASE COMMITMENTS
The
Company leases certain facilities and equipment under various operating
leases. Future minimum lease commitments on operating leases that
have initial or remaining non-cancelable lease terms in excess of one year as of
December 31, 2007 consisted of only one lease as follows (in
thousands):
|
|
Lease
Commitments
|
|
|
|
|
|
2008
|
|
$
|
103
|
|
2009
|
|
|
97
|
|
2010
|
|
|
101
|
|
|
|
$
|
301
|
|
Rent
expense for the years ended December 31, 2007, 2006, and 2005 was $74,000,
$60,000, and $122,000, respectively. As of December 31, 2007,
2006, and 2005, the Company had no sublease arrangements.
NOTE
15. CONTINGENCIES
Various
lawsuits and claims have been brought against us in the normal course of our
business.
In
October 2003, we were served with a summons and complaint in Superior Court of
North Carolina regarding unpaid invoices for services rendered by one of our
subcontractors. The amount in dispute was approximately $200,000 and
is included in accounts payable. Subsequent to March 31, 2004, we settled this
litigation. Under the terms of the settlement agreement, we agreed to
pay a total of $189,000 plus interest over a 19-month period ending November 15,
2005. The Company is in the process of negotiating a series of payments for the
remaining liability of approximately $80,000.
Under the
indemnification clause of the Company’s standard reseller agreements and
software license agreements, the Company agrees to defend the reseller/licensee
against third party claims asserting infringement by the Company’s products of
certain intellectual property rights, which may include patents, copyrights,
trademarks or trade secrets, and to pay any judgments entered on such claims
against the reseller/licensee.
NOTE
16. SELECTED QUARTERLY FINANCIAL DATA
(UNAUDITED)
|
|
First
Quarter
|
|
|
Second
Quarter
|
|
|
Third
Quarter
|
|
|
Fourth
Quarter
|
|
|
|
(In
thousands, except per share data)
|
|
2007:
|
|
|
|
|
|
|
|
|
|
|
|
|
Net
revenues
|
|
$
|
232
|
|
|
$
|
316
|
|
|
$
|
387
|
|
|
$
|
873
|
|
Gross
margin
|
|
|
65
|
|
|
|
160
|
|
|
|
82
|
|
|
|
564
|
|
Net
income/(loss)
|
|
|
(529
|
)
|
|
|
(452
|
)
|
|
|
(966
|
)
|
|
|
(29
|
)
|
Net
loss/share –basic and diluted attributed
to
common stockholders
|
|
$
|
(0.01
|
)
|
|
$
|
(0.01
|
)
|
|
$
|
(0.02
|
)
|
|
|
--
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006:
|
|
|
|
|
|
|
|
|
|
|
|
|
Net
revenues
|
|
$
|
281
|
|
|
$
|
320
|
|
|
$
|
248
|
|
|
$
|
123
|
|
Gross
margin/(loss)
|
|
|
75
|
|
|
|
114
|
|
|
|
60
|
|
|
|
(44
|
)
|
Net
loss
|
|
|
(576
|
)
|
|
|
(515
|
)
|
|
|
(647
|
)
|
|
|
(1,259
|
)
|
Net
loss/share –basic and diluted attributed to common
stockholders
|
|
$
|
(0.01
|
)
|
|
$
|
(0.01
|
)
|
|
$
|
(0.01
|
)
|
|
$
|
(0.22
|
)
|
NOTE
17. SUBSEQUENT EVENTS
In March
2008, the Company was notified that a group of investors including two members
of the Board of Directors acquired a short term promissory note due SDS Merchant
Fund in the principal amount of $250,000. The note is unsecured and bears
interest at 10% per annum. Also in March, our Board of Directors approved a
resolution to convert this debt plus accrued interest into common stock of the
Company. The total principal and interest amounted to $361,827 and is being
converted into 1,417,264 shares of common stock. Mr. John Steffens, the
Company’s Chairman, will acquire 472,516 shares and Mr. Bruce Miller, also a
member of our Board of Directors, will acquire 472,374 shares.
In March
2008, the Company amended the terms of its Note Payable with BluePhoenix
Solutions. Under the terms of the original Note, the Company was to make a
principal reduction payment in the amount of $350,000 on January 30, 2009. The
Company and BluePhoenix agreed to accelerate that principal payment to March and
April 2008 in return for a conversion of $50,000 into 195,848 shares of the
Company’s common stock. In March, the Company paid $200,000 plus accrued
interest and in April, the Company will pay $100,000 plus accrued
interest.
F -
28
THE
SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED WITH THE SECURITIES AND
EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON
AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE
"SECURITIES ACT"), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT
TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO
AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE
REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH
APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO
THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY
ACCEPTABLE TO THE COMPANY.
October
29, 2007
188,285
Shares
|
Warrant
No. 2007PN01-01
|
CICERO,
INC.
STOCK
PURCHASE WARRANT
THIS IS
TO CERTIFY THAT JOHN L. STEFFENS (the “
Holder
”), or its
registered assigns, is entitled, at any time prior to the Expiration Date (as
hereinafter defined), to purchase from CICERO, INC., a Delaware corporation (the
“
Company
”) (the
Company and the Holder are hereinafter referred to collectively as the “
Parties
” and
individually as a “
Party
”),
188,285
shares of Common Stock
(as hereinafter defined and subject to adjustment as provided herein), in whole
or in part, at a purchase price of $0.18 per share (subject to adjustment as
provided herein), on the terms and conditions and pursuant to the provisions
hereinafter set forth.
As used
in this Warrant, the following terms have the respective meanings set forth
below:
“
Additional Shares of Common
Stock
” shall mean all shares of Common Stock issued by the Company after
the Closing, other than Warrant Stock.
“
Business Day
” shall
mean any day that is not a Saturday or Sunday or a day on which banks are
required or permitted to be closed in the State of New York.
“
Closing Date
” shall
have the meaning set forth in the Purchase Agreement.
“
Commission
” shall
mean the Securities and Exchange Commission or any other Federal agency then
administering the Securities Act and other Federal securities
laws.
Exhibit
4.19
“
Common Stock
” shall
mean (except where the context otherwise indicates) the common stock, $.001 par
value, of the Company as constituted on the Closing Date, and any capital stock
into which such Common Stock may thereafter be changed, and shall also include
(i) capital stock of the Company of any other class (regardless of how
denominated) issued to the holders of shares of Common Stock upon any
reclassification thereof which is also not preferred as to dividends or assets
over any other class of stock of the Company and which is not subject to
redemption and (ii) shares of common stock of any successor or acquiring
corporation (as defined in Section 4.4) received by or distributed to the
holders of Common Stock of the Company in the circumstances contemplated by
Section 4.4.
“
Convertible
Securities
” shall mean evidences of indebtedness, shares of stock or
other securities which are convertible into or exchangeable, with or without
payment of additional consideration in cash or property, for Additional Shares
of Common Stock, either immediately or upon the occurrence of a specified date
or a specified event.
“
Current Market Price
”
shall mean, in respect of any share of Common Stock on any date herein specified
(i) the closing sales price on such day on the NASDAQ National Market System
(“NASDAQ”) or the principal stock exchange on which such Common Stock is listed
or admitted to trading, (ii) if no sale takes place on such day on NASDAQ or any
such exchange, the average of the last reported closing bid and asked prices on
such day as officially quoted on NASDAQ or any such exchange, (iii) if the
Common Stock is not then listed or admitted to trading on NASDAQ or any stock
exchange, the average of the last reported closing bid and asked prices on such
day in the over-the-counter market, as furnished by the National Association of
Securities Dealers Automatic Quotation System or the National Quotation Bureau,
Inc., (iv) if neither such corporation at the time is engaged in the business of
reporting such prices, as furnished by any similar firm then engaged in such
business, or (v) if there is no such firm, as furnished by any member of the
NASD selected mutually by the Holder and the Company or, if they cannot agree
upon such selection, as selected by two such members of the NASD, one of which
shall be selected by the Holder and one of which shall be selected by the
Company.
“
Current Warrant
Price
” shall mean, in respect of a share of Common Stock at any date
herein specified, $0.18 per share of Common Stock as of the date hereof, subject
to adjustment as provided herein.
"
Date of Exercise
"
shall have the meaning set forth in Section 2.1(b).
“
Exchange Act
” shall
mean the Securities Exchange Act of 1934, as amended, or any similar Federal
statute, and the rules and regulations of the Commission thereunder, all as the
same shall be in effect from time to time.
“
Exercise Period
”
shall mean the period during which this Warrant is exercisable pursuant to
Section 2.1.
“
Expiration Date
”
shall mean October 30, 2017.
“
Holder
” shall mean
the Person in whose name the Warrant set forth herein is registered on the books
of the Company maintained for such purpose.
Exhibit
4.19
“
NASD
” shall mean the
National Association of Securities Dealers, Inc., or any successor corporation
thereto.
“
Other Property
” shall
have the meaning set forth in Section 4.4.
“
Outstanding
” shall
mean, when used with reference to Common Stock, at any date as of which the
number of shares thereof is to be determined, all issued shares of Common Stock,
except shares then owned or held by or for the account of the Company or any
subsidiary thereof, and shall include all shares issuable in respect of
outstanding scrip or any certificates representing fractional interests in
shares of Common Stock.
“
Person
” shall mean
any individual, sole proprietorship, partnership, limited liability company,
joint venture, trust, unincorporated organization, association, corporation,
institution, public benefit corporation, entity or government (whether Federal,
state, county, city, municipal or otherwise, including, without limitation, any
instrumentality, division, agency, body or department thereof).
"
Proceeding
" shall
have the meaning set forth in Section 14.8.
“
Restricted Common
Stock
” shall mean shares of Common Stock which are, or which upon their
issuance on the exercise of this Warrant would be, evidenced by a certificate
bearing the restrictive legend set forth in the Purchase Agreement.
“
Securities Act
” shall
mean the Securities Act of 1933, as amended, or any similar Federal statute, and
the rules and regulations of the Commission thereunder, all as the same shall be
in effect at the time.
"
Trading Day(s)
" shall
mean any day on which the primary market on which such shares of Common Stock
are listed is open for trading.
“
Warrants
” shall mean
this Warrant and all warrants issued upon transfer, division or combination of,
or in substitution for, any thereof. All Warrants shall at all times
be identical as to terms and conditions and date, except as to the number of
shares of Common Stock for which they may be exercised.
“
Warrant Price
” shall
mean an amount equal to (i) the number of shares of Common Stock being purchased
upon exercise of this Warrant pursuant to Section 2.1, multiplied by (ii) the
Current Warrant Price as of the date of such exercise.
“
Warrant Stock
” shall
mean the shares of Common Stock purchased by the holders of the Warrants upon
the exercise thereof.
2.1.
Manner of
Exercise
. (a) From and after the Closing Date and until 6:30
P.M., New York time, on the Expiration Date, the Holder may exercise this
Warrant, for all or any part of the number of shares of Common Stock purchasable
hereunder.
Exhibit
4.19
(b) In
order to exercise this Warrant, in whole or in part, the Holder shall deliver to
the Company at its office at 8000 Regency Parkway, Suite 542, Cary, North
Carolina 27518 or at the office or agency designated by the Company pursuant to
Section 13, (i) a written notice of the Holder’s election to exercise this
Warrant, which notice shall specify the number of shares of Common Stock to be
purchased, (ii) payment of the Warrant Price and (iii) this
Warrant. Such notice shall be substantially in the form of the
subscription form appearing at the end of this Warrant as
Exhibit A
, duly
executed by the Holder or its agent or attorney. Upon receipt
thereof, the Company shall, as promptly as practicable, and in any event within
three (3) Business Days thereafter, issue or cause to be issued and deliver or
cause to be delivered to the Holder a certificate or certificates representing
the aggregate number of full shares of Common Stock issuable upon such exercise,
together with cash in lieu of any fraction of a share, as hereinafter
provided. The stock certificate or certificates so delivered shall
be, to the extent possible, in such denomination or denominations as such Holder
shall request in the notice and shall be registered in the name of the Holder
or, subject to Section 8, such other name as shall be designated in the
notice. This Warrant shall be deemed to have been exercised and such
certificate or certificates shall be deemed to have been issued, and the Holder
or any other Person so designated to be named therein shall be deemed to have
become a holder of record of such shares for all purposes, as of the date the
notice, together with the cash or check or checks and this Warrant, is received
by the Company as described above and all taxes required to be paid by the
Holder, if any, pursuant to Section 2.2 prior to the issuance of such shares
have been paid (such date, the "
Date of
Exercise
"). If this Warrant shall have been exercised in part,
the Company shall, at the time of delivery of the certificate or certificates
representing Warrant Stock, deliver to the Holder a new Warrant evidencing the
rights of the Holder to purchase the unpurchased shares of Common Stock called
for by this Warrant, which new Warrant shall in all other respects be identical
with this Warrant, or, at the request of the Holder, appropriate notation may be
made on this Warrant and the same returned to the
Holder. Notwithstanding any provision herein to the contrary, the
Company shall not be required to register shares in the name of any Person who
acquired this Warrant (or part hereof) or any Warrant Stock otherwise than in
accordance with this Warrant. If the Company fails to deliver to the Holder the
required Warrant Stock in accordance with and pursuant to this Section by the
third Trading Day after the Date of Exercise, then the Holder will have the
right to rescind such exercise.
(c) The
Company's obligations to issue and deliver Warrant Stock in accordance with the
terms hereof are absolute and unconditional, irrespective of any action or
inaction by the Holder to enforce the same, any waiver or consent with respect
to any provision hereof, the recovery of any judgment against any Person or any
action to enforce the same, or any setoff, counterclaim, recoupment, limitation
or termination, or any breach or alleged breach by the Holder or any other
Person of any obligation to the Company or any violation or alleged violation of
law by the Holder or any other Person, and irrespective of any other
circumstance which might otherwise limit such obligation of the Company to the
Holder in connection with the issuance of Warrant Stock.
(d) Payment
of the Warrant Price shall be made at the option of the Holder by (i) wire
transfer to an account designated by the Company, (ii) certified or official
bank check, and/or (iii) by the Holder’s surrender to the Company of that number
of shares of Warrant Stock (or the right to receive such number of shares) or
shares of Common Stock having an aggregate Current Market Price equal to or
greater than the Current Warrant Price for all shares then being purchased
(including those being surrendered), or (iv) any combination thereof, duly
endorsed by or accompanied by appropriate instruments of transfer duly executed
by the Holder or by the Holder’s attorney duly authorized in
writing.
Exhibit
4.19
2.2.
Payment of
Taxes
. All shares of Common Stock issuable upon the exercise
of this Warrant pursuant to the terms hereof shall be validly issued, fully paid
and nonassessable and without any preemptive rights. The Company
shall pay all expenses in connection with, and all taxes and other governmental
charges that may be imposed with respect to, the issue or delivery thereof,
unless such tax or charge is imposed by law upon the Holder, in which case such
taxes or charges shall be paid by the Holder. The Holder or its
transferee shall pay any transfer tax due and payable in respect of a transfer
of this Warrant or the Warrant Stock to a party other than the
Holder.
2.3.
Fractional
Shares
. The Company shall not be required to issue a
fractional share of Common Stock upon exercise of any Warrant. As to
any fraction of a share which the Holder of one or more Warrants, the rights
under which are exercised in the same transaction, would otherwise be entitled
to purchase upon such exercise, the Company shall pay a cash adjustment in
respect of such final fraction in an amount equal to the same fraction of (x)
the Current Market Price per share of Common Stock on the date of exercise, so
long as there continues to be a public market for the Common Stock, or (y) in
the event there is no public market for the Common Stock, the fair market value
thereof as reasonably determined by the Board of Directors of the
Company.
2.4.
Continued
Validity
. A holder of shares of Common Stock issued upon the
exercise of this Warrant, in whole or in part (other than a holder who acquires
such shares after the same have been publicly sold pursuant to a Registration
Statement under the Securities Act or sold pursuant to Rule 144 thereunder),
shall continue to be entitled to all rights, and subject to all obligations, to
which it would have been entitled or obligated, as applicable, as the Holder
under Sections 8, 9 and 14 of this Warrant. The Company will, at the
time of each exercise of this Warrant, in whole or in part, upon the request of
the holder of the shares of Common Stock issued upon such exercise hereof,
acknowledge in writing, in form reasonably satisfactory to such holder, its
continuing obligation to afford to such holder all such rights;
provided
,
however
, that if such
holder shall fail to make any such request, such failure shall not affect the
continuing obligation of the Company to afford to such holder all such
rights.
2.5
Limitation on
Exercise
. Notwithstanding anything to the contrary contained
herein, the number of shares of Common Stock that may be acquired by the Holder
upon any exercise of this Warrant (or otherwise in respect hereof) shall be
limited to the extent necessary to insure that, following such exercise (or
other issuance), the total number of shares of Common Stock then beneficially
owned by such Holder and its affiliates and any other Persons whose beneficial
ownership of Common Stock would be aggregated with the Holder's for purposes of
Section 13(d) of the Exchange Act, does not exceed 4.999% of the total number of
issued and outstanding shares of Common Stock (including for such purpose the
shares of Common Stock issuable upon such exercise). For such
purposes, beneficial ownership shall be determined in accordance with Section
13(d) of the Exchange Act and the rules and regulations promulgated
thereunder. Each delivery of a notice of exercise under Section 2.1
will constitute a representation by the Holder that it has evaluated the
limitation set forth in this paragraph and determined that issuance of the full
number of Warrant Shares requested in such notice of exercise is permitted under
this paragraph. By written notice to the Company, the Holder may
waive the provisions of this Section but (i) any such waiver will not be
effective until the 61st day after such notice is delivered to the Company, and
(ii) any such waiver will apply only to the Holder and not to any other holder
of Warrants
Exhibit
4.19
3.
|
TRANSFER; DIVISION AND
COMBINATION
|
3.1.
Transfer
. Subject
to compliance with Section 10, transfer of this Warrant and all rights
hereunder, in whole or in part, shall be registered on the books of the Company
to be maintained for such purpose, upon surrender of this Warrant at the
principal office of the Company specified in Section 2.1 or the office or agency
designated by the Company pursuant to Section 11, together with a written
assignment of this Warrant substantially in the form of
Exhibit B
hereto duly
executed by the Holder or its agent or attorney. Upon such surrender,
the Company shall, subject to Section 8, execute and deliver a new Warrant or
Warrants in the name of the assignee or assignees and in the denomination
specified in such instrument of assignment, and shall issue to the assignor a
new Warrant evidencing the portion of this Warrant not so assigned, and this
Warrant shall promptly be cancelled. A Warrant, if properly assigned
in compliance with Section 8, may be exercised by a new Holder for the purchase
of shares of Common Stock without having a new Warrant issued.
3.2.
Division and
Combination
. Subject to Section 8, this Warrant may be divided
or combined with other Warrants upon presentation hereof at the aforesaid office
or agency of the Company, together with a written notice specifying the names
and denominations in which new Warrants are to be issued, signed by the Holder
or its agent or attorney. Subject to compliance with Section 3.1 and
with Section 8, as to any transfer which may be involved in such division or
combination, the Company shall execute and deliver a new Warrant or Warrants in
exchange for the Warrant or Warrants to be divided or combined in accordance
with such notice.
3.3.
Expenses
. The
Company shall prepare, issue and deliver at its own expense the new Warrant or
Warrants to be delivered under this Section 3.
3.4.
Maintenance of
Books
. The Company agrees to maintain, at its aforesaid office
or agency, books for the registration and the registration of transfer of the
Warrants.
The
number of shares of Common Stock for which this Warrant is exercisable, or the
price at which such shares may be purchased upon exercise of this Warrant, shall
be subject to adjustment from time to time as set forth in this Section
4. The Company shall give each Holder notice of any event described
below which requires an adjustment pursuant to this Section 4 at the time of
such event.
4.1.
Stock Dividends,
Subdivisions and Combinations
. If at any time the Company
shall:
Exhibit
4.19
(a)
take a record of the holders of its Common Stock for the
purpose of entitling them to receive a dividend payable in, or other
distribution of, Additional Shares of Common Stock;
(b) subdivide
its outstanding shares of Common Stock into a larger number of shares of Common
Stock; or
(c) combine
its outstanding shares of Common Stock into a smaller number of shares of Common
Stock;
then (i)
the number of shares of Common Stock for which this Warrant is exercisable
immediately after the occurrence of any such event shall be adjusted to equal
the number of shares of Common Stock which a record holder of the same number of
shares of Common Stock for which this Warrant is exercisable immediately prior
to the occurrence of such event would own or be entitled to receive after the
happening of such event, and (ii) the Current Warrant Price shall be adjusted to
equal (A) the Current Warrant Price multiplied by the number of shares of Common
Stock for which this Warrant is exercisable immediately prior to the adjustment
divided by (B) the number of shares for which this Warrant is exercisable
immediately after such adjustment.
4.2.
Certain Other
Distributions
. If at any time the Company shall take a record
of the holders of its Common Stock for the purpose of entitling them to receive
any dividend or other distribution of:
(a)
cash;
(b) any
evidences of its indebtedness, any shares of its stock or any other securities
or property of any nature whatsoever (other than cash, Convertible Securities or
Additional Shares of Common Stock); or
(c) any
warrants or other rights to subscribe for or purchase any evidences of its
indebtedness, any shares of its stock or any other securities or property of any
nature whatsoever (other than cash, Convertible Securities or Additional Shares
of Common Stock);
then (i)
the number of shares of Common Stock for which this Warrant is exercisable shall
be adjusted to equal the product of the number of shares of Common Stock for
which this Warrant is exercisable immediately prior to such adjustment by a
fraction (A) the numerator of which shall be the Current Market Price per share
of Common Stock at the date of taking such record and (B) the denominator of
which shall be such Current Market Price per share of Common Stock minus the
amount allocable to one share of Common Stock of any such cash so distributable
and of the fair value (as determined in good faith by the Board of Directors of
the Company) of any and all such evidences of indebtedness, shares of stock,
other securities or property or warrants or other subscription or purchase
rights so distributable, and (ii) the Current Warrant Price shall be adjusted to
equal (A) the Current Warrant Price multiplied by the number of shares of Common
Stock for which this Warrant is exercisable immediately prior to the adjustment
divided by (B) the number of shares for which this Warrant is exercisable
immediately after such adjustment. A reclassification of the Common
Stock (other than a change in par value, or from par value to no par value or
from no par value to par value) into shares of Common Stock and shares of any
other class of stock shall be deemed a distribution by the Company to the
holders of its Common Stock of such shares of such other class of stock within
the meaning of this Section 4.2 and, if the outstanding shares of Common Stock
shall be changed into a larger or smaller number of shares of Common Stock as a
part of such reclassification, such change shall be deemed a subdivision or
combination, as the case may be, of the outstanding shares of Common Stock
within the meaning of Section 4.1.
Exhibit
4.19
4.3.
Other Provisions Applicable
to Adjustments under this Section
. The following provisions
shall be applicable to the making of adjustments of the number of shares of
Common Stock for which this Warrant is exercisable and the Current Warrant Price
provided for in this Section 4:
(a)
When Adjustments to Be
Made
. The adjustments required by this Section 4 shall be made
whenever and as often as any specified event requiring an adjustment shall
occur, except that any adjustment of the number of shares of Common Stock for
which this Warrant is exercisable that would otherwise be required may be
postponed (except in the case of a subdivision or combination of shares of
Common Stock, as provided for in Section 4.1) up to, but not beyond the date of
exercise if such adjustment either by itself or with other adjustments not
previously made adds or subtracts less than 1% of the shares of Common Stock for
which this Warrant is exercisable immediately prior to the making of such
adjustment. Any adjustment representing a change of less than such
minimum amount (except as aforesaid) which is postponed shall be carried forward
and made as soon as such adjustment, together with other adjustments required by
this Section 4 and not previously made, would result in a minimum adjustment or
on the date of exercise. For the purpose of any adjustment, any
specified event shall be deemed to have occurred at the close of business on the
date of its occurrence.
(b)
Fractional
Interests
. In computing adjustments under this Section 4,
fractional interests in Common Stock shall be taken into account to the nearest
1/10th of a share.
(c)
When Adjustment Not
Required
. If the Company shall take a record of the holders of
its Common Stock for the purpose of entitling them to receive a dividend or
distribution and shall, thereafter and before the distribution to stockholders
thereof, legally abandon its plan to pay or deliver such dividend or
distribution, then thereafter no adjustment shall be required by reason of the
taking of such record and any such adjustment previously made in respect thereof
shall be rescinded and annulled.
(d)
Escrow of Warrant
Stock
. If after any property becomes distributable pursuant to
this Section 4 by reason of the taking of any record of the holders of Common
Stock, but prior to the occurrence of the event for which such record is taken,
and the Holder exercises this Warrant, any Additional Shares of Common Stock
issuable upon exercise by reason of such adjustment shall be deemed the last
shares of Common Stock for which this Warrant is exercised (notwithstanding any
other provision to the contrary herein) and such shares or other property shall
be held in escrow for the Holder by the Company to be issued to the Holder upon
and to the extent that the event actually takes place, upon payment of the then
Current Warrant Price. Notwithstanding any other provision to the
contrary herein, if the event for which such record was taken fails to occur or
is rescinded, then such escrowed shares shall be cancelled by the Company and
escrowed property returned.
Exhibit
4.19
4.4.
Reorganization,
Reclassification, Merger, Consolidation or Disposition of Assets
. In case
the Company shall reorganize its capital, reclassify its capital stock,
consolidate or merge with or into another corporation or other business entity
(where the Company is not the surviving corporation or where there is a change
in or distribution with respect to the Common Stock of the Company), or sell,
transfer or otherwise dispose of all or substantially all its property, assets
or business to another corporation or other business entity and, pursuant to the
terms of such reorganization, reclassification, merger, consolidation or
disposition of assets, shares of common stock of the successor or acquiring
corporation, or any cash, shares of stock or other securities or property of any
nature whatsoever (including warrants or other subscription or purchase rights)
in addition to or in lieu of common stock of the successor or acquiring
corporation (“
Other
Property
”), are to be received by or distributed to the holders of Common
Stock of the Company, then each Holder shall have the right thereafter to
receive, upon exercise of such Warrant, the number of shares of common stock of
the successor or acquiring corporation or of the Company, if it is the surviving
corporation, and Other Property receivable upon or as a result of such
reorganization, reclassification, merger, consolidation or disposition of assets
by a holder of the number of shares of Common Stock for which this Warrant is
exercisable immediately prior to such event. In case of any such
reorganization, reclassification, merger, consolidation or disposition of
assets, at the Holder's option and request, any successor to the Company or
surviving entity shall expressly assume the due and punctual observance and
performance of each and every covenant and condition of this Warrant to be
performed and observed by the Company and all the obligations and liabilities
hereunder in order to provide for adjustments of shares of Common Stock for
which this Warrant is exercisable which shall be as nearly equivalent as
practicable to the adjustments provided for in this Section 4 and issue to the
Holder a new warrant substantially in the form of this Warrant and consistent
with the foregoing provisions and evidencing the Holder's right to purchase the
Other Property for the aggregate Current Market Price upon exercise
thereof. For purposes of this Section 4.4, “common stock of the
successor or acquiring corporation” shall include stock of such corporation of
any class which is not preferred as to dividends or assets over any other class
of stock of such corporation and which is not subject to redemption and shall
also include any evidences of indebtedness, shares of stock or other securities
which are convertible into or exchangeable for any such stock, either
immediately or upon the arrival of a specified date or the happening of a
specified event and any warrants or other rights to subscribe for or purchase
any such stock. The foregoing provisions of this Section 4.4 shall
similarly apply to successive reorganizations, reclassifications, mergers,
consolidations or disposition of assets.
5.
|
NOTICES TO WARRANT
HOLDERS
|
5.1.
Notice of
Adjustments
. Whenever the number of shares of Common Stock for which this
Warrant is exercisable, or whenever the price at which a share of such Common
Stock may be purchased upon exercise of the Warrants, shall be adjusted pursuant
to Section 4, the Company shall forthwith prepare a certificate to be executed
by the chief financial officer of the Company setting forth, in reasonable
detail, the event requiring the adjustment and the method by which such
adjustment was calculated (including a description of the basis on which the
Board of Directors of the Company determined the fair value of any evidences of
indebtedness, shares of stock, other securities or property or warrants or other
subscription or purchase rights referred to in Section 4.2) specifying the
number of shares of Common Stock for which this Warrant is exercisable and (if
such adjustment was made pursuant to Section 4.4) describing the number and kind
of any other shares of stock or Other Property for which this Warrant is
exercisable, and any change in the purchase price or prices thereof, after
giving effect to such adjustment or change. The Company shall
promptly cause a signed copy of such certificate to be delivered to each Holder
in accordance with Section 14.2. The Company shall keep at its office
or agency designated pursuant to Section 11 copies of all such certificates and
cause the same to be available for inspection at said office during normal
business hours by any Holder or any prospective purchaser of a Warrant
designated by a Holder thereof.
Exhibit
4.19
5.2.
Notice of Corporate
Action
. If at any time:
(a) the
Company shall take a record of the holders of its Common Stock for the purpose
of entitling them to receive a dividend (other than a cash dividend payable out
of earnings or earned surplus legally available for the payment of dividends
under the laws of the jurisdiction of incorporation of the Company) or other
distribution, or any right to subscribe for or purchase any evidences of its
indebtedness, any shares of stock of any class or any other securities or
property, or to receive any other right;
(b) there
shall be any capital reorganization of the Company, any reclassification or
recapitalization of the capital stock of the Company or any consolidation or
merger of the Company with, or any sale, transfer or other disposition of all or
substantially all the property, assets or business of the Company to, another
corporation; or
(c) there
shall be a voluntary or involuntary dissolution, liquidation or winding up of
the Company;
then, in
any one or more of such cases, the Company shall give to the Holder (i) at least
ten (10) days’ prior written notice of the date on which a record date shall be
selected for such dividend, distribution or right or for determining rights to
vote in respect of any such reorganization, reclassification, merger,
consolidation, sale, transfer, disposition, dissolution, liquidation or winding
up, and (ii) in the case of any such reorganization, reclassification, merger,
consolidation, sale, transfer, disposition, dissolution, liquidation or winding
up, at least ten (10) days’ prior written notice of the date when the same shall
take place. Such notice in accordance with the foregoing clause also
shall specify (A) the date on which any such record is to be taken for the
purpose of such dividend, distribution or right, the date on which the holders
of Common Stock shall be entitled to any such dividend, distribution or right,
and the amount and character thereof, and (B) the date on which any such
reorganization, reclassification, merger, consolidation, sale, transfer,
disposition, dissolution, liquidation or winding up is to take place and the
time, if any such time is to be fixed, as of which the holders of Common Stock
shall be entitled to exchange their shares of Common Stock for securities or
other property deliverable upon such reorganization, reclassification, merger,
consolidation, sale, transfer, disposition, dissolution, liquidation or winding
up. Each such written notice shall be sufficiently given if addressed
to the Holder and delivered in accordance with Section 14.2.
The
Company has all corporate power necessary for the authorization, execution and
delivery of this Warrant and this Warrant constitutes a valid and binding
obligation of the Company enforceable against the Company in accordance with its
terms, except as the same may be limited by bankruptcy, insolvency, moratorium
and other laws of general application affecting the enforcement of creditors’
rights.
Exhibit
4.19
6.
|
RESERVATION AND
AUTHORIZATION OF COMMON STOCK; REGISTRATION WITH OR APPROVAL OF ANY
GOVERNMENTAL AUTHORITY
|
From and
after the Closing Date, the Company shall at all times reserve and keep
available for issue upon the exercise of Warrants such number of its authorized
but unissued shares of Common Stock as will be sufficient to permit the exercise
in full of all outstanding Warrants. All shares of Common Stock which
shall be so issuable, when issued upon exercise of any Warrant and payment
therefor in accordance with the terms of such Warrant, shall be duly and validly
issued and fully paid and nonassessable, and not subject to preemptive
rights.
Before
taking any action which would result in an adjustment in the number of shares of
Common Stock for which this Warrant is exercisable or in the Current Warrant
Price, the Company shall obtain all such authorizations or exemptions thereof,
or consents thereto, as may be necessary from any public regulatory body or
bodies having jurisdiction thereof.
If any
shares of Common Stock required to be reserved for issuance upon exercise of
Warrants require registration or qualification with any governmental authority
or other governmental approval or filing under any Federal or state law
(otherwise than as provided in Section 8) before such shares may be so issued,
the Company will in good faith and as expeditiously as possible and at its
expense endeavor to cause such shares to be duly registered.
7.
|
TAKING OF RECORD;
STOCK AND WARRANT AND WARRANT TRANSFER
BOOKS
|
In the
case of all dividends or other distributions by the Company to the holders of
its Common Stock with respect to which any provision of Section 4 refers to the
taking of a record of such holders, the Company will in each such case take such
a record and will take such record as of the close of business on a Business
Day. The Company will not at any time, except upon dissolution,
liquidation or winding up of the Company, close its stock transfer books or
Warrant transfer books so as to result in preventing or delaying the exercise or
transfer of any Warrant.
8.
|
RESTRICTIONS ON
TRANSFERRABILITY
|
The
Warrants and the Warrant Stock shall not be transferred except in accordance
with the terms and conditions of the Purchase Agreement.
The
Company shall cooperate with each Holder of a Warrant and each holder of
Restricted Common Stock in supplying such information as may be reasonably
necessary for such holder to complete and file any information reporting forms
presently or hereafter required by the Commission as a condition to the
availability of an exemption from the Securities Act for the sale of any Warrant
or Restricted Common Stock.
Exhibit
4.19
Upon
receipt by the Company from any Holder of evidence reasonably satisfactory to it
of the ownership of and the loss, theft, destruction or mutilation of this
Warrant and indemnity reasonably satisfactory to it, and in case of mutilation
upon surrender and cancellation hereof, the Company will execute and deliver in
lieu hereof a new Warrant of like tenor to such Holder;
provided
, in the case
of mutilation, no indemnity shall be required if this Warrant in identifiable
form is surrendered to the Company for cancellation.
As long
as any of the Warrants remain outstanding, the Company shall maintain an office
or agency (which may be the principal executive offices of the Company) where
the Warrants may be presented for exercise, registration of transfer, division
or combination as provided in this Warrant.
So long
as the Company has a class of equity securities registered pursuant to Section
12 of the Exchange Act, the Company will file on or before the required date all
regular or periodic reports (pursuant to the Exchange Act) required to be filed
with the Commission pursuant to the Exchange Act and will deliver to the Holder
promptly upon their becoming available (unless such reports are available
through the Commission’s EDGAR system) one copy of each report, notice or proxy
statement sent by the Company to its stockholders generally, and of each regular
or periodic report (pursuant to the Exchange Act) and any Registration
Statement, prospectus or written communication (other than transmittal letters)
(pursuant to the Securities Act), filed by the Company with (a) the Commission
or (b) any securities exchange on which shares of Common Stock are
listed.
13.
|
NO RIGHTS AS
STOCKHOLDERS; LIMITATIONS OF
LIABILITY
|
Except as
otherwise provided herein, this Warrant shall not entitle the Holder to any
rights as a stockholder of the Company, including, without limitation, the right
to vote, to receive dividends and other distributions or to receive notice of or
attend meetings of stockholders or any other proceedings of the Company unless
and to the extent exercised for shares of Common Stock in accordance with the
terms hereof. No provision hereof, in the absence of affirmative
action by the Holder to exercise its rights to purchase shares of Common Stock
hereunder, and no enumeration herein of the rights or privileges of the Holder
hereof, shall give rise to any liability of such Holder for the purchase price
of any Common Stock or as a stockholder of the Company, whether such liability
is asserted by the Company or by creditors of the Company.
14.1.
Nonwaiver and
Expenses
. No course of dealing or any delay or failure to
exercise any right hereunder on the part of the Holder shall operate as a waiver
of such right or otherwise prejudice the Holder’s rights, powers or
remedies. If the Company fails to make, when due, any payments
provided for hereunder, or fails to comply with any other provision of this
Warrant, the Company shall pay to the Holder such amounts as shall be sufficient
to cover any costs and expenses including, but not limited to, reasonable
attorneys’ fees, including those of appellate proceedings, incurred by the
Holder in collecting any amounts due pursuant hereto or in otherwise enforcing
any of its rights, powers or remedies hereunder.
Exhibit
4.19
14.2.
Notice
Generally
. Any notice, demand, request, consent, approval,
declaration, delivery or other communication hereunder to be made pursuant to
the provisions of this Warrant shall be sufficiently given or made if in writing
and either delivered in person with receipt acknowledged or sent by registered
or certified mail, return receipt requested, postage prepaid, or by telecopy and
confirmed by telecopy answerback, addressed as follows:
If to the
Company:
Cicero,
Inc.
8000
Regency Parkway
Suite
542
Cary, NC
27518
Attn: John
P. Broderick
If to the
Holder:
At
its last known address appearing on the books and records of the Company
maintained for such purpose.
or at
such other address as may be substituted by notice given as herein
provided. The giving of any notice required hereunder may be waived
in writing by the party entitled to receive such notice. Every
notice, demand, request, consent, approval, declaration or other communication
hereunder shall be deemed to have been duly given and effective on the earliest
of (a) the date of transmission, if such notice or communication is delivered
via facsimile at the facsimile number specified in this Section prior to 6:30
p.m. (New York City time) on a business day, (b) the next business day after the
date of transmission, if such notice or communication is delivered via facsimile
at the facsimile number specified in this Section on a day that is not a
business day or later than 6:30 p.m. (New York City time) on any business day,
(c) the business day following the date of mailing, if sent by U.S. nationally
recognized overnight courier service, or (d) upon actual receipt by the party to
whom such notice is required to be given. As used herein, a “business day” means
any day except Saturday, Sunday and any day which shall be a federal legal
holiday or a day on which banking institutions in the State of New York are
authorized or required by law or other governmental action to
close.
14.3.
Remedies
. Each holder
of Warrant and Warrant Stock, in addition to being entitled to exercise all
rights granted by law, including recovery of damages, will be entitled to
specific performance of its rights under this Warrant. The Company
agrees that monetary damages would not be adequate compensation for any loss
incurred by reason of a breach by it of the provisions of this Warrant and
hereby agrees to waive the defense in any action for specific performance that a
remedy at law would be adequate.
14.4.
Successors and
Assigns
. Subject to the provisions of Sections 3.1 and 8, this Warrant
and the rights evidenced hereby shall inure to the benefit of and be binding
upon the successors of the Company and the successors and assigns of the
Holder. The provisions of this Warrant are intended to be for the
benefit of all Holders from time to time of this Warrant and, with respect to
Section 8 hereof, holders of Warrant Stock, and shall be enforceable by any such
Holder or holder of Warrant Stock.
Exhibit
4.19
14.5.
Amendment
. This
Warrant may be modified or amended or the provisions hereof waived with the
written consent of the Company and the Holder.
14.6
Severability
.
Wherever possible, each provision of this Warrant shall be interpreted in such
manner as to be effective and valid under applicable law, but if any provision
of this Warrant shall be prohibited by or invalid under applicable law, such
provision shall be ineffective to the extent of such prohibition or invalidity,
without invalidating the remainder of such provision or the remaining provisions
of this Warrant.
14.7
Headings
. The
headings used in this Warrant are for the convenience of reference only and
shall not, for any purpose, be deemed a part of this Warrant.
14.8
Governing Law
. All
questions concerning the construction, validity, enforcement and interpretation
of this Warrant shall be governed by and construed and enforced in accordance
with the internal laws of the State of Delaware, without regard to the
principles of conflicts of law thereof. Each party agrees that all
proceedings concerning the interpretations, enforcement and defense of the
transactions contemplated by this Warrant (whether brought against a party
hereto or its respective affiliates, directors, officers, shareholders,
employees or agents) (each a "
Proceeding
") shall be
commenced exclusively in the state and federal courts sitting in the State of
Delaware. Each party hereto hereby irrevocably submits to the
exclusive jurisdiction of the state and federal courts sitting in the State of
Delaware for the adjudication of any dispute hereunder or in connection herewith
or with any transaction contemplated hereby or discussed herein (including with
respect to the enforcement of this Warrant), and hereby irrevocably waives, and
agrees not to assert in any Proceeding, any claim that it is not personally
subject to the jurisdiction of any such court, that such Proceeding is
improper. Each party hereto hereby irrevocably waives personal
service of process and consents to process being served in any such Proceeding
by mailing a copy thereof via registered or certified mail or overnight delivery
(with evidence of delivery) to such party at the address in effect for notices
to it under this Warrant and agrees that such service shall constitute good and
sufficient service of process and notice thereof. Nothing contained
herein shall be deemed to limit in any way any right to serve process in any
manner permitted by law. Each party hereto hereby irrevocably waives, to the
fullest extent permitted by applicable law, any and all right to trial by jury
in any legal proceeding arising out of or relating to this Warrant or the
transactions contemplated hereby. If either party shall commence a Proceeding to
enforce any provisions of this Warrant, then the prevailing party in such
Proceeding shall be reimbursed by the other party for its attorneys fees and
other costs and expenses incurred with the investigation, preparation and
prosecution of such Proceeding
Exhibit
4.19
IN
WITNESS WHEREOF, the Company has caused this Warrant to be duly executed and its
corporate seal to be impressed hereon as of the day and year first above
written.
|
CICERO,
INC.
|
|
|
|
|
|
|
|
By:
|
|
|
|
John
P. Broderick,
|
|
|
Chief
Financial and Operating Officer
|
Exhibit
4.19
EXHIBIT
A
SUBSCRIPTION
FORM
[To be
executed only upon exercise of Warrant]
The
undersigned registered owner of this Warrant irrevocably exercises this Warrant
for the purchase of ______ Shares of Common Stock of CICERO, INC., and herewith
makes payment therefor, all at the price and on the terms and conditions
specified in this Warrant and requests that certificates for the shares of
Common Stock hereby purchased (and any securities or other property issuable
upon such exercise) be issued in the name of and delivered to _____________
whose address is ________________________________________ and, if such shares of
Common Stock shall not include all of the shares of Common Stock issuable as
provided in this Warrant, that a new Warrant of like tenor and date for the
balance of the shares of Common Stock issuable hereunder be delivered to the
undersigned.
|
|
|
|
(Name
of Registered Owner)
|
|
|
|
|
|
|
|
|
|
|
|
(Signature
of Registered Owner)
|
|
|
|
|
|
|
|
|
|
|
|
(Street
Address)
|
|
|
|
|
|
|
|
|
|
|
|
(City) (State) (Zip
Code)
|
|
NOTICE
:
|
The
signature on this subscription must correspond with the name as written
upon the face of the within Warrant in every particular, without
alteration or enlargement or any change
whatsoever.
|
Exhibit
4.19
EXHIBIT
B
ASSIGNMENT
FORM
FOR VALUE
RECEIVED the undersigned registered owner of this Warrant hereby sells, assigns
and transfers unto the Assignee named below all of the rights of the undersigned
under this Warrant, with respect to the number of shares of Common Stock set
forth below:
Name and Address of
Assignee
|
|
No. of Shares
of
|
|
|
Common
Stock
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
and does
hereby irrevocably constitute and appoint __________________________
attorney-in-fact to register such transfer on the books of CICERO, INC.,
maintained for the purpose, with full power of substitution in the
premises.
Dated:
|
|
|
Print
Name:
|
|
|
|
|
|
|
|
|
|
Signature:
|
|
|
|
|
|
|
|
|
|
Witness:
|
|
|
NOTICE:
|
The
signature on this subscription must correspond with the name as written
upon the face of the within Warrant in every particular, without
alteration or enlargement or any change
whatsoever.
|
EMPLOYMENT
AGREEMENT
This
Employment Agreement (the “Agreement”) is made effective this 4
th
day of
January, 2007, by and between CICERO, INC., a Delaware corporation (the
“Company”), and Anthony Pizi, a resident of the State of New Jersey (the
“Employee”).
In
consideration of the mutual covenants, promises and conditions set forth in this
Agreement, and for other good and valuable consideration, the receipt and
sufficiency of which are hereby acknowledged, the parties agree as
follows:
1.
|
Employment
. The
Company hereby employs Employee and Employee hereby accepts such
employment upon the terms and conditions set forth in this
Agreement.
|
2.
|
Duties of
Employee
. Employee’s title will be Chief Information
Officer and Business Development Officer. Employee will be
based in New Jersey. Employee agrees to perform and discharge
such other duties as may be assigned to Employee from time to time by the
Company to the reasonable satisfaction of the Company, and such duties
will be consistent with those duties regularly and customarily assigned by
the Company to the position of Chief Information Officer and Business
Development Officer. Employee also agrees to comply
with all of the Company's policies, standards and regulations and to
follow the instructions and directives as promulgated by the Chief
Executive Officer of the Company. Employee will devote
Employee's full professional and business-related time, skills and best
efforts to such duties and will not, during the term of this Agreement, be
engaged (whether or not during normal business hours) in any other
business or professional activity, whether or not such activity is pursued
for gain, profit or other pecuniary advantage, without the prior written
consent of the Chief Executive Officer of the Company. This
Section will not be construed to prevent Employee from (a) investing
personal assets in businesses which do not compete with the Company in
such form or manner that will not require any services on the part of
Employee in the operation or the affairs of the companies in which such
investments are made and in which Employee's participation is solely that
of an investor; (b) purchasing securities in any corporation whose
securities are listed on a national securities exchange or regularly
traded in the over-the-counter market, provided that Employee at no time
owns, directly or indirectly, in excess of one percent (1%) of the
outstanding stock of any class of any such corporation engaged in a
business competitive with that of the Company; or (c) participating in
conferences, preparing and publishing papers or books, teaching or joining
or participating in any professional associations or trade
group.
|
3.
|
Term
. The
term of this Agreement will be at-will, and can be terminated by either
party at any time, with or without cause, subject to the provisions of
Section 4 of this Agreement.
|
Exhibit
10.15
|
(a)
|
Termination by Company
for Cause
. The Company may terminate this Agreement and
all of its obligations hereunder immediately, including the obligation to
pay Employee severance, vacation pay or any further accrued benefits or
remuneration, if any of the following events
occur:
|
|
(i)
|
Employee
materially breaches any of the terms or conditions set forth in this
Agreement and fails to cure such breach within ten (10) days after
Employee's receipt from the Company of written notice of such breach
(notwithstanding the foregoing, no cure period shall be applicable to
breaches by Employee of Sections 10 through 14 of this
Agreement);
|
|
(ii)
|
Employee
commits any other act materially detrimental to the business or reputation
of the Company;
|
|
(iii)
|
Employee
engages in dishonest or illegal activities or commits or is convicted of
any crime involving fraud, deceit or moral turpitude;
or
|
|
(iv)
|
Employee
dies or becomes mentally or physically incapacitated or disabled so as to
be unable to perform Employee's duties under this Agreement even with a
reasonable accommodation. Without limiting the generality of
the foregoing, Employee's inability adequately to perform services under
this Agreement for a period of sixty (60) consecutive days will be
conclusive evidence of such mental or physical incapacity or disability,
unless such inability is pursuant to a mental or physical
incapacity or disability covered by the Family Medical Leave Act, in which
case such sixty (60) day period shall be extended to a one hundred and
twenty (120) day period.
|
|
(b)
|
Termination by Company
Without Cause
. The Company may terminate Employee's
employment pursuant to this Agreement for reasons other than those stated
in Section 4(a) upon at least thirty (30) days' prior written notice to
Employee. In the event Employee's employment with the Company is
terminated by the Company without cause, the Company shall be obligated to
pay Employee a lump sum severance payment equal to one (1) year of
Employee’s then base salary payable within thirty (30) days after the date
of termination. In addition, Employee will be entitled to payment of all
unused vacation days at his current daily rate and any accrued but unpaid
salary or earned bonuses. Any option grants or restricted stock awards
made to employee will immediately vest. The payment
to Employee for all deferred salaries and earned
bonuses will be paid within 30 days by the Company. Other than the
severance payments set forth in this Section 4(b), Employee
will be entitled to receive no further remuneration and will not be
entitled to participate in any Company benefit programs following his
termination by the Company, whether such termination is with or without
cause.
|
|
(c)
|
Termination by
Employee for Cause
. In the event there occurs a
substantial change in the Employee’s job duties, or there is a decrease in
or a failure to provide the compensation or vested benefits under this
Agreement initiated by either the Company or as a result of
a Change in Control (as defined below) of the Company, Employee
shall have the right to resign his employment and will be entitled to a
lump sum severance payment equal to twelve (12) months of Employee’s then
base salary payable within thirty (30) days after the date of termination.
In addition, Employee will be entitled to payment of all unused vacation
days at his current daily rate and a lump sum equal to all deferred
salaries and earned bonuses. In addition, all Employee’s then outstanding
but unvested stock options shall vest one hundred percent
(100%). Employee shall have 12 months from the date written
notice is given to Employee about the announcement and closing of a
transaction resulting a Change of Control that would result in a
substantial change in the Employee’s job duties or decrease his
compensation or vested benefits under this Agreement to resign
or this Section 4(c) shall not apply. In the event Employee
resigns from the Company for any other reason, Employee will not be
entitled to receive or accrue any further Company benefits or other
remuneration under this Agreement, and Employee specifically agrees that
he will not be entitled to receive any severance
pay.
|
For
purposes of this Section 4, a Change in Control shall be deemed to have occurred
if any of the following occur:
|
(i)
|
the
merger of consolidation of the Company with or into another unaffiliated
entity, or the merger of another unaffiliated entity into the Company or
another subsidiary thereof with the effect that immediately after such
transaction the stockholders of the Company immediately prior to such
transaction hold less than fifty percent (50%) of the total voting power
of all securities generally entitled to vote in the election of directors,
managers or trustees of the entity surviving such merger or
consolidation.;
|
|
(ii)
|
the
sale or transfer of more than fifty-one percent (51%) of the Company’s
then outstanding voting stock (other than a restructuring event which
results in the continuation of the Company’s business by an affiliated
entity) to unaffiliated person or group (as such term is used in Section
13(d)(3) of the Securities Exchange Act of 1934, as amended);
or
|
|
(iii)
|
the
adoption by the stockholders of the Company of a plan relating to the
liquidation or dissolution of the
Company.
|
Exhibit
10.15
5.
|
Compensation and
Benefits
.
|
|
(a)
|
Annual
Salary
. During the term of this Agreement and for all
services rendered by Employee under this Agreement, the Company will pay
Employee a base salary of One Hundred Twenty Five Thousand Dollars
($125,000.00) per annum in equal bi-monthly installments. Such
annual salary will be subject to adjustments by any increases given in the
normal course of business.
|
|
(b)
|
Variable
Incentive
Compensation
. Employee shall be eligible to receive
incentive compensation in the form of cash commissions, in the amount set
forth in Exhibit C.
|
|
(c)
|
Equity
Awards
. Upon the successful completion of
the recapitalization and name change into Cicero,
Inc., and the formal approval of a new Cicero, Inc. Employee Stock Options
Plan, Employee is hereby awarded a Stock Option Grant equal to
0.9% of the fully diluted shares of either Cicero, Inc. at the prevailing
market price on the day of grant. These options shall vest 1/3 immediately
and 1/3 on each of the next two anniversaries of the date of grant. Where
possible under existing tax laws, these option grants will be Incentive
Stock Option Grants otherwise these options will be Non Qualified Options.
In addition, Employee will be granted a restricted stock award equal to
0.9% of the fully diluted shares of either Cicero, Inc.. The restricted
stock award will vest upon the resignation or termination of employee or
upon a change in control as defined in Section 4 (c) above. The Company
will utilize its best efforts to register the restricted stock award
within 60 days of grant.
|
6.
|
Vacation.
Employee
shall be eligible for four (4) weeks of paid vacation annually, provided
that such vacation is scheduled at such times that do not interfere with
the Company’s legitimate business
needs.
|
7.
|
Other
Benefits
. Employee will be entitled to such fringe
benefits as may be provided from time-to-time by the Company to its
employees, including, but not limited to, group health insurance, life and
disability insurance, and any other fringe benefits now or hereafter
provided by the Company to its employees, if and when Employee meets the
eligibility requirements for any such benefit. The Company
reserves the right to change or discontinue any employee benefit plans or
programs now being offered to its employees; provided, however, that all
benefits provided for employees of the same position and status as
Employee will be provided to Employee on an equal
basis.
|
8.
|
Business
Expenses
. Employee will be reimbursed for all reasonable
expenses incurred in the discharge of Employee's duties under this
Agreement pursuant to the Company's standard reimbursement
policies.
|
9.
|
Withholding
. The
Company will deduct and withhold from the payments made to Employee under
this Agreement, state and federal income taxes, FICA and other amounts
normally withheld from compensation due
employees.
|
10.
|
Non-Disclosure of
Proprietary Information
. Employee recognizes and
acknowledges that the Trade Secrets (as defined below) and Confidential
Information (as defined below) of the Company and its affiliates and all
physical embodiments thereof (as they may exist from time-to-time,
collectively, the “Proprietary Information”) are valuable, special and
unique assets of the Company's and its affiliates' businesses. Employee
further acknowledges that access to such Proprietary Information is
essential to the performance of Employee's duties under this
Agreement. Therefore, in order to obtain access to such
Proprietary Information, Employee agrees that, except with respect to
those duties assigned to him by the Company, Employee will hold in
confidence all Proprietary Information and will not reproduce, use,
distribute, disclose, publish or otherwise disseminate any Proprietary
Information, in whole or in part, and will take no action causing, or fail
to take any action necessary to prevent causing, any Proprietary
Information to lose its character as Proprietary Information, nor will
Employee make use of any such information for Employee's own purposes or
for the benefit of any person, firm, corporation, association or other
entity (except the Company) under any
circumstances.
|
For
purposes of this Agreement, the term “Trade Secrets” means information,
including, but not limited to, any technical or nontechnical data, formula,
pattern, compilation, program, device, method, technique, drawing, process,
financial data, financial plan, product plan, list of actual or potential
customers or suppliers, or other information similar to any of the foregoing,
which derives economic value, actual or potential, from not being generally
known to, and not being readily ascertainable by proper means by, other persons
who can derive economic value from its disclosure or use. For
purposes of this Agreement, the term “Trade Secrets” does not include
information that Employee can show by competent proof (i) was known to Employee
and reduced to writing prior to disclosure by the Company (but only if Employee
promptly notifies the Company of Employee’s prior knowledge); (ii) was generally
known to the public at the time the Company disclosed the information to
Employee; (iii) became generally known to the public after disclosure
by the Company through no act or omission of Employee; or (iv) was disclosed to
Employee by a third party having a bona fide right both to possess the
information and to disclose the information to Employee. The term
“Confidential Information” means any data or information of the Company, other
than trade secrets, which is valuable to the Company and not generally known to
competitors of the Company. The provisions of this Section 6 will
apply to Trade Secrets for so long as such information remains a trade secret
and to Confidential Information during Employee’s employment with the Company
and for a period of two (2) years following any termination of Employee’s
employment with the Company for whatever reason.
Exhibit
10.15
11.
|
Non-Solicitation
Covenants
. Employee agrees that during Employee's
employment by the Company and for a period of two (2) year following the
termination of Employee's employment for whatever reason, Employee will
not, directly or indirectly, on Employee's own behalf or in the service of
or on behalf of any other individual or entity, divert, solicit or attempt
to divert or solicit any individual or entity (i) who is a client of the
Company at any time during the six (6)-month period prior to Employee's
termination of employment with the Company (“Client”), or was actively
sought by the Company as a prospective client, and (ii) with whom Employee
had material contact while employed by the Company to
provide similar services or products as such provided by
Employee for the Company to such Clients or prospects. Employee
further agrees and represents that during Employee's employment by the
Company and for a period of two (2) year following any termination of
Employee's employment for whatever reason, Employee will not, directly or
indirectly, on Employee's own behalf or in the service of, or on behalf of
any other individual or entity, divert, solicit or hire away, or attempt
to divert, solicit or hire away, to or for any individual or entity which
is engaged in providing similar services or products to that provided by
the Company, any person employed by the Company for whom Employee had
supervisory responsibility or with whom Employee had material contact
while employed by the Company, whether or not such employee is a full-time
employee or temporary employee of the Company, whether or not such
employee is employed pursuant to written agreement and whether or not such
employee is employed for a determined period or at-will. For
purposes of this Agreement, “material contact” exists between Employee and
a Client or potential Client when (1) Employee established and/or nurtured
the Client or potential Client; (2) the Client or potential Client and
Employee interacted to further a business relationship or contract with
the Company; (3) Employee had access to confidential information and/or
marketing strategies or programs regarding the Client or potential Client;
and/or (4) Employee learned of the Client or potential Client through the
efforts of the Company providing Employee with confidential Client
information, including but not limited to the Client’s identify, for
purposes of furthering a business
relationship.
|
12.
|
Existing Restrictive
Covenants
. Except as provided in Exhibit B, Employee has
not entered into any agreement with any employer or former employer: (a)
to keep in confidence any confidential information, or (b) to not compete
with any former employer. Employee represents and warrants that
Employee's employment with the Company does not and will not breach any
agreement which Employee has with any former employer to keep in
confidence confidential information or not to compete with any such former
employer. Employee will not disclose to the Company or use on
its behalf any confidential information of any other party required to be
kept confidential by
Employee.
|
13.
|
Return of Proprietary
Information
. Employee acknowledges that as a result of
Employee's employment with the Company, Employee may come into the
possession and control of Proprietary Information, such as proprietary
documents, drawings, specifications, manuals, notes, computer programs, or
other proprietary material. Employee acknowledges, warrants and
agrees that Employee will return to the Company all such items and any
copies or excerpts thereof, and any other properties, files or documents
obtained as a result of Employee's employment with the Company,
immediately upon the termination of Employee's employment with the
Company.
|
14.
|
Proprietary
Rights
. During the course of Employee's employment with
the Company, Employee may make, develop or conceive of useful processes,
machines, compositions of matter, computer software, algorithms, works of
authorship expressing such algorithm, or any other discovery, idea,
concept, document or improvement which relates to or is useful to the
Company's Business (the “Inventions”), whether or not subject to copyright
or patent protection, and which may or may not be considered Proprietary
Information. Employee acknowledges that all such Inventions
will be “works made for hire” under United States copyright law and will
remain the sole and exclusive property of the Company. Employee
also hereby assigns and agrees to assign to the Company, in perpetuity,
all right, title and interest Employee may have in and to such Inventions,
including without limitation, all copyrights, and the right to apply for
any form of patent, utility model, industrial design or similar
proprietary right recognized by any state, country or
jurisdiction. Employee further agrees, at the Company's request
and expense, to do all things and sign all documents or instruments
necessary, in the opinion of the Company, to eliminate any ambiguity as to
the ownership of, and rights of the Company to, such Inventions, including
filing copyright and patent registrations and defending and enforcing in
litigation or otherwise all such
rights.
|
Employee
will not be obligated to assign to the Company any Invention made by Employee
while in the Company's employ which does not relate to any business or activity
in which the Company is or may reasonably be expected to become engaged, except
that Employee is so obligated if the same relates to or is based on Proprietary
Information to which Employee will have had access during and by virtue of
Employee's employment or which arises out of work assigned to Employee by the
Company. Employee will not be obligated to assign any Invention which
may be wholly conceived by Employee after Employee leaves the employ of the
Company, except that Employee is so obligated if such Invention involves the
utilization of Proprietary Information obtained while in the employ of the
Company. Employee is not obligated to assign any Invention that
relates to or would be useful in any business or activities in which the Company
is engaged if such Invention was conceived and reduced to practice by Employee
prior to Employee's employment with the Company. Employee agrees that
any such Invention is set forth on Exhibit “A” to this
Agreement.
Exhibit
10.15
15.
|
Remedies
. Employee
agrees and acknowledges that the violation of any of the covenants or
agreements contained in Sections 10 through 14 of this Agreement would
cause irreparable injury to the Company, that the remedy at law for any
such violation or threatened violation thereof would be inadequate, and
that the Company will be entitled, in addition to any other remedy, to
temporary and permanent injunctive or other equitable relief without the
necessity of proving actual damages or posting a
bond.
|
16.
|
Severability
. In
case one or more of the provisions contained in this Agreement is for any
reason held to be invalid, illegal or unenforceable in any respect, the
parties agree that it is their intent that the same will not affect any
other provision in this Agreement, and this Agreement will be construed as
if such invalid or illegal or unenforceable provision had never been
contained herein. It is the intent of the parties that this
Agreement be enforced to the maximum extent permitted by
law.
|
17.
|
Entire
Agreement
. This Agreement embodies the entire agreement
of the parties relating to the subject matter of this Agreement and
supersedes all prior agreements, oral or written, regarding the subject
matter hereof. No amendment or modification of this
Agreement will be valid or binding upon the parties unless made in writing
and signed by the parties.
|
18.
|
Governing
Law
. This Agreement is entered into and will be
interpreted and enforced pursuant to the laws of the State of New
Jersey. The parties hereto hereby agree that the appropriate
forum and venue for any disputes between any of the parties hereto arising
out of this Agreement shall be any federal court in the state where the
Employee has his principal place of residence and each of the parties
hereto hereby submits to the personal jurisdiction of any such
court. The foregoing shall not limit the rights of any party to
obtain execution of judgment in any other jurisdiction. The
parties further agree, to the extent permitted by law, that a final and
unappealable judgment against either of them in any action or proceeding
contemplated above shall be conclusive and may be enforced in any other
jurisdiction within or outside the United States by suit on the judgment,
a certified exemplified copy of which shall be conclusive evidence of the
fact and amount of such
judgment.
|
19.
|
Surviving
Terms
. Sections 4, 6, 7, 10, 11 and 14 of this Agreement
shall survive termination of this
Agreement.
|
IN
WITNESS WHEREOF, the parties have executed this Agreement as of the day and year
first above written.
CICERO,
INC.
By:
|
|
|
|
|
|
|
|
Name:
|
|
|
Anthony
Pizi
|
Title:
|
|
|
|
Exhibit
10.15
EXHIBIT
A
INVENTIONS
Employee
represents that there are no Inventions.
|
_________________
|
|
Employee
Initials
|
EXHIBIT
B
EXISTING RESTRICTIVE
COVENANTS
Exhibit
10.15
EXHIBIT
C
Variable
Compensation
Variable Cash
Commissions:
Employee
is entitled to the following cash commissions based upon revenues as recognized
under generally accepted accounting principles and payable within 30 days of
receipt from customer:
Software
Licenses:
20%
of the first $500,000 software license revenues
15%
of software license revenues exceeding $500,000 but less than
$750,000
10%
of software license revenues exceeding $750,000
Service
revenues:
5%
of all service revenues
Maintenance
commissions:
Employee
will be entitled to a 2% commission on Merrill Lynch maintenance revenues only.
No other commissions will be paid for maintenance revenues.
Subscription
revenues:
Employee
is eligible for commissions on subscription revenues based upon the allocation
of those revenues for GAAP purposes under licenses, maintenance and services.
The established commission rates above will be in effect. Any subscription
revenues based upon a profit sharing scenario will be separately negotiated
prior to any effective date of such an agreement.
Assigned
accounts:
Merrill
Lynch and any affiliates
New
accounts as registered
12
EMPLOYMENT
AGREEMENT
This
Employment Agreement (the “Agreement”) is made and entered into this 1
st
day of
January, 2007, by and between CICERO INC, a Delaware corporation (the
“Company”), and John P. Broderick, a resident of the State of New Jersey (the
“Employee”).
In
consideration of the mutual covenants, promises and conditions set forth in this
Agreement, and for other good and valuable consideration, the receipt and
sufficiency of which are hereby acknowledged, the parties agree as
follows:
1.
|
Employment
. The
Company hereby employs Employee and Employee hereby accepts such
employment upon the terms and conditions set forth in this
Agreement.
|
2.
|
Duties of
Employee
. Employee will be based in New Jersey or North
Carolina at the discretion of the Company. Employee’s title
will be Chief Executive Officer, Chief Financial Officer, Chief Operating
Officer and Corporate Secretary and Employee will report directly to the
Board of Directors of the Company. Employee agrees
to perform and discharge such other duties as may be assigned to Employee
from time to time by the Company to the reasonable satisfaction of the
Board of Directors , and such duties will be consistent with those duties
regularly and customarily assigned by the Company to the position of Chief
Executive Officer, Chief Financial Officer and
Secretary. Employee agrees to comply with all of the Company's
policies, standards and regulations and to follow the instructions and
directives as promulgated by the Board of Directors of the
Company. Employee will devote Employee's full professional and
business-related time, skills and best efforts to such duties and will
not, during the term of this Agreement, be engaged (whether or not during
normal business hours) in any other business or professional activity,
whether or not such activity is pursued for gain, profit or other
pecuniary advantage, without the prior written consent of the Board of
Directors of the Company. This Section will not be construed to
prevent Employee from (a) investing personal assets in businesses which do
not compete with the Company in such form or manner that will not require
any services on the part of Employee in the operation or the affairs of
the companies in which such investments are made and in which Employee's
participation is solely that of an investor; (b) purchasing securities in
any corporation whose securities are listed on a national securities
exchange or regularly traded in the over-the-counter market, provided that
Employee at no time owns, directly or indirectly, in excess of one percent
(1%) of the outstanding stock of any class of any such corporation engaged
in a business competitive with that of the Company; or (c) participating
in conferences, preparing and publishing papers or books, teaching or
joining or participating in any professional associations or trade group,
so long as the Board of Directors of the Company approves such
participation, preparation and publication or teaching prior to Employee’s
engaging therein.
|
3.
|
Term
. The
term of this Agreement will be at-will, and can be terminated by either
party at any time, with or without cause, subject to the provisions of
Section 4 of this Agreement.
|
|
(a)
|
Termination by Company
for Cause
. The Company may terminate this Agreement and
all of its obligations hereunder immediately, including the obligation to
pay Employee severance, vacation pay or any further accrued benefits or
remuneration, if any of the following events
occur:
|
|
(i)
|
Employee
materially breaches any of the terms or conditions set forth in this
Agreement and fails to cure such breach within ten (10) days after
Employee's receipt from the Company of written notice of such breach
(notwithstanding the foregoing, no cure period shall be applicable to
breaches by Employee of Sections 10 through 14 of this
Agreement);
|
|
(ii)
|
Employee
commits any other act materially detrimental to the business or reputation
of the Company;
|
|
(iii)
|
Employee
engages in dishonest or illegal activities or commits or is convicted of
any crime involving fraud, deceit or moral turpitude;
or
|
|
(iv)
|
Employee
dies or becomes mentally or physically incapacitated or disabled so as to
be unable to perform Employee's duties under this Agreement even with a
reasonable accommodation. Without limiting the generality of
the foregoing, Employee's inability adequately to perform services under
this Agreement for a period of sixty (60) consecutive days will be
conclusive evidence of such mental or physical incapacity or disability,
unless such inability is pursuant to a mental or physical
incapacity or disability covered by the Family Medical Leave Act, in which
case such sixty (60) day period shall be extended to a one hundred and
twenty (120) day period.
|
|
(b)
|
Termination by Company
Without Cause
. The Company may terminate Employee's
employment pursuant to this Agreement for reasons other than those stated
in Section 4(a) upon at least thirty (30) days' prior written notice to
Employee. In the event Employee's employment with the Company is
terminated by the Company without cause, the Company shall be obligated to
pay Employee a lump sum severance payment equal to twelve (12) months of
Employee’s then base salary payable within thirty (30)
days after the date of termination. In addition,
Employee will be entitled to payment of all unused vacation days at his
current daily rate and any accrued but unpaid salary or earned bonuses.
Any option grants or restricted stock awards made to employee will
immediately vest. The payment to Employee
for all deferred salaries and earned bonuses will be paid
within 30 days by the Company. Other than the severance payments set forth
in this Section 4(b), Employee will be entitled to receive no further
remuneration and will not be entitled to participate in any Company
benefit programs following his termination by the Company, whether such
termination is with or without
cause.
|
|
(c)
|
Termination by
Employee for Cause
. In the event of a Change of Control
(as defined below) of the Company that results in either a substantial
reduction or change of title in the Employee’s job duties related to his
position as CFO or CEO, ,or a decrease in or a failure to provide the
compensation or vested benefits under this Agreement or the Company
initiates a substantial reduction or change of title in the Employee’s job
duties related to his position as CFO, Employee shall have the right to
resign his employment and will be entitled to a lump sum severance payment
equal to twelve (12) months of Employee’s then base salary payable within
thirty (30) days after the date of termination In
addition, Employee will be entitled to payment of all unused vacation days
at his current daily rate and a lump sum equal to all deferred salaries
and earned bonuses. In addition, all Employee’s then outstanding but
unvested stock options shall vest one hundred percent
(100%). Employee shall have 12 months from the date written
notice is given to Employee about the announcement and closing of a
transaction resulting in a Change in Control of the Company that would
result in a substantial change in the Employee’s job duties or decrease
his compensation or vested benefits under this Agreement to resign or this
Section 4(c) shall not apply. In the event Employee resigns
from the Company for any other reason, Employee will not be entitled to
receive or accrue any further Company benefits or other remuneration under
this Agreement, and Employee specifically agrees that he will not be
entitled to receive any severance
pay.
|
For
purposes of this Section 4, a Change in Control shall be deemed to have occurred
if any of the following occur:
|
(i)
|
the
merger or consolidation of the Company with or into another unaffiliated
entity, or the merger of another unaffiliated entity into the Company or
another subsidiary thereof with the effect that immediately after such
transaction the stockholders of the Company immediately prior to such
transaction hold less than fifty percent (50%) of the total voting power
of all securities generally entitled to vote in the election of directors,
managers or trustees of the entity surviving such merger or
consolidation. This provision will not apply to any
reorganization and reverse merger between the Company and any subsidiary
(or any other similar entity established for a similar
purpose);
|
|
(ii)
|
the
sale or transfer of more than fifty-one percent (51%) of the Company’s
then outstanding voting stock (other than a restructuring event which
results in the continuation of the Company’s business by an affiliated
entity) to unaffiliated person or group (as such term is used in Section
13(d)(3) of the Securities Exchange Act of 1934, as amended);
or
|
|
(iii)
|
the
adoption by the stockholders of the Company of a plan relating to the
liquidation or dissolution of the
Company.
|
5.
|
Compensation and
Benefits
.
|
|
(a)
|
Annual
Salary
. During the term of this Agreement and for all
services rendered by Employee under this Agreement, the Company will pay
Employee a base salary of One Hundred and Seventy-Five Thousand Dollars
($175,000.00) per annum in equal bi-monthly installments, retroactive to
January 1, 2007. In order to reach a targeted compensation for
2007 the Employee will receive a Bonus of 8.3% of the value of either the
IBM or IRMC contract effective upon payment and capped at
$25,000.
|
|
(b)
|
Incentive
Compensation
. Employee is eligible for
an annual bonus upon the Company reaching certain pre tax
income levels (after accounting for all bonuses) as set forth
in Exhibit C. Said bonus will be payable after the annual
accounts have been presented to the Compensation Committee. Exhibit C
attached hereto provides the benchmarks associated with achieving the
Incentive Compensation.
|
|
(c)
|
Equity
Awards
. Upon the successful amendment of the Company’s
charter to increase the authorized shares necessary to effect the
recapitalization of the Company and the associated conversion of debt and
equity, (the Conversion Event) and the approval of a new Employee Stock
Option Plan by the Board of Directors, Employee is
hereby awarded a Stock Option Grant equal to 1.35% of the fully
diluted shares of Cicero, Inc. at the prevailing market price
on the day of grant. These options shall vest 1/3 immediately and 1/3 on
each of the next two anniversaries of the date of grant. Where possible
under existing tax laws, these option grants will be Incentive Stock
Option Grants otherwise these options will be Non Qualified Options. In
addition, Employee will be granted a restricted stock award equal to 1.35%
of the fully diluted shares of Cicero, Inc. common stock. The
restricted stock award will vest upon the resignation or termination of
employee or upon a change in control as defined in Section 4 (c) above.
The Company will utilize its best efforts to register the restricted stock
award within 60 days of grant.
|
6.
|
Vacation.
Employee
shall be eligible for four (4) weeks of paid vacation annually, provided
that such vacation is scheduled at such times that do not interfere with
the Company’s legitimate business
needs.
|
7.
|
Other
Benefits
. Employee will be entitled to such fringe
benefits as may be provided from time-to-time by the Company to its
employees, including, but not limited to, group health insurance, life and
disability insurance, and any other fringe benefits now or hereafter
provided by the Company to its employees, if and when Employee meets the
eligibility requirements for any such benefit. The Company
reserves the right to change or discontinue any employee benefit plans or
programs now being offered to its employees; provided, however, that all
benefits provided for employees of the same position and status as
Employee will be provided to Employee on an equal
basis.
|
8.
|
Business
Expenses
. Employee will be reimbursed for all reasonable
expenses incurred in the discharge of Employee's duties under this
Agreement pursuant to the Company's standard reimbursement
policies.
|
9.
|
Withholding
. The
Company will deduct and withhold from the payments made to Employee under
this Agreement, state and federal income taxes, FICA and other amounts
normally withheld from compensation due
employees.
|
10.
|
Non-Disclosure of
Proprietary Information
. Employee recognizes and
acknowledges that the Trade Secrets (as defined below) and Confidential
Information (as defined below) of the Company and its affiliates and all
physical embodiments thereof (as they may exist from time-to-time,
collectively, the “Proprietary Information”) are valuable, special and
unique assets of the Company's and its affiliates' businesses. Employee
further acknowledges that access to such Proprietary Information is
essential to the performance of Employee's duties under this
Agreement. Therefore, in order to obtain access to such
Proprietary Information, Employee agrees that, except with respect to
those duties assigned to him by the Company, Employee will hold
in confidence all Proprietary Information and will not reproduce, use,
distribute, disclose, publish or otherwise disseminate any Proprietary
Information, in whole or in part, and will take no action causing, or fail
to take any action necessary to prevent causing, any Proprietary
Information to lose its character as Proprietary Information, nor will
Employee make use of any such information for Employee's own purposes or
for the benefit of any person, firm, corporation, association or other
entity (except the Company) under any
circumstances.
|
For
purposes of this Agreement, the term “Trade Secrets” means information,
including, but not limited to, any technical or nontechnical data, formula,
pattern, compilation, program, device, method, technique, drawing, process,
financial data, financial plan, product plan, list of actual or potential
customers or suppliers, or other information similar to any of the foregoing,
which derives economic value, actual or potential, from not being generally
known to, and not being readily ascertainable by proper means by, other persons
who can derive economic value from its disclosure or use. For
purposes of this Agreement, the term “Trade Secrets” does not include
information that Employee can show by competent proof (i) was known to Employee
and reduced to writing prior to disclosure by the Company (but only if Employee
promptly notifies the Company of Employee’s prior knowledge); (ii) was generally
known to the public at the time the Company disclosed the information to
Employee; (iii) became generally known to the public after disclosure
by the Company through no act or omission of Employee; or (iv) was disclosed to
Employee by a third party having a bona fide right both to possess the
information and to disclose the information to Employee. The term
“Confidential Information” means any data or information of the Company, other
than trade secrets, which is valuable to the Company and not generally known to
competitors of the Company. The provisions of this Section 6 will
apply to Trade Secrets for so long as such information remains a trade secret
and to Confidential Information during Employee’s employment with the Company
and for a period of two (2) years following any termination of Employee’s
employment with the Company for whatever reason.
Exhibit
10.16
11.
|
Non-Solicitation
Covenants
. Employee agrees that during Employee's
employment by the Company and for a period of two (2) year
following the termination of Employee's employment for whatever reason,
Employee will not, directly or indirectly, on Employee's own behalf or in
the service of or on behalf of any other individual or entity, divert,
solicit or attempt to divert or solicit any individual or entity (i) who
is a client of the Company at any time during the six (6)-month period
prior to Employee's termination of employment with the Company (“Client”),
or was actively sought by the Company as a prospective client, and (ii)
with whom Employee had material contact while employed by the Company to
provide similar services or products as such provided by
Employee for the Company to such Clients or prospects. Employee
further agrees and represents that during Employee's employment by the
Company and for a period of two (2) year following any
termination of Employee's employment for whatever reason, Employee will
not, directly or indirectly, on Employee's own behalf or in the service
of, or on behalf of any other individual or entity, divert, solicit or
hire away, or attempt to divert, solicit or hire away, to or for any
individual or entity which is engaged in providing similar services or
products to that provided by the Company, any person employed by the
Company for whom Employee had supervisory responsibility or with whom
Employee had material contact while employed by the Company, whether or
not such employee is a full-time employee or temporary employee of the
Company, whether or not such employee is employed pursuant to written
agreement and whether or not such employee is employed for a determined
period or at-will. For purposes of this Agreement, “material
contact” exists between Employee and a Client or potential Client when (1)
Employee established and/or nurtured the Client or potential Client; (2)
the Client or potential Client and Employee interacted to further a
business relationship or contract with the Company; (3) Employee had
access to confidential information and/or marketing strategies or programs
regarding the Client or potential Client; and/or (4) Employee learned of
the Client or potential Client through the efforts of the Company
providing Employee with confidential Client information, including but not
limited to the Client’s identify, for purposes of furthering a business
relationship.
|
12.
|
Existing Restrictive
Covenants
. Except as provided in Exhibit B, Employee has
not entered into any agreement with any employer or former employer: (a)
to keep in confidence any confidential information, or (b) to not compete
with any former employer. Employee represents and warrants that
Employee's employment with the Company does not and will not breach any
agreement which Employee has with any former employer to keep in
confidence confidential information or not to compete with any such former
employer. Employee will not disclose to the Company or use on
its behalf any confidential information of any other party required to be
kept confidential by
Employee.
|
13.
|
Return of Proprietary
Information
. Employee acknowledges that as a result of
Employee's employment with the Company, Employee may come into the
possession and control of Proprietary Information, such as proprietary
documents, drawings, specifications, manuals, notes, computer programs, or
other proprietary material. Employee acknowledges, warrants and
agrees that Employee will return to the Company all such items and any
copies or excerpts thereof, and any other properties, files or documents
obtained as a result of Employee's employment with the Company,
immediately upon the termination of Employee's employment with the
Company.
|
14.
|
Proprietary
Rights
. During the course of Employee's employment with
the Company, Employee may make, develop or conceive of useful processes,
machines, compositions of matter, computer software, algorithms, works of
authorship expressing such algorithm, or any other discovery, idea,
concept, document or improvement which relates to or is useful to the
Company's Business (the “Inventions”), whether or not subject to copyright
or patent protection, and which may or may not be considered Proprietary
Information. Employee acknowledges that all such Inventions
will be “works made for hire” under United States copyright law and will
remain the sole and exclusive property of the Company. Employee
also hereby assigns and agrees to assign to the Company, in perpetuity,
all right, title and interest Employee may have in and to such Inventions,
including without limitation, all copyrights, and the right to apply for
any form of patent, utility model, industrial design or similar
proprietary right recognized by any state, country or
jurisdiction. Employee further agrees, at the Company's request
and expense, to do all things and sign all documents or instruments
necessary, in the opinion of the Company, to eliminate any ambiguity as to
the ownership of, and rights of the Company to, such Inventions, including
filing copyright and patent registrations and defending and enforcing in
litigation or otherwise all such
rights.
|
Exhibit
10.16
Employee
will not be obligated to assign to the Company any Invention made by Employee
while in the Company's employ which does not relate to any business or activity
in which the Company is or may reasonably be expected to become engaged, except
that Employee is so obligated if the same relates to or is based on Proprietary
Information to which Employee will have had access during and by virtue of
Employee's employment or which arises out of work assigned to Employee by the
Company. Employee will not be obligated to assign any Invention which
may be wholly conceived by Employee after Employee leaves the employ of the
Company, except that Employee is so obligated if such Invention involves the
utilization of Proprietary Information obtained while in the employ of the
Company. Employee is not obligated to assign any Invention that
relates to or would be useful in any business or activities in which the Company
is engaged if such Invention was conceived and reduced to practice by Employee
prior to Employee's employment with the Company. Employee agrees that
any such Invention is set forth on Exhibit “A” to this Agreement.
15.
|
Remedies
. Employee
agrees and acknowledges that the violation of any of the covenants or
agreements contained in Sections 10 through 14 of this Agreement would
cause irreparable injury to the Company, that the remedy at law for any
such violation or threatened violation thereof would be inadequate, and
that the Company will be entitled, in addition to any other remedy, to
temporary and permanent injunctive or other equitable relief without the
necessity of proving actual damages or posting a
bond.
|
16.
|
Severability
. In
case one or more of the provisions contained in this Agreement is for any
reason held to be invalid, illegal or unenforceable in any respect, the
parties agree that it is their intent that the same will not affect any
other provision in this Agreement, and this Agreement will be construed as
if such invalid or illegal or unenforceable provision had never been
contained herein. It is the intent of the parties that this
Agreement be enforced to the maximum extent permitted by
law.
|
17.
|
Entire
Agreement
. This Agreement embodies the entire agreement
of the parties relating to the subject matter of this Agreement and
supersedes all prior agreements, oral or written, regarding the subject
matter hereof. No amendment or modification of this
Agreement will be valid or binding upon the parties unless made in writing
and signed by the parties.
|
18.
|
Governing
Law
. This Agreement is entered into and will be
interpreted and enforced pursuant to the laws of the State of New
Jersey. The parties hereto hereby agree that the appropriate
forum and venue for any disputes between any of the parties hereto arising
out of this Agreement shall be any federal court in the state where the
Employee has his principal place of residence and each of the parties
hereto hereby submits to the personal jurisdiction of any such
court. The foregoing shall not limit the rights of any party to
obtain execution of judgment in any other jurisdiction. The
parties further agree, to the extent permitted by law, that a final and
unappealable judgment against either of them in any action or proceeding
contemplated above shall be conclusive and may be enforced in any other
jurisdiction within or outside the United States by suit on the judgment,
a certified exemplified copy of which shall be conclusive evidence of the
fact and amount of such
judgment.
|
19.
|
Surviving
Terms
. Sections 4, 10, 11, 14, 15 and 18 of this
Agreement shall survive termination of this
Agreement.
|
IN
WITNESS WHEREOF, the parties have executed this Agreement as of the day and year
first above written.
CICERO,
INC.
By:
|
|
|
|
|
|
|
|
Name:
|
|
|
John
P. Broderick
|
Title:
|
|
|
|
Exhibit
10.16
EXHIBIT
A
INVENTIONS
Employee
represents that there are no Inventions.
|
_________________
|
|
Employee
Initials
|
EXHIBIT
B
EXISTING RESTRICTIVE
COVENANTS
Exhibit
10.16
EXHIBIT
C
VARIABLE
COMPENSATION
Annual Cash
Bonus:
Employee
is entitled to an annual cash bonus payable after the Company has reported its
results for the year. This annual cash bonus is tied to Operating Net Income
before taxes (defined as above) as per the chart below:
Operating
Net Income Net Income Range (before tax)
|
|
From
|
|
|
To
|
|
|
Variable
Compensation
|
|
|
|
Less
than $1,000,000
|
|
|
|
|
|
None
|
|
Tier
1
|
|
$
|
$1,000,000
|
|
|
$
|
1,499,999
|
|
|
$
|
100,000
|
|
Tier
2
|
|
$
|
1,500,000
|
|
|
$
|
1,999,999
|
|
|
$
|
200,000
|
|
Tier
3
|
|
$
|
greater
than 2,000,000
|
|
|
|
|
|
|
$
|
300,000
|
|
Performance
significantly in excess of Tier 3 may result in an additional reward at the
discretion of the Compensation Committee
12
ADDENDUM
#3
AGREEMENT
made this 16th day of August, 2007, between REGENCY PARK CORPORATION,
INCORPORATED, a North Carolina corporation having its principal place of
business in Cary, North Carolina (the “Landlord”), and CICERO, INC.,
a Delaware corporation, successor by merger to the
interests of Level 8 Systems Inc. a Delaware corporation (hereinafter
referred to as the “Original Tenant”) having its principal place of business in
Princeton, New Jersey (Cicero, Inc. being hereinafter referred to as the
“Tenant”).
W
I T N E S S E T H:
WHEREAS,
the Landlord and Original Tenant entered into a written Lease Agreement dated
November 07, 2003, (herein called the “Lease”), whereby the Landlord
leased Premises to the Original Tenant in a building at 8000 Regency
Parkway, Suite 542, Cary, North Carolina (herein called the
“Building”); and Addendum #1 dated July 07, 2005; and Addendum #2 dated January
31, 2007; and
WHEREAS,
The Tenant wishes to expand it’s Premises in the Building and extend the lease
Term; and is the successor in interest to the interests of the Original Tenant
under the Lease by operation of law, and has agreed to execute this document
confirming its assumption of all of the Original Tenant’s obligations under the
Lease.
NOW,
THEREFORE, it is hereby mutually agreed as follows:
1.
|
The
Term of the Lease shall be extended to December 31, 2010 and the tenant
shall have the right to expand into the Expansion Premises as shown on
Exhibit A attached hereto.
|
2.
|
The
Annual Rental due under Article 2.01 ANNUAL RENTAL of the Lease Agreement
shall be Fifty-Six Thousand One Hundred Sixty-Three and 96/100 Dollars
($56,163.96) payable in equal monthly installments of Four Thousand Six
Hundred Eighty and 33/100 Dollars ($4,680.33) in advance, on or before the
first day of each calendar month, commencing January 01, 2008, extending
throughout and including December 31,
2008.
|
The
Annual Rental due under Article 2.01 ANNUAL RENTAL of the Lease Agreement shall
be Fifty-Six Thousand Nine Hundred Three and 00/100 Dollars ($56,903.00) payable
in equal monthly installments of Four Thousand Seven Hundred Forty-One and
92/100 Dollars ($4,741.92) in advance, on or before the first day of each
calendar month, commencing January 01, 2009, extending throughout and including
December 31, 2009
The
Annual Rental due under Article 2.01 ANNUAL RENTAL of the Lease Agreement shall
be Fifty-Nine Thousand One Hundred Twenty and 00/100 Dollars ($59,120.00)
payable in equal monthly installments of Four Thousand Seven Hundred Forty-One
and 92/100 Dollars ($4,926.67) in advance, on or before the first day of each
calendar month, commencing January 01, 2010, extending throughout and including
December 31, 2010
3.
|
Subject
to approval by the Board of Directors of CICERO, INC. no later than
November 01, 2007, the Tenant shall have the right to lease the adjoining
Two Thousand Eighty-Two (2,082) square feet. Should the Tenant receive
said Board approval, and notify Landlord in writing of same on or before
November 01, 2007, Landlord shall commence the Tenant improvements in the
Expansion Premises in accordance with paragraph F of that letter of
proposal dated July 26, 2007, restated here:
FIT-UP
: The
landlord, at it’s cost, shall do the improvement to the adjacent new
Premises in accordance with a plan provided by IS Design, mutually agreed
upon by the Tenant and the Landlord. The Tenant shall be responsible for
all furniture, fittings and equipment, including cable, data and telecom
wiring.
|
Upon
approval by the Board of Directors of CICERO, INC. for the acquisition of the
Expansion Premises, to include the adjoining Two Thousand Eighty-Two (2,082)
square feet, to create a total Premises of Five Thousand Thirty-Eight (5,038)
square feet, known as Suite 542, Annual Rental due, commencing January 01, 2008
for the newly combined space shall be as follows:
Annual
Rental due Ninety-Five Thousand, Seven Hundred Twenty-Two and 00/100 Dollars
($95,722.00) payable in equal monthly installments of Seven Thousand Nine
Hundred Seventy-Six and 83/100 Dollars ($7,976.83) in advance, on or before the
first day of each calendar month, commencing January 01, 2008, extending
throughout and including December 31, 2008.
Annual
Rental due Ninety-Six Thousand, Nine Hundred Eighty-One and 50/100 Dollars
($96,981.50) payable in equal monthly installments of Eight Thousand Eighty-One
and 79/100 Dollars ($8,081.79) in advance, on or before the first day of each
calendar month, commencing January 01, 2009, extending throughout and including
December 31, 2009.
Annual
Rental due One Hundred Thousand, Seven Hundred Sixty and 00/100 Dollars
($100,760.00) payable in equal monthly installments of Eight Thousand Three
Hundred Ninety-Six and 67/100 Dollars ($8,396.67) in advance, on or before the
first day of each calendar month, commencing January 01, 2010, extending
throughout and including December 31, 2010.
4.
|
If
said Expansion of Premises is NOT APPROVED by the Board of Directors of
CICERO, INC. by the specified aforementioned date, CICERO, INC. shall pay
to the Landlord the Rental due on Five Thousand Thirty-Eight (5,038)
square feet for the period from January 01, 2008 through and including
April 30, 2008. No improvements to the Expansion Premises shall commence
without the written aforementioned approval by the Board of Directors of
CICERO, INC. The Landlord will use its best efforts to lease the Expansion
Premises of Two Thousand Eighty-Two (2,082) square feet during this same
period. If the Landlord, is able to Lease the Expansion Premises of Two
Thousand Eighty-Two (2,082) square feet prior to April 01, 2008 then at
such time as the Substitute Tenant occupies said Expansion Premises prior
to April 30, 2008, CICERO, INC. shall be relieved of its obligations for
the Expansion Premises from such date as the Substitute Tenant takes
occupancy.
|
Except as
herein modified, the Lease and its Addendum shall continue in full force and
effect.
IN
WITNESS WHEREOF, this instrument has been duly executed by the parties hereto as
of the day and year first above written.
|
|
REGENCY
PARK CORPORATION, INCORPORATED
|
|
|
Landlord
|
|
(Corporate
Seal)
|
|
|
|
|
|
|
|
|
|
|
|
By:
|
|
|
|
|
|
Eric
M. Salomon
|
|
ATTEST:
|
|
|
Vice
President
|
|
|
|
|
|
|
|
|
|
|
|
Audrey
Tuck
|
|
|
|
|
Assistant
Secretary
|
|
|
|
|
|
|
Cicero,
Inc.
|
|
(Corporate
Seal)
|
|
Tenant
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
By:
|
|
|
|
|
|
|
|
|
|
Title:
|
|
|
ATTEST/WITNESS:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EXHIBIT
A
3
CICERO,
INC.
2007
EMPLOYEE STOCK OPTION PLAN
TABLE OF
CONTENTS
|
|
Page
|
ARTICLE
I.
|
PURPOSE
|
1
|
|
|
|
ARTICLE
II.
|
DEFINITIONS
|
1
|
|
|
|
ARTICLE
III.
|
ADMINISTRATION
|
3
|
|
|
|
ARTICLE
IV.
|
SHARE
AND OTHER LIMITATIONS
|
5
|
|
|
|
ARTICLE
V.
|
ELIGIBILITY
|
6
|
|
|
|
ARTICLE
VI.
|
STOCK
OPTION GRANTS
|
6
|
|
|
|
ARTICLE
VII.
|
NON-TRANSFERABILITY
|
9
|
|
|
|
ARTICLE
VIII.
|
CHANGE
IN CONTROL PROVISIONS
|
9
|
|
|
|
ARTICLE
IX.
|
TERMINATION
OR AMENDMENT OF PLAN
|
11
|
|
|
|
ARTICLE
X.
|
UNFUNDED
PLAN
|
11
|
|
|
|
ARTICLE
XI.
|
GENERAL
PROVISIONS
|
11
|
|
|
|
ARTICLE
XII.
|
EFFECTIVE
DATE OF PLAN
|
13
|
|
|
|
ARTICLE
XIII.
|
TERM
OF PLAN
|
13
|
|
|
|
ARTICLE
XIV.
|
NAME
OF PLAN
|
13
|
CICERO,
INC.
2007
EMPLOYEE STOCK OPTION PLAN
ARTICLE
I
PURPOSE
The
purpose of this Cicero, Inc. 2007 Employee Stock Option Plan (the “Plan”) is to
enhance the profitability and value of Cicero, Inc. (the “Company”) for the
benefit of its shareholders by enabling the Company to offer certain employees
and Consultants (as defined herein) of the Company and its Subsidiaries (as
defined herein) and non-employee directors of the Company stock based incentives
in the Company, thereby creating a means to raise the level of stock ownership
by employees, Consultants and non-employee directors in order to attract, retain
and reward such individuals and strengthen the mutuality of interests between
such individuals and the Company’s shareholders.
ARTICLE
II
DEFINITIONS
For
purposes of this Plan, the following terms shall have the following
meanings:
2.1. “Board”
shall mean the Board of Directors of the Company.
2.2. “Cause”
shall mean, with respect to a Participant’s Termination of Relationship, unless
otherwise determined by the Committee at grant, willful misconduct in connection
with the Participant’s employment of consultancy or willful failure to perform
his or her employment of consultancy responsibilities in the best interests of
the Company (including, without limitation, breach by the Participant of any
provision of any employment, non-disclosure, non-competition or other similar
agreement between the Participant and the Company), as determined by the
Committee, which determination shall be final, conclusive and
binding. With respect to a Participant’s Termination of Directorship,
Cause shall mean any act or failure to act that constitutes “cause” for removal
of a director under applicable New Jersey law.
2.3. “Change
in Control” shall have the meaning set forth in Article VIII.
2.4. “Code”
shall mean the Internal Revenue Code of 1986, as amended. Any
reference to any section of the Code shall also be a reference to any successor
provision.
2.5. “Committee”
shall mean a committee of the Board appointed from time to time by the Board,
which Committee shall be intended to consist of three or more directors who are
non-employee directors as defined in Rule 16b-3 (as defined herein) and outside
directors as defined under Section 162(m) of the Code (as defined
herein). If for any reason the appointed Committee does not meet the
requirements of Rule 16b-3 or Section 162(m) of the Code, such noncompliance
with the requirements of Rule 16b-3 or Section 162(m) of the Code shall not
affect the validity of the awards, grants, interpretations or other actions of
the Committee. Notwithstanding the forgoing, with respect to grants
of Options to non-employee directors and any action hereunder relating to
Options held by non-employee directors, the Committee shall mean the
Board. If and to the extent that no Committee exists which has the
authority to administer the Plan, the functions of the Committee shall be
exercised by the Board.
2.6. “Common
Stock” means the Common Stock, par value $0.001 per share, of the
Company.
2.7. “Consultant”
means any advisor or consultant to the Company or its subsidiaries who is
eligible pursuant Article V to be granted Options under this Plan.
2.8. “Disability”
shall mean total and permanent disability, as defined in Section 22(e)(3) of the
Code.
2.9. “Effective
Date” shall mean the effective date of the Plan as defined in Article
XII.
2.10. “Eligible
Employee” shall mean the employees of the Company and its subsidiaries who are
eligible pursuant to Article V to be granted Options under this
Plan.
2.11. “Exchange
Act” shall mean the Securities Exchange Act of 1934.
2.12. “Fair
Market Value” for purposes of this Plan, unless otherwise required by an
applicable provision of the Code or any regulations issued thereunder, shall
mean, as of any date, the last sales price reported for the Common Stock on the
applicable date (i) as reported by the principal national securities exchange in
the United States on which it is then traded, or (ii) if not traded on any such
national securities exchange, as quoted on an automated quotation system
sponsored by the National Association of Securities Dealers. If the
Common Stock is not readily tradable on a national securities exchange or any
system sponsored by the National Association of Securities Dealers, its Fair
Market Value shall be set in good faith by the Committee. For
purposes of the grant of any Option, the applicable date shall be the date for
which the last sales price is available at the time of the grant.
2.13. “Good
Reason” shall mean, with respect to a Participant’s Termination of Relationship,
unless otherwise determined by the Committee at grant, a voluntary termination
due to “good reason,” as the Committee, in its sole discretion, decides to treat
as a Good Reason termination. Notwithstanding the foregoing, with
respect to a Participant’s Termination of Employment, Good Reason shall mean, in
the case where there is an employment agreement between the Company or a
Subsidiary and the Participant in effect at the time of the grant that defines
“good reason” (or words of like import), a termination that is or would be
deemed “good reason” (or words of like import) as defined under such employment
agreement at the time of grant.
2.14. “Incentive
Stock Option” shall mean any Stock Option awarded under this Plan intended to
be, and designated as, an “Incentive Stock Option” within the meaning of Section
422 of the Code.
2.15. “Non-Qualified
Stock Option” shall mean any Stock Option awarded under this Plan that is not an
Incentive Stock Option.
2.16. “Participant”
shall mean the following persons to whom an Option has been granted pursuant to
this Plan: (i) Eligible Employees of the Company or its Subsidiaries; (ii)
Consultants of the Company or its Subsidiaries; and (iii) non-employee directors
of the Company.
2.17. “Retirement”
with respect to a Participant’s Termination of Relationship shall mean a
Termination of Relationship without Cause from the Company and/or a Subsidiary
by a Participant who has attained (i) at least the age of sixty-five (65) or
(ii) such earlier date after age fifty-five (55) as approved by the Committee
with regard to such Participant. With respect to a Participant’s
Termination of Directorship, Retirement shall mean the failure to stand for
reelection or the failure to be reelected after a Participant has attained the
age of sixty-five (65).
2.18. “Rule
16b-3” shall mean Rule 16b-3 under Section 16(b) of the Exchange Act as then in
effect or any successor provision.
2.19. “Section
162(m) of the Code” shall mean the exception for performance based compensation
under Section 162(m) of the Code and any Treasury regulations
thereunder.
2.20. “Stock
Options” or “Option” shall mean any option to purchase shares of Common Stock
granted to Eligible Employees, Consultants or non-employee directors pursuant to
Article VI.
2.21. “Subsidiary”
shall mean any corporation that is defined as a subsidiary corporation in
Section 424(f) of the Code.
2.22. “Ten
Percent Shareholder” shall meant a person owning Common Stock of the Company
possessing more than ten percent (10%) of the total combined voting power of all
classes of stock of the Company as defined in Section 422 of the
Code.
2.23. “Termination
of Consultancy” shall mean (i) an individual is no longer acting as a Consultant
to the Company or a Subsidiary or (ii) when an entity which is retaining a
Participant as a Consultant ceases to be a Subsidiary, unless the Participant
thereupon is retained as a Consultant by the Company or another
Subsidiary.
2.24. “Termination
of Directorship” shall mean, with respect to a non-employee director, that the
non-employee director has ceased to be a director of the Company for any
reason.
2.25.
“Termination of Employment” shall mean (i) a termination of
service (for reasons other than a military or personal leave of absence granted
by the Company) of a Participant from the Company and its Subsidiaries or (ii)
when an entity which is employing a Participant ceases to be a Subsidiary,
unless the Participant thereupon becomes employed by the Company or another
Subsidiary.
2.26. “Termination
of Relationship” shall mean a Termination of Employment or a Termination of
Consultancy, as applicable.
2.27. “Transfer”
or “Transferred” shall mean anticipate, alienate, attach, sell, assign, pledge,
encumber, charge or otherwise transfer.
2.28. “Withholding
Election” shall have the meaning set forth in Section 11.4.
ARTICLE
III
ADMINISTRATION
3.1.
The
Committee
. The Plan shall be administered and interpreted by
the Committee.
3.2.
Awards
. The
Committee shall have full authority to grant Stock Options, pursuant to the
terms of this Plan. In particular, the Committee shall have the
authority:
(a) to
select the Eligible Employees, Consultants and non-employee directors to whom
Stock Options may from time to time be granted hereunder;
(b) to
determine whether and to what extent Stock Options are to be granted hereunder
to one or more Eligible Employees, Consultants or non-employee
directors;
(c) to
determine, in accordance with the terms of the Plan, the number of shares of
Common Stock to be covered by each Stock Option granted to an Eligible Employee,
Consultant or non-employee director;
(d) to
determine the terms and conditions, not inconsistent with the terms of this
Plan, of any Stock Options granted hereunder to an Eligible Employee, Consultant
or non-employee director (including, but not limited to, the share price, any
restriction or limitation, any vesting schedule or acceleration thereof, or any
forfeiture restrictions or waiver thereof, and the share of Common Stock
relating thereto, based on such factors, if any, as the Committee shall
determine, in its sole discretion);
(e) to
determine whether and under what circumstances a Stock Option may be settled in
cash and/or Common Stock under Subsection 6.3(d);
(f) to
determine whether to require Eligible Employees, Consultants, and non-employee
directors, as a condition of the granting of any Option, to not sell or
otherwise dispose of shares acquired pursuant to the exercise of an Option for a
period of time as determined by the Committee, in its sole discretion, following
the date of the acquisition of such Option.
3.3.
Guidelines
. Subject
to Article IX hereof, the Committee shall have the authority to:
(a) adopt,
alter and repeal such administrative rules, guidelines and practices governing
this Plan and perform all acts, including the delegation of its administrative
responsibilities, as it shall, from time to time, deem advisable;
(b) construe
and interpret the terms and provisions of this Plan and any Option granted under
this Plan (and any agreements relating thereto); and
(c) otherwise
supervise the administration of this Plan.
The
Committee may correct any defect, supply any omission or reconcile any
inconsistency in this Plan or in any agreement relating thereto in the manner
and to the extent it shall deem necessary to carry this Plan into effect, but
only to the extent any such action would be permitted under the applicable
provisions of Rule 16b-3 (if any) and the applicable provisions of Section
162(m) of the Code (if any). The Committee may adopt special
guidelines and provisions for persons who are residing in, or subject to, the
taxes of, countries other than the United States to comply with applicable tax
and securities laws. If and solely to the extent applicable, this
Plan is intended to comply with Rule 16b-3 and Section 162(m) of the Code and
shall be limited, construed and interpreted in a manner so as to comply
therewith.
3.4.
Decisions
Final
. Any decision, interpretation or other action made or
taken in good faith by or at the direction of the Company, the Board or the
Committee (or any of its members) arising out of or in connection with the Plan
shall be within the absolute discretion of all and each of them, as the case may
be, and shall be final, conclusive and binding on the Company and all employees,
directors, consultants and Participants and their respective heirs, executors,
administrators successors and assigns.
3.5.
Reliance on
Counsel
. The Company, the Board or the Committee may consult
with legal counsel, who may be counsel for the Company or other counsel, with
respect to its obligations or duties hereunder, or with respect to any action or
proceeding or any question of law, and shall not be liable with respect to any
action taken or omitted by it in good faith pursuant to the advice of such
counsel.
3.6.
Procedures
. If
the Committee is appointed, the Board shall designate one of the member of the
Committee as chairman and the Committee shall hold meetings, subject to the
Bylaws of the Company, at such times and places as it shall deem
advisable. A majority of the Committee members shall constitute a
quorum. All determinations of the Committee shall be made by a
majority of its members. Any decision or determination reduced to
writing and singed by all Committee members in accordance with the Bylaws of the
Company shall be fully effective as if it had been made by a vote at a meeting
duly called and held. The Committee shall keep minutes of its
meetings and shall make such rules and regulations for the conduct of its
business as it shall deem advisable.
3.7.
Designation of Advisors –
Liability
.
(a) The
Committee may designate officers of the Company and professional advisors to
assist the Committee in the administration of the Plan and may grant authority
to employees to execute agreements or other documents on behalf of the
Committee.
(b) The
Committee may employ such legal counsel, consultants and agents as it may deem
desirable for the administration of the Plan and may rely upon any opinion
received from any such counsel or consultant and any computation received from
such consultant or agent. Expenses incurred by the Committee or Board
in the engagement of any such counsel, consultant or agent shall be paid by the
Company. The Committee, its members and any person designated
pursuant to paragraph 3.7.1 above shall not be liable for any action or
determination made in good faith with respect to the Plan. To the
maximum extent permitted by applicable law, no officer or former officer of the
Company or member or former member of the Committee or the Board shall be liable
of any action or determination made in good faith with respect to the Plan or
any Stock Option granted under it. To the maximum extent permitted by
applicable law and the Certificate of Incorporation and Bylaws of the Company
and to the extent not covered by insurance, each officer or former officer and
member and former member of the Committee or the Board shall be indemnified and
held harmless by the Company against any cost or expense (including reasonable
fees of counsel reasonably acceptable to the Company) or liability (including
any sum paid in settlement of a claim with the approval of the Company), and
advanced amounts necessary to pay the foregoing at the earliest time and to the
fullest extent permitted, arising out of any act or omission to act in
connection with the Plan, except to the extent arising out of such officer’s or
former officer’s, member’s or former member’s own fraud or bad
faith. Such indemnification shall be in addition to any rights of
indemnification the officers, directors or members or former officers, director
or members may have under applicable law or under the Certificate of
Incorporation or Bylaws of the Company or Subsidiary. Notwithstanding
anything else herein, this indemnification will not apply to the actions or
determinations made by an individual with regard to Stock Options granted to him
or her under this Plan.
ARTICLE
IV
SHARE AND
OTHER LIMITATIONS
4.1.
Shares
.
(a)
General
Limitation
. The aggregate number of shares of Common Stock
which may be issued under this Plan with respect to which Stock Options may be
granted shall not exceed 4,500,000 shares (subject to increase or decrease
pursuant to Section 4.2) which may be either authorized and unissued Common
Stock or Common Stock held or acquired for the treasury of the
Company. If any Stock Option granted under this Plan expires,
terminates or is cancelled for any reason without having been exercised in full
or the Company repurchases any Stock Option pursuant to Section 6.3(f), the
number of shares of Common Stock underlying the repurchased Option, and/or the
number of shares of Common Stock underlying any unexercised Option shall again
be available for the purposes of Options under the Plan.
(b)
Individual Participant
Limitations
. The maximum number of shares of Common Stock
subject to any Option which may be granted under this Plan to each Participant
shall not exceed 1,000,000 shares (subject to any increase or decrease pursuant
to Section 4.2) during any fiscal year of the Company.
4.2.
Changes
.
(a) The
existence of the Plan and the Options granted hereunder shall not affect in any
way the right or power of the Board or the shareholders of the Company to make
or authorize any adjustment, recapitalization, reorganization or other change in
the Company’s capital structure or its business, any merger or consolidation of
the Company or any Subsidiary, any issue of bonds, debentures, preferred or
prior preference stock ahead of or affecting Common Stock, the dissolution or
liquidation of the Company or any Subsidiary, any sale or transfer of all or
part of the assets or business or any other corporate act of
proceeding.
(b) In
the event of any such change in the capital structure or business of the Company
by reason of any stock dividend or distribution, stock split or reverse stock
split, recapitalization, reorganization, merger, consolidation, split-up,
combination or exchange of shares, distribution with respect to its outstanding
Common Stock or capital stock other than Common Stock, sale or transfer of all
or part of the assets or business, reclassification of its capital stock, or any
similar changes affecting the Company’s capital structure or business and the
Committee determines an adjustment is appropriate under the Plan, the number and
kind of shares or other property (including cash) to be issued upon exercise of
an outstanding Option and the purchase price thereof shall be appropriately
adjusted consistent with such change in such manner as the Committee may deem
equitable to prevent substantial dilution or enlargement of the rights granted
to, or available for, Participants under this Plan or as otherwise necessary to
reflect the change, and, any such adjustment determined by the Committee shall
be final, conclusive and binding on the Company and all Participants and
employees and their respective heirs, executors, administrators, successors and
assigns.
(c) Fractional
Shares of Common Stock resulting from any adjustment in Options pursuant to this
Article IV shall be aggregated until, and eliminated at, the time of exercise by
rounding down from fractions less than one-half (1/2) and rounding up for
fractions equal to or greater than one-half (1/2). No cash
settlements shall be made with respect to fractional shares eliminated by
rounding. Notice of any adjustment shall be given by the Committee to
each Participant whose Option has been adjusted and such adjustment (whether or
not such notice is given) shall be effective and binding for all purposes of the
Plan.
(d) In
the event of a merger or consolidation in which the Company is not the surviving
entity or in the event of any transaction that results in the acquisition of all
or substantially all of the Company’s outstanding Common Stock by a single
person or entity or by a group of persons or entities acting in concert, or in
the event of the sale or transfer of all or substantially all of the Company’s
assets (all of the foregoing being referred to as “Acquisition Events”), then
the Committee may, in its sole discretion, terminate all outstanding Options of
Eligible Employees, Consultants and non-employee directors, effective as of the
date of the Acquisition Event, by delivering notice of termination to each such
Participant at least twenty (20) days prior to the date of consummation of the
Acquisition Event; provided, however, that during the period from the date on
which such notice of termination is delivered to the consummation of the
Acquisition Event, , each such Participant shall have the right to exercise in
full all of his or her Options that are outstanding (without regard to
exercisability otherwise contained in the Option Agreement) but contingent on
occurrence of the Acquisition Event, and provided that if the Acquisition Event
does not take place within the specified period after giving such notice for any
reason whatsoever, the notice and exercise shall be null and void.
If the
Acquisition Event occurs, to the extent the Committee does not terminate the
outstanding Options pursuant to this Section 4.2(d), then the provisions of
Section 4.2(b) shall apply.
ARTICLE
V
ELIGIBILITY
All
employees and Consultants of the Company and its subsidiaries and all
non-employee directors of the Company are eligible to be granted Stock Options
under this Plan. Eligibility under this Plan may be determined by the
Committee in its sole discretion.
ARTICLE
VI
STOCK
OPTION GRANTS
6.1.
Options
. Each
Stock Option granted hereunder shall be one of two types: (i) an Incentive Stock
Option intended to satisfy the requirements of Section 422 of the Code; or (ii)
a Non-Qualified Stock Option.
6.2.
Grants
. The
Committee shall have the authority to grant to any Eligible Employee one or more
Incentive Stock Options, Non-Qualified Stock Options or both types of Stock
Options. The Committee shall have the authority to grant to any
Consultants one or more Non-Qualified Stock Options. The Board shall
have the authority to grant to any non-employee director one or more
Non-Qualified Stock Options. To the extent that any Stock Option does
not qualify as an Incentive Stock Option (whether because of its provisions or
the time or manner of its exercise or otherwise), such Stock Option or the
portion thereof which does not qualify, shall constitute a separate
Non-Qualified Stock Option.
6.3.
Terms of
Options
. Options granted under this Plan shall be subject to
the following terms and conditions, and shall be in such form and contain such
additional terms and conditions, not inconsistent with the terms of this Plan,
as the Committee shall deem desirable:
(a)
Option Price
. The
option price per share of Common Stock purchasable under an Incentive Stock
Option shall be determined by the Committee at the time of grant but shall not
be less than 100% of the Fair Market Value of the share of Common Stock at the
time of grant; provided, however, if an Incentive Stock Option is granted to a
Ten Percent Shareholder, the purchase price shall be no less than 110% of the
Fair Market Value of the Common Stock. The purchase price of shares
of Common Stock subject to Non-Qualified Stock Options shall be determined by
the Committee.
(b)
Option Term
. The
term of each Stock Option shall be fixed by the Committee, but no Stock Option
shall be exercisable more than ten (10) years after the date the Option is
granted; provided, however, that the term of an Incentive Stock Option granted
to a Ten Percent Shareholder may not exceed five (5) years.
(c)
Exercisability
. Stock
Options shall be exercisable at such time or times and subject to such terms and
conditions as shall be determined by the Committee at grant. If the
Committee provides, in its sole discretion, that any Stock Option is exercisable
subject to certain limitations (including, without limitation, that it is
exercisable only in installments or within certain time periods), the Committee
may waive such limitations on the exercisability at any time at or
after the grant date in whole or in part (including, without limitation, that
the Committee may waive the installment exercise provisions or accelerate the
time which Options may be exercised), based on such factors, if any, as the
Committee shall determine, in its sole discretion.
(d)
Method of
Exercise
. Subject to whatever installment exercise and waiting
period provisions apply under 6.3(c) above, Stock Options may be exercised in
whole or in part at any time during the Option term, by giving written notice of
exercise to the Company specifying the number of shares to be
purchased. Such notice shall be accompanied by payment in full of the
purchase price in such form, or other arrangement for the satisfaction of the
purchase price, as the Committee may accept. If and to the extent
determined by the Committee in its sole discretion at or after the grant,
payment in full or in part may also be made in the form of Common Stock withheld
from the shares to be received on the exercise of the Stock Option hereunder or
Common Stock owned by the Participant (and for which the Participant has good
title, free and clear or all liens and encumbrances) based on the Fair Market
Value of the Common Stock on the payment date as determined by the
Committee. No shares of Common Stock shall be issued until payment,
as provided herein, therefore has been made or provided for and the Participant
shall have none of the rights of a holders of shares of Common Stock until such
shares of Common Stock have been issued.
(e)
Incentive Stock Option
Limitations
. To the extent that the aggregate Fair Market
value (determined as of the time of grant) of the Common Stock with respect to
which Incentive Stock Options are exercisable for the first time by an Eligible
Employee during any calendar year under the Plan and/or other stock option plan
of the Company or any Subsidiary or parent corporation (within the meaning of
Section 424(e) of the Code) exceeds $100,000, such Options shall be treated as
Options which are not Incentive Stock Options.
Should
the foregoing provision not be necessary in order for the Stock Options to
qualify as Incentive Stock Options, or should any additional provisions be
required, the Committee may amend the Plan accordingly, without the necessity of
obtaining the approval of the shareholders of the Company.
(f)
Buy Out and Settlement
Provisions
. The Committee may at any time on behalf of the
Company offer to buy out an Option previously granted, based on such terms and
conditions as the Committee shall establish and communicate to the Participant
at the time that such offer is made.
(g)
Form, Modification, Extension and
Renewal of Options
. Subject to the terms and conditions and
within the limitations of the Plan, an Option shall be evidenced by such form of
agreement or grant as approved by the Committee, and the Committee may modify,
extend or renew outstanding Options granted under the Plan (provided that the
rights of a Participant are not reduced without his consent), or accept the
surrender of outstanding Options (up to the extent not theretofore exercised)
and authorize the granting of new Options in substitution thereof (to the extent
not theretofore exercised).
(h)
Other Terms and
Conditions
. Options may contain such other provisions, which
shall not be inconsistent with any of the foregoing terms of the Plan, as the
Committee shall deem appropriate including, without limitation, permitting
“reloads” such that the same number of Options are granted as the number of
Options exercised, shares used to pay for the exercise price of Options or
shares used to pay withholding taxes (“Reloads”). With respect to
Reloads, the exercise price of the new Stock Option shall be the Fair Market
Value on the date of the Reload and the term of the Stock Option shall be the
same as the remaining term of the Options that are exercised, if applicable, or
such other exercise price and term as determined by the
Committee.
6.4.
Termination of
Relationship
. The following rules apply with regard to Options
upon the Termination of Relationship of a Participant:
(a)
Termination by Reason of
Death
. If a Participant’s Termination of Relationship is by
reason of death, any Stock Option held by such Participant, unless otherwise
determined by the Committee at grant or, if no rights of the Participant’s
estate are reduced, thereafter, may be exercised, to the extent exercisable at
the Participant’s death, by the legal representative of the estate, at any time
within a period of one (1) year from the date of such death, but in no event
beyond the expiration of the stated term of the Stock Option.
(b)
Termination by Reason of
Disability
. If a Participant’s Termination of Relationship is
by reason of Disability, any Stock Option held by such Participant, unless
otherwise determined by the Committee at grant or, if no rights of the
Participant are reduced, thereafter, may be exercised, to the extent exercisable
at the Participant’s termination, by the Participant (or the legal
representative of the Participant’s estate if the Participant dies after
termination) at any time within a period of one (1) year from the date of such
termination, but in no event beyond the expiration of the stated term of such
Stock Option.
(c)
Termination by Reason of
Retirement
. If a Participant’s Termination of Relationship is
by reason of Retirement, any Stock Option held by such Participant, unless
otherwise determined by the Committee at grant, or, if no rights of the
Participant are reduced, thereafter, shall be fully vested and may thereafter be
exercised by the Participant at any time within a period of one (1) year from
the date of such termination, but in no event beyond the expiration of the
stated term of such Stock Option; provided, however, that, if the Participant
dies within such exercise period, any unexercised Stock Option held by such
Participant shall thereafter be exercisable, to the extent to which it was
exercisable at the time of death, for a period of one (1) year (or such other
period as the Committee may specify at grant or, if no rights of Participant’s
estate are reduced, thereafter) from the date of such death, but in no event
beyond the expiration of the stated term of such Stock Option.
(d)
Involuntary Termination Without
Cause or Termination for Good Reason
. If a Participant’s
Termination of Relationship is by involuntary termination without Cause or for
Good Reason, any Stock Option held by such Participant, unless otherwise
determined by the Committee at grant or, if no rights of the Participant are
reduced, thereafter, may be exercised, to the extent exercisable at termination,
by the Participant at any time within a period of ninety (90) days from the date
of such termination, but in no event beyond the expiration of the stated term of
such Stock Option.
(e)
Termination Without Good
Reason
. If a Participant’s Termination of Relationship is
voluntary but without Good Reason and such Termination of Relationship occurs
prior to, or more than ninety (90) days after, the occurrence of an event which
would be grounds for Termination of Relationship by the Company for Cause
(without regard to any notice or cure period requirements), any Stock Option
held by the Participant, unless otherwise determined by the Committee at grant
or, if no rights of the Participant are reduced, thereafter, may be exercised,
to the extent exercisable at termination, by the Participant at any time within
a period of thirty (30) days from the date of such Termination of Relationship,
but in no event beyond the expiration of the stated term of such Stock
Option.
(f)
Other
Termination
. Unless otherwise determined by the Committee at
grant or, if no rights of the Participant are reduced, thereafter, if a
Participant’s Termination of Relationship is for any reason other than death,
Disability, Retirement, Good Reason, involuntary termination without Cause or
voluntary termination as provided in Subsection 6.4(e) above, any Stock Option
held by such Participant shall thereupon terminate and expire as of the date of
termination, provided that (unless the Committee determines a different period
upon grant or, if no rights of the Participant are reduced, thereafter) in the
event such termination is for Cause or is a voluntary termination without Good
Reason or voluntary resignation within ninety (90) days after occurrence of an
event which would be grounds for Termination of Relationship by the Company for
Cause (without regard to any notice or cure period requirement), any Stock
Option held by Participant at the time of occurrence of the event which would be
grounds for Termination of Relationship for Cause shall be deemed to have
terminated and expired upon occurrence of the event which would be grounds for
Termination of Relationship by the Company for Cause.
6.5.
Termination of
Directorship
. The following rules apply with regard to Options
upon Termination of Directorship:
(a)
Death, Disability or Otherwise
Ceasing to be a Director Other than for Cause
. Except as
otherwise determined by the Committee at grant or, if no rights of the
Participant are reduced, thereafter, upon the Termination of Directorship, on
account of Disability, death, Retirement, resignation, failure to stand for
reelection or failure to be reelected or otherwise other than as set forth in
6.5(b) below, all outstanding Options then exercisable and not exercised by the
Participant prior to such Termination of Directorship shall remain exercisable,
to the extent exercisable at the Termination of Directorship, by the Participant
or, in the case of death, by the Participant’s estate or by the person given
authority to exercise such Options by his or her will or by operation of law,
for a one (1) year period commencing on the date of the Termination of
Directorship, provided that such one (1) year period shall not extend beyond the
expiration of the stated term of such Options.
(b)
Cause
. Upon
removal, failure to stand for reelection or failure to be re-nominated for
Cause, or if the Company obtains or discovers information after Termination of
Directorship that such Participant had engaged in conduct that would have
justified a removal for Cause during such directorship, all outstanding Options
of such Participant shall immediately terminate and shall be null and
void.
(c)
Cancellation of
Options
. No Options that were not exercisable during the
period such person serves as a director shall thereafter become exercisable upon
a Termination of Directorship for any reason or no reason whatsoever, and such
Options shall terminate and become null and void upon Termination of
Directorship.
ARTICLE
VII
NON-TRANSFERABILITY
No Stock
Option shall be Transferable by the Participant otherwise than by will or by the
laws of descent and distribution. All Stock Options shall be
exercisable, during the Participant’s lifetime, only by the
Participant. No Stock Option shall, except as otherwise specifically
provided by law or herein, be Transferable in any manner, and any
attempt to Transfer any such Option shall be void, and no such Option shall in
any manner be liable for or subject to the debts, contracts, liabilities,
engagements or torts of any person who shall be entitled to such Option, nor
shall it be subject to attachment or legal process for or against such
person.
ARTICLE
VIII
CHANGE IN
CONTROL PROVISIONS
8.1
Benefits
. In
the event of a Change in Control of the Company (as defined below), except as
otherwise provided by the Committee upon the grant of an Option, the Participant
shall be entitled to the following benefits:
(a) Subject
to paragraph (b) below, all outstanding Options of the Participants granted
prior to the Change in Control shall be fully vested and immediately exercisable
in their entirety. The Committee, in its sole discretion, may provide
for the purchase of any such Stock Options by the Company for an amount of cash
equal to the excess of the Change in Control price (as defined below) of the
shares of Common Stock covered by the Stock Options, over the aggregate exercise
price of such Stock Options. For purposes of this Section 8.1, Change
in Control price shall mean the higher of (i) the highest price per share of
Common Stock paid in any transaction related to the Change in Control
of the Company or (ii) the highest Fair Market Value per share of Common Stock
at any time during thr sixty (60) day period preceding a Change in
Control.
(b) Notwithstanding
anything to the contrary herein, unless the Committee provides otherwise at the
time an Option is granted to an Eligible Employee or Consultant hereunder or
thereafter, no acceleration of exercisability shall occur with respect to such
Option if the Committee reasonably determines in good faith, prior to the
occurrence of the Change in Control, that the Options shall be honored or
assumed, or new rights substituted therefore (each such honored, assumed or
substituted option hereinafter called an “Alternative Option”), by such
Participant’s employer (or the parent of such employer), or in the case of a
Consultant, by the entity (or its parent or subsidiary) which retains the
Consultant, immediately following the Change in Control, provided that any such
Alternative Option must meet the following criteria:
(i) the
Alternative Option must be based on stock which is traded on an established
securities market, or which will be traded within thirty (30) days of the Change
in Control;
(ii) the
Alternative Option must provide such Participant with rights and entitlements
substantially equivalent to or better then the rights, terms and conditions
applicable under such Option, including, but not limited to, an identical or
better exercise schedule; and
(iii) the
Alternative Option must have economic value substantially equivalent to the
value of such Option (determined at the time of the Change in
Control).
For
purposes of Incentive Stock Options, any assumed or substituted Option shall
comply with the requirements of Treasury regulation §1.425-1 (and any amendment
thereto).
8.2
Change in
Control
. A Change in Control shall be deemed to have
occurred:
(a) upon
any “person” as such term is used in Section 13(d) and 14(d) of the Exchange Act
(other than the Company, any trustee or other fiduciary holding securities under
any employee benefit plan of the Company, any company owned, directly or
indirectly, by the shareholders of the Company in substantially the same
proportions as their ownership in Common Stock of the Company), becoming the
owner (as defined in Rule 13d-3 under the Exchange Act), directly or indirectly,
of securities of the Company representing fifty percent (50%) or more of the
combined voting power of the Company’s then outstanding securities (including,
without limitation, securities owned at the time of any increase in
ownership);
(b) upon
a merger or consolidation of the Company with any other corporation other than a
merger or consolidation which would result in the voting securities of the
Company outstanding immediately prior thereto continuing to represent (either by
remaining outstanding or by being converted into voting securities of the
surviving entity) more then fifty percent (50%) of the combined voting power of
the voting securities of the Company or such surviving entity outstanding
immediately after such merger or consolidation; or
(c) upon
the shareholders’ of the Company approval of a plan of complete liquidation of
the Company or an agreement for the sale or disposition by the Company of all or
substantially all of the Company’s assets other than the sale of all or
substantially all of the assets of the Company to a person or persons who
beneficially own, directly or indirectly, at least fifty percent
(50%) or more of the combined voting power of the outstanding voting
securities of the Company at the time of the sale.
ARTICLE
IX
TERMINATION
OR AMENDMENT OF PLAN
9.1
Termination or
Amendment
. Notwithstanding any other provisions of this Plan,
the Board may at any time, and from time to time, amend, in whole or in part,
any or all of the provisions of the Plan, or suspend or terminate it entirely,
retroactively or otherwise; provided, however, that, unless otherwise required
by law or specifically provided herein, the rights of a Participant with respect
to the Options granted prior to such amendment, suspension or termination, may
not be impaired without the consent of the Participant and, provided further,
without the approval of the shareholders of the Company, if and to the extent
required by the applicable provisions of Rule 16b-3 or under the applicable
provisions of Section 162(m) of the Code or, with regard to Incentive Stock
Options, Section 422 of the Code, no amendment may be made which would: (i)
increase the maximum individual Participant limitations under Section 4.1(b);
(ii) change the classification of employees eligible to receive Options under
this Plan; (iii) extend the maximum option period under Section 6.3; or (iv)
require shareholder approval in order for the Plan to continue to comply with
the applicable provisions, if any, of Section 162(m) of the Code or, with
regards to Incentive Stock Options, Section 422 of the Code. In no
event may the Plan be amended without the approval of the shareholders of the
Company in accordance with applicable law or other requirements to
increase the aggregate number of shares of Common Stock that may be issued under
the Plan or to make any other amendment that would require shareholder approval
under the rules of any exchange or system on which the Company’s securities are
listed or traded at the request of the Company.
The
Committee may amend the terms of any Option theretofore granted, prospectively
or retroactively, but, subject to Article IV above or as otherwise specifically
provided herein, no such amendment or other action by the Committee shall impair
the rights of any holder without the holder’s consent.
ARTICLE
X
UNFUNDED
PLAN
10.1.
Unfunded Status if
Plan
. This Plan is intended to constitute an “unfunded” plan
for incentive compensation. With respect to any payments as to which
a Participant has a fixed and vested interest but which are not yet made to a
Participant by the Company, nothing contained herein shall give any such
Participant any rights that are greater than those of a general creditor of the
Company.
ARTICLE
XI
GENERAL
PROVISIONS
11.1.
Legend
. The
Committee may require each person receiving shares of Common Stock pursuant to
the exercise of a Stock Option under the Plan to represent to and agree with the
Company in writing that the Participant is acquiring the shares without a view
to distribution thereof. In addition to any legend required by this
Plan, the certificates for such shares may include any legend which the
Committee deems appropriate to reflect any restrictions on
Transfer.
All
certificates for shares of Common Stock delivered under the Plan shall be
subject to such stock transfer orders and other restrictions as the Committee
may deem advisable under the rules, regulations and other requirement of the
Securities and Exchange Commission, any stock exchange upon which the Common
Stock is then listed or any national securities association system upon whose
system the Common Stock is then quoted, any applicable federal or state
securities law, and any applicable corporate law, and the Committee may cause a
legend or legends to be put on any such certificates to make appropriate
reference to such restrictions.
11.2.
Other
Plans
. Nothing contained in this Plan shall prevent the Board
from adopting other or additional compensation arrangements, subject to
shareholder approval if such approval is required; and such arrangements may be
either generally applicable or applicable only in specific cases.
11.3.
No Rights to
Employment/Consultancy/Directorship
. Neither this Plan nor the
grant of any Option hereunder shall give any Participant or other individual any
right with respect to continuance of employment or consultancy by the Company or
any Subsidiary, nor shall there be a limitation in any way on the right of the
Company or any Subsidiary by which an employee is employed or if a consultant,
retained, to terminate his employment or consultancy at any
time. Neither this Plan nor the grant of any Option hereunder shall
impose any obligation on the Company to retain any Participant as a director,
nor shall it impose on the part of any Participant any obligation to remain as a
director of the Company.
11.4.
Withholding of
Taxes
. The Company shall have the right, if necessary or
desirable (as determined by the Company), to deduct from any payment to be made
to a Participant, or to otherwise require, prior to the issuance or delivery of
any shares of Common Stock or the payment of any cash hereunder, payment by the
Participant of, any Federal, state or local taxes required by law to be
withheld.
The
Committee may permit any such withholding obligation with regard to any
Participant to be satisfied by reducing the number of shares of Common Stock
otherwise deliverable or by delivering shares of Common Stock already
owned. Any fraction of a share of Common Stock required to satisfy
such tax obligations shall be disregarded and the amount due shall be paid
instead of cash by the Participant.
11.5.
Listing and Other
Conditions
.
(a) As
long as the Common Stock is listed on a national securities exchange or system
sponsored by a national securities association, the issue of any shares of
Common Stock pursuant to the exercise of an Option shall be conditioned upon
such shares being listed on such exchange or system. The Company
shall have no obligation to issue such shares unless and until such shares are
so listed, and the right to exercise any Option with respect to such shares
shall be conditioned upon such listing and shall be suspended until such listing
has been effected.
(b) If
at any time counsel to the Company shall be of the opinion that any sale or
delivery of shares of Common Stock pursuant to the exercise of an Option is or
may in the circumstances be unlawful or result in the imposition of excise taxes
on the Company under the statutes, rules or regulations of any applicable
jurisdiction, the Company shall have no obligation to make such sale or
delivery, or to make any application of to effect or to maintain any
qualification or registration under the Securities Act of 1933, as amended, or
otherwise with respect to the shares of Common Stock, and the right to exercise
any Option shall be suspended until, in the opinion of said counsel, such sale
or delivery shall be lawful or will not result in the imposition of excise taxes
on the Company.
(c) Upon
termination of any period of suspension under this Section 11.5, any Option
affected by such suspension which shall not have expired or terminated shall be
reinstated as to all shares available before suspension and as to shares which
would otherwise have become available during the period of such suspension, but
no such suspension shall extend the term of any Option.
11.6.
Governing
Law
. This Plan shall be governed and constructed in accordance
with the laws of the State of New Jersey (regardless of the law that might
otherwise govern under applicable New Jersey principals of conflicts of
laws).
11.7.
Construction
. Wherever
any words are used in this Plan in the masculine gender they shall be construed
as though they were also used in the feminine gender in all cases where they
would so apply, and wherever any words are used herein in the singular form they
shall be construed as though they were also used in the plural form in all cases
where they would so apply.
11.8.
Other
Benefits
. No Stock Option granted under this Plan shall be
deemed compensation for purposes of computing benefits under any retirement plan
of the Company or its Subsidiaries nor affect any benefits under any other
benefit plan now or subsequently in effect under which the availability or
amount of benefits is related to the level of compensation.
11.9.
Costs
. The
Company shall bear all expenses included in the administering this Plan,
including expenses of issuing Common Stock pursuant to the exercise of any
Options hereunder.
11.10.
No Right to Same
Benefits
. The provisions of Options need not be the same with
respect to each Participant, and such Options to individual Participants need
not be the same in subsequent years.
11.11.
Death/Disability
. The
Committee may in its discretion require the transferee of a Participant to
supply it with written notice of the Participant’s death or Disability and to
supply it with a copy of the will (in the case of a Participant’s death) or such
other evidence as the Committee deems necessary to establish the validity of the
transfer of an Option. The Committee may also require the agreement
of the transferee to be bound by all of the terms and conditions of the
Plan.
11.12.
Section 16(b) of the
Exchange Act
. All elections and transactions under the Plan by
persons subject to Section 16 of the Exchange Act involving shares of Common
Stock are intended to comply with any applicable exemptive condition under Rule
16b-3. To the extent applicable, the Committee may establish and
adopt written administrative guidelines, designated to facilitate compliance
with Section 16(b) of the Exchange Act, as it may deem necessary or proper for
the administration and operation of the Plan and the transaction of business
thereunder. For purposes of this paragraph, the Company shall be
deemed publicly held when and if the Company has a class of common equity
securities registered under Section 12 of the Exchange Act.
11.13.
Severability of
Provisions
. If any provision of the Plan shall be invalid or
unenforceable, such invalidity or unenforceability shall not affect any other
provisions hereof, and the Plan shall be construed and enforced as if such
provisions had not been included.
11.14.
Headings and
Captions
. The headings and captions herein are provided for
reference and convenience only, shall not be considered part of the Plan and
shall not be employed in the construction of the Plan.
ARTICLE
XII
EFFECTIVE
DATE OF PLAN
The Plan
shall take effect upon adoption by the Board, but the Plan (and any grants of
Options made prior to the shareholder approval mentioned herein) shall be
subject to the requisite approval of the shareholders of the
Company. In the absence of such approval, such Options shall be null
and void.
ARTICLE
XIII
TERM OF
PLAN
No Stock
Option shall be granted pursuant to the Plan on or after the tenth anniversary
of the earlier of the date the Plan is adopted or the date of shareholder
approval, but Options granted prior to such tenth anniversary may extend beyond
that date.
ARTICLE
XIV
NAME OF
PLAN
This Plan
shall be known as the Cicero, Inc. 2007 Employee Stock Option Plan.
13
AGREEMENT
Dated October 30,
2007
The
parties to this agreement are Cicero Inc. (the “Company”) and BluePhoenix
Solutions Ltd. (“BluePhoenix”).
Pursuant
to a guaranty agreement between BluePhoenix and Bank Hapoalim B.M.
(the “Bank”), BluePhoenix has guaranteed certain obligations of the
Company under the Company’s promissory note (the “Bank Note”) dated September
28, 2001, in favor of the Bank, which is due and payable on or about October 30,
2007 (the “Guaranty”). The outstanding principal amount of the
Bank Note is $1,971,000.
The
parties wish to enter into an agreement with respect to, among other things, (a)
the repayment in full of the Bank Note, and (b) the issuance by the Company to
BluePhoenix of (i) a senior note in the principal amount of
$1,021,000 in the form of exhibit A (the “New Note”) and (ii) 2,546,149
fully-paid and nonassessable shares of the Company’s common stock, free and
clear of any adverse claim (the “Shares”).
Accordingly,
the parties agree as follows:
1.
Repayment of the Bank
Note
. Simultaneously with the execution and delivery of
this agreement, (a) the Company is repaying $300,000 principal amount of the
Bank Note and all accrued interest on the Bank Note to the date of this
agreement, (b) BluePhoenix is repaying $1,671,000 principal amount of the Bank
Note, (c) the Bank is discharging the Company and BluePhoenix from all
liabilities and obligations in respect of the Bank Note and the Guaranty, and
(d) the Company is issuing to BluePhoenix the Note and the
Shares. Accordingly, the Company has no further liabilities or
obligations arising from (y) the agreement pursuant to exhibit 6.1.1
of the asset purchase agreement dated August 8, 2001 between the Company and
BluePhoenix, which required that the Company repay the indebtedness under the
Bank Note immediately upon the consummation of a financing by the Company or any
of its direct or indirect subsidiaries to the extent of 10% of any net proceeds
of any such financing, or (z) any Irrevocable Instruction Letters issued by the
Company to any bank pursuant to any Guaranty Extension Agreement between the
Company and BluePhoenix requiring the Company to repay certain amounts under the
Bank Note.
2.
Negative
Covenant
. As long as any portion of the New
Note remains outstanding, the Company shall not, and shall not permit any of its
subsidiaries to, incur or otherwise create any indebtedness for borrowed money,
except for Permitted Indebtedness (as defined below). As used in this
agreement, the term “Permitted Indebtedness” means (a) indebtedness
for borrowed money of the Company that is not due and payable as to principal
prior to the repayment in full of the indebtedness under the New Note and that
is not secured, directly or indirectly, by the grant of a security interest in
any assets or shares of the Company or any of its subsidiaries or an agreement
not to grant any such security interest, unless the indebtedness under the New
Note is equally and ratably secured, or (b) indebtedness set forth in exhibit
A.
Exhibit
10.23
3.
Option to Acquire Additional
Shares
. If the Company fails to pay when due
any principal of or interest on the New Note,
BluePhoenix may, at its option, exercisable from time to time by
notice given to the Company, elect to require the Company to issue to
BluePhoenix a number of fully paid and nonassessable
shares of the Company’s common stock, free and clear of any adverse claim,
determined by dividing the amount of that payment by 75% of the average closing
sale price of a share of such stock on the ten trading days immediately
preceding the exercise of such option (or, if there is no closing sale price on
a particular trading day, the average of the closing bid and asked price on that
trading day shall be used). If, from time to time, BluePhoenix makes
that election, the Company shall, not later than five business days after such
election, issue to BluePhoenix a certificate evidencing such
shares.
(a) The
Company agrees that all shares issued pursuant to section 1 shall be registered
for sale by BluePhoenix pursuant to a registration statement on Form S-1 to be
filed with the Securities and Exchange Commission (the “SEC”) before February 1,
2008. The Company shall use its reasonable best efforts to cause such
registration statement to be declared effective not later than April 1, 2008
(the “Effective Date”), and to remain effective and current thereafter, until
(a) all the certificates evidencing the unsold shares covered by the
registration statement cease to bear any restrictive legends, (b) no such shares
are subject to any stop transfer orders, and (c) all the unsold shares covered
by the registration statement may be sold publicly without registration under
the Securities Act of 1933 (without limitation as to volume in any
period). If the registration statement referred to above shall not
have been declared effective on or before April 1, 2008 or
shall not be current on April 1, 2008, the Company shall immediately
issue to BluePhoenix 50,000 additional shares of its common stock. If
the registration statement is required to be effective and current but is not
effective and current on any August 1, December 1, or April 1 thereafter, the
Company shall, at each such time, issue to BluePhoenix an additional 50,000
shares of its common stock.
(b) Notwithstanding
anything to the contrary in this section 4, if the Company is or becomes a party
to any agreement with any other person or entity respecting registration of
shares under Securities Act of 1933, which agreement contains provisions
entitling such other person or entity to rights not otherwise
provided to BluePhoenix under this section 4, this section 4 shall be
deemed amended to the extent necessary to provide BluePhoenix such
additional rights (but without adversely affecting the rights otherwise provided
under this section 4).
5.
Partnership
. Both
parties have expressed a mutual interest in forming a partnership to explore
additional capabilities to market and sell Cicero. Specifically, BluePhoenix has
indicated a willingness to establish a partnership with the Company for the
purpose of including the Company’s Cicero product in its desktop modernization
solutions. Each party shall use all reasonable efforts to negotiate the terms of
such a partnership within 30 days after the date of this
agreement. The parties agree that, notwithstanding the foregoing,
neither party shall have any liability or obligation if for any reason or for no
reason the parties fail so to agree on the terms of such
partnership.
Exhibit
10.23
6.
Releases
(a) The
Company, on its own behalf and on behalf of each of its subsidiaries and
controlled affiliates, hereby releases, acquits, and forever discharges
BluePhoenix and its affiliates, agents, representatives, officers, directors,
and employees, whether in their individual or representative capacities, and
their successors and assigns from, and acknowledge the full accord and
satisfaction of, any and all claims, accounts, debts, obligations, demands,
damages, actions, or suits of whatever nature, whether in contract, tort, or
otherwise, now accrued known or unknown, arising out of any and all transactions
and occurrences up to and including the execution and delivery of this
agreement.
(b) BluePhoenix
on its own behalf and on behalf of each of its subsidiaries and controlled
affiliates, hereby releases, acquits and forever discharges the Company and its
affiliates, agents, representatives, officers and directors and employees
whether in their individual or representative capacities, and their successors
and assigns from, and acknowledge the full accord and satisfaction of, any and
all claims, accounts, debts, obligations, demands, damages, actions, or suits of
whatever nature, whether in contract, tort, or otherwise, now accrued known or
unknown, arising out of any and all transactions and occurrences up to and
including the execution and delivery of this agreement.
(c) Notwithstanding
anything to the contrary in this section 6, nothing in this section 6 is
intended to, or shall, release either party from any liabilities or obligations
under this agreement or the New Note.
7.
Miscellaneous
(a)
Governing
Law
. This agreement shall be governed by and construed
in accordance with the law of the state of New York, without giving effect to
its conflict of law principles.
(b)
Headings
. The
section headings of this agreement are for reference purposes only, and are to
be given no effect in the construction or interpretation of this
agreement.
(c)
Notices
. All
notices and other communications under this agreement shall be in writing and
may be given by any of the following methods: (i) personal delivery; (ii)
facsimile transmission; (iii) registered or certified mail, postage prepaid,
return receipt requested; or (iv) overnight delivery service. Notices
shall be sent to the appropriate party at its address or facsimile number given
below (or at such other address or facsimile number for that party as shall be
specified by notice given under this section 7(c)):
Exhibit
10.23
|
(y)
|
if
to the Company, to it at:
|
|
|
|
|
|
8000
Regency Parkway, Suite 542
|
|
|
Cary,
North Carolina 27518
|
|
|
Attention: Mr.
John Broderick
|
|
|
|
|
|
With
a copy to:
|
|
|
|
|
|
Golenbock,
Eiseman, Assor, Bell and Peskoe, LLP
|
|
|
437
Madison Avenue
|
|
|
New
York, NY 10022
|
|
|
Attention:
Lawrence Bell, Esq.
|
|
|
|
|
(z)
|
if
to BluePhoenix, to it at:
|
|
|
|
|
|
8
Maskit Street
|
|
|
P.O.
Box 2062
|
|
|
Herzlia
46120
|
|
|
Israel
|
|
|
Attention: Chief
Financial Officer
|
|
|
|
|
|
with
a copy to:
|
|
|
|
|
|
Law
Office of Edward W. Kerson
|
|
|
80
University Place, Third Floor
|
|
|
New
York, New York 10003-4564
|
All such
notices and communications shall be deemed received upon (v) actual receipt by
the addressee, (vi) actual delivery to the appropriate address, or (vii) in the
case of a facsimile transmission, upon transmission by the sender and issuance
by the transmitting machine of a confirmation slip confirming that the number of
pages constituting the notice have been transmitted without error. In
the case of notices sent by facsimile transmission, the sender shall
contemporaneously mail a copy of the notice to the addressee at the address
provided for above. However, such mailing shall in no way alter the
time at which the facsimile notice is deemed received.
(d)
Separability
. The
invalidity of unenforceability of any provision of this agreement shall not
affect the validity or enforceability of any other provision of this agreement,
which shall remain in full force and effect.
Exhibit
10.23
(e)
Waiver
. Either
party may waive compliance by the other with any provision of this
agreement. No waiver of any provision shall be construed as a waiver
of any other provision. Any waiver must be in writing and signed by
the waiving party.
(f)
Counterparts
. This
agreement may be executed in counterparts, each of which shall be deemed an
original, but both of which together shall constitute one and the same
instrument.
(g)
Submission to
Jurisdiction
. Each party hereby irrevocably submits to the
jurisdiction of the Supreme Court of the State of New York, New York County, in
connection with any claim or controversy under this Agreement, and agrees to
waive any claim of forum inconvenience (or other similar claim) in connection
therewith.
(h)
Entire
Agreement
. This agreement is a complete statement of all the
terms of the arrangements between the parties with respect to the matters
provided for, supersedes all previous agreements and understandings between the
parties with respect to those matters, and cannot be changed or terminated
orally.
|
CICERO,
INC.
|
|
|
|
|
|
|
|
By:
|
|
|
|
John
Broderick
|
|
|
Chief
Executive and Chief Financial Officer
|
|
|
|
|
|
|
|
BLUEPHOENIX
SOLUTIONS LTD.
|
|
|
|
|
|
|
|
By:
|
|
Exhibit
10.23
SENIOR PROMISSORY
NOTE
$1,021,000.00
New York, New York
|
October 30,
2007
|
FOR VALUE
RECEIVED, the undersigned, Cicero Inc., a Delaware corporation (the "Maker"),
hereby promises to pay, in lawful money of the United States of America, to the
order of BluePhoenix Solutions (the "Payee"), the principal sum of
$1,021,000.00, at such address as the holder of this promissory note
and security agreement (this “Note”) may specify from time to time by notice
given to the Maker at 8000 Regency Parkway, Suite 542, Cary, North Carolina
27518, Attention: Mr. John Broderick (the “Maker’s
Address”). The Maker agrees to pay interest (computed on the basis of
a 360-day year of twelve 30-day months) on the outstanding principal amount of
this Note at a rate of LIBOR +1% per annum until the principal shall have become
due and payable. The Maker agrees to pay $350,000 of principal on
January 30, 2009, and $671,000 of principal on December 31, 2011. Accrued and
unpaid interest on the unpaid principal amount hereof shall be payable on each
Required Payment Date.
Notwithstanding
any provision to the contrary in this Note, the entire principal sum of this
Note, and all accrued and unpaid interest thereon, shall immediately become due
and payable (without demand for payment, notice of non-payment, presentment,
notice of dishonor, protest, notice of protest, or any other notice, all of
which are hereby expressly waived by the Maker) upon the occurrence of any of
the following (any such occurrence, a “Default”):
(a)
the
default by the Maker of any payment or other obligation under this Note;
or
(b) the
entry of an order, judgment, or decree by a court of competent jurisdiction for
relief in respect of the Maker under any applicable federal or state bankruptcy
or reorganization law or other similar law, and the continuance of any such
order, judgment, or decree unstayed, unbonded, and in effect for a period of 30
consecutive days, or (i) the Maker shall file a petition or an answer or consent
seeking relief under any applicable federal or state bankruptcy or
reorganization law or other similar law, or (ii) the consent by the Maker to the
filing of any such petition or to the appointment of or taking possession by a
trustee, custodian, or other similar official of the Maker or any substantial
part of its assets, or (iii) the failure of the Maker generally to
pay its debts as such debts become due, or the taking of action by the Maker in
furtherance of any such action.
If the
Maker fails to make any payment of principal of, or interest on this Note in
accordance with the preceding provisions of this Note, the Company shall issue
to the Payee, as promptly as practicable, a number of shares of the Company’s
fully paid and nonassessable shares of common stock equal to the product of 100
and the then unpaid balance under this Note. Nothing in this paragraph is
intended to, or shall, affect the Maker’s obligations, or the Payee’s rights,
under this Note, including, without limitation, the obligation of the Maker to
pay principal of, and interest on, this Note in accordance with the preceding
provisions of this Note.
Failure
or delay of the Payee to assert any right or remedy herein shall not be deemed a
waiver of such right or remedy or of any other right hereunder. A
waiver on one occasion shall not operate as a bar to or waiver of any such right
or remedy on any future occasion. No single, partial, or other
exercise of any right or remedy by the Payee shall preclude any other or future
exercise thereof. No waiver by the Payee will be effective, unless it
is in writing and signed by the Payee.
This Note
may not be changed or terminated orally, nor may any of its provisions be
waived, except by an agreement in writing signed by the party against whom
enforcement of such change or termination is sought.
If at any
time this transaction would be usurious under applicable law, then, regardless
of any provision in this Note to the contrary, it is agreed that the total of
all consideration that constitutes interest under applicable law that is
contracted for, charged, or received upon this Note shall under no circumstances
exceed the maximum rate of interest allowed by applicable law now or hereafter
in effect, and any excess theretofore paid shall be credited on this Note by the
holder hereof or refunded to the Maker, if this Note has been paid.
The
remedies provided for herein shall be in addition to all other remedies
existing, in the Payee's favor, under the applicable law (including equity) of
any jurisdiction.
This Note
and the legality, validity, and performance of the terms hereof shall be
governed by and enforced, determined, and construed in accordance with the
internal laws of the State of New York applicable to commercial contracts,
transactions, and obligations entered into, and to be performed in, New York,
and without giving effect to the conflict of laws principles
thereof.
The Maker
hereby irrevocably submits to the jurisdiction of the Supreme Court of the State
of New York, New York County, in connection with any claim or controversy under
this Note.
The Maker
hereby agrees to be bound by any expedited process or procedure in effect from
time to time under New York law for the enforcement by the Payee of his rights
under this Note.
This Note
shall be binding upon the Maker and the Maker's successors, and
assigns.
The Maker
shall pay all costs of collection (including reasonable counsel fees and
disbursements), if default is made in payment of this Note, and, in addition,
shall reimburse the
Payee for
all costs and expenses in connection with the preparation and negotiation of
this Note.
Any
notice under this Note shall be in writing and shall be considered given when
mailed by registered mail, return receipt requested, as follows:
If to the
Maker, to it at the Maker’s address (or at such other address as the Maker may
specify by notice given to the Payee from time to time)
If to the
Payee, to it at the Payee’s address of 8 Maskit Street, P.O. Box
2062, Herzlia 46120, Israel, Attention: Chief Financial
Officer..
The Maker
acknowledges that, except as set forth in this Note, neither the Maker nor the
Payee has entered into any agreement with the other with respect to the subject
matter of this Note.
|
CICERO
INC.
|
|
|
|
|
|
|
|
By:
|
|
|
|
|
John
Broderick
|
|
|
Chief
Executive and Chief Financial
Officer
|
Exhibit
10.24
PROMISSORY
NOTE
$300,000.00
|
October
29, 2007
|
FOR VALUE
RECEIVED,
Cicero, Inc.
,
a Delaware corporation (together with its successors and assigns, the “
Obligor
”), hereby
promises to pay to the order of
JOHN L. STEFFENS
(together
with its successors and assigns, the “
Holder
”), the
principal sum of Three Hundred Thousand Dollars and No/100 ($300,000) (the
“
Note Amount
”)
on October 30, 2009 (the “
Maturity Date
”),
together with interest on the outstanding principal sum at the
rate of 3% per annum
from the date hereof until such principal sum is paid in full.
The
payment of principal or interest shall be paid on a quarterly basis and shall be
made by check to the Holder of this Note. Any outstanding principal or interest
shall be paid on the Maturity Date at the address in the continental United
States to which such Holder has, by written notice delivered to Obligor, not
less than five business days prior to such payment date, directed Obligor to
make such payment or, if no such notice is timely received by Obligor, by check
posted to such Holder at its last known address of which the Obligor has
notice.
The
principal of and interest on this Note are payable in such coin or currency of
the United States of America as at the time of payment is legal tender for the
payment of public and private debts. All such interest shall be
calculated based upon a 360-day year and paid for the actual number of days
elapsed including the first day but excluding the last
day. Notwithstanding anything herein to the contrary, the interest or
any amount deemed to be interest payable by Obligor with respect to this Note
shall not exceed the maximum amount permitted by applicable law.
Obligor
may prepay this Note in whole at any time or in part from time to time without
premium or penalty at par plus accrued and unpaid interest.
In case
one or more of the following events (each an “
Event of Default
”)
(whatever the reason for such Event of Default and whether it shall be voluntary
or involuntary or be effected by operation of law or pursuant to any judgment,
decree or order of any court or any order, rule or regulation of any
administrative or governmental body) shall have occurred and be
continuing:
(i)
any
representation or warranty made by the Obligor in any certificate or other
document delivered shall prove to have been incorrect in any material respect
when made;
(ii)
the
appointment of a custodian, receiver, or liquidator for Obligor or any of its
property which such appointment is not discharged or dismissed within 60
days;
(iii)
the
adjudication of the Obligor as insolvent;
(iv)
the
making by the Obligor of an assignment for the benefit of its
creditors;
Exhibit
10.24
(v)
an
admission by the Obligor of his inability to pay its debts as they become
due;
(vi)
the
commencement of any proceeding under any bankruptcy or similar law by or against
the Obligor which is not discharged or dismissed within 60 days; or
(vii)
failure
on the part of Obligor to duly observe or perform in any material respect any of
the covenants or agreements on the part of the Obligor contained herein for a
period of 10 days after the date on which written notice specifying such failure
and demanding that Obligor remedy the same, shall have been given to Obligor by
the Holder of this Note,
then, and
in each and every such case, the principal of and accrued interest on this Note
shall become immediately due and payable without any declaration or other act on
the part of the Holder of this Note.
In case
this Note shall become mutilated, defaced or be apparently destroyed, lost or
stolen, Obligor shall execute and deliver a replacement Note in exchange and in
substitution for the mutilated or defaced Note, or in lieu of and in
substitution for the Note so apparently destroyed, lost or stolen. In
every case the Holder of this Note shall furnish to Obligor such security or
indemnity as may be reasonably required by Obligor to indemnify and defend and
to save Obligor harmless and, in every case of destruction, loss or theft
evidence to Obligor’s reasonable satisfaction of the apparent destruction, loss
or theft of such Note and of the ownership thereof.
No
failure or delay by any party in exercising any right, power or privilege
hereunder shall operate as a waiver thereof nor shall any single or partial
exercise thereof preclude any other or further exercise thereof or the exercise
of any other right, power or privilege. The rights and remedies
herein provided shall be cumulative and not exclusive or any rights or remedies
provided by law.
The
Obligor hereby waives demand, presentment, notice of dishonor, diligence,
protest, notice of protest and all other notices or demands relating to this
Note. The Obligor also (a) acknowledges and agrees that, in any suit,
action, or proceeding under this Note, the courts of the State of North Carolina
or the courts of the United States District Court for the District of North
Carolina shall have exclusive jurisdiction, (b) consents to the jurisdiction of
such courts and (c) consents to and waives any objection which the Obligor now
has or may hereafter have to proper venue existing in any of such
courts. This Note shall be governed by, and construed in accordance
with, the laws of the State of North Carolina, without regard to conflict of
laws principles thereof.
THE
OBLIGOR HEREBY KNOWINGLY, VOLUNTARILY AND INTENTIONALLY WAIVES ANY RIGHTS IT MAY
NOW HAVE OR HEREAFTER HAVE TO A TRIAL BY JURY IN RESPECT TO ANY SUIT, ACTION OR
PROCEEDING ARISING OUT OF OR RELATING TO THIS PROMISSORY NOTE.
Exhibit
10.24
IN
WITNESS WHEREOF, Obligor has caused this Note to be executed on and as of this
29th day of October, 2007.
|
CICERO,
INC.
|
|
|
|
|
|
By:
|
|
|
Name:
|
John
Broderick
|
|
Title:
|
Chief
Executive and Chief Financial
Officer
|
Securities
Purchase Agreement
By
and Among
Cicero,
Inc.,
And
The
Purchasers Listed On Schedule I
Dated
As Of FEBRUARY 26, 2007
Exhibit
10.25
SECURITIES
PURCHASE AGREEMENT
THIS
SECURITIES PURCHASE AGREEMENT (this “
Agreement
”) is dated
as of February 26, 2007, by and among CICERO, INC., a Delaware corporation (the
“
Company
”), and
the various purchasers listed on Schedule I hereto (each referred to herein as a
“
Purchaser
”
and, collectively, the "
Purchasers
").
WHEREAS,
the Company and the Purchasers are executing and delivering this Agreement in
reliance upon the exemption from securities registration afforded by Rule 506
under Regulation D as promulgated by the United States Securities and Exchange
Commission (the “
Commission
”) under
Section 4(2) of the Securities Act of 1933, as amended (the “
Securities
Act
”);
WHEREAS,
subject to the terms and conditions set forth in this Agreement, the Company
desires to issue and sell to the Purchasers, and the Purchasers desire to
acquire from the Company,
shares of common stock
of the Company, par value $.001 per share (the “
Common Stock
”);
and
WHEREAS,
contemporaneously with the execution and delivery of this Agreement, the parties
hereto are executing and delivering a Registration Rights Agreement
substantially in the form of
Exhibit B
attached
hereto (the “
Registration Rights
Agreement
”) pursuant to which the Company has agreed to provide certain
registration rights under the Securities Act and the rules and regulations
promulgated thereunder, and applicable state securities laws.
NOW,
THEREFORE, in consideration of the promises and mutual covenants and agreements
hereinafter, the Company and the Purchasers hereby agree as
follows:
Exhibit
10.25
ARTICLE
I.
PURCHASE
AND SALE
1.1
Purchase and Sale.
On the
Closing Date (as defined below), subject to the terms and conditions set forth
herein, the Company shall issue and sell to each Purchaser and each Purchaser,
severally and not jointly, shall purchase from the Company the
shares of Common Stock
as set forth on
Schedule I
(the
"
Shares
"). The
aggregate purchase price for the Shares purchased by the Purchasers
shall be $500,000.
1.2
Closing.
a.
The
Closing
. The closing (the “
Closing
”) of the
purchase and sale of the Common Stock shall take place at the offices
of the Company, 8000 Regency Parkway, Suite 542, Cary, North Carolina 27518,
immediately following the execution hereof or such later date or different
location as the parties shall agree, but in no event prior to the date that the
conditions set forth in Section 4.1 have been satisfied or waived by the
appropriate party (such date of the Closing, the “
Closing
Date
”). At the Closing:
(i) Each
Purchaser shall deliver to the Company (1) this Agreement, duly executed by such
Purchaser, (2) the Registration Rights Agreement, duly executed by such
Purchaser and (3) its portion of the purchase price as set forth next to its
name on
Schedule
I
in United States dollars in immediately available funds to an account
or accounts designated in writing by the Company; and
(ii) The
Company shall deliver to each Purchaser (1) this Agreement, duly executed by the
Company, (2) the Registration Rights Agreement, duly executed by the Company,
and (3) a certificate evidencing the number of shares of Common Stock
purchased by such Purchaser as set forth on
Schedule I
hereto,
registered in the name of such Purchaser.
ARTICLE
II.
REPRESENTATIONS
AND WARRANTIES
2.1
Representations and
Warranties of the Company
. The Company represents and warrants
to each of the Purchasers that the statements contained in this Section 2.1 are
true, correct and complete as of the date hereof, and will be true correct and
complete as of the Closing Date (unless specifically made as of another date),
except as specified to the contrary in the corresponding paragraph of the
disclosure schedule prepared by the Company accompanying this Agreement (the
"
Company Disclosure
Schedules
"):
Exhibit
10.25
a.
Organization and
Qualification
. The Company duly incorporated, validly existing
and in good standing under the laws of Delaware, with the requisite corporate
power and authority to own and use its properties and assets and to carry on its
business as currently conducted. The Company is duly qualified as a foreign
corporation to do business and is in good standing as a foreign corporation in
each jurisdiction in which the nature of the business conducted or property
owned by it makes such qualification necessary, except where the failure to be
so qualified or in good standing, as the case may be, would not, individually or
in the aggregate, (x) adversely affect the legality, validity or enforceability
of any of this Agreement or the Transaction Documents (as defined in Section
2.1(b)) or any of the transactions contemplated hereby or thereby, (y) have or
result in a material adverse effect on the results of operations, assets, or
financial condition of the Company, taken as a whole or (z) impair the Company’s
ability to perform fully on a timely basis its obligations under any Transaction
Document (any of (x), (y) or (z), being a “
Material Adverse
Effect
”). The Company has made available to the Purchaser true
and correct copies of the Company's Certificate of Incorporation, as amended and
as in effect on the date hereof (the “
Certificate of
Incorporation
”), and the Company's Bylaws, as in effect on the date
hereof (the “
Bylaws
”).
b.
Authorization;
Enforcement
. The Company has the requisite corporate power and
authority to enter into and to consummate the transactions contemplated by this
Agreement and the Registration Rights Agreement (collectively, the “
Transaction
Documents
”), and otherwise to carry out its obligations hereunder and
thereunder. The execution and delivery of each of this Agreement and
the Transaction Documents by the Company and the consummation by it of the
transactions contemplated hereby and thereby have been duly authorized by all
necessary corporate action by the Company. Each of this Agreement and
the Transaction Documents has been duly executed by the Company and when
delivered in accordance with the terms hereof will constitute the valid and
binding obligation of the Company enforceable against the Company in accordance
with its terms, except as such enforceability may be limited by applicable
bankruptcy, insolvency, reorganization, moratorium, liquidation or similar laws
relating to, or affecting generally the enforcement of, creditors’ rights and
remedies or by other equitable principles of general application and except that
rights to indemnification and contribution may be limited by Federal or state
securities laws or public policy relating thereto.
c.
Capitalization
. As
of the date hereof, the authorized capital stock of the Company is as set forth
in
Schedule
2.1(c)
. All of such outstanding shares of capital stock have
been, or upon issuance will be, validly authorized and issued, fully paid and
nonassessable. No securities of the Company are entitled to preemptive or
similar rights, and no Person (as hereinafter defined) has any right of first
refusal, preemptive right, right of participation, or any similar right to
participate in the transactions contemplated by the Transaction
Documents. Except as a result of the purchase and sale of the Shares
and those outstanding warrants as identified in Schedule 2.1(c), there are no
outstanding options, warrants, script rights to subscribe to, calls or
commitments of any character whatsoever relating to, or securities, rights or
obligations convertible into or exchangeable for, or giving any Person any right
to subscribe for or acquire, any shares of Common Stock, or contracts,
commitments, understandings or arrangements by which the Company or any
subsidiary is or may become bound to issue additional shares of Common Stock, or
securities or rights convertible or exchangeable into shares of Common
Stock. The issue and sale of the Shares will not obligate
the Company to issue shares of Common Stock or other securities to any Person
(other than the Purchasers) and will not result in a right of any holder of
Company securities to adjust the exercise, conversion, exchange or reset price
under such securities.
Exhibit
10.25
d.
Authorization and Validity;
Issuance of Shares
. The Shares are and will at all times hereafter
continue to be duly authorized and reserved for issuance and, when issued and
paid for in accordance with this Agreement and the Transaction Documents, will
be validly issued, fully paid and non-assessable, free and clear of all
liens.
e.
No
Conflicts
. The execution, delivery and performance of this
Agreement and each of the Transaction Documents by the Company and the
consummation by the Company of the transactions contemplated hereby and thereby
do not and will not (i) conflict with or violate any provision of the
Certificate of Incorporation, Bylaws or other organizational documents of the
Company, (ii)
subject to obtaining the
consents referred to in Section 2.1(f), conflict with, or constitute a default
(or an event which with notice or lapse of time or both would become a default)
under, or give to others any rights of termination, amendment, acceleration or
cancellation of, any agreement, indenture, patent, patent license or instrument
(evidencing a Company debt or otherwise) to which the Company is a party or by
which any property or asset of the Company is bound or affected, except where
such conflict or violation has not resulted or would not reasonably be expected
to result, individually or in the aggregate, in a Material Adverse Effect, or
(iii) result in a violation of any law, rule, regulation, order, judgment,
injunction, decree or other restriction of any court or governmental authority
to which the Company is subject (including Federal and state securities laws and
regulations and the rules and regulations of the principal market or exchange on
which the Common Stock is traded or listed), or by which any material property
or asset of the Company is bound, except where such conflict has not resulted or
would not reasonably be expected to result, individually or in the aggregate, in
a Material Adverse Effect.
f.
Consents and
Approvals
. The Company is not required to obtain any consent, waiver,
authorization or order of, give any notice to, or make any filing or
registration with, any court or other federal, state, local or other
governmental authority, regulatory or self regulatory agency, or other Person in
connection with the execution, delivery and performance by the Company of this
Agreement or the Transaction Documents, other than (i) the filing of a
registration statement with the Commission, which shall be filed in accordance
with and in the time periods set forth in the Registration Rights Agreement,
(ii) the application(s) or any letter(s) acceptable to the Nasdaq National
Market (“
Nasdaq
”) for the
listing of the Common Stock with Nasdaq (and with any other national securities
exchange or market on which the Common Stock is then listed), and (iii) any
filings, notices or registrations under applicable Federal or state securities
laws (together with the consents, waivers, authorizations, orders, notices and
filings referred to on
Schedule 2.1(f),
the
“
Required
Approvals
”), except where failure to do so has not resulted or would not
reasonably result, individually, or in the aggregate, in a Material Adverse
Effect. “
Person
” means an
individual or corporation, partnership, trust, incorporated or unincorporated
association, joint venture, limited liability company, joint stock company,
government (or an agency or subdivision thereof) or other entity of any
kind.
g.
Litigation;
Proceedings
. Except as specifically set forth on
Schedule 2.1(g)
or in
the SEC Documents (as hereinafter defined), there is no action, suit, notice of
violation, proceeding or investigation pending or, to the knowledge of the
Company, threatened against or affecting the Company or any of its subsidiaries
or any of their respective properties before or by any court, governmental or
administrative agency or regulatory authority (Federal, state, county, local or
foreign) (collectively, an “
Action
”) which (i)
adversely affects or challenges the legality, validity or enforceability of any
of this Agreement or the Transaction Documents or (ii) would reasonably be
expected to, individually or in the aggregate, have a Material Adverse
Effect. Neither the Company nor any subsidiary, nor, to the knowledge
of the Company, any officer thereof, is or has been, nor, to the knowledge of
the Company, any director thereof is or has been for the last three years, the
subject of any Action involving a claim of violation of or liability under
federal or state securities laws or a claim of breach of fiduciary
duty. There has not been, and, to the knowledge of the Company, there
is not pending or contemplated, any investigation by the Commission involving
the Company or any current or former director that was a director of the Company
at any time during the last three years or officer of the
Company. The Commission has not issued any stop order or other order
suspending the effectiveness of any registration statement filed by the Company
or any subsidiary under the Exchange Act or the Securities Act.
Exhibit
10.25
h.
No Default or
Violation
. The Company (i) is not in default under or in violation of any
indenture, loan or other credit agreement or any other agreement or instrument
to which it is a party or by which it or any of its properties is bound and
which is required to be included as an exhibit to any SEC Document (as defined
in Section 2.1(j)) or will be required to be included as an exhibit to the
Company’s next filing under either the Securities Act or the Securities Exchange
Act of 1934, as amended (the “
Exchange Act
”), (ii)
is not in violation of any order of any court, arbitrator or governmental body
applicable to it, (iii) is not in violation of any statute, rule or
regulation of any governmental authority to which it is subject, (iv) is not in
default under or in violation of its Certificate of Incorporation, Bylaws or
other organizational documents, respectively in the case of (i), (ii) and (iii),
except where such violations have not resulted or would not reasonably result,
individually or in the aggregate, in a Material Adverse Effect.
i.
Private
Offering
. The Company and all Persons acting on its behalf
have not made, directly or indirectly, and will not make, offers or sales of any
securities or solicited any offers to buy any security under circumstances that
would require registration of the Common Stock or the issuance of
such securities under the Securities Act. Subject to the accuracy and
completeness of the representations and warranties of the Purchasers contained
in Section 2.2, the offer, sale and issuance by the Company to the
Purchasers of the Common Stock and is exempt from the
registration requirements of the Securities Act.
j.
SEC Documents; Financial
Statements
. The Common Stock of the Company is registered pursuant to
Section 12(g) of the Exchange Act. Since December 31, 2000, the
Company has filed all reports, schedules, forms, statements and other documents
required to be filed by it, with the Commission, pursuant to Section 13, 14 or
15(d) of the Exchange Act (the foregoing materials and all exhibits included
therein and financial statements and schedules thereto and documents (other than
exhibits to such documents) incorporated by reference therein being collectively
referred to herein as the “
SEC Documents
”), on a
timely basis or has received a valid extension of such time of filing and has
filed any such SEC Documents prior to the expiration of any such
extension. As of their respective dates, the SEC Documents complied
in all material respects with the requirements of the Securities Act and the
Exchange Act and the rules and regulations of the Commission promulgated
thereunder, and none of the SEC Documents, when filed, contained any untrue
statement of a material fact or omitted to state a material fact required to be
stated therein or necessary in order to make the statements therein, in light of
the circumstances under which they were made, not misleading. The
financial statements of the Company included in the SEC Documents comply in all
material respects with applicable accounting requirements and the rules and
regulations of the Commission with respect thereto as in effect at the time of
filing. Such financial statements have been prepared in accordance
with generally accepted accounting principles applied on a consistent basis
during the periods involved ("
GAAP
"), except as may
be otherwise specified in such financial statements or the notes thereto, and
fairly present in all material respects the financial position of the Company
and its consolidated subsidiaries as of and for the dates thereof and the
results of operations and cash flows for the periods then ended, subject, in the
case of unaudited statements, to normal, immaterial, year-end audit
adjustments.
Exhibit
10.25
k.
Material
Changes
. Since the date of the latest audited financial
statements included within the SEC Documents, except as specifically disclosed
in the SEC Documents, (i) there has been no event, occurrence or development
that has had or that could result in a Material Adverse Effect, (ii) the Company
has not incurred any liabilities (contingent or otherwise) other than (A) trade
payables and accrued expenses incurred in the ordinary course of business
consistent with past practice and (B) liabilities not required to be reflected
in the Company's financial statements pursuant to GAAP or required to be
disclosed in filings made with the Commission, (iii) the Company has not altered
its method of accounting or the identity of its auditors, (iv) the Company has
not declared or made any dividend or distribution of cash or other property to
its stockholders or purchased, redeemed or made any agreements to purchase or
redeem any shares of its capital stock, and (v) the Company has not issued any
equity securities to any officer, director or affiliate, except pursuant to
existing Company stock option plans. The Company does not have pending before
the Commission any request for confidential treatment of
information.
l.
Patents and
Trademarks
. The Company and its subsidiaries have, or have
rights to use, all patents, patent applications, trademarks, trademark
applications, service marks, trade names, copyrights, licenses and other similar
rights that are necessary or material for use in connection with their
respective businesses as described in the SEC Documents and which the failure to
so have could have, or reasonably be expected to result in, a Material Adverse
Effect (collectively, the "
Intellectual Property
Rights
"). Neither the Company nor any subsidiary has received
a written notice that the Intellectual Property Rights used by the Company or
any subsidiary violates or infringes upon the rights of any Person which if
determined adversely to the Company would, individually or in the aggregate have
a Material Adverse Effect. To the knowledge of the Company, all such
Intellectual Property Rights are enforceable and there is no existing
infringement by another Person of any of the Intellectual Property
Rights.
m.
Transactions With Affiliates
and Employees
. Except as set forth in SEC Documents, none of
the officers or directors of the Company and, to the knowledge of the Company,
none of the employees of the Company is presently a party to any transaction
with the Company or any subsidiary (other than for services as employees,
officers and directors), including any contract, agreement or other arrangement
providing for the furnishing of services to or by, providing for rental of real
or personal property to or from, or otherwise requiring payments to or from any
officer, director or such employee or, to the knowledge of the Company, any
entity in which any officer, director, or any such employee has a substantial
interest or is an officer, director, trustee or partner.
Exhibit
10.25
n.
Solvency
. Except
as set forth in the SEC Documents, based on the financial condition of the
Company as of the Closing Date, (i) the Company's fair saleable value of its
assets exceeds the amount that will be required to be paid on or in respect of
the Company's existing debts and other liabilities (including known contingent
liabilities) as they mature; (ii) the Company's assets do not constitute
unreasonably small capital to carry on its business for the current fiscal year
as now conducted and as proposed to be conducted including its capital needs
taking into account the particular capital requirements of the business
conducted by the Company, and projected capital requirements and capital
availability thereof; and (iii) the current cash flow of the Company, together
with the proceeds the Company would receive, were it to liquidate all of its
assets, after taking into account all anticipated uses of the cash, would be
sufficient to pay all amounts on or in respect of its debt when such amounts are
required to be paid. The Company does not intend to incur debts
beyond its ability to pay such debts as they mature (taking into account the
timing and amounts of cash to be payable on or in respect of its
debt).
o.
Listing and Maintenance
Requirements
. The Company has not, in the two years preceding
the date hereof, received notice (written or oral) from any exchange
or market on which the Common Stock is or has been listed or quoted to the
effect that the Company is not in compliance with the listing or maintenance
requirements of such exchange or market. The Company is, and has no reason to
believe that it will not in the foreseeable future continue to be, in compliance
with all such listing and maintenance requirements. The issuance and
sale of the Shares hereunder does not contravene the rules and
regulations of the Nasdaq OTC Market and no approval of the shareholders of the
Company is required for the Company to issue and deliver to the Purchasers the
number of Shares contemplated by this Agreement.
p.
Registration
Rights
. The Company has not granted or agreed to grant to any
Person any rights (including "piggy-back" registration rights) to have any
securities of the Company registered with the Commission or any other
governmental authority that have not been satisfied except as noted on the
Disclosure Schedules.
q.
Broker’s
Fees
. No fees or commissions or similar payments with respect
to the transactions contemplated by this Agreement or the Transaction Documents
have been paid or will be payable by the Company to any third party broker,
financial advisor, finder, investment banker, or bank. The Purchaser
shall have no obligation with respect to any fees or with respect to any claims
made by or on behalf of other Persons for fees of a type contemplated in this
Section 2.1(q) that may be due in connection with the transactions
contemplated by this Agreement and the Transaction Documents.
2.2
Representations and
Warranties of the Purchasers
. Each of the Purchasers,
severally and not jointly, hereby represents and warrants to the Company as
follows:
Exhibit
10.25
a.
Organization;
Authority
. Such Purchaser, as applicable, is a corporation or
a limited liability company or limited partnership duly formed, validly existing
and in good standing under the laws of the jurisdiction of its incorporation or
formation with the requisite power and authority, corporate or otherwise, to
enter into and to consummate the transactions contemplated hereby and by this
Agreement and the Transaction Documents and otherwise to carry out its
obligations hereunder and thereunder. The purchase by such Purchaser,
as applicable, of the shares of Common Stock hereunder has been duly
authorized by all necessary action on the part of such
Purchaser. Each of this Agreement and the Transaction Documents has
been duly executed and delivered by each Purchaser and constitutes the valid and
legally binding obligation of each Purchaser, enforceable against such Purchaser
in accordance with its terms, subject to bankruptcy, insolvency, fraudulent
transfer, reorganization, moratorium and similar laws of general applicability
relating to or affecting creditors’ rights generally and to general principles
of equity and except that rights to indemnification and contribution may be
limited by Federal or state securities laws or public policy relating
thereto.
b.
Investment
Intent
. Such Purchaser is acquiring the shares of Common
Stock for its own account and not with a present view to or for
distributing or reselling the shares of Common Stock or any part thereof or
interest therein in violation of the Securities Act. Nothing contained herein
shall be deemed a representation or warranty by such Purchaser to hold the
Shares for any period of time. Such Purchaser is acquiring
the Shares hereunder in the ordinary course of its business. Such
Purchaser does not have any agreement or understanding, directly or indirectly,
with any Person to distribute any of the Shares.
c.
Purchaser
Status
. At the time such Purchaser was offered the Common
Stock, and at the Closing Date, (i) it was and will be an “accredited investor”
as defined in Rule 501 under the Securities Act and (ii) such Purchaser, either
alone or together with its representatives, had and will have such knowledge,
sophistication and experience in business and financial matters so as to be
capable of evaluating the merits and risks of the prospective investment in the
Common Stock. Such Purchaser is not a registered broker-dealer under Section 15
of the Exchange Act.
d.
Reliance
. Such
Purchaser understands and acknowledges that (i) the shares of Common Stock are
being offered and sold to the Purchaser without registration under the
Securities Act in a private placement that is exempt from the registration
provisions of the Securities Act under Section 4(2) of the Securities Act or
Regulation D promulgated thereunder and (ii) the availability of such exemption
depends in part on, and the Company will rely upon the accuracy and truthfulness
of, the representations set forth in this Section 2.2 and such Purchaser hereby
consents to such reliance.
e.
Information
. Such
Purchaser and its advisors, if any, have been furnished with all materials
relating to the business, finances and operations of the Company and materials
relating to the offer and sale of the Common Stock which have been
requested by such Purchaser or its advisors. Such Purchaser and its
advisors, if any, have been afforded the opportunity to ask questions of the
Company. The Purchaser understands that its investment in the Common
Stock involves a significant degree of risk. Neither such inquiries
nor any other investigation conducted by or on behalf of such Purchaser or its
representatives or counsel shall modify, amend or affect such Purchaser's right
to rely on the truth, accuracy and completeness of the Company's representations
and warranties contained in this Agreement or the Transaction
Documents.
Exhibit
10.25
f.
Governmental
Review
. Such Purchaser understands that no United States
Federal or state agency or any other government or governmental agency has
passed upon or made any recommendation or endorsement of the Common
Stock.
g.
Residency
. Such
Purchaser is a resident of the jurisdiction set forth immediately beside such
Purchaser’s name on
Schedule I
hereto.
The
Company acknowledges and agrees that the Purchasers make no representations or
warranties with respect to the transactions contemplated hereby other than those
specifically set forth in this Section 2.2.
ARTICLE
III.
OTHER
AGREEMENTS
3.1
Transfer Restrictions.
a. If
any Purchaser should decide to dispose of the Common Stock held by it, such
Purchaser understands and agrees that it may do so (1) only pursuant to an
effective registration statement under the Securities Act, (2) pursuant to an
available exemption from the registration requirements of the Securities Act,
(3) to an affiliate of the Purchaser, or (4) pursuant to Rule 144 promulgated
under the Securities Act (“Rule 144”). In connection with any
transfer of any Common Stock other than pursuant to an effective registration
statement, Rule 144, to the Company or to an affiliate of the Purchasers, the
Company may require the transferor thereof to provide to the Company a written
opinion of counsel experienced in the area of United States securities laws
selected by the transferor, the form and substance of which opinion shall be
customary for opinions of counsel in comparable transactions and reasonably
acceptable to the Company, to the effect that such transfer does not require
registration of such transferred securities under the Securities Act; provided,
however, that if the Common Stock may be sold pursuant to Rule 144(k), no
written opinion of counsel shall be required from any Purchaser if such
Purchaser provides reasonable assurances that such security can be sold pursuant
to Rule 144(k). Notwithstanding the foregoing, the Company hereby
consents to and agrees to register any transfer by any Purchaser to an affiliate
of such Purchaser, provided that the transferee certifies to the Company that it
is an “accredited investor” as defined in Rule 501(a) under the Securities
Act. Any such transferee shall agree in writing to be bound by the
terms of this Agreement and the Transaction Documents
and shall have the
rights of a Purchaser under this Agreement and the Transaction
Documents. The Company shall not require an opinion of counsel in
connection with the transfer of the shares of Common Stock to an affiliate of a
Purchaser.
b. The
Purchasers agree to the imprinting, so long as is required by this Section
3.1(b), of the following legend on the Common Stock:
Exhibit
10.25
THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED WITH THE SECURITIES
AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE
UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED
(THE "SECURITIES ACT"), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT
PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR
PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE
REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH
APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO
THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY
ACCEPTABLE TO THE COMPANY. THESE SECURITIES MAY BE PLEDGED IN
CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH
SHARES.
The
Company acknowledges and agrees that a Purchaser may from time to time pledge
pursuant to a bona fide margin agreement or grant a security interest in some or
all of the shares of Common Stock and if required under the terms of such
arrangement, such Purchaser may transfer pledged or secured shares of Common
Stock to the pledgees or secured parties. Such a pledge or transfer
would not be subject to approval of the Company and no legal opinion of the
pledgee, secured party or pledgor shall be required in connection
therewith. Further, no notice shall be required of such
pledge. At the appropriate Purchaser's expense, the Company will
execute and deliver such reasonable documentation as a pledgee or secured party
reasonably request in connection with a pledge or transfer of the shares of
Common Stock, including the preparation and filing of any required prospectus
supplement under Rule 424(b)(3) of the Securities Act or other applicable
provision of the Securities Act to appropriately amend the list of selling
stockholders thereunder.
Neither
the Common Stock shall contain the legend set forth above (or any other legend)
(i) while a registration statement covering the resale of such security is
effective under the Securities Act, (ii) if in the written opinion of counsel to
the Company experienced in the area of United States securities laws such legend
is not required under applicable requirements of the Securities Act (including
judicial interpretations and pronouncements issued by the staff of the
Commission) or (iii) if such Common Stock may be sold pursuant to Rule
144(k). The Company agrees that it will provide any Purchaser, upon
request, with a certificate or certificates representing shares of Common Stock
free from such legend at such time as such legend is no longer required
hereunder. If such certificate or certificates had previously been
issued with such a legend or any other legend, the Company shall, upon request
and upon the delivery of the legended certificate(s), reissue such certificate
or certificates free of any legend. The Company agrees that following the
effective date of the registration statement meeting the requirements set forth
in the Registration Rights Agreement and covering the resale of the Shares by
the Purchasers or at such time as such legend is no longer required under this
Section 3.1, it will, no later than three Trading Days (as such term is defined
in the Registration Rights Agreement) following the delivery by a Purchaser to
the Company or the Company's transfer agent of a certificate representing Shares
an issued with a restrictive legend, deliver or cause to be delivered to such
Purchaser a certificate representing such Shares that is free from all
restrictive and other legends.
Exhibit
10.25
When the
Company is required to cause unlegended certificates to replace previously
issued legended certificates, if unlegended certificates are not delivered to a
Holder within three (3) Business Days of submission by that Holder of legended
certificate(s) to the Company’s transfer agent together with a representation
letter in customary form, the Company shall be liable to the Holder for
liquidated damages in an amount equal to 1.5% of the aggregate purchase price of
the securities evidenced by such certificate(s) for each thirty (30) day period
(or portion thereof) beyond such three (3) Business Days that the unlegended
certificates have not been so delivered
3.2
Stop Transfer
Instruction
. The Company may not make any notation on its
records or give instructions to any transfer agent of the Company which enlarge
the restrictions on transfer set forth in Section 3.1.
3.3
Not used.
3.4
Furnishing of
Information.
As long as any Purchaser owns shares of Common
Stock, the Company covenants to timely file (or obtain extensions in respect
thereof and file within the applicable grace period) all reports required to be
filed by the Company after the date hereof pursuant to the Exchange
Act. Upon the request of any such Person, the Company shall deliver
to such Person a written certification of a duly authorized officer as to
whether it has complied with the preceding sentence. As long as any Purchaser
owns shares of Common Stock if the Company is not required to file reports
pursuant to such laws, it will prepare and furnish to the Purchasers and make
publicly available in accordance with Rule 144(c) such information as is
required for the Purchasers to sell the Shares under Rule 144.
3.5
Integration
. The
Company shall not, and shall use its best efforts to ensure that no affiliate of
the Company shall, sell, offer for sale or solicit offers to buy or otherwise
negotiate in respect of any security (as defined in Section 2 of the Securities
Act) that would be integrated with the offer or sale of the shares of Common
Stock hereunder in a manner that would require the registration under the
Securities Act of the sale of the shares Common Stock to the Purchasers, or that
would be integrated with the offer or sale of the Shares for purposes of the
rules and regulations of the Nasdaq National Market, if such integration would
result in a violation of any such rule or regulation.
3.6
Non-Public
Information
. Except for information regarding the transaction
contemplated by this Agreement and the Transaction Documents and the terms and
conditions hereof and thereof, the Company covenants and agrees that neither it
nor any other Person acting on its behalf will provide any Purchaser or its
agents or counsel with any information that the Company believes constitutes
material non-public information, unless prior thereto such Purchaser shall have
executed a written agreement regarding the confidentiality and use of such
information. The Company understands and confirms that each Purchaser
shall be relying on the foregoing representations in effecting transactions in
securities of the Company. Notwithstanding anything to the contrary
herein, no Purchaser shall engage in any trading activity in the Company's
securities in violation of Regulation M of the Exchange Act.
Exhibit
10.25
3.7
Use of
Proceeds
. The Company shall use the net proceeds from the sale
of the shares of Common Stock hereunder for working capital purposes. The
Company shall not use the net proceeds from the sale of the shares of Common
Stock hereunder to repay any of its short-term or long-term debt
instruments
3.8
Best
Efforts
. Each of the parties hereto shall use its best efforts
to satisfy each of the conditions to be satisfied by it as provided in Article
IV of this Agreement.
3.9
Subsequent Placements.
a. From
the date hereof until the Effective Date, the Company will not directly or
indirectly, offer, sell or grant any option to purchase (or announce any offer,
sale, grant or any option to purchase) any of its Common Stock or other
securities which entitle the holder thereof to receive Common Stock, including
without limitation any debt, preferred stock or other instrument or security
that is, at any time during its life and under any circumstances, convertible
into or exchangeable for Common Stock.
b.
The restrictions contained in paragraph (a) of this Section shall
not apply to: (i) the granting of options, restricted stock, stock appreciation
rights or similar instruments to employees, officers, directors and consultants
of the Company pursuant to any stock option or similar plan duly adopted by the
Company or to the issuance of shares of Common Stock upon exercise of such
options or other rights, (ii) issuances of shares of Common Stock pursuant to
any acquisition by the Company of the assets or capital stock of a business
pursuant to a merger, asset sale or other business combination; (iii) issuances
of shares of Common Stock upon conversion of the Company’s Series A1 Convertible
Redeemable Preferred Stock (the “
Series A1 Preferred
Stock
”) (as described on Schedule 2.1(c));
ARTICLE
IV.
CONDITIONS
4.1
Closing.
a.
Conditions Precedent to the
Obligation of the Company to Sell the Shares of Common
Stock
. The obligation of the Company to sell the shares of
Common Stock is subject to the satisfaction or waiver by the Company,
at or before the Closing Date, of each of the following conditions:
(i)
Accuracy of the Purchasers’
Representations and Warranties
. The representations and
warranties of each Purchaser in this Agreement shall be true and correct in all
material respects as of the date when made and as of the Closing
Date;
(ii)
Performance by the
Purchasers
. Each Purchaser shall have performed, satisfied and
complied in all material respects with all covenants, agreements and conditions
required by this Agreement to be performed, satisfied or complied with by such
Purchaser at or before the Closing Date; and
Exhibit
10.25
(iii)
No
Injunction
. No statute, rule, regulation, executive order,
decree, ruling or injunction shall have been enacted, entered, promulgated or
endorsed by any court or governmental authority of competent jurisdiction which
prohibits the consummation of any of the transactions contemplated by this
Agreement or the Transaction Documents.
b.
Conditions Precedent to the
Obligation of the Purchasers to Purchase the Shares of Common
Stock at the Closing
. The obligation of each
Purchaser hereunder to acquire and pay for the shares of Common
Stock at the Closing is subject to the satisfaction or waiver by
Purchaser, at or before the Closing Date, of each of the following
conditions:
(i)
Accuracy of the Company’s
Representations and Warranties
. The representations and
warranties of the Company set forth in this Agreement shall be true and correct
in all respects as of the date when made and as of the Closing
Date;
(ii)
Performance by the
Company
. The Company shall have performed, satisfied and
complied in all respects with all covenants, agreements and conditions required
by this Agreement to be performed, satisfied or complied with by the Company at
or before the Closing Date;
(iii)
No
Injunction
. No statute, rule, regulation, executive order,
decree, ruling or injunction shall have been enacted, entered, promulgated or
endorsed by any court or governmental authority of competent jurisdiction which
prohibits the consummation of any of the transactions contemplated by this
Agreement and the Transaction Documents;
(iv)
Required
Approvals
. All Required Approvals shall have been obtained;
and
(v)
Shares of Common
Stock
. The Company shall have duly reserved the number of
shares of Common Stock acquired by the Purchasers on the Closing
Date.
ARTICLE
V.
INDEMNIFICATION
5.1
Indemnification
. The
Company will indemnify and hold the Purchasers and their directors, officers,
shareholders, partners, employees and agents (each, a "
Purchaser Party
")
harmless from any and all losses, liabilities, obligations, claims,
contingencies, damages, costs and expenses, including all judgments, amounts
paid in settlements, court costs and reasonable attorneys' fees and costs of
investigation that any such Purchaser Party may suffer or incur as a result of
or relating to (a) any misrepresentation, breach or inaccuracy, or any
allegation by a third party that, if true, would constitute a breach or
inaccuracy, of any of the representations, warranties, covenants or agreements
made by the Company in this Agreement or in the other Transaction Documents; or
(b) any cause of action, suit or claim brought or made against such Purchaser
Party and solely arising out of or solely resulting from the execution,
delivery, performance or enforcement of this Agreement or any of the other
Transaction Documents. The Company will reimburse such Purchaser for
its reasonable legal and other expenses (including the cost of any
investigation, preparation and travel in connection therewith) incurred in
connection therewith, as such expenses are incurred. Notwithstanding the
foregoing, the Company shall not be required to indemnify any the Purchaser
under the terms of this Article V with respect to any claim or violation for
which indemnification is expressly excluded under the Registration Rights
Agreement.
Exhibit
10.25
ARTICLE
VI.
MISCELLANEOUS
6.1
Entire
Agreement
. This Agreement, together with the Exhibits and
Schedules hereto and the Transaction Documents contain the entire understanding
of the parties with respect to the subject matter hereof and supersede all prior
agreements and understandings, oral or written, with respect to such
matters.
6.2
Notices
. Whenever
it is provided herein that any notice, demand, request, consent, approval,
declaration or other communication shall or may be given to or served upon any
of the parties by another, or whenever any of the parties desires to give or
serve upon another any such communication with respect to this Agreement, each
such notice, demand, request, consent, approval, declaration or other
communication shall be in writing and either shall be delivered in person with
receipt acknowledged or by registered or certified mail, return receipt
requested, postage prepaid, or by telecopy and confirmed by telecopy answerback
addressed as follows:
If to the
Company:
Cicero,
Inc.
8000
Regency Parkway
Cary,
North Carolina 27518
Attn: John
P. Broderick
With
a Copy to:
Golenbock
Eiseman, Assor Bell and Peskoe LLP
437
Madison Ave
New York,
NY 10022
Attn: Lawrence
Bell, Esq.
Exhibit
10.25
If to the Purchasers
: To the
address set forth on the counterpart signature page of such Purchaser or at such
other address as may be substituted by notice given as herein
provided. The giving of any notice required hereunder may be waived
in writing by the party entitled to receive such notice. Every
notice, demand, request, consent, approval, declaration or other communication
hereunder shall be deemed to have been duly given and effective on the earliest
of (a) the date of transmission, if such notice or communication is delivered
via facsimile at the facsimile number specified in this Section prior to 6:30
p.m. (New York City time) on a business day, (b) the next business day after the
date of transmission, if such notice or communication is delivered via facsimile
at the facsimile number specified in this Section on a day that is not a
business day or later than 6:30 p.m. (New York City time) on any business day,
(c) the business day following the date of mailing, if sent by U.S. nationally
recognized overnight courier service, or (d) upon actual receipt by the party to
whom such notice is required to be given. As used herein, a “business day” means
any day except Saturday, Sunday and any day which shall be a federal legal
holiday or a day on which banking institutions in the State of New York are
authorized or required by law or other governmental action to
close.
6.3
Amendments;
Waivers
. No provision of this Agreement may be waived or
amended except in a written instrument signed, in the case of an amendment, by
both the Company and each of the Purchasers or, in the case of a waiver, by the
party against whom enforcement of any such waiver is sought. No
waiver of any default with respect to any provision, condition or requirement of
this Agreement shall be deemed to be a continuing waiver in the future or a
waiver of any other provision, condition or requirement hereof, nor shall any
delay or omission of either party to exercise any right hereunder in any manner
impair the exercise of any such right accruing to it thereafter.
6.4
Headings
. The
headings herein are for convenience only, do not constitute a part of this
Agreement and shall not be deemed to limit or affect any of the provisions
hereof.
6.5
References.
References
herein to Sections are to Sections of this Agreement, unless otherwise expressly
provided.
6.6
Successors and Assigns;
Assignability
. Neither this Agreement nor any right, remedy,
obligation or liability arising hereunder or by reason hereof shall be
assignable by either the Company or the Purchasers without the prior written
consent of the other party. In the event that such prior written
consent is obtained and this Agreement is assigned by either party, all
covenants contained herein shall bind and inure to the benefit of the parties
hereto and their respective successors and assigns.
6.7
No Third-Party
Beneficiaries
. This Agreement is intended for the benefit of
the parties hereto and their respective permitted successors and assigns and is
not for the benefit of, nor may any provision hereof be enforced by, any other
Person.
6.8
Governing Law; Waiver of
Jury Trial
. All questions concerning the construction, validity,
enforcement and interpretation of this Agreement shall be governed by and
construed and enforced in accordance with the internal laws of the State of
Delaware, without regard to the principles of conflicts of law
thereof. Each party agrees that all proceedings concerning the
interpretations, enforcement and defense of the transactions contemplated by
this Agreement and any other Transaction Documents (whether brought against a
party hereto or its respective affiliates, directors, officers, shareholders,
employees or agents) (each a "
Proceeding
") shall be
commenced exclusively in the state and federal courts sitting in the City of New
York, Borough of Manhattan. Each party hereto hereby irrevocably
submits to the exclusive jurisdiction of the state and federal courts sitting in
the City of New York, Borough of Manhattan for the adjudication of any dispute
hereunder or in connection herewith or with any transaction contemplated hereby
or discussed herein (including with respect to the enforcement of the any of the
Transaction Documents), and hereby irrevocably waives, and agrees not to assert
in any Proceeding, any claim that it is not personally subject to the
jurisdiction of any such court, that such Proceeding is
improper. Each party hereto hereby irrevocably waives personal
service of process and consents to process being served in any such Proceeding
by mailing a copy thereof via registered or certified mail or overnight delivery
(with evidence of delivery) to such party at the address in effect for notices
to it under this Agreement and agrees that such service shall constitute good
and sufficient service of process and notice thereof. Nothing
contained herein shall be deemed to limit in any way any right to serve process
in any manner permitted by law. Each party hereto hereby irrevocably waives, to
the fullest extent permitted by applicable law, any and all right to trial by
jury in any legal proceeding arising out of or relating to this Agreement or the
transactions contemplated hereby. If either party shall commence a Proceeding to
enforce any provisions of a Transaction Document, then the prevailing party in
such Proceeding shall be reimbursed by the other party for its attorneys fees
and other costs and expenses incurred with the investigation, preparation and
prosecution of such Proceeding.
Exhibit
10.25
6.9
Survival
. The
representations, warranties, agreements and covenants contained herein shall
survive following the Closing.
6.10
Execution
. This
Agreement may be executed in two or more counterparts, all of which when taken
together shall be considered one and the same agreement and shall become
effective when counterparts have been signed by each party and delivered to the
other party, it being understood that both parties need not sign the same
counterpart. In the event that any signature is delivered by
facsimile transmission, such signature shall create a valid and binding
obligation of the party executing (or on whose behalf such signature is
executed) with the same force and effect as if such facsimile signature page
were an original thereof.
6.11
Not
used
.
6.12
Publicity
. The
Purchasers shall not issue any press release or make any public disclosure
regarding the transactions contemplated hereby unless such press release or
public disclosure is approved by the Company in
advance. Notwithstanding the foregoing, each of the parties hereto
may, in documents required to be filed by it with the SEC or other regulatory
bodies, make such statements with respect to the transactions contemplated
hereby as each may be advised by counsel is legally necessary or advisable, and
may make such disclosure as it is advised by its counsel is required by
law.
6.13
Severability
. In
case any one or more of the provisions of this Agreement shall be invalid or
unenforceable in any respect, the validity and enforceability of the remaining
terms and provisions of this Agreement shall not in any way be affected or
impaired thereby and the parties will attempt to agree upon a valid and
enforceable provision which shall be a reasonable substitute therefore, and upon
so agreeing, shall incorporate such substitute provision in this
Agreement.
Exhibit
10.25
6.14
Further
Assurances
. Each party shall do and perform, or cause to be
done and performed, all such further acts and things, and shall execute and
deliver all such other agreements, certificates, instruments and documents, as
the other party may reasonably request in order to carry out the intent and
accomplish the purposes of this Agreement and the consummation of the
transactions contemplated hereby.
6.15
Replacement of
Certificates
. If any certificate or instrument evidencing any shares of
Common Stock is mutilated, lost, stolen or destroyed, the Company shall issue or
cause to be issued in exchange and substitution for and upon cancellation
thereof, or in lieu of and substitution therefore, a new certificate or
instrument, but only upon receipt of evidence reasonably satisfactory to the
Company of such loss, theft or destruction and customary and reasonable
indemnity, if requested. The applicants for a new certificate or
instrument under such circumstances shall also pay any reasonable third-party
costs associated with the issuance of such replacement shares.
6.16
Remedies
. In addition
to being entitled to exercise all rights provided herein or granted by law,
including recovery of damages, each of the Purchasers and the Company will be
entitled to specific performance under this Agreement or the Transaction
Documents. The parties agree that monetary damages may not be
adequate compensation for any loss incurred by reason of any breach of
obligations described in the foregoing sentence and hereby agrees to waive in
any action for specific performance of any such obligation the defense that a
remedy at law would be adequate.
6.17
Independent Nature of
Purchasers' Obligations and Rights
. The obligations of each
Purchaser under this Agreement or any Transaction Document are several and not
joint with the obligations of any other Purchaser, and no Purchaser shall be
responsible in any way for the performance of the obligations of any other
Purchaser under this Agreement or any Transaction Document. Nothing
contained herein or in any Transaction Document, and no action taken by any
Purchaser pursuant thereto, shall be deemed to constitute the Purchasers as a
partnership, an association, a joint venture or any other kind of entity, or
create a presumption that the Purchasers are in any way acting in concert or as
a group with respect to such obligations or the transactions contemplated by
this Agreement or any the Transaction Document. Each Purchaser shall
be entitled to independently protect and enforce its rights, including without
limitation the rights arising out of this Agreement or out of the other
Transaction Documents, and it shall not be necessary for any other Purchaser to
be joined as an additional party in any proceeding for such
purpose.
6.18
Fees and
Expenses
. Except as set forth in the Registration Rights
Agreement, and except as provided herein, each Party shall pay the fees and
expenses of its advisers, accountants and other experts.
Exhibit
10.25
IN
WITNESS WHEREOF, the parties hereto have caused this Securities Purchase
Agreement to be duly executed by their respective authorized persons as of the
day and year first above written.
|
CICERO,
INC.
|
|
|
|
|
|
|
|
By:
|
|
|
|
John
P. Broderick
|
|
|
Chief
Executive Officer
|
|
|
|
|
|
|
|
PURCHASERS:
|
|
|
|
|
[COUNTERPART
SIGNATURE PAGES FOLLOW]
|
IN
WITNESS WHEREOF, the parties hereto have caused this Securities Purchase
Agreement to be duly executed by their respective authorized persons as of the
day and year first above written.
|
PURCHASER
|
|
|
|
|
|
|
|
|
|
|
|
(Name
of Purchaser)
|
|
|
|
|
|
|
By:
|
|
|
|
|
(Signature
of Purchaser(s))
|
|
|
|
|
|
|
Name:
|
|
|
|
|
(Name
of Signatory if Purchaser is an Entity)
|
|
|
|
|
|
Title:
|
|
|
|
|
(if
Purchaser is an Entity)
|
|
|
|
|
|
|
|
|
|
|
Purchase
Price:
|
$____________
|
|
|
|
|
|
|
|
|
|
|
Address
for Notice:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
With
a copy to:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exhibit
10.25
SCHEDULE
I
Name
and
|
|
Number
of Shares of Common Stock
|
|
Address of
Purchaser
|
Residence
|
at
Closing
Date
|
Purchase
Price
|
|
|
|
|
|
|
|
$15,000.00
|
C.
Glen Dugdale
|
DE
|
111,690
|
|
Box
4550
|
|
|
|
Greenville,
DE 19807
|
|
|
|
|
|
|
|
|
|
|
|
Queequeg
Partners, LP
|
NY
|
169,898
|
$22,813.27
|
Jonathan
Gallen
|
|
|
|
299
Park Avenue
|
|
|
|
New
York, NY 10171
|
|
|
|
|
|
|
|
|
|
|
|
Ahab
Partners, LP
|
NY
|
880,000
|
$118,184.00
|
Jonathan
Gallen
|
|
|
|
299
Park Avenue
|
|
|
|
New
York, NY 10171
|
|
|
|
|
|
|
|
|
|
|
|
Ahab
International, Ltd.
|
NY
|
1,120,000
|
$150,416.00
|
Jonathan
Gallen
|
|
|
|
299
Park Avenue
|
|
|
|
New
York, NY 10171
|
|
|
|
|
|
|
|
|
|
|
|
Maurice
Wills
|
CA
|
100,000
|
$13,430.00
|
27102
Woodbrook Road
|
|
|
|
Rancho
Palos Verdes, CA 90275
|
|
|
|
|
|
|
|
|
|
|
|
Mark
& Carolyn Landis
|
NJ
|
74,460
|
$10,000.00
|
503
Lake Drive
|
|
|
|
Princeton,
NJ 08540
|
|
|
|
|
|
|
|
|
|
|
|
Scott
Lustgarten
|
PA
|
44,676
|
$6,000.00
|
418
Hillbrook Road
|
|
|
|
Bryn
Mawr, PA 19010
|
|
|
|
|
|
|
|
|
|
|
|
Bruce
D. Miller
|
MA
|
148,920
|
$20,000.00
|
P.O.
Box 2306
|
|
|
|
Nantucket,
MA 02584
|
|
|
|
|
|
|
|
|
|
|
|
Richard
Nager
|
PA
|
29,784
|
$4,000.00
|
44
Righters Mill Road
|
|
|
|
Gladwyne,
PA 19035
|
|
|
|
|
|
|
|
|
|
|
|
Jonathan
P. Robinson
|
PA
|
37,230
|
$5,000.00
|
205
Exeter Road
|
|
|
|
Devon,
PA 19333
|
|
|
|
|
|
|
|
|
|
|
|
John
L. Steffens
|
NY
|
1,006,379
|
$135,156.73
|
65
East 55
th
Street, 33
rd
Floor
|
|
|
|
New
York, NY 10022
|
|
|
|
Exhibit
10.25
EXHIBIT
A
CICERO
DISCLOSURE SCHEDULES
These
Disclosure Schedules are being furnished by Cicero, Inc. (the “
Company
”), dated as
of February 22, 2007.
No
reference to or disclosure of any item or matter in these Disclosure Schedules
shall be construed as an admission or indication that such item or other matter
is material or that such item or other matter is required to be referred to or
disclosed. The inclusion and discussion of any document, agreement,
conflict or situation in these Disclosure Schedules is not an admission of the
effectiveness, enforceability, or interpretation of the document, agreement,
conflict or situation.
Items
identified on the following Schedules are deemed disclosed for purposes of all
Schedules to which they relate.
These
Disclosure Schedules do not contain Material Non-Public
Information.
Exhibit
10.25
Schedule 2.1 (c)
Capitalization
Authorized
and Outstanding Capital Stock
The
Company's Certificate of Incorporation, as amended on December 29, 2006,
authorizes the Company to issue 215,000,000 shares of Common Stock, par value
$0.001 per share, of which 35,150,832 were outstanding as of close of business
on February 9, 2007 (confirmed with American Stock Transfer and Trust
Company). An additional 1,763,476 shares of Common Stock are reserved
for issuance upon the conversion of the Series A1 Preferred Stock. An
additional 324,067 shares of Common Stock are reserved for issuance upon the
exercise of the warrants described below.
The
Company's Certificate of Incorporation authorizes it to issue 10,000,000 shares
of Preferred Stock, par value $0.001 per share. Of the authorized
Preferred Stock, the following series have been issued:
1,763
shares have been designated Series A1 Convertible Redeemable Preferred Stock,
all of which were issued January 2007, and all of which are currently
outstanding;
Preemptive
Rights
None.
Stock
Options
As of
January 10, 2007, 110,200 options to purchase Common Stock were outstanding
under the Company’s Employee and Outside Director Stock Option Plans. The
Company’s 1997 Plan has approximately 320,000 shares available to grant and the
Plan expires in 2007. The Company does plan to create a new Employee and Outside
Director Stock Option Plan.
Warrants
324,067
shares of Common Stock are reserved for issuance upon the exercise of warrants
(all are subject to Registration Rights Agreements) as follows:
Exhibit
10.25
Warrant
Holders
:
|
|
Granted
:
|
|
|
Remaining
:
|
|
|
Exercise
Price
:
|
|
Early
Adopter Warrants as part of the Senior Reorganization
Notes
|
|
|
201,115
|
|
|
|
201,115
|
|
|
$
|
2.00
|
|
Former
Series D-1 Preferred Stock Purchasers
|
|
|
41,581
|
|
|
|
22,931
|
|
|
$
|
7.00
|
|
Former
Series D-2 Preferred Stock Purchasers
|
|
|
24,157
|
|
|
|
10,914
|
|
|
$
|
20.00
|
|
Former
Financing Warrants
|
|
|
55,3671
|
|
|
|
28,095
|
|
|
$
|
40.00
|
|
Purchasers
in January 2002 Private Placement
|
|
|
4,764
|
|
|
|
2,131
|
|
|
$
|
60.00
|
|
Purchasers
in October 2003 Private Placement
|
|
|
474
|
|
|
|
445
|
|
|
$
|
45.00
|
|
Purchasers
in January 2004 Private Placement
|
|
|
33,692
|
|
|
|
13,838
|
|
|
$
|
37.00
|
|
Convertible
notes
|
|
|
18,750
|
|
|
|
18,750
|
|
|
$
|
8.00
|
|
Convertible
notes
|
|
|
20,000
|
|
|
|
20,000
|
|
|
$
|
10.00
|
|
Convertible
notes
|
|
|
901
|
|
|
|
901
|
|
|
$
|
17.00
|
|
Convertible
notes
|
|
|
7,893
|
|
|
|
1,875
|
|
|
$
|
32.00
|
|
Former
Series C Preferred Stock Purchasers.
|
|
|
11,461
|
|
|
|
3,072
|
|
|
$
|
38.00
|
|
Rights
to Subscribe
None
Exhibit
10.25
Registration
Rights Agreements
Registration
Rights Agreement with Existing Preferred Stockholders.
The
Company has entered into an amended registration rights agreements to provide
for the registration of the shares underlying the Series A1 Preferred Stock.
Such agreement will also provide for the registration of the shares underlying
warrants or shares of common stock issued in the future pursuant to the terms of
the respective certificates of designation.
Registration
Rights Agreement with Participants in the January 2002 Private Placement of
Common Stock and Warrants.
The
shares of common stock and the shares issuable upon exercise of the related
warrants are subject to a Registration Rights Agreement and are currently
registered. Such shares were issued in the Company’s January 2002
private placement of common stock and warrants.
Registration
Rights Agreement with Participants in the October 2003 Private Placement of
Common Stock and Warrants.
The
shares of common stock and the shares issuable upon exercise of the related
warrants are subject to a Registration Rights Agreement and are currently
registered. Such shares were issued in the Company’s October 2003
private placement of common stock and warrants.
Registration
Rights Agreement with Participants in the January 2004 Private Placement of
Common Stock and Warrants.
The
shares of common stock and the shares issuable upon exercise of the related
warrants are subject to a Registration Rights Agreement and are currently
registered. Such shares were issued in the Company’s January 2004
private placement of common stock and warrants.
Registration
Rights Agreement with MLBC.
On
January 3, 2002, the Company entered into a registration rights agreement with
MLBC, Inc. (“
MLBC
”), an affiliate
of Merrill Lynch, Pierce, Fenner & Smith Incorporated (“
Merrill
Lynch
”). This agreement grants registration rights to MLBC
with respect to 1,250 shares of Common Stock of the Company ( as adjusted for
the reverse stock split) and replaces the previous registration rights agreement
with Merrill Lynch for 1,000 shares of Common Stock of the
Company. The Company complied with Merrill Lynch's demand to register
the original 1,000 shares upon effectiveness of its Form S-3 registration
statement, Reg. No. 333-61494 , effective as of June 14, 2001 and as amended by
Post-Effective Amendment No. 1, filed October 18, 2001 (subsequently
withdrawn). MLBC subsequently requested that it not be included on an
updated registration statement and withdrew its request to be
included. Accordingly, MLBC still retains “piggy-back” and demand
rights with respect to a total of 1,229 shares of Common Stock. The
additional 21 shares of Common Stock were distributed by MLBC and have been
registered for resale in the names of the transferees.
Exhibit
10.25
Registration
Rights Agreement as Part of the Note and Warrant Offering.
In August
2004, the Company entered into a registration rights agreement with the holders
of the Senior Reorganization Note and Warrant Offering. The conversion of the
Notes into Senior Debt and Warrants was contingent and dependent upon the
Company’s shareholders approving the merger and reorganization
(“Recapitalization”) of the Company which was completed on November 16,
2006.
Registration Rights Agreement as Part
of the Convertible Bridge Notes
.
As part
of the Term Sheet for Convertible Bridge Note financing, the Company entered
into a registration rights agreement with the holders of Convertible Bridge
Notes within 90 days after consummation of the recapitalization.
Registration
Rights Agreement with Liraz Systems, Ltd.
On
November 30, 2006, the Company entered into a registration rights agreement
with Liraz Systems, Ltd. (“Liraz”) pursuant to a guaranty agreement between
Liraz and Bank Hapoalim B.M. This agreement grants registration
rights to Liraz with respect to certain shares of Common Stock of the Company
and a warrant to purchase 3,600,000 shares of the Company’s Common Stock issued
as part of the guaranty extension agreement of the Company’s bank note to Bank
Hapoalim NY.
Schedule
2.1 (f) Consents
None
Schedule
2.1 (g) Litigation
Various
lawsuits and claims have been brought against us in the normal course of our
business. In January 2003, an action was brought against us in the Circuit Court
of Loudon County, Virginia, for a breach of a real estate lease. The case was
settled in August 2003. Under the terms of the settlement agreement, we agreed
to assign a note receivable with recourse equal to the unpaid portion of the
note should the note obligor default on future payments. The unpaid balance of
the note was $545,000, of which the current unpaid principal portion is
approximately $216,000 and it matures in December 2007. We assessed
the probability of liability under the recourse provisions using a weighted
probability cash flow analysis and have recognized a long-term liability in the
amount of $131,000.
In
October 2003, we were served with a summons and complaint in Superior Court of
North Carolina regarding unpaid invoices for services rendered by one of our
subcontractors. The amount in dispute was approximately $200,000 and
is included in accounts payable. Subsequent to March 31, 2004, we settled this
litigation. Under the terms of the settlement agreement, we agreed to
pay a total of $189,000 plus interest over a 19-month period ending November 15,
2005. The Company is in the process of negotiating a series of payments for the
remaining liability of approximately $80,000.
In March
2004, we were served with a summons and complaint in Superior Court of North
Carolina regarding a security deposit for a sublease in Virginia. The amount in
dispute is approximately $247,000. In October 2004, we reached a
settlement agreement wherein we agreed to pay $160,000 over a 36-month period
ending October 2007.
Exhibit
10.25
In
August 2004, we were notified that we were in default under an
existing lease agreement for office facilities in Princeton, New Jersey. The
amount of the default is approximately $65,000. Under the terms of the lease
agreement, we may be liable for future rents should the space remain vacant. We
have reached a settlement agreement with the landlord which calls for a total
payment of $200,000 and is included in accounts payable, over a 31-month period
ending October 2007.
In April
2005, we were notified that Critical Mass Mail, Inc. had filed a claim against
us for failure to pay certain liabilities under an Asset Purchase Agreement
dated January 9, 2004. We in turn filed that Critical Mass Mail, Inc. failed to
deliver certain assets and other documents under the same Asset purchase
agreement. We had already reserved the potential liability under the Agreement
as part of the asset purchase accounting. On March 1, 2006, Critical Mass Mail
amended their complaint and is seeking damages of approximately $600,000 for our
failure to timely register the underlying securities issued in the Asset
Purchase. In December 2006 we settled this litigation. Under the terms of the
settlement agreement, the Company agreed to pay the sum of $45,000 in monthly
installments over nine consecutive months beginning on December 1, 2006 and to
issue Critical Mass Mail, Inc. $50,000 value of common shares of Cicero, Inc,
based on the trailing three day average price for Cicero common stock after such
stock initially trades on the OTC Bulletin Board.
Under the
indemnification clause of the Company’s standard reseller agreements and
software license agreements, the Company agrees to defend the reseller/licensee
against third party claims asserting infringement by the Company’s products of
certain intellectual property rights, which may include patents, copyrights,
trademarks or trade secrets, and to pay any judgments entered on such claims
against the reseller/licensee.
Exhibit
10.25
EXHIBIT
B
REGISTRATION RIGHTS
AGREEMENT
This
REGISTRATION RIGHTS AGREEMENT (this “
Agreement
”), dated as
of February 26, 2007, is entered into by and between CICERO, INC., a Delaware
corporation (the “
Company
”),
and _____________________________ (the “
Purchaser
”).
W I T N E S S E T
H
:
This
Agreement is made pursuant to that certain Purchase Agreement, dated as of the
date hereof, by and between the Company and the Purchaser (the “
Purchase Agreement
”),
and pursuant to that certain Commitment Agreement, dated as of the date hereof,
by and between the Company and the Purchaser (the “Commitment
Agreement”)
.
The
Company and the Purchaser hereby agree as follows:
1.
Definitions
. Unless
otherwise defined herein, terms defined in the Purchase Agreement and the
Commitment Agreement are used herein as therein defined, and the following shall
have (unless otherwise provided elsewhere in this Agreement) the following
respective meanings (such meanings being equally applicable to both the singular
and plural form of the terms defined):
“
Affiliate
” means,
with respect to any Person, any other Person that directly or indirectly
controls or is controlled by or under common control with such
Person. For the purposes of this definition, “
control
,” when used
with respect to any Person, means the possession, direct or indirect, of the
power to direct or cause the direction of the management and policies of such
Person, whether through the ownership of voting securities, by contract or
otherwise, and the terms “
affiliated
,” “
controlling
” and
“
controlled
”
have meanings correlative to the foregoing.
“
Agreement
” shall mean
this Registration Rights Agreement, including all amendments, modifications and
supplements and any exhibits or schedules to any of the foregoing, and shall
refer to the Agreement as the same may be in effect at the time such reference
becomes operative.
“
Business Day
” shall
mean any day that is not a Saturday, a Sunday or a day on which banks are
required or permitted to be closed in the State of New York.
“
Commission
” shall
mean the Securities and Exchange Commission or any other federal agency then
administering the Securities Act and other federal securities laws.
“
Holder
or
Holders
” means the
holder or holders, as the case may be, from time to time of the Registrable
Securities.
Exhibit
10.25
“
NASD
” shall mean the
National Association of Securities Dealers, Inc., or any successor corporation
thereto.
“
Registrable
Securities
” shall mean the shares of Common Stock issuable upon
conversion of the Convertible Bridge Notes and the purchase of common
stock.
2.
Registration
. As
soon as practicable following the Closing Date and within ninety (90) days of
the such date, the Company shall prepare and file with the Commission a
Registration Statement (the “
Registration
Statement
”) which shall cover all of the Registrable
Securities. The Registration Statement shall be on Form S-1 or any
successor form. The Company shall use its best efforts to cause the
Registration Statement to be declared effective under the Securities Act within
one hundred eighty (180) days of the Closing Date.
3.
Registration
Procedures
. Subject to the provisions of Section 2, the
Company will:
(a) prepare
and file with the Commission a Registration Statement with respect to such
securities and use its best efforts to cause such Registration Statement to
become and remain effective for a period of time required for the disposition of
such securities by the Holder thereof, but not to exceed two (2)
years;
(b) prepare
and file with the Commission such amendments and supplements to such
Registration Statement and the prospectus used in connection therewith as may be
necessary to keep such Registration Statement effective and to comply with the
provisions of the Securities Act with respect to the sale or other disposition
of all securities covered by such Registration Statement until the earlier of
such time as all of such securities have been disposed of in a public offering
or the expiration of two (2) years;
(c) furnish
to each Holder such number of copies of a summary prospectus or other
prospectus, including a preliminary prospectus, in conformity with the
requirements of the Securities Act, and such other documents, as such Holder may
reasonably request;
(d) use
its best efforts to register or qualify the securities covered by such
Registration Statement under such other securities or blue sky laws of such
jurisdictions within the United States as each Holder shall reasonably request
to the extent such registration or qualification is required in such
jurisdictions (
provided
,
however
, that the
Company shall not be obligated to qualify as a foreign corporation to do
business under the laws of any jurisdiction in which it is not then qualified or
to file any general consent to service of process), and do such other reasonable
acts and things as may be required of it to enable such Holder to consummate the
disposition in such jurisdiction of the securities covered by such Registration
Statement;
Exhibit
10.25
(e) furnish,
at the request of any Holder during registration of Registrable Securities
pursuant to Section 2, on the date that such shares of Registrable Securities
are delivered to the underwriters for sale pursuant to such registration or, if
such Registrable Securities are not being sold through underwriters, on the date
that the Registration Statement with respect to such shares of Registrable
Securities becomes effective, (1) an opinion, dated as of such date, of the
independent counsel representing the Company for the purposes of such
registration, addressed to the underwriters, if any, and if such Registrable
Securities are not being sold through underwriters, then to the Holder making
such request, in customary form and covering matters of the type customarily
covered in such legal opinions; and (2) a comfort letter dated such date,
from the independent certified public accountants of the Company, addressed to
the underwriters, if any, and if such Registrable Securities are not being sold
through underwriters, then to the Holder making such request and, if such
accountants refuse to deliver such letter to such Holder, then to the Company,
in a customary form and covering matters of the type customarily covered by such
comfort letters and as the underwriters or such Holder shall reasonably
request;
(f) enter
into customary agreements (including an underwriting agreement in customary
form) and take such other actions as are reasonably required in order to
expedite or facilitate the disposition of such Registrable
Securities;
(g) notify
each Holder as promptly as practicable upon the occurrence of any event as a
result of which the prospectus included in a Registration Statement, as then in
effect, contains an untrue statement of material fact or omits to state a
material fact required to be stated therein or necessary to make the statements
therein not misleading in light of the circumstances then existing, and as
promptly as possible, prepare, file and furnish to such Holder a reasonable
number of copies of a supplement or an amendment to such prospectus as may be
necessary so that such prospectus does not contain an untrue statement of
material fact or omits to state a material fact required to be stated therein or
necessary to make the statements therein not misleading in light of the
circumstances then existing;
(h) provide
each Holder and its representatives the opportunity to conduct reasonable
inquiry of the Company’s financial and other records during normal business
hours and make available its officers, directors and employees for questions
regarding information which such Holder may reasonably request in order to
conduct any due diligence; and
(i) otherwise
use its best efforts to comply with all applicable rules and regulations of the
Commission, and make available to the Holders, as soon as reasonably
practicable, but not later than eighteen (18) months after the effective date of
the Registration Statement, an earnings statement covering the period of at
least twelve (12) months beginning with the first full month after the effective
date of such Registration Statement, which earnings statement shall satisfy the
provisions of Section 11(a) of the Securities Act.
4.
Expenses
. All
expenses incident to the Company’s compliance with the terms of this Agreement,
including, without limitation, all registration and filing fees, printing
expenses, fees and disbursements of counsel for the Company, expenses of any
special audits incident to or required by any such registration and expenses of
complying with the securities or blue sky laws of any jurisdiction pursuant to
Section 3(d), shall be paid by the Company, except that:
(a) all
such expenses in connection with any amendment or supplement to the Registration
Statement or prospectus filed more than two (2) years after the effective date
of such Registration Statement because any Holder has not effected the
disposition of the securities requested to be registered shall be paid by such
Holder;
Exhibit
10.25
(b) the
Company shall not be liable for any fees, discounts or commissions to any
underwriter or any fees or disbursements of counsel for any underwriter in
respect of the securities sold by such Holder; and
(c) any
incremental expenses incurred by the Company as a result of the inclusion of a
Holder’s Registrable Securities in an underwritten offering where the Holder or
any of its Affiliates is an underwriter of the Registrable Securities which
inclusion of such Holder’s Registrable Securities requires a “qualified
independent underwriter” under the applicable rules of the NASD shall be paid by
such Holder.
5.
Indemnification and
Contribution
. (a) In the event of any registration
of any Registrable Securities under the Securities Act pursuant to this
Agreement, the Company shall indemnify and hold harmless the Holder of such
Registrable Securities, such Holder’s directors and officers, and each other
person (including each underwriter) who participated in the offering of such
Registrable Securities and each other person, if any, who controls such Holder
or such participating person within the meaning of the Securities Act, against
any losses, claims, damages or liabilities, joint or several, to which such
Holder or any such director or officer or participating person or controlling
person may become subject under the Securities Act or any other statute or at
common law, insofar as such losses, claims, damages or liabilities (or actions
in respect thereof) arise out of or are based upon (i) any alleged untrue
statement of any material fact contained, on the effective date thereof, in any
Registration Statement under which such securities were registered under the
Securities Act, any preliminary prospectus or final prospectus contained
therein, or any amendment or supplement thereto, or (ii) any alleged
omission to state therein a material fact required to be stated therein or
necessary to make the statements therein not misleading, and shall reimburse
such Holder or such director, officer or participating person or controlling
person for any legal or any other expenses reasonably incurred by such Holder or
such director, officer or participating person or controlling person in
connection with investigating or defending any such loss, claim, damage,
liability or action. Notwithstanding anything to the contrary set
forth in this Section 5(a), the Company shall not be liable to indemnify any
person in any such case to the extent that any such loss, claim, damage or
liability arises out of or is based upon (1) any actual or alleged untrue
statement or actual or alleged omission either (x) made in such Registration
Statement, preliminary prospectus, prospectus or amendment or supplement in
reliance upon and in conformity with written information furnished to the
Company by such Holder specifically for use therein or so furnished for such
purposes by any underwriter or (y) that had been corrected in a preliminary
prospectus, prospectus supplement or amendment which had been furnished to such
Holder prior to any distribution of the document alleged to contain the untrue
statement or omission to offerees or purchasers, (2) any offer or sale of
Registrable Securities after receipt by such Holder of a Standstill Notice under
Section 3(g) and prior to the delivery of the prospectus supplement or amendment
contemplated by Section 3(g), or (3) the Holder’s failure to comply with the
prospectus delivery requirements under the Securities Act or failure to
distribute its Registrable Securities in a manner consistent with its intended
plan of distribution as provided to the Company and disclosed in the
Registration Statement. Notwithstanding the foregoing, the Company
shall not be required to indemnify any person for amounts paid in settlement of
any claim without the prior written consent of the Company, which consent shall
not be unreasonably withheld. Such indemnity shall remain in full
force and effect regardless of any investigation made by or on behalf of such
Holder or such director, officer or participating person or controlling person,
and shall survive the transfer of such securities by such
Holder.
Exhibit
10.25
(b) Each
Holder, by acceptance hereof, agrees to indemnify and hold harmless the Company,
its directors and officers and each person who participated in such offering and
each other person, if any, who controls the Company within the meaning of the
Securities Act against any losses, claims, damages or liabilities, joint or
several, to which the Company or any such director or officer or any such person
may become subject under the Securities Act or any other statute or at common
law, insofar as such losses, claims, damages or liabilities (or actions in
respect thereof) arise out of or are based upon (i) information in writing
provided to the Company by the Holder specifically for use in the following
documents and contained, on the effective date thereof, in any Registration
Statement under which securities were registered under the Securities Act at the
request of the Holder, any preliminary prospectus or final prospectus contained
therein, or any amendment or supplement thereto, (ii) Holder’s offer or sale of
Registrable Securities after receipt by such Holder of a Standstill Notice under
Section 3(g) and prior to the delivery of the prospectus supplement or amendment
contemplated by Section 3(g), (iii) Holder’s failure to comply with the
prospectus delivery requirements under the Securities Act or failure to
distribute its Registrable Securities in a manner consistent with its intended
plan of distribution as provided to the Company and disclosed in the
Registration Statement, (iv) Holder’s failure to comply with Regulation M under
the Exchange Act, or (v) Holder’s failure to comply with any rules and
regulations applicable because the Holder is, or is an Affiliate of, a
registered broker-dealer. Notwithstanding the provisions of this
paragraph (b) or paragraph (c) below, no Holder shall be required to indemnify
any person pursuant to this Section 5 or to contribute pursuant to paragraph (c)
below in an amount in excess of the amount of the aggregate net proceeds
received by such Holder in connection with any such registration under the
Securities Act.
(c) If
the indemnification provided for in this Section 5 from the indemnifying party
is unavailable to an indemnified party hereunder in respect of any losses,
claims, damages, liabilities or expenses referred to therein, then the
indemnifying party, in lieu of indemnifying such indemnified party, shall
contribute to the amount paid or payable by such indemnified party as a result
of such losses, claims, damages, liabilities or expenses in such proportion as
is appropriate to reflect the relative fault of the indemnifying party and
indemnified parties in connection with the actions which resulted in such
losses, claims, damages, liabilities or expenses, as well as any other relevant
equitable considerations. The relative fault of such indemnifying
party and indemnified parties shall be determined by reference to, among other
things, whether any action in question, including any untrue or alleged untrue
statement of a material fact or omission or alleged omission to state a material
fact, has been made by, or relates to information supplied by, such indemnifying
party or indemnified parties, and the parties’ relative intent, knowledge,
access to information and opportunity to correct or prevent such
action. The amount paid or payable by a party as a result of the
losses, claims, damages, liabilities and expenses referred to above shall be
deemed to include any legal or other fees or expenses reasonably incurred by
such party in connection with any investigation or proceeding.
Exhibit
10.25
The
parties hereto agree that it would not be just and equitable if contribution
pursuant to this Section 5(c) were determined by pro rata allocation or by any
other method of allocation which does not take account of the equitable
considerations referred to in the immediately preceding paragraph. No
Person guilty of fraudulent misrepresentation (within the meaning of Section
11(f) of the Securities Act) shall be entitled to contribution from any Person
who was not guilty of such fraudulent misrepresentation.
6.
Certain Limitations on
Registration Rights
. Notwithstanding the other provisions of
this Agreement:
(a) the
Company shall not be obligated to register the Registrable Securities of Holders
if, in the opinion of counsel to the Company reasonably satisfactory to the
Holder and its counsel (or, if the Holder has engaged an investment banking
firm, to such investment banking firm and its counsel), the sale or other
disposition of such Holder’s Registrable Securities, in the manner proposed by
such Holder (or by such investment banking firm), may be effected without
registering such Registrable Securities under the Securities Act;
(b) the
Company shall not be obligated to register the Registrable Securities of any
Holder pursuant to Section 2 if the Company has had a registration statement,
under which the Holder had a right to have its Registrable Securities included
pursuant to Section 2, declared effective within one hundred and twenty (120)
days prior to the date of the request pursuant to Section 2; and
(c) the
Company shall have the right to delay the filing or effectiveness of the
registration statement required pursuant to Section 2 hereof during one or more
periods aggregating not more than forty five (45) days in any twelve-month
period in the event that (i) the Company would, in accordance with the advice of
its counsel, be required to disclose in the prospectus information not otherwise
then required by law to be publicly disclosed and (ii) in the judgment of the
Company’s Board of Directors, there is a reasonable likelihood that such
disclosure would materially and adversely affect any existing or prospective
material business situation, transaction or negotiation or otherwise materially
and adversely affect the Company.
7.
Selection of Managing
Underwriters
. The managing underwriter or underwriters for any
offering of Registrable Securities to be registered pursuant to Section 2 shall
be selected by the Holders of a majority of the shares being so registered and
shall be reasonably acceptable to the Company.
8.
Holder
Agreements
. (a) No Holder may participate in an
underwritten offering provided for hereunder unless such Holder (i) agrees to
sell the Holder’s Registrable Securities on the basis provided in the
underwriting arrangements contemplated for such offering as reasonably requested
by the managing underwriter, (ii) completes and executes all questionnaires,
powers of attorney, indemnities, underwriting agreements and other documents
reasonably required under the terms of such underwriting arrangements as
reasonably requested by the managing underwriter, and (iii) agrees to bear the
Holder’s pro rata portion of all underwriting discounts and
commissions.
Exhibit
10.25
(b) Each
Holder agrees to comply with Regulation M under the Exchange Act in connection
with its offer and sale of Registrable Securities.
(c) Each
Holder agrees that it will not sell any Registrable Securities registered under
the Securities Act pursuant to the terms of this Agreement until a Registration
Statement (and any associated post-effective amendment) relating thereto has
been declared effective and the Holder has been provided copies of the related
prospectus, as amended or supplemented to date.
(d) Each
Holder agrees to comply with the prospectus delivery requirements of the
Securities Act as applicable in connection with the sale of Registrable
Securities registered under the Securities Act pursuant to a Registration
Statement.
(e) Each
Holder agrees that upon receipt of a Standstill Notice pursuant to Section 3(g),
the Holder shall immediately discontinue offers and sales of Registrable
Securities registered under the Securities Act pursuant to any Registration
Statements covering such Registrable Securities until such Holder receives
copies of the supplemented or amended prospectus contemplated by Section 3(g) or
notice from the Company that no such supplement or amendment is
required.
9.
Miscellaneous
.
(a)
No Inconsistent
Agreements
. The Company will not hereafter enter into any
agreement with respect to its securities which conflicts with the rights granted
to the Holders in this Agreement.
(b)
Remedies
. Each
Holder, in addition to being entitled to exercise all rights granted by law,
including recovery of damages, will be entitled to specific performance of its
rights under this Agreement. The Company agrees that monetary damages
would not be adequate compensation for any loss incurred by reason of a breach
by it of the provisions of this Agreement and hereby agrees to waive the defense
in any action for specific performance that a remedy at law would be
adequate. In any action or proceeding brought to enforce any
provision of this Agreement or where any provision hereof is validly asserted as
a defense, the successful party shall be entitled to recover reasonable
attorneys’ fees in addition to any other available remedy.
(c)
Amendments and
Waivers
. Except as otherwise provided herein, the provisions
of this Agreement may not be amended, modified or supplemented, and waivers or
consents to departure from the provisions hereof may not be given unless the
Company has obtained the written consent of the Holder.
(d)
Notice
Generally
. Any notice, demand, request, consent, approval,
declaration, delivery or other communication hereunder to be made pursuant to
the provisions of this Agreement shall be sufficiently given or made if in
writing and either delivered in person with receipt acknowledged or sent by
registered or certified mail, return receipt requested, postage prepaid, or by
telecopy and confirmed by telecopy answerback, addressed as
follows:
Exhibit
10.25
If to the
Company:
Cicero,
Inc.
8000
Regency Parkway, Suite 542
Cary,
North Carolina 27518
Attn: John
P. Broderick
With a Copy
to:
Golenbock
Eiseman Assor Bell & Peskoe LLP
437
Madison Avenue
New York,
New York 10022
Attn: Lawrence
Bell, Esq.
If to the
Holders:
To
the address set forth on the counterpart signature page of such Purchaser or at
such other address as may be substituted by notice given as herein
provided. The giving of any notice required hereunder may be waived
in writing by the party entitled to receive such notice. Every
notice, demand, request, consent, approval, declaration, delivery or other
communication hereunder shall be deemed to have been duly given or served on the
date on which personally delivered, with receipt acknowledged, telecopied and
confirmed by telecopy answerback or three (3) Business Days after the same shall
have been deposited in the United States mail.
(e)
Rule
144
. With a view to making available to the Holders the
benefits of Rule 144 under the Securities Act (“
Rule 144
”) and any
other rule or regulation of the Commission that may at any time permit the
Holder to sell securities of the Company to the public without registration, the
Company agrees that it will:
(i) make
and keep public information available, as those terms are understood and defined
in Rule 144;
(ii) file
with the Commission in a timely manner all reports and other documents required
of the Company under the Exchange Act; and
(iii) furnish
to a Holder, so long as such Holder owns any Registrable Securities, forthwith
upon request (A) a written statement by the Company, if true, that it has
complied with the reporting requirements of Rule 144, the Securities Act and the
Exchange Act, (B) a copy of the most recent annual or quarterly report of the
Company and such other reports and documents so filed by the Company, and (C)
such other information as may be reasonably requested in availing such Holder of
any rule or regulation of the Commission which permits the selling of any such
securities without registration.
(f)
Successors and
Assigns
. This Agreement shall inure to the benefit of and be
binding upon the successors and assigns of each of the parties hereto including
any person to whom Registrable Securities are transferred.
(g)
Headings
. The
headings in this Agreement are for convenience of reference only and shall not
limit or otherwise affect the meaning hereof.
Exhibit
10.25
(h)
Governing Law;
Jurisdiction
. This Agreement shall be governed by, construed
and enforced in accordance with the laws of the State of Delaware without giving
effect to the conflict of laws provisions thereof. Service of process
on the parties in any action arising out of or relating to this Agreement shall
be effective if mailed to the parties in accordance with Section 9(d)
hereof.
The parties
hereto waive all right to trial by jury in any action or proceeding to enforce
or defend any rights hereunder.
(i)
Severability
. Wherever
possible, each provision of this Agreement shall be interpreted in such manner
as to be effective and valid under applicable law, but if any provision of this
Agreement shall be prohibited by or invalid under applicable law, such provision
shall be ineffective to the extent of such prohibition or invalidity, without
invalidating the remainder of such provision or the remaining provisions of this
Agreement.
(j)
Entire
Agreement
. This Agreement, together with the License Agreement
and the Subscription Agreement, represents the complete agreement and
understanding of the parties hereto in respect of the subject matter contained
herein and therein. This Agreement supersedes all prior agreements
and understandings between the parties with respect to the subject matter
hereof.
(k)
Counterparts
. This
Agreement may be executed in any number of counterparts, all of which taken
together shall be considered one and the same agreement and shall become
effective when counterparts have been signed by each party and delivered to the
other party, it being understood that both parties need not sign the same
counterpart. In the event that any signature is delivered by
facsimile transmission, such signature shall create a valid and binding
obligation of the party executing (or on whose behalf such signature is
executed) with the same force and effect as if such facsimile signature page
were an original thereof.
[SIGNATURE
PAGES ATTACHED HERETO]
Exhibit
10.25
IN
WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date
first above written.
|
CICERO,
INC.
|
|
|
|
|
|
|
|
By:
|
|
|
|
John
P. Broderick,
|
|
|
Chief
Executive and Financial Officer
|
|
|
|
|
|
|
|
PURCHASER:
|
|
|
|
|
|
|
|
By:
|
|
|
Name:
|
|
|
Title:
|
|
Securities
Purchase Agreement
By
and Among
Cicero,
Inc.,
And
The
Purchasers Listed On Schedule I
Dated
As Of August 15, 2007
Exhibit
10.26
SECURITIES
PURCHASE AGREEMENT
THIS
SECURITIES PURCHASE AGREEMENT (this “
Agreement
”) is dated
as of August 15, 2007, by and among CICERO, INC., a Delaware corporation (the
“
Company
”), and
the various purchasers listed on Schedule I hereto (each referred to herein as a
“
Purchaser
”
and, collectively, the "
Purchasers
").
WHEREAS,
the Company and the Purchasers are executing and delivering this Agreement in
reliance upon the exemption from securities registration afforded by Rule 506
under Regulation D as promulgated by the United States Securities and Exchange
Commission (the “
Commission
”) under
Section 4(2) of the Securities Act of 1933, as amended (the “
Securities
Act
”);
WHEREAS,
subject to the terms and conditions set forth in this Agreement, the Company
desires to issue and sell to the Purchasers, and the Purchasers desire to
acquire from the Company,
shares of common stock
of the Company, par value $.001 per share (the “
Common Stock
”);
and
WHEREAS,
contemporaneously with the execution and delivery of this Agreement, the parties
hereto are executing and delivering a Registration Rights Agreement
substantially in the form of
Exhibit B
attached
hereto (the “
Registration Rights
Agreement
”) pursuant to which the Company has agreed to provide certain
registration rights under the Securities Act and the rules and regulations
promulgated thereunder, and applicable state securities laws.
NOW,
THEREFORE, in consideration of the promises and mutual covenants and agreements
hereinafter, the Company and the Purchasers hereby agree as
follows:
Exhibit
10.26
ARTICLE
I.
PURCHASE
AND SALE
1.1 Purchase
and Sale.
On the
Closing Date (as defined below), subject to the terms and conditions set forth
herein, the Company shall issue and sell to each Purchaser and each Purchaser,
severally and not jointly, shall purchase from the Company the
shares of Common Stock
as set forth on
Schedule I
(the
"
Shares
"). The
aggregate purchase price for the Shares purchased by the Purchasers
shall not exceed $500,000.
1.2 Closing.
a.
The
Closing
. The closing (the “
Closing
”) of the
purchase and sale of the Common Stock shall take place at the offices
of the Company, 8000 Regency Parkway, Suite 542, Cary, North Carolina 27518,
immediately following the execution hereof or such later date or different
location as the parties shall agree, but in no event prior to the date that the
conditions set forth in Section 4.1 have been satisfied or waived by the
appropriate party (such date of the Closing, the “
Closing
Date
”). At the Closing:
(i) Each
Purchaser shall deliver to the Company (1) this Agreement, duly executed by such
Purchaser, (2) the Registration Rights Agreement, duly executed by such
Purchaser and (3) its portion of the purchase price as set forth next to its
name on
Schedule
I
in United States dollars in immediately available funds to an account
or accounts designated in writing by the Company; and
(ii) The
Company shall deliver to each Purchaser (1) this Agreement, duly executed by the
Company, (2) the Registration Rights Agreement, duly executed by the Company,
and (3) a certificate evidencing the number of shares of Common Stock
purchased by such Purchaser as set forth on
Schedule I
hereto,
registered in the name of such Purchaser.
ARTICLE
II.
REPRESENTATIONS
AND WARRANTIES
2.1
Representations and
Warranties of the Company
. The Company represents and warrants
to each of the Purchasers that the statements contained in this Section 2.1 are
true, correct and complete as of the date hereof, and will be true correct and
complete as of the Closing Date (unless specifically made as of another date),
except as specified to the contrary in the corresponding paragraph of the
disclosure schedule prepared by the Company accompanying this Agreement (the
"
Company Disclosure
Schedules
"):
Exhibit
10.26
a.
Organization and
Qualification
. The Company duly incorporated, validly existing
and in good standing under the laws of Delaware, with the requisite corporate
power and authority to own and use its properties and assets and to carry on its
business as currently conducted. The Company is duly qualified as a foreign
corporation to do business and is in good standing as a foreign corporation in
each jurisdiction in which the nature of the business conducted or property
owned by it makes such qualification necessary, except where the failure to be
so qualified or in good standing, as the case may be, would not, individually or
in the aggregate, (x) adversely affect the legality, validity or enforceability
of any of this Agreement or the Transaction Documents (as defined in Section
2.1(b)) or any of the transactions contemplated hereby or thereby, (y) have or
result in a material adverse effect on the results of operations, assets, or
financial condition of the Company, taken as a whole or (z) impair the Company’s
ability to perform fully on a timely basis its obligations under any Transaction
Document (any of (x), (y) or (z), being a “
Material Adverse
Effect
”). The Company has made available to the Purchaser true
and correct copies of the Company's Certificate of Incorporation, as amended and
as in effect on the date hereof (the “
Certificate of
Incorporation
”), and the Company's Bylaws, as in effect on the date
hereof (the “
Bylaws
”).
b.
Authorization;
Enforcement
. The Company has the requisite corporate power and
authority to enter into and to consummate the transactions contemplated by this
Agreement and the Registration Rights Agreement (collectively, the “
Transaction
Documents
”), and otherwise to carry out its obligations hereunder and
thereunder. The execution and delivery of each of this Agreement and
the Transaction Documents by the Company and the consummation by it of the
transactions contemplated hereby and thereby have been duly authorized by all
necessary corporate action by the Company. Each of this Agreement and
the Transaction Documents has been duly executed by the Company and when
delivered in accordance with the terms hereof will constitute the valid and
binding obligation of the Company enforceable against the Company in accordance
with its terms, except as such enforceability may be limited by applicable
bankruptcy, insolvency, reorganization, moratorium, liquidation or similar laws
relating to, or affecting generally the enforcement of, creditors’ rights and
remedies or by other equitable principles of general application and except that
rights to indemnification and contribution may be limited by Federal or state
securities laws or public policy relating thereto.
c.
Capitalization
. As
of the date hereof, the authorized capital stock of the Company is as set forth
in
Schedule
2.1(c)
. All of such outstanding shares of capital stock have
been, or upon issuance will be, validly authorized and issued, fully paid and
nonassessable. No securities of the Company are entitled to preemptive or
similar rights, and no Person (as hereinafter defined) has any right of first
refusal, preemptive right, right of participation, or any similar right to
participate in the transactions contemplated by the Transaction
Documents. Except as a result of the purchase and sale of the Shares
and those outstanding warrants as identified in Schedule 2.1(c), there are no
outstanding options, warrants, script rights to subscribe to, calls or
commitments of any character whatsoever relating to, or securities, rights or
obligations convertible into or exchangeable for, or giving any Person any right
to subscribe for or acquire, any shares of Common Stock, or contracts,
commitments, understandings or arrangements by which the Company or any
subsidiary is or may become bound to issue additional shares of Common Stock, or
securities or rights convertible or exchangeable into shares of Common
Stock. The issue and sale of the Shares will not obligate
the Company to issue shares of Common Stock or other securities to any Person
(other than the Purchasers) and will not result in a right of any holder of
Company securities to adjust the exercise, conversion, exchange or reset price
under such securities.
Exhibit
10.26
d.
Authorization and Validity;
Issuance of Shares
. The Shares are and will at all times hereafter
continue to be duly authorized and reserved for issuance and, when issued and
paid for in accordance with this Agreement and the Transaction Documents, will
be validly issued, fully paid and non-assessable, free and clear of all
liens.
e.
No
Conflicts
. The execution, delivery and performance of this
Agreement and each of the Transaction Documents by the Company and the
consummation by the Company of the transactions contemplated hereby and thereby
do not and will not (i) conflict with or violate any provision of the
Certificate of Incorporation, Bylaws or other organizational documents of the
Company, (ii)
subject to obtaining the
consents referred to in Section 2.1(f), conflict with, or constitute a default
(or an event which with notice or lapse of time or both would become a default)
under, or give to others any rights of termination, amendment, acceleration or
cancellation of, any agreement, indenture, patent, patent license or instrument
(evidencing a Company debt or otherwise) to which the Company is a party or by
which any property or asset of the Company is bound or affected, except where
such conflict or violation has not resulted or would not reasonably be expected
to result, individually or in the aggregate, in a Material Adverse Effect, or
(iii) result in a violation of any law, rule, regulation, order, judgment,
injunction, decree or other restriction of any court or governmental authority
to which the Company is subject (including Federal and state securities laws and
regulations and the rules and regulations of the principal market or exchange on
which the Common Stock is traded or listed), or by which any material property
or asset of the Company is bound, except where such conflict has not resulted or
would not reasonably be expected to result, individually or in the aggregate, in
a Material Adverse Effect.
f.
Consents and
Approvals
. The Company is not required to obtain any consent, waiver,
authorization or order of, give any notice to, or make any filing or
registration with, any court or other federal, state, local or other
governmental authority, regulatory or self regulatory agency, or other Person in
connection with the execution, delivery and performance by the Company of this
Agreement or the Transaction Documents, other than (i) the filing of a
registration statement with the Commission, which shall be filed in accordance
with and in the time periods set forth in the Registration Rights Agreement,
(ii) the application(s) or any letter(s) acceptable to the Nasdaq National
Market (“
Nasdaq
”) for the
listing of the Common Stock with Nasdaq (and with any other national securities
exchange or market on which the Common Stock is then listed), and (iii) any
filings, notices or registrations under applicable Federal or state securities
laws (together with the consents, waivers, authorizations, orders, notices and
filings referred to on
Schedule 2.1(f),
the
“
Required
Approvals
”), except where failure to do so has not resulted or would not
reasonably result, individually, or in the aggregate, in a Material Adverse
Effect. “
Person
” means an
individual or corporation, partnership, trust, incorporated or unincorporated
association, joint venture, limited liability company, joint stock company,
government (or an agency or subdivision thereof) or other entity of any
kind.
g.
Litigation;
Proceedings
. Except as specifically set forth on
Schedule 2.1(g)
or in
the SEC Documents (as hereinafter defined), there is no action, suit, notice of
violation, proceeding or investigation pending or, to the knowledge of the
Company, threatened against or affecting the Company or any of its subsidiaries
or any of their respective properties before or by any court, governmental or
administrative agency or regulatory authority (Federal, state, county, local or
foreign) (collectively, an “
Action
”) which (i)
adversely affects or challenges the legality, validity or enforceability of any
of this Agreement or the Transaction Documents or (ii) would reasonably be
expected to, individually or in the aggregate, have a Material Adverse
Effect. Neither the Company nor any subsidiary, nor, to the knowledge
of the Company, any officer thereof, is or has been, nor, to the knowledge of
the Company, any director thereof is or has been for the last three years, the
subject of any Action involving a claim of violation of or liability under
federal or state securities laws or a claim of breach of fiduciary
duty. There has not been, and, to the knowledge of the Company, there
is not pending or contemplated, any investigation by the Commission involving
the Company or any current or former director that was a director of the Company
at any time during the last three years or officer of the
Company. The Commission has not issued any stop order or other order
suspending the effectiveness of any registration statement filed by the Company
or any subsidiary under the Exchange Act or the Securities Act.
Exhibit
10.26
h.
No Default or
Violation
. The Company (i) is not in default under or in violation of any
indenture, loan or other credit agreement or any other agreement or instrument
to which it is a party or by which it or any of its properties is bound and
which is required to be included as an exhibit to any SEC Document (as defined
in Section 2.1(j)) or will be required to be included as an exhibit to the
Company’s next filing under either the Securities Act or the Securities Exchange
Act of 1934, as amended (the “
Exchange Act
”), (ii)
is not in violation of any order of any court, arbitrator or governmental body
applicable to it, (iii) is not in violation of any statute, rule or
regulation of any governmental authority to which it is subject, (iv) is not in
default under or in violation of its Certificate of Incorporation, Bylaws or
other organizational documents, respectively in the case of (i), (ii) and (iii),
except where such violations have not resulted or would not reasonably result,
individually or in the aggregate, in a Material Adverse Effect.
i.
Private
Offering
. The Company and all Persons acting on its behalf
have not made, directly or indirectly, and will not make, offers or sales of any
securities or solicited any offers to buy any security under circumstances that
would require registration of the Common Stock or the issuance of
such securities under the Securities Act. Subject to the accuracy and
completeness of the representations and warranties of the Purchasers contained
in Section 2.2, the offer, sale and issuance by the Company to the
Purchasers of the Common Stock and is exempt from the
registration requirements of the Securities Act.
j.
SEC Documents; Financial
Statements
. The Common Stock of the Company is registered pursuant to
Section 12(g) of the Exchange Act. Since December 31, 2000, the
Company has filed all reports, schedules, forms, statements and other documents
required to be filed by it, with the Commission, pursuant to Section 13, 14 or
15(d) of the Exchange Act (the foregoing materials and all exhibits included
therein and financial statements and schedules thereto and documents (other than
exhibits to such documents) incorporated by reference therein being collectively
referred to herein as the “
SEC Documents
”), on a
timely basis or has received a valid extension of such time of filing and has
filed any such SEC Documents prior to the expiration of any such
extension. As of their respective dates, the SEC Documents complied
in all material respects with the requirements of the Securities Act and the
Exchange Act and the rules and regulations of the Commission promulgated
thereunder, and none of the SEC Documents, when filed, contained any untrue
statement of a material fact or omitted to state a material fact required to be
stated therein or necessary in order to make the statements therein, in light of
the circumstances under which they were made, not misleading. The
financial statements of the Company included in the SEC Documents comply in all
material respects with applicable accounting requirements and the rules and
regulations of the Commission with respect thereto as in effect at the time of
filing. Such financial statements have been prepared in accordance
with generally accepted accounting principles applied on a consistent basis
during the periods involved ("
GAAP
"), except as may
be otherwise specified in such financial statements or the notes thereto, and
fairly present in all material respects the financial position of the Company
and its consolidated subsidiaries as of and for the dates thereof and the
results of operations and cash flows for the periods then ended, subject, in the
case of unaudited statements, to normal, immaterial, year-end audit
adjustments.
Exhibit
10.26
k.
Material
Changes
. Since the date of the latest audited financial
statements included within the SEC Documents, except as specifically disclosed
in the SEC Documents, (i) there has been no event, occurrence or development
that has had or that could result in a Material Adverse Effect, (ii) the Company
has not incurred any liabilities (contingent or otherwise) other than (A) trade
payables and accrued expenses incurred in the ordinary course of business
consistent with past practice and (B) liabilities not required to be reflected
in the Company's financial statements pursuant to GAAP or required to be
disclosed in filings made with the Commission, (iii) the Company has not altered
its method of accounting or the identity of its auditors, (iv) the Company has
not declared or made any dividend or distribution of cash or other property to
its stockholders or purchased, redeemed or made any agreements to purchase or
redeem any shares of its capital stock, and (v) the Company has not issued any
equity securities to any officer, director or affiliate, except pursuant to
existing Company stock option plans. The Company does not have pending before
the Commission any request for confidential treatment of
information.
l.
Patents and
Trademarks
. The Company and its subsidiaries have, or have
rights to use, all patents, patent applications, trademarks, trademark
applications, service marks, trade names, copyrights, licenses and other similar
rights that are necessary or material for use in connection with their
respective businesses as described in the SEC Documents and which the failure to
so have could have, or reasonably be expected to result in, a Material Adverse
Effect (collectively, the "
Intellectual Property
Rights
"). Neither the Company nor any subsidiary has received
a written notice that the Intellectual Property Rights used by the Company or
any subsidiary violates or infringes upon the rights of any Person which if
determined adversely to the Company would, individually or in the aggregate have
a Material Adverse Effect. To the knowledge of the Company, all such
Intellectual Property Rights are enforceable and there is no existing
infringement by another Person of any of the Intellectual Property
Rights.
m.
Transactions With Affiliates
and Employees
. Except as set forth in SEC Documents, none of
the officers or directors of the Company and, to the knowledge of the Company,
none of the employees of the Company is presently a party to any transaction
with the Company or any subsidiary (other than for services as employees,
officers and directors), including any contract, agreement or other arrangement
providing for the furnishing of services to or by, providing for rental of real
or personal property to or from, or otherwise requiring payments to or from any
officer, director or such employee or, to the knowledge of the Company, any
entity in which any officer, director, or any such employee has a substantial
interest or is an officer, director, trustee or partner.
Exhibit
10.26
n.
Solvency
. Except
as set forth in the SEC Documents, based on the financial condition of the
Company as of the Closing Date, (i) the Company's fair saleable value of its
assets exceeds the amount that will be required to be paid on or in respect of
the Company's existing debts and other liabilities (including known contingent
liabilities) as they mature; (ii) the Company's assets do not constitute
unreasonably small capital to carry on its business for the current fiscal year
as now conducted and as proposed to be conducted including its capital needs
taking into account the particular capital requirements of the business
conducted by the Company, and projected capital requirements and capital
availability thereof; and (iii) the current cash flow of the Company, together
with the proceeds the Company would receive, were it to liquidate all of its
assets, after taking into account all anticipated uses of the cash, would be
sufficient to pay all amounts on or in respect of its debt when such amounts are
required to be paid. The Company does not intend to incur debts
beyond its ability to pay such debts as they mature (taking into account the
timing and amounts of cash to be payable on or in respect of its
debt).
o.
Listing and Maintenance
Requirements
. The Company has not, in the two years preceding
the date hereof, received notice (written or oral) from any exchange
or market on which the Common Stock is or has been listed or quoted to the
effect that the Company is not in compliance with the listing or maintenance
requirements of such exchange or market. The Company is, and has no reason to
believe that it will not in the foreseeable future continue to be, in compliance
with all such listing and maintenance requirements. The issuance and
sale of the Shares hereunder does not contravene the rules and
regulations of the Nasdaq OTC Market and no approval of the shareholders of the
Company is required for the Company to issue and deliver to the Purchasers the
number of Shares contemplated by this Agreement.
p.
Registration
Rights
. The Company has not granted or agreed to grant to any
Person any rights (including "piggy-back" registration rights) to have any
securities of the Company registered with the Commission or any other
governmental authority that have not been satisfied except as noted on the
Disclosure Schedules.
q.
Broker’s
Fees
. No fees or commissions or similar payments with respect
to the transactions contemplated by this Agreement or the Transaction Documents
have been paid or will be payable by the Company to any third party broker,
financial advisor, finder, investment banker, or bank. The Purchaser
shall have no obligation with respect to any fees or with respect to any claims
made by or on behalf of other Persons for fees of a type contemplated in this
Section 2.1(q) that may be due in connection with the transactions
contemplated by this Agreement and the Transaction Documents.
2.2
Representations and
Warranties of the Purchasers
. Each of the Purchasers,
severally and not jointly, hereby represents and warrants to the Company as
follows:
a.
Organization;
Authority
. Such Purchaser, as applicable, is a corporation or
a limited liability company or limited partnership duly formed, validly existing
and in good standing under the laws of the jurisdiction of its incorporation or
formation with the requisite power and authority, corporate or otherwise, to
enter into and to consummate the transactions contemplated hereby and by this
Agreement and the Transaction Documents and otherwise to carry out its
obligations hereunder and thereunder. The purchase by such Purchaser,
as applicable, of the shares of Common Stock hereunder has been duly
authorized by all necessary action on the part of such
Purchaser. Each of this Agreement and the Transaction Documents has
been duly executed and delivered by each Purchaser and constitutes the valid and
legally binding obligation of each Purchaser, enforceable against such Purchaser
in accordance with its terms, subject to bankruptcy, insolvency, fraudulent
transfer, reorganization, moratorium and similar laws of general applicability
relating to or affecting creditors’ rights generally and to general principles
of equity and except that rights to indemnification and contribution may be
limited by Federal or state securities laws or public policy relating
thereto.
Exhibit
10.26
b.
Investment
Intent
. Such Purchaser is acquiring the shares of Common
Stock for its own account and not with a present view to or for
distributing or reselling the shares of Common Stock or any part thereof or
interest therein in violation of the Securities Act. Nothing contained herein
shall be deemed a representation or warranty by such Purchaser to hold the
Shares for any period of time. Such Purchaser is acquiring
the Shares hereunder in the ordinary course of its business. Such
Purchaser does not have any agreement or understanding, directly or indirectly,
with any Person to distribute any of the Shares.
c.
Purchaser
Status
. At the time such Purchaser was offered the Common
Stock, and at the Closing Date, (i) it was and will be an “accredited investor”
as defined in Rule 501 under the Securities Act and (ii) such Purchaser, either
alone or together with its representatives, had and will have such knowledge,
sophistication and experience in business and financial matters so as to be
capable of evaluating the merits and risks of the prospective investment in the
Common Stock. Such Purchaser is not a registered broker-dealer under Section 15
of the Exchange Act.
d.
Reliance
. Such
Purchaser understands and acknowledges that (i) the shares of Common Stock are
being offered and sold to the Purchaser without registration under the
Securities Act in a private placement that is exempt from the registration
provisions of the Securities Act under Section 4(2) of the Securities Act or
Regulation D promulgated thereunder and (ii) the availability of such exemption
depends in part on, and the Company will rely upon the accuracy and truthfulness
of, the representations set forth in this Section 2.2 and such Purchaser hereby
consents to such reliance.
e.
Information
. Such
Purchaser and its advisors, if any, have been furnished with all materials
relating to the business, finances and operations of the Company and materials
relating to the offer and sale of the Common Stock which have been
requested by such Purchaser or its advisors. Such Purchaser and its
advisors, if any, have been afforded the opportunity to ask questions of the
Company. The Purchaser understands that its investment in the Common
Stock involves a significant degree of risk. Neither such inquiries
nor any other investigation conducted by or on behalf of such Purchaser or its
representatives or counsel shall modify, amend or affect such Purchaser's right
to rely on the truth, accuracy and completeness of the Company's representations
and warranties contained in this Agreement or the Transaction
Documents.
Exhibit
10.26
f.
Governmental
Review
. Such Purchaser understands that no United States
Federal or state agency or any other government or governmental agency has
passed upon or made any recommendation or endorsement of the Common
Stock.
g.
Residency
. Such
Purchaser is a resident of the jurisdiction set forth immediately beside such
Purchaser’s name on
Schedule I
hereto.
The
Company acknowledges and agrees that the Purchasers make no representations or
warranties with respect to the transactions contemplated hereby other than those
specifically set forth in this Section 2.2.
ARTICLE
III.
OTHER
AGREEMENTS
3.1 Transfer
Restrictions.
a. If
any Purchaser should decide to dispose of the Common Stock held by it, such
Purchaser understands and agrees that it may do so (1) only pursuant to an
effective registration statement under the Securities Act, (2) pursuant to an
available exemption from the registration requirements of the Securities Act,
(3) to an affiliate of the Purchaser, or (4) pursuant to Rule 144 promulgated
under the Securities Act (“Rule 144”). In connection with any
transfer of any Common Stock other than pursuant to an effective registration
statement, Rule 144, to the Company or to an affiliate of the Purchasers, the
Company may require the transferor thereof to provide to the Company a written
opinion of counsel experienced in the area of United States securities laws
selected by the transferor, the form and substance of which opinion shall be
customary for opinions of counsel in comparable transactions and reasonably
acceptable to the Company, to the effect that such transfer does not require
registration of such transferred securities under the Securities Act; provided,
however, that if the Common Stock may be sold pursuant to Rule 144(k), no
written opinion of counsel shall be required from any Purchaser if such
Purchaser provides reasonable assurances that such security can be sold pursuant
to Rule 144(k). Notwithstanding the foregoing, the Company hereby
consents to and agrees to register any transfer by any Purchaser to an affiliate
of such Purchaser, provided that the transferee certifies to the Company that it
is an “accredited investor” as defined in Rule 501(a) under the Securities
Act. Any such transferee shall agree in writing to be bound by the
terms of this Agreement and the Transaction Documents
and shall have the
rights of a Purchaser under this Agreement and the Transaction
Documents. The Company shall not require an opinion of counsel in
connection with the transfer of the shares of Common Stock to an affiliate of a
Purchaser.
b. The
Purchasers agree to the imprinting, so long as is required by this Section
3.1(b), of the following legend on the Common Stock:
THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED WITH THE SECURITIES
AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE
UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED
(THE "SECURITIES ACT"), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT
PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR
PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE
REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH
APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO
THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY
ACCEPTABLE TO THE COMPANY. THESE SECURITIES MAY BE PLEDGED IN
CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH
SHARES.
Exhibit
10.26
The
Company acknowledges and agrees that a Purchaser may from time to time pledge
pursuant to a bona fide margin agreement or grant a security interest in some or
all of the shares of Common Stock and if required under the terms of such
arrangement, such Purchaser may transfer pledged or secured shares of Common
Stock to the pledgees or secured parties. Such a pledge or transfer
would not be subject to approval of the Company and no legal opinion of the
pledgee, secured party or pledgor shall be required in connection
therewith. Further, no notice shall be required of such
pledge. At the appropriate Purchaser's expense, the Company will
execute and deliver such reasonable documentation as a pledgee or secured party
reasonably request in connection with a pledge or transfer of the shares of
Common Stock, including the preparation and filing of any required prospectus
supplement under Rule 424(b)(3) of the Securities Act or other applicable
provision of the Securities Act to appropriately amend the list of selling
stockholders thereunder.
Neither
the Common Stock shall contain the legend set forth above (or any other legend)
(i) while a registration statement covering the resale of such security is
effective under the Securities Act, (ii) if in the written opinion of counsel to
the Company experienced in the area of United States securities laws such legend
is not required under applicable requirements of the Securities Act (including
judicial interpretations and pronouncements issued by the staff of the
Commission) or (iii) if such Common Stock may be sold pursuant to Rule
144(k). The Company agrees that it will provide any Purchaser, upon
request, with a certificate or certificates representing shares of Common Stock
free from such legend at such time as such legend is no longer required
hereunder. If such certificate or certificates had previously been
issued with such a legend or any other legend, the Company shall, upon request
and upon the delivery of the legended certificate(s), reissue such certificate
or certificates free of any legend. The Company agrees that following the
effective date of the registration statement meeting the requirements set forth
in the Registration Rights Agreement and covering the resale of the Shares by
the Purchasers or at such time as such legend is no longer required under this
Section 3.1, it will, no later than three Trading Days (as such term is defined
in the Registration Rights Agreement) following the delivery by a Purchaser to
the Company or the Company's transfer agent of a certificate representing Shares
an issued with a restrictive legend, deliver or cause to be delivered to such
Purchaser a certificate representing such Shares that is free from all
restrictive and other legends.
Exhibit
10.26
When the
Company is required to cause unlegended certificates to replace previously
issued legended certificates, if unlegended certificates are not delivered to a
Holder within three (3) Business Days of submission by that Holder of legended
certificate(s) to the Company’s transfer agent together with a representation
letter in customary form, the Company shall be liable to the Holder for
liquidated damages in an amount equal to 1.5% of the aggregate purchase price of
the securities evidenced by such certificate(s) for each thirty (30) day period
(or portion thereof) beyond such three (3) Business Days that the unlegended
certificates have not been so delivered
3.2
Stop Transfer
Instruction
. The Company may not make any notation on its
records or give instructions to any transfer agent of the Company which enlarge
the restrictions on transfer set forth in Section 3.1.
3.3
Not used.
3.4
Furnishing of
Information.
As long as any Purchaser owns shares of Common
Stock, the Company covenants to timely file (or obtain extensions in respect
thereof and file within the applicable grace period) all reports required to be
filed by the Company after the date hereof pursuant to the Exchange
Act. Upon the request of any such Person, the Company shall deliver
to such Person a written certification of a duly authorized officer as to
whether it has complied with the preceding sentence. As long as any Purchaser
owns shares of Common Stock if the Company is not required to file reports
pursuant to such laws, it will prepare and furnish to the Purchasers and make
publicly available in accordance with Rule 144(c) such information as is
required for the Purchasers to sell the Shares under Rule 144.
3.5
Integration
. The
Company shall not, and shall use its best efforts to ensure that no affiliate of
the Company shall, sell, offer for sale or solicit offers to buy or otherwise
negotiate in respect of any security (as defined in Section 2 of the Securities
Act) that would be integrated with the offer or sale of the shares of Common
Stock hereunder in a manner that would require the registration under the
Securities Act of the sale of the shares Common Stock to the Purchasers, or that
would be integrated with the offer or sale of the Shares for purposes of the
rules and regulations of the Nasdaq National Market, if such integration would
result in a violation of any such rule or regulation.
3.6
Non-Public
Information
. Except for information regarding the transaction
contemplated by this Agreement and the Transaction Documents and the terms and
conditions hereof and thereof, the Company covenants and agrees that neither it
nor any other Person acting on its behalf will provide any Purchaser or its
agents or counsel with any information that the Company believes constitutes
material non-public information, unless prior thereto such Purchaser shall have
executed a written agreement regarding the confidentiality and use of such
information. The Company understands and confirms that each Purchaser
shall be relying on the foregoing representations in effecting transactions in
securities of the Company. Notwithstanding anything to the contrary
herein, no Purchaser shall engage in any trading activity in the Company's
securities in violation of Regulation M of the Exchange Act.
3.7
Use of
Proceeds
. The Company shall use the net proceeds from the sale
of the shares of Common Stock hereunder for working capital purposes. The
Company shall not use the net proceeds from the sale of the shares of Common
Stock hereunder to repay any of its short-term or long-term debt
instruments
Exhibit
10.26
3.8
Best
Efforts
. Each of the parties hereto shall use its best efforts
to satisfy each of the conditions to be satisfied by it as provided in Article
IV of this Agreement.
3.9 Subsequent
Placements.
a. From
the date hereof until the Effective Date, the Company will not directly or
indirectly, offer, sell or grant any option to purchase (or announce any offer,
sale, grant or any option to purchase) any of its Common Stock or other
securities which entitle the holder thereof to receive Common Stock, including
without limitation any debt, preferred stock or other instrument or security
that is, at any time during its life and under any circumstances, convertible
into or exchangeable for Common Stock.
b.
The restrictions contained in paragraph (a) of this Section shall
not apply to: (i) the granting of options, restricted stock, stock appreciation
rights or similar instruments to employees, officers, directors and consultants
of the Company pursuant to any stock option or similar plan duly adopted by the
Company or to the issuance of shares of Common Stock upon exercise of such
options or other rights, (ii) issuances of shares of Common Stock pursuant to
any acquisition by the Company of the assets or capital stock of a business
pursuant to a merger, asset sale or other business combination; (iii) issuances
of shares of Common Stock upon conversion of the Company’s Series A1 Convertible
Redeemable Preferred Stock (the “
Series A1 Preferred
Stock
”) (as described on Schedule 2.1(c));
ARTICLE
IV.
CONDITIONS
4.1 Closing.
a.
Conditions Precedent to the
Obligation of the Company to Sell the Shares of Common
Stock
. The obligation of the Company to sell the shares of
Common Stock is subject to the satisfaction or waiver by the Company,
at or before the Closing Date, of each of the following conditions:
(i)
Accuracy of the Purchasers’
Representations and Warranties
. The representations and
warranties of each Purchaser in this Agreement shall be true and correct in all
material respects as of the date when made and as of the Closing
Date;
(ii)
Performance by the
Purchasers
. Each Purchaser shall have performed, satisfied and
complied in all material respects with all covenants, agreements and conditions
required by this Agreement to be performed, satisfied or complied with by such
Purchaser at or before the Closing Date; and
(iii)
No
Injunction
. No statute, rule, regulation, executive order,
decree, ruling or injunction shall have been enacted, entered, promulgated or
endorsed by any court or governmental authority of competent jurisdiction which
prohibits the consummation of any of the transactions contemplated by this
Agreement or the Transaction Documents.
Exhibit
10.26
b.
Conditions Precedent to the
Obligation of the Purchasers to Purchase the Shares of Common
Stock at the Closing
. The obligation of each
Purchaser hereunder to acquire and pay for the shares of Common
Stock at the Closing is subject to the satisfaction or waiver by
Purchaser, at or before the Closing Date, of each of the following
conditions:
(i)
Accuracy of the Company’s
Representations and Warranties
. The representations and
warranties of the Company set forth in this Agreement shall be true and correct
in all respects as of the date when made and as of the Closing
Date;
(ii)
Performance by the
Company
. The Company shall have performed, satisfied and
complied in all respects with all covenants, agreements and conditions required
by this Agreement to be performed, satisfied or complied with by the Company at
or before the Closing Date;
(iii)
No
Injunction
. No statute, rule, regulation, executive order,
decree, ruling or injunction shall have been enacted, entered, promulgated or
endorsed by any court or governmental authority of competent jurisdiction which
prohibits the consummation of any of the transactions contemplated by this
Agreement and the Transaction Documents;
(iv)
Required
Approvals
. All Required Approvals shall have been obtained;
and
(v)
Shares of Common
Stock
. The Company shall have duly reserved the number of
shares of Common Stock acquired by the Purchasers on the Closing
Date.
ARTICLE
V.
INDEMNIFICATION
5.1
Indemnification
. The
Company will indemnify and hold the Purchasers and their directors, officers,
shareholders, partners, employees and agents (each, a "
Purchaser Party
")
harmless from any and all losses, liabilities, obligations, claims,
contingencies, damages, costs and expenses, including all judgments, amounts
paid in settlements, court costs and reasonable attorneys' fees and costs of
investigation that any such Purchaser Party may suffer or incur as a result of
or relating to (a) any misrepresentation, breach or inaccuracy, or any
allegation by a third party that, if true, would constitute a breach or
inaccuracy, of any of the representations, warranties, covenants or agreements
made by the Company in this Agreement or in the other Transaction Documents; or
(b) any cause of action, suit or claim brought or made against such Purchaser
Party and solely arising out of or solely resulting from the execution,
delivery, performance or enforcement of this Agreement or any of the other
Transaction Documents. The Company will reimburse such Purchaser for
its reasonable legal and other expenses (including the cost of any
investigation, preparation and travel in connection therewith) incurred in
connection therewith, as such expenses are incurred. Notwithstanding the
foregoing, the Company shall not be required to indemnify any the Purchaser
under the terms of this Article V with respect to any claim or violation for
which indemnification is expressly excluded under the Registration Rights
Agreement.
Exhibit
10.26
ARTICLE
VI.
MISCELLANEOUS
6.1
Entire
Agreement
. This Agreement, together with the Exhibits and
Schedules hereto and the Transaction Documents contain the entire understanding
of the parties with respect to the subject matter hereof and supersede all prior
agreements and understandings, oral or written, with respect to such
matters.
6.2
Notices
. Whenever
it is provided herein that any notice, demand, request, consent, approval,
declaration or other communication shall or may be given to or served upon any
of the parties by another, or whenever any of the parties desires to give or
serve upon another any such communication with respect to this Agreement, each
such notice, demand, request, consent, approval, declaration or other
communication shall be in writing and either shall be delivered in person with
receipt acknowledged or by registered or certified mail, return receipt
requested, postage prepaid, or by telecopy and confirmed by telecopy answerback
addressed as follows:
If to the
Company:
Cicero,
Inc.
8000
Regency Parkway, Suite 542
Cary,
North Carolina 27518
Attn: John
P. Broderick
With
a Copy to:
Golenbock
Eiseman, Assor Bell and Peskoe LLP
437
Madison Ave
New York,
NY 10022
Attn: Lawrence
Bell, Esq.
Exhibit
10.26
If to the Purchasers
: To the
address set forth on the counterpart signature page of such Purchaser or at such
other address as may be substituted by notice given as herein
provided. The giving of any notice required hereunder may be waived
in writing by the party entitled to receive such notice. Every
notice, demand, request, consent, approval, declaration or other communication
hereunder shall be deemed to have been duly given and effective on the earliest
of (a) the date of transmission, if such notice or communication is delivered
via facsimile at the facsimile number specified in this Section prior to 6:30
p.m. (New York City time) on a business day, (b) the next business day after the
date of transmission, if such notice or communication is delivered via facsimile
at the facsimile number specified in this Section on a day that is not a
business day or later than 6:30 p.m. (New York City time) on any business day,
(c) the business day following the date of mailing, if sent by U.S. nationally
recognized overnight courier service, or (d) upon actual receipt by the party to
whom such notice is required to be given. As used herein, a “business day” means
any day except Saturday, Sunday and any day which shall be a federal legal
holiday or a day on which banking institutions in the State of New York are
authorized or required by law or other governmental action to
close.
6.3
Amendments;
Waivers
. No provision of this Agreement may be waived or
amended except in a written instrument signed, in the case of an amendment, by
both the Company and each of the Purchasers or, in the case of a waiver, by the
party against whom enforcement of any such waiver is sought. No
waiver of any default with respect to any provision, condition or requirement of
this Agreement shall be deemed to be a continuing waiver in the future or a
waiver of any other provision, condition or requirement hereof, nor shall any
delay or omission of either party to exercise any right hereunder in any manner
impair the exercise of any such right accruing to it thereafter.
6.4
Headings
. The
headings herein are for convenience only, do not constitute a part of this
Agreement and shall not be deemed to limit or affect any of the provisions
hereof.
6.5
References.
References
herein to Sections are to Sections of this Agreement, unless otherwise expressly
provided.
6.6
Successors and Assigns;
Assignability
. Neither this Agreement nor any right, remedy,
obligation or liability arising hereunder or by reason hereof shall be
assignable by either the Company or the Purchasers without the prior written
consent of the other party. In the event that such prior written
consent is obtained and this Agreement is assigned by either party, all
covenants contained herein shall bind and inure to the benefit of the parties
hereto and their respective successors and assigns.
6.7
No Third-Party
Beneficiaries
. This Agreement is intended for the benefit of
the parties hereto and their respective permitted successors and assigns and is
not for the benefit of, nor may any provision hereof be enforced by, any other
Person.
Exhibit
10.26
6.8
Governing Law; Waiver of
Jury Trial
. All questions concerning the construction, validity,
enforcement and interpretation of this Agreement shall be governed by and
construed and enforced in accordance with the internal laws of the State of
Delaware, without regard to the principles of conflicts of law
thereof. Each party agrees that all proceedings concerning the
interpretations, enforcement and defense of the transactions contemplated by
this Agreement and any other Transaction Documents (whether brought against a
party hereto or its respective affiliates, directors, officers, shareholders,
employees or agents) (each a "
Proceeding
") shall be
commenced exclusively in the state and federal courts sitting in the City of New
York, Borough of Manhattan. Each party hereto hereby irrevocably
submits to the exclusive jurisdiction of the state and federal courts sitting in
the City of New York, Borough of Manhattan for the adjudication of any dispute
hereunder or in connection herewith or with any transaction contemplated hereby
or discussed herein (including with respect to the enforcement of the any of the
Transaction Documents), and hereby irrevocably waives, and agrees not to assert
in any Proceeding, any claim that it is not personally subject to the
jurisdiction of any such court, that such Proceeding is
improper. Each party hereto hereby irrevocably waives personal
service of process and consents to process being served in any such Proceeding
by mailing a copy thereof via registered or certified mail or overnight delivery
(with evidence of delivery) to such party at the address in effect for notices
to it under this Agreement and agrees that such service shall constitute good
and sufficient service of process and notice thereof. Nothing
contained herein shall be deemed to limit in any way any right to serve process
in any manner permitted by law. Each party hereto hereby irrevocably waives, to
the fullest extent permitted by applicable law, any and all right to trial by
jury in any legal proceeding arising out of or relating to this Agreement or the
transactions contemplated hereby. If either party shall commence a Proceeding to
enforce any provisions of a Transaction Document, then the prevailing party in
such Proceeding shall be reimbursed by the other party for its attorneys fees
and other costs and expenses incurred with the investigation, preparation and
prosecution of such Proceeding.
6.9
Survival
. The
representations, warranties, agreements and covenants contained herein shall
survive following the Closing.
6.10
Execution
. This
Agreement may be executed in two or more counterparts, all of which when taken
together shall be considered one and the same agreement and shall become
effective when counterparts have been signed by each party and delivered to the
other party, it being understood that both parties need not sign the same
counterpart. In the event that any signature is delivered by
facsimile transmission, such signature shall create a valid and binding
obligation of the party executing (or on whose behalf such signature is
executed) with the same force and effect as if such facsimile signature page
were an original thereof.
6.11
Not
used
.
6.12
Publicity
. The
Purchasers shall not issue any press release or make any public disclosure
regarding the transactions contemplated hereby unless such press release or
public disclosure is approved by the Company in
advance. Notwithstanding the foregoing, each of the parties hereto
may, in documents required to be filed by it with the SEC or other regulatory
bodies, make such statements with respect to the transactions contemplated
hereby as each may be advised by counsel is legally necessary or advisable, and
may make such disclosure as it is advised by its counsel is required by
law.
6.13
Severability
. In
case any one or more of the provisions of this Agreement shall be invalid or
unenforceable in any respect, the validity and enforceability of the remaining
terms and provisions of this Agreement shall not in any way be affected or
impaired thereby and the parties will attempt to agree upon a valid and
enforceable provision which shall be a reasonable substitute therefore, and upon
so agreeing, shall incorporate such substitute provision in this
Agreement.
Exhibit
10.26
6.14
Further
Assurances
. Each party shall do and perform, or cause to be
done and performed, all such further acts and things, and shall execute and
deliver all such other agreements, certificates, instruments and documents, as
the other party may reasonably request in order to carry out the intent and
accomplish the purposes of this Agreement and the consummation of the
transactions contemplated hereby.
6.15
Replacement of
Certificates
. If any certificate or instrument evidencing any shares of
Common Stock is mutilated, lost, stolen or destroyed, the Company shall issue or
cause to be issued in exchange and substitution for and upon cancellation
thereof, or in lieu of and substitution therefore, a new certificate or
instrument, but only upon receipt of evidence reasonably satisfactory to the
Company of such loss, theft or destruction and customary and reasonable
indemnity, if requested. The applicants for a new certificate or
instrument under such circumstances shall also pay any reasonable third-party
costs associated with the issuance of such replacement shares.
6.16
Remedies
. In addition
to being entitled to exercise all rights provided herein or granted by law,
including recovery of damages, each of the Purchasers and the Company will be
entitled to specific performance under this Agreement or the Transaction
Documents. The parties agree that monetary damages may not be
adequate compensation for any loss incurred by reason of any breach of
obligations described in the foregoing sentence and hereby agrees to waive in
any action for specific performance of any such obligation the defense that a
remedy at law would be adequate.
6.17
Independent Nature of
Purchasers' Obligations and Rights
. The obligations of each
Purchaser under this Agreement or any Transaction Document are several and not
joint with the obligations of any other Purchaser, and no Purchaser shall be
responsible in any way for the performance of the obligations of any other
Purchaser under this Agreement or any Transaction Document. Nothing
contained herein or in any Transaction Document, and no action taken by any
Purchaser pursuant thereto, shall be deemed to constitute the Purchasers as a
partnership, an association, a joint venture or any other kind of entity, or
create a presumption that the Purchasers are in any way acting in concert or as
a group with respect to such obligations or the transactions contemplated by
this Agreement or any the Transaction Document. Each Purchaser shall
be entitled to independently protect and enforce its rights, including without
limitation the rights arising out of this Agreement or out of the other
Transaction Documents, and it shall not be necessary for any other Purchaser to
be joined as an additional party in any proceeding for such
purpose.
6.18
Fees and
Expenses
. Except as set forth in the Registration Rights
Agreement, and except as provided herein, each Party shall pay the fees and
expenses of its advisers, accountants and other experts.
Exhibit
10.26
IN
WITNESS WHEREOF, the parties hereto have caused this Securities Purchase
Agreement to be duly executed by their respective authorized persons as of the
day and year first above written.
|
CICERO,
INC.
|
|
|
|
|
|
|
|
By:
|
|
|
|
John
P. Broderick
|
|
|
Chief
Executive Officer
|
|
|
|
|
|
|
|
PURCHASERS:
|
|
|
|
|
[COUNTERPART
SIGNATURE PAGES FOLLOW]
|
Exhibit
10.26
IN
WITNESS WHEREOF, the parties hereto have caused this Securities Purchase
Agreement to be duly executed by their respective authorized persons as of the
day and year first above written.
|
PURCHASER
|
|
|
|
|
|
|
|
|
|
|
(Name
of Purchaser)
|
|
|
|
|
|
|
By:
|
|
|
|
|
(Signature
of Purchaser(s))
|
|
|
|
|
|
|
Name:
|
|
|
|
|
(Name
of Signatory if Purchaser is an Entity)
|
|
|
|
|
|
Title:
|
|
|
|
|
(if
Purchaser is an Entity)
|
|
|
|
|
|
|
|
|
|
|
Purchase
Price:
|
$____________
|
|
|
|
|
|
|
|
|
|
|
Address
for Notice:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
With
a copy to:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exhibit
10.26
SCHEDULE
I
Name
and
|
|
Number
of Shares
of
Common Stock
|
|
Address of
Purchaser
|
Residence
|
at Closing
Date
|
Purchase
Price
|
|
|
|
|
|
|
|
|
Ahab
International, Ltd.
|
NY
|
109,890
|
$27,000.00
|
c/o
Ahab Capital Management, Inc.
|
|
|
|
Mr.
Jonathan Gallen
|
|
|
|
299
Park Avenue, 17
th
Floor
|
|
|
|
New
York, NY 10171
|
|
|
|
|
|
|
|
|
|
|
|
Ahab
Partners, L.P.
|
NY
|
93,610
|
$23,000.00
|
c/o
Ahab Capital Management, Inc.
|
|
|
|
Mr.
Jonathan Gallen
|
|
|
|
299
Park Avenue, 17
th
Floor
|
|
|
|
New
York, NY 10171
|
|
|
|
|
|
|
|
|
|
|
|
Dr.
Leonard Corwin
|
NJ
|
10,175
|
$2,500.00
|
5403
Pointe Gate Drive
|
|
|
|
Livingston,
NJ 07039
|
|
|
|
|
|
|
|
|
|
|
|
Dr.
Richard H. Blanck
|
NY
|
12,210
|
$3,000.00
|
9
Hickory Road
|
|
|
|
Manhasset
Hills, NY 11040
|
|
|
|
|
|
|
|
|
|
|
|
Sandra
Grodko
|
NJ
|
40,700
|
$10,000.00
|
596
South Forest Drive
|
|
|
|
Teaneck,
NJ 07666
|
|
|
|
|
|
|
|
|
|
|
|
Steven
Grodko
|
NJ
|
124,135
|
$30,500.00
|
596
South Forest Drive
|
|
|
|
Teaneck,
NJ 07666
|
|
|
|
|
|
|
|
|
|
|
|
Joan
Howard
|
MD
|
28,490
|
$7,000.00
|
10470
Fair Oaks
|
|
|
|
Columbia,
MD 21044
|
|
|
|
|
|
|
|
|
|
|
|
Dr.
Richard Keates
|
PA
|
122,100
|
$30,000.00
|
99
N. Main Street
|
|
|
|
New
Hope, PA 18938
|
|
|
|
|
|
|
|
|
|
|
|
Scott
Lustgarten
|
PA
|
40,700
|
$10,000.00
|
418
Hillbrook Road
|
|
|
|
Bryn
Mawr, PA 19010
|
|
|
|
Exhibit
10.26
SCHEDULE
I
PAGE
–2-
Name
and
|
|
Number
of Shares
of
Common Stock
|
|
Address of
Purchaser
|
Residence
|
at Closing
Date
|
Purchase
Price
|
|
|
|
|
|
|
|
|
Douglas
Miller
|
NC
|
28,490
|
$7,000.00
|
101
Tred Avon Court
|
|
|
|
Chocowinity,
NC 27817
|
|
|
|
|
|
|
|
|
|
|
|
Bruce
Miller
|
MA
|
40,700
|
$10,000.00
|
P.O.
Box 2306
|
|
|
|
Nantucket,
MA 02584
|
|
|
|
|
|
|
|
|
|
|
|
Stephen
Paneyko
|
NJ
|
81,400
|
$20,000.00
|
30
Duncan Lane
|
|
|
|
Skillman,
NJ 08558
|
|
|
|
|
|
|
|
|
|
|
|
Don
Peppers
|
GA
|
101,750
|
$25,000.00
|
P.O.
Box 30607
|
|
|
|
340
W. 40
th
St.
|
|
|
|
Sea
Island, GA 31561
|
|
|
|
|
|
|
|
|
|
|
|
Bruce
Percelay
|
MA
|
40,700
|
$10,000.00
|
276
Newbury Street
|
|
|
|
Boston,
MA 02116
|
|
|
|
|
|
|
|
|
|
|
|
Jonathan
Robinson
|
PA
|
20,350
|
$5,000.00
|
12
Great Woods Lane
|
|
|
|
Malvern,
PA 19355
|
|
|
|
|
|
|
|
|
|
|
|
John
L. Steffens
|
NY
|
1,017,501
|
$250,000.00
|
65
East 55
th
Street, 33
rd
Floor
|
|
|
|
New
York, NY10022
|
|
|
|
|
|
|
|
|
|
|
|
James
Stevens
|
TX
|
40,700
|
$10,000.00
|
8818
Ashridge Park Dr.
|
|
|
|
Spring,
TX 77379
|
|
|
|
|
|
|
|
|
|
|
|
AmChris
Consulting Group, LLC
|
MD
|
40,700
|
$10,000.00
|
Christine
Sweet
|
|
|
|
2438
Killarney Terrace
|
|
|
|
Odenton,
MD 21113
|
|
|
|
Exhibit
10.26
SCHEDULE
I
PAGE
-3-
Name
and
|
|
Number
of Shares
of
Common Stock
|
|
Address of
Purchaser
|
Residence
|
at Closing
Date
|
Purchase
Price
|
|
|
|
|
|
|
|
|
Dr.
Hervey Weitzman
|
CT
|
20,350
|
$5,000.00
|
68
N. Park Avenue
|
|
|
|
Easton,
CT 06612
|
|
|
|
|
|
|
|
|
|
|
|
Roger
Wittenbach
|
MD
|
20,350
|
$5,000.00
|
10
Woodward Lane
|
|
|
|
Lutherville,
MD 21093
|
|
|
|
Exhibit
10.26
EXHIBIT
A
CICERO
DISCLOSURE SCHEDULES
These
Disclosure Schedules are being furnished by Cicero, Inc. (the “
Company
”), dated as
of July 31, 2007.
No
reference to or disclosure of any item or matter in these Disclosure Schedules
shall be construed as an admission or indication that such item or other matter
is material or that such item or other matter is required to be referred to or
disclosed. The inclusion and discussion of any document, agreement,
conflict or situation in these Disclosure Schedules is not an admission of the
effectiveness, enforceability, or interpretation of the document, agreement,
conflict or situation.
Items
identified on the following Schedules are deemed disclosed for purposes of all
Schedules to which they relate.
These
Disclosure Schedules do not contain Material Non-Public
Information.
Exhibit
10.26
Schedule 2.1 (c)
Capitalization
Authorized
and Outstanding Capital Stock
The
Company's Certificate of Incorporation, as amended on December 29, 2006,
authorizes the Company to issue 215,000,000 shares of Common Stock, par value
$0.001 per share, of which 39,005,379 were outstanding as of close of business
on July 31, 2007 (confirmed with American Stock Transfer and Trust
Company). An additional 1,763,476 shares of Common Stock are reserved
for issuance upon the conversion of the Series A1 Preferred Stock of which
1,688,287 shares are outstanding. An additional 303,802 shares of
Common Stock are reserved for issuance upon the exercise of the warrants
described below.
The
Company's Certificate of Incorporation authorizes it to issue 10,000,000 shares
of Preferred Stock, par value $0.001 per share. Of the authorized
Preferred Stock, the following series have been issued:
1,763
shares have been designated Series A1 Convertible Redeemable Preferred Stock,
all of which were issued January 2007, and 1,688 are currently
outstanding;
Preemptive
Rights
None.
Stock
Options
As of
July 31, 2007, 45,315 options to purchase Common Stock were outstanding under
the Company’s Employee and Outside Director Stock Option Plans. The Company’s
1997 Plan has approximately 37,830 shares available to grant and the Plan
expires in 2007. The Company’s Board of Directors have approved a new Cicero Inc
2007 Employee Stock Option Plan and reserved 4,500,000 shares for future
issuance. As of July 31, 2007, no options have been granted..
Warrants
303,802
shares of Common Stock are reserved for issuance upon the exercise of warrants
(all are subject to Registration Rights Agreements) as follows:
Warrant
Holders
:
|
|
Granted
:
|
|
|
Remaining
:
|
|
|
Exercise
Price
:
|
|
Early
Adopter Warrants as part of the Senior Reorganization
Notes
|
|
|
201,115
|
|
|
|
201,115
|
|
|
$
|
10.00
|
|
Former
Series D-1 Preferred Stock Purchasers
|
|
|
41,581
|
|
|
|
22,931
|
|
|
$
|
7.00
|
|
Former
Series D-2 Preferred Stock Purchasers
|
|
|
24,157
|
|
|
|
8,208
|
|
|
$
|
20.00
|
|
Former
Financing
Warrants
|
|
|
55,3671
|
|
|
|
29,726
|
|
|
$
|
40.00
|
|
Convertible
notes
|
|
|
18,750
|
|
|
|
18,750
|
|
|
$
|
8.00
|
|
Convertible
notes
|
|
|
20,000
|
|
|
|
20,000
|
|
|
$
|
10.00
|
|
Miscellaneous
Warrants
|
|
|
1,000
|
|
|
|
1,000
|
|
|
$
|
38.00
|
|
Former
Series C Preferred Stock Purchasers.
|
|
|
11,461
|
|
|
|
2,072
|
|
|
$
|
38.00
|
|
Exhibit
10.26
Rights
to Subscribe
None
Registration
Rights Agreements
Registration
Rights Agreement with Existing Preferred Stockholders.
The
Company has entered into an amended registration rights agreements to provide
for the registration of the shares underlying the Series A1 Preferred Stock.
Such agreement will also provide for the registration of the shares underlying
warrants or shares of common stock issued in the future pursuant to the terms of
the respective certificates of designation.
Registration
Rights Agreement with Participants in the January 2002 Private Placement of
Registration
Rights Agreement with MLBC.
On
January 3, 2002, the Company entered into a registration rights agreement with
MLBC, Inc. (“
MLBC
”), an affiliate
of Merrill Lynch, Pierce, Fenner & Smith Incorporated (“
Merrill
Lynch
”). This agreement grants registration rights to MLBC
with respect to 1,250 shares of Common Stock of the Company and replaces the
previous registration rights agreement with Merrill Lynch for 1,000 shares of
Common Stock of the Company. The Company complied with Merrill
Lynch's demand to register the original 1,000 shares upon effectiveness of its
Form S-3 registration statement, Reg. No. 333-61494 , effective as of June 14,
2001 and as amended by Post-Effective Amendment No. 1, filed October 18, 2001
(subsequently withdrawn). MLBC subsequently requested that it not be
included on an updated registration statement and withdrew its request to be
included. Accordingly, MLBC still retains “piggy-back” and demand
rights with respect to a total of 1,229 shares of Common Stock. The
additional 21 shares of Common Stock were distributed by MLBC and have been
registered for resale in the names of the transferees.
Exhibit
10.26
Registration
Rights Agreement as Part of the Note and Warrant Offering.
In August
2004, the Company entered into a registration rights agreement with the holders
of the Senior Reorganization Note and Warrant Offering. The
conversion of the Notes into Senior Debt and Warrants was contingent and
dependent upon the Company’s shareholders approving the merger and
reorganization (“Recapitalization”) of the Company which was completed on
November 16, 2006.
Registration Rights Agreement as Part
of the Convertible Bridge Notes
.
As part
of the Term Sheet for Convertible Bridge Note financing, the Company entered
into a registration rights agreement with the holders of Convertible Bridge
Notes within 90 days after consummation of the recapitalization.
Registration
Rights Agreement with Liraz Systems, Ltd.
On
November 30, 2006, the Company entered into a registration rights agreement with
Liraz Systems, Ltd. (“Liraz”) pursuant to a guaranty agreement between Liraz and
Bank Hapoalim B.M. This agreement grants registration rights to Liraz
with respect to certain shares of Common Stock of the Company and a warrant to
purchase 36,000 shares of the Company’s Common Stock issued as part of the
guaranty extension agreement of the Company’s bank note to Bank Hapoalim,
N.Y.
Schedule
2.1 (f) Consents
None
Schedule
2.1 (g) Litigation
Various
lawsuits and claims have been brought against us in the normal course of our
business. In January 2003, an action was brought against us in the Circuit Court
of Loudon County, Virginia, for a breach of a real estate lease. The case was
settled in August 2003. Under the terms of the settlement agreement, we agreed
to assign a note receivable with recourse equal to the unpaid portion of the
note should the note obligor default on future payments. The unpaid balance of
the note was $545,000, of which the current unpaid principal portion is
approximately $62,000 and it matures in December 2007.
At the maturity date of the note, we
will be liable for additional payments totaling approximately $31,000 which we
have recognized as a current liability.
.
In
October 2003, we were served with a summons and complaint in Superior Court of
North Carolina regarding unpaid invoices for services rendered by one of our
subcontractors. The amount in dispute was approximately $200,000 and
is included in accounts payable. Subsequent to March 31, 2004, we settled this
litigation. Under the terms of the settlement agreement, we agreed to
pay a total of $189,000 plus interest over a 19-month period ending November 15,
2005. The Company is in the process of negotiating a series of payments for the
remaining liability of approximately $80,000.
In March
2004, we were served with a summons and complaint in Superior Court of North
Carolina regarding a security deposit for a sublease in Virginia. The amount in
dispute is approximately $247,000.
Exhibit
10.26
In October 2004, we
reached a settlement agreement wherein we agreed to pay $160,000 over a 36-month
period ending October 2007.
In
August 2004, we were notified that we were in default under an
existing lease agreement for office facilities in Princeton, New Jersey. The
amount of the default is approximately $65,000. Under the terms of the lease
agreement, we may be liable for future rents should the space remain vacant. We
have reached a settlement agreement with the landlord which calls for a total
payment of $200,000 and is included in accounts payable, over a 31-month period
ending October 2007.
In
October 2005, we were notified that Critical Mass Mail, Inc. had filed a claim
against us for failure to pay certain liabilities under an Asset Purchase
Agreement dated January 9, 2004. We in turn filed that Critical Mass Mail, Inc.
failed to deliver certain assets and other documents under the same Asset
purchase agreement. We had already reserved the potential liability under the
Agreement as part of the asset purchase accounting. In February, 2006, Critical
Mass Mail amended their complaint and is seeking damages of approximately
$600,000 for our failure to timely register the underlying securities issued in
the Asset Purchase. In December 2006 we settled this litigation. Under the terms
of the settlement agreement, the Company agreed to pay the sum of $45,000 in
monthly installments over nine consecutive months beginning on December 1, 2006
and to issue Critical Mass Mail, Inc. $50,000 value of common shares of Cicero,
Inc, based on the trailing three day average price for Cicero common stock after
such stock initially trades on the OTC Bulletin Board.
Under the
indemnification clause of the Company’s standard reseller agreements and
software license agreements, the Company agrees to defend the reseller/licensee
against third party claims asserting infringement by the Company’s products of
certain intellectual property rights, which may include patents, copyrights,
trademarks or trade secrets, and to pay any judgments entered on such claims
against the reseller/licensee.
Exhibit
10.26
EXHIBIT
B
REGISTRATION RIGHTS
AGREEMENT
This
REGISTRATION RIGHTS AGREEMENT (this “
Agreement
”), dated as
of August 15, 2007, is entered into by and between CICERO, INC., a Delaware
corporation (the “
Company
”),
and _____________________________ (the “
Purchaser
”).
W I T N E S S E T
H
:
This
Agreement is made pursuant to that certain Purchase Agreement, dated as of the
date hereof, by and between the Company and the Purchaser (the “
Purchase Agreement
”),
and pursuant to that certain Commitment Agreement, dated as of the date hereof,
by and between the Company and the Purchaser (the “Commitment
Agreement”)
.
The
Company and the Purchaser hereby agree as follows:
1.
Definitions
. Unless
otherwise defined herein, terms defined in the Purchase Agreement and the
Commitment Agreement are used herein as therein defined, and the following shall
have (unless otherwise provided elsewhere in this Agreement) the following
respective meanings (such meanings being equally applicable to both the singular
and plural form of the terms defined):
“
Affiliate
” means,
with respect to any Person, any other Person that directly or indirectly
controls or is controlled by or under common control with such
Person. For the purposes of this definition, “
control
,” when used
with respect to any Person, means the possession, direct or indirect, of the
power to direct or cause the direction of the management and policies of such
Person, whether through the ownership of voting securities, by contract or
otherwise, and the terms “
affiliated
,” “
controlling
” and
“
controlled
”
have meanings correlative to the foregoing.
“
Agreement
” shall mean
this Registration Rights Agreement, including all amendments, modifications and
supplements and any exhibits or schedules to any of the foregoing, and shall
refer to the Agreement as the same may be in effect at the time such reference
becomes operative.
“
Business Day
” shall
mean any day that is not a Saturday, a Sunday or a day on which banks are
required or permitted to be closed in the State of New York.
“
Commission
” shall
mean the Securities and Exchange Commission or any other federal agency then
administering the Securities Act and other federal securities laws.
“
Holder
or
Holders
” means the
holder or holders, as the case may be, from time to time of the Registrable
Securities.
Exhibit
10.26
“
NASD
” shall mean the
National Association of Securities Dealers, Inc., or any successor corporation
thereto.
“
Registrable
Securities
” shall mean the shares of Common Stock issuable upon
conversion of the Convertible Bridge Notes and the purchase of common
stock.
2.
Registration
. As
soon as practicable following the Closing Date and within ninety (90) days of
the such date, the Company shall prepare and file with the Commission a
Registration Statement (the “
Registration
Statement
”) which shall cover all of the Registrable
Securities. The Registration Statement shall be on Form S-1 or any
successor form. The Company shall use its best efforts to cause the
Registration Statement to be declared effective under the Securities Act within
one hundred eighty (180) days of the Closing Date.
3.
Registration
Procedures
. Subject to the provisions of Section 2, the
Company will:
(a) prepare
and file with the Commission a Registration Statement with respect to such
securities and use its best efforts to cause such Registration Statement to
become and remain effective for a period of time required for the disposition of
such securities by the Holder thereof, but not to exceed two (2)
years;
(b) prepare
and file with the Commission such amendments and supplements to such
Registration Statement and the prospectus used in connection therewith as may be
necessary to keep such Registration Statement effective and to comply with the
provisions of the Securities Act with respect to the sale or other disposition
of all securities covered by such Registration Statement until the earlier of
such time as all of such securities have been disposed of in a public offering
or the expiration of two (2) years;
(c) furnish
to each Holder such number of copies of a summary prospectus or other
prospectus, including a preliminary prospectus, in conformity with the
requirements of the Securities Act, and such other documents, as such Holder may
reasonably request;
(d) use
its best efforts to register or qualify the securities covered by such
Registration Statement under such other securities or blue sky laws of such
jurisdictions within the United States as each Holder shall reasonably request
to the extent such registration or qualification is required in such
jurisdictions (
provided
,
however
, that the
Company shall not be obligated to qualify as a foreign corporation to do
business under the laws of any jurisdiction in which it is not then qualified or
to file any general consent to service of process), and do such other reasonable
acts and things as may be required of it to enable such Holder to consummate the
disposition in such jurisdiction of the securities covered by such Registration
Statement;
(e) furnish,
at the request of any Holder during registration of Registrable Securities
pursuant to Section 2, on the date that such shares of Registrable Securities
are delivered to the underwriters for sale pursuant to such registration or, if
such Registrable Securities are not being sold through underwriters, on the date
that the Registration Statement with respect to such shares of Registrable
Securities becomes effective, (1) an opinion, dated as of such date, of the
independent counsel representing the Company for the purposes of such
registration, addressed to the underwriters, if any, and if such Registrable
Securities are not being sold through underwriters, then to the Holder making
such request, in customary form and covering matters of the type customarily
covered in such legal opinions; and (2) a comfort letter dated such date,
from the independent certified public accountants of the Company, addressed to
the underwriters, if any, and if such Registrable Securities are not being sold
through underwriters, then to the Holder making such request and, if such
accountants refuse to deliver such letter to such Holder, then to the Company,
in a customary form and covering matters of the type customarily covered by such
comfort letters and as the underwriters or such Holder shall reasonably
request;
Exhibit
10.26
(f) enter
into customary agreements (including an underwriting agreement in customary
form) and take such other actions as are reasonably required in order to
expedite or facilitate the disposition of such Registrable
Securities;
(g) notify
each Holder as promptly as practicable upon the occurrence of any event as a
result of which the prospectus included in a Registration Statement, as then in
effect, contains an untrue statement of material fact or omits to state a
material fact required to be stated therein or necessary to make the statements
therein not misleading in light of the circumstances then existing, and as
promptly as possible, prepare, file and furnish to such Holder a reasonable
number of copies of a supplement or an amendment to such prospectus as may be
necessary so that such prospectus does not contain an untrue statement of
material fact or omits to state a material fact required to be stated therein or
necessary to make the statements therein not misleading in light of the
circumstances then existing;
(h) provide
each Holder and its representatives the opportunity to conduct reasonable
inquiry of the Company’s financial and other records during normal business
hours and make available its officers, directors and employees for questions
regarding information which such Holder may reasonably request in order to
conduct any due diligence; and
(i) otherwise
use its best efforts to comply with all applicable rules and regulations of the
Commission, and make available to the Holders, as soon as reasonably
practicable, but not later than eighteen (18) months after the effective date of
the Registration Statement, an earnings statement covering the period of at
least twelve (12) months beginning with the first full month after the effective
date of such Registration Statement, which earnings statement shall satisfy the
provisions of Section 11(a) of the Securities Act.
4.
Expenses
. All
expenses incident to the Company’s compliance with the terms of this Agreement,
including, without limitation, all registration and filing fees, printing
expenses, fees and disbursements of counsel for the Company, expenses of any
special audits incident to or required by any such registration and expenses of
complying with the securities or blue sky laws of any jurisdiction pursuant to
Section 3(d), shall be paid by the Company, except that:
(a) all
such expenses in connection with any amendment or supplement to the Registration
Statement or prospectus filed more than two (2) years after the effective date
of such Registration Statement because any Holder has not effected the
disposition of the securities requested to be registered shall be paid by such
Holder;
Exhibit
10.26
(b) the
Company shall not be liable for any fees, discounts or commissions to any
underwriter or any fees or disbursements of counsel for any underwriter in
respect of the securities sold by such Holder; and
(c) any
incremental expenses incurred by the Company as a result of the inclusion of a
Holder’s Registrable Securities in an underwritten offering where the Holder or
any of its Affiliates is an underwriter of the Registrable Securities which
inclusion of such Holder’s Registrable Securities requires a “qualified
independent underwriter” under the applicable rules of the NASD shall be paid by
such Holder.
5.
Indemnification and
Contribution
. (a) In the event of any registration
of any Registrable Securities under the Securities Act pursuant to this
Agreement, the Company shall indemnify and hold harmless the Holder of such
Registrable Securities, such Holder’s directors and officers, and each other
person (including each underwriter) who participated in the offering of such
Registrable Securities and each other person, if any, who controls such Holder
or such participating person within the meaning of the Securities Act, against
any losses, claims, damages or liabilities, joint or several, to which such
Holder or any such director or officer or participating person or controlling
person may become subject under the Securities Act or any other statute or at
common law, insofar as such losses, claims, damages or liabilities (or actions
in respect thereof) arise out of or are based upon (i) any alleged untrue
statement of any material fact contained, on the effective date thereof, in any
Registration Statement under which such securities were registered under the
Securities Act, any preliminary prospectus or final prospectus contained
therein, or any amendment or supplement thereto, or (ii) any alleged
omission to state therein a material fact required to be stated therein or
necessary to make the statements therein not misleading, and shall reimburse
such Holder or such director, officer or participating person or controlling
person for any legal or any other expenses reasonably incurred by such Holder or
such director, officer or participating person or controlling person in
connection with investigating or defending any such loss, claim, damage,
liability or action. Notwithstanding anything to the contrary set
forth in this Section 5(a), the Company shall not be liable to indemnify any
person in any such case to the extent that any such loss, claim, damage or
liability arises out of or is based upon (1) any actual or alleged untrue
statement or actual or alleged omission either (x) made in such Registration
Statement, preliminary prospectus, prospectus or amendment or supplement in
reliance upon and in conformity with written information furnished to the
Company by such Holder specifically for use therein or so furnished for such
purposes by any underwriter or (y) that had been corrected in a preliminary
prospectus, prospectus supplement or amendment which had been furnished to such
Holder prior to any distribution of the document alleged to contain the untrue
statement or omission to offerees or purchasers, (2) any offer or sale of
Registrable Securities after receipt by such Holder of a Standstill Notice under
Section 3(g) and prior to the delivery of the prospectus supplement or amendment
contemplated by Section 3(g), or (3) the Holder’s failure to comply with the
prospectus delivery requirements under the Securities Act or failure to
distribute its Registrable Securities in a manner consistent with its intended
plan of distribution as provided to the Company and disclosed in the
Registration Statement. Notwithstanding the foregoing, the Company
shall not be required to indemnify any person for amounts paid in settlement of
any claim without the prior written consent of the Company, which consent shall
not be unreasonably withheld. Such indemnity shall remain in full
force and effect regardless of any investigation made by or on behalf of such
Holder or such director, officer or participating person or controlling person,
and shall survive the transfer of such securities by such
Holder.
Exhibit
10.26
(b) Each
Holder, by acceptance hereof, agrees to indemnify and hold harmless the Company,
its directors and officers and each person who participated in such offering and
each other person, if any, who controls the Company within the meaning of the
Securities Act against any losses, claims, damages or liabilities, joint or
several, to which the Company or any such director or officer or any such person
may become subject under the Securities Act or any other statute or at common
law, insofar as such losses, claims, damages or liabilities (or actions in
respect thereof) arise out of or are based upon (i) information in writing
provided to the Company by the Holder specifically for use in the following
documents and contained, on the effective date thereof, in any Registration
Statement under which securities were registered under the Securities Act at the
request of the Holder, any preliminary prospectus or final prospectus contained
therein, or any amendment or supplement thereto, (ii) Holder’s offer or sale of
Registrable Securities after receipt by such Holder of a Standstill Notice under
Section 3(g) and prior to the delivery of the prospectus supplement or amendment
contemplated by Section 3(g), (iii) Holder’s failure to comply with the
prospectus delivery requirements under the Securities Act or failure to
distribute its Registrable Securities in a manner consistent with its intended
plan of distribution as provided to the Company and disclosed in the
Registration Statement, (iv) Holder’s failure to comply with Regulation M under
the Exchange Act, or (v) Holder’s failure to comply with any rules and
regulations applicable because the Holder is, or is an Affiliate of, a
registered broker-dealer. Notwithstanding the provisions of this
paragraph (b) or paragraph (c) below, no Holder shall be required to indemnify
any person pursuant to this Section 5 or to contribute pursuant to paragraph (c)
below in an amount in excess of the amount of the aggregate net proceeds
received by such Holder in connection with any such registration under the
Securities Act.
(c) If
the indemnification provided for in this Section 5 from the indemnifying party
is unavailable to an indemnified party hereunder in respect of any losses,
claims, damages, liabilities or expenses referred to therein, then the
indemnifying party, in lieu of indemnifying such indemnified party, shall
contribute to the amount paid or payable by such indemnified party as a result
of such losses, claims, damages, liabilities or expenses in such proportion as
is appropriate to reflect the relative fault of the indemnifying party and
indemnified parties in connection with the actions which resulted in such
losses, claims, damages, liabilities or expenses, as well as any other relevant
equitable considerations. The relative fault of such indemnifying
party and indemnified parties shall be determined by reference to, among other
things, whether any action in question, including any untrue or alleged untrue
statement of a material fact or omission or alleged omission to state a material
fact, has been made by, or relates to information supplied by, such indemnifying
party or indemnified parties, and the parties’ relative intent, knowledge,
access to information and opportunity to correct or prevent such
action. The amount paid or payable by a party as a result of the
losses, claims, damages, liabilities and expenses referred to above shall be
deemed to include any legal or other fees or expenses reasonably incurred by
such party in connection with any investigation or proceeding.
Exhibit
10.26
The
parties hereto agree that it would not be just and equitable if contribution
pursuant to this Section 5(c) were determined by pro rata allocation or by any
other method of allocation which does not take account of the equitable
considerations referred to in the immediately preceding paragraph. No
Person guilty of fraudulent misrepresentation (within the meaning of Section
11(f) of the Securities Act) shall be entitled to contribution from any Person
who was not guilty of such fraudulent misrepresentation.
6.
Certain Limitations on
Registration Rights
. Notwithstanding the other provisions of
this Agreement:
(a) the
Company shall not be obligated to register the Registrable Securities of Holders
if, in the opinion of counsel to the Company reasonably satisfactory to the
Holder and its counsel (or, if the Holder has engaged an investment banking
firm, to such investment banking firm and its counsel), the sale or other
disposition of such Holder’s Registrable Securities, in the manner proposed by
such Holder (or by such investment banking firm), may be effected without
registering such Registrable Securities under the Securities Act;
(b) the
Company shall not be obligated to register the Registrable Securities of any
Holder pursuant to Section 2 if the Company has had a registration statement,
under which the Holder had a right to have its Registrable Securities included
pursuant to Section 2, declared effective within one hundred and twenty (120)
days prior to the date of the request pursuant to Section 2; and
(c) the
Company shall have the right to delay the filing or effectiveness of the
registration statement required pursuant to Section 2 hereof during one or more
periods aggregating not more than forty five (45) days in any twelve-month
period in the event that (i) the Company would, in accordance with the advice of
its counsel, be required to disclose in the prospectus information not otherwise
then required by law to be publicly disclosed and (ii) in the judgment of the
Company’s Board of Directors, there is a reasonable likelihood that such
disclosure would materially and adversely affect any existing or prospective
material business situation, transaction or negotiation or otherwise materially
and adversely affect the Company.
7.
Selection of Managing
Underwriters
. The managing underwriter or underwriters for any
offering of Registrable Securities to be registered pursuant to Section 2 shall
be selected by the Holders of a majority of the shares being so registered and
shall be reasonably acceptable to the Company.
8.
Holder
Agreements
. (a) No Holder may participate in an
underwritten offering provided for hereunder unless such Holder (i) agrees to
sell the Holder’s Registrable Securities on the basis provided in the
underwriting arrangements contemplated for such offering as reasonably requested
by the managing underwriter, (ii) completes and executes all questionnaires,
powers of attorney, indemnities, underwriting agreements and other documents
reasonably required under the terms of such underwriting arrangements as
reasonably requested by the managing underwriter, and (iii) agrees to bear the
Holder’s pro rata portion of all underwriting discounts and
commissions.
Exhibit
10.26
(b) Each
Holder agrees to comply with Regulation M under the Exchange Act in connection
with its offer and sale of Registrable Securities.
(c) Each
Holder agrees that it will not sell any Registrable Securities registered under
the Securities Act pursuant to the terms of this Agreement until a Registration
Statement (and any associated post-effective amendment) relating thereto has
been declared effective and the Holder has been provided copies of the related
prospectus, as amended or supplemented to date.
(d) Each
Holder agrees to comply with the prospectus delivery requirements of the
Securities Act as applicable in connection with the sale of Registrable
Securities registered under the Securities Act pursuant to a Registration
Statement.
(e) Each
Holder agrees that upon receipt of a Standstill Notice pursuant to Section 3(g),
the Holder shall immediately discontinue offers and sales of Registrable
Securities registered under the Securities Act pursuant to any Registration
Statements covering such Registrable Securities until such Holder receives
copies of the supplemented or amended prospectus contemplated by Section 3(g) or
notice from the Company that no such supplement or amendment is
required.
9.
Miscellaneous
.
(a)
No Inconsistent
Agreements
. The Company will not hereafter enter into any
agreement with respect to its securities which conflicts with the rights granted
to the Holders in this Agreement.
(b)
Remedies
. Each
Holder, in addition to being entitled to exercise all rights granted by law,
including recovery of damages, will be entitled to specific performance of its
rights under this Agreement. The Company agrees that monetary damages
would not be adequate compensation for any loss incurred by reason of a breach
by it of the provisions of this Agreement and hereby agrees to waive the defense
in any action for specific performance that a remedy at law would be
adequate. In any action or proceeding brought to enforce any
provision of this Agreement or where any provision hereof is validly asserted as
a defense, the successful party shall be entitled to recover reasonable
attorneys’ fees in addition to any other available remedy.
(c)
Amendments and
Waivers
. Except as otherwise provided herein, the provisions
of this Agreement may not be amended, modified or supplemented, and waivers or
consents to departure from the provisions hereof may not be given unless the
Company has obtained the written consent of the Holder.
(d)
Notice
Generally
. Any notice, demand, request, consent, approval,
declaration, delivery or other communication hereunder to be made pursuant to
the provisions of this Agreement shall be sufficiently given or made if in
writing and either delivered in person with receipt acknowledged or sent by
registered or certified mail, return receipt requested, postage prepaid, or by
telecopy and confirmed by telecopy answerback, addressed as
follows:
Exhibit
10.26
If to the
Company:
Cicero, Inc.
8000
Regency Parkway, Suite 542
Cary,
North Carolina 27518
Attn: John
P. Broderick
With a Copy
to:
Golenbock
Eiseman Assor Bell & Peskoe LLP
437
Madison Avenue
New York,
New York 10022
Attn: Lawrence
Bell, Esq.
If to the
Holders:
To
the address set forth on the counterpart signature page of such Purchaser or at
such other address as may be substituted by notice given as herein
provided. The giving of any notice required hereunder may be waived
in writing by the party entitled to receive such notice. Every
notice, demand, request, consent, approval, declaration, delivery or other
communication hereunder shall be deemed to have been duly given or served on the
date on which personally delivered, with receipt acknowledged, telecopied and
confirmed by telecopy answerback or three (3) Business Days after the same shall
have been deposited in the United States mail.
(e)
Rule
144
. With a view to making available to the Holders the
benefits of Rule 144 under the Securities Act (“
Rule 144
”) and any
other rule or regulation of the Commission that may at any time permit the
Holder to sell securities of the Company to the public without registration, the
Company agrees that it will:
(i) make
and keep public information available, as those terms are understood and defined
in Rule 144;
(ii) file
with the Commission in a timely manner all reports and other documents required
of the Company under the Exchange Act; and
(iii) furnish
to a Holder, so long as such Holder owns any Registrable Securities, forthwith
upon request (A) a written statement by the Company, if true, that it has
complied with the reporting requirements of Rule 144, the Securities Act and the
Exchange Act, (B) a copy of the most recent annual or quarterly report of the
Company and such other reports and documents so filed by the Company, and (C)
such other information as may be reasonably requested in availing such Holder of
any rule or regulation of the Commission which permits the selling of any such
securities without registration.
(f)
Successors and
Assigns
. This Agreement shall inure to the benefit of and be
binding upon the successors and assigns of each of the parties hereto including
any person to whom Registrable Securities are transferred.
(g)
Headings
. The
headings in this Agreement are for convenience of reference only and shall not
limit or otherwise affect the meaning hereof.
Exhibit
10.26
(h)
Governing Law;
Jurisdiction
. This Agreement shall be governed by, construed
and enforced in accordance with the laws of the State of Delaware without giving
effect to the conflict of laws provisions thereof. Service of process
on the parties in any action arising out of or relating to this Agreement shall
be effective if mailed to the parties in accordance with Section 9(d)
hereof.
The parties
hereto waive all right to trial by jury in any action or proceeding to enforce
or defend any rights hereunder.
(i)
Severability
. Wherever
possible, each provision of this Agreement shall be interpreted in such manner
as to be effective and valid under applicable law, but if any provision of this
Agreement shall be prohibited by or invalid under applicable law, such provision
shall be ineffective to the extent of such prohibition or invalidity, without
invalidating the remainder of such provision or the remaining provisions of this
Agreement.
(j)
Entire
Agreement
. This Agreement, together with the License Agreement
and the Subscription Agreement, represents the complete agreement and
understanding of the parties hereto in respect of the subject matter contained
herein and therein. This Agreement supersedes all prior agreements
and understandings between the parties with respect to the subject matter
hereof.
(k)
Counterparts
. This
Agreement may be executed in any number of counterparts, all of which taken
together shall be considered one and the same agreement and shall become
effective when counterparts have been signed by each party and delivered to the
other party, it being understood that both parties need not sign the same
counterpart. In the event that any signature is delivered by
facsimile transmission, such signature shall create a valid and binding
obligation of the party executing (or on whose behalf such signature is
executed) with the same force and effect as if such facsimile signature page
were an original thereof.
[SIGNATURE
PAGES ATTACHED HERETO]
Exhibit
10.26
IN
WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date
first above written.
|
CICERO,
INC.
|
|
|
|
|
|
|
|
By:
|
|
|
|
John
P. Broderick,
|
|
|
Chief
Executive and Financial Officer
|
|
|
|
|
|
|
|
PURCHASER:
|
|
|
|
|
|
|
|
By:
|
|
|
Name:
|
|
|
Title:
|
|
Exhibit
21.1
Subsidiaries
(all are 100% owned)
Name
|
|
Jurisdiction
|
Level
8 Technologies, Inc.
|
|
Delaware
|
|
|
|
Cicero
Technologies, Inc,
|
|
Delaware
|
|
|
|
Cicero
Technologies Acquisition, LLC
|
|
Delaware
|
|
|
|
Template
Software de Mexico, S.A. de C.V.
|
|
Mexico
|
|
|
|
Level
8 Systems Australia Pty Ltd
|
|
Australia
|
|
|
|
Template
Software Holding GmbH
|
|
Germany
|
Template
SoftwareGeschaftsfuhrungs GmbH
|
|
Germany
|
Template
Software GmbH
|
|
Germany
|
|
|
|
Level
8 Worldwide Holdings Ltd
|
|
Delaware
|
Seer
Technologies de Argentina S.A
|
|
Argentina
|
Level
8 FSC, Inc
|
|
Barbados
|
Level
8 Benelux B.V
|
|
Netherlands
|
Seer
Technologies do Brasil Ltd.
|
|
Brazil
|
Level
8 Canada, Inc
|
|
Canada
|
Level
8 Europe (Deutschland) GmbH
|
|
Germany
|
Level
8 Ireland Limited
|
|
Ireland
|
Level
8 Systems Nordic AB
|
|
Sweden
|
Seer
Korea Co., Limited
|
|
South
Korea
|
Seer
Technologies Singapore PTY, Limited
|
|
Singapore
|
Seer
Technologies Hong Kong Limited
|
|
Hong
Kong
|
|
|
|
3020126
Canada, Inc. (fka Bizware)
|
|
Canada
|
Exhibit
22.1
CONSENT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the
Board of Directors of
Cicero
Inc.
We
consent to the incorporation by reference in the Annual Report on Form 10-K of
Cicero Inc and subsidiaries for the years ended December 31, 2007 and 2006 of
our report dated March 10, 2008, (which report expresses an unqualified opinion
and includes an explanatory paragraph relating to the Company's ability to
continue as a going concern) relating to the financial statements for the three
years ended December 31, 2007, 2006 and 2005.
|
/s/Margolis
& Company P.C.
|
|
|
|
Certified
Public Accountants
|
Bala
Cynwyd, PA
March 27,
2008
Exhibit
31.1
CERTIFICATIONS
I, John
P. Broderick, certify that:
1.
|
I
have reviewed this Annual Report on Form 10-K of Cicero Inc., formerly
Level 8 Systems, Inc.;
|
2.
|
Based
on my knowledge, this report does not contain any untrue statement of a
material fact or omit to state a material fact necessary to make the
statements made, in light of the circumstances under which such statements
were made, not misleading with respect to the period covered by this
report;
|
3.
|
Based
on my knowledge, the financial statements, and other financial information
included in this report, fairly present in all material respects the
financial condition, results of operations and cash flows of the
registrant as of, and for, the periods presented in this
report;
|
4.
|
I
am responsible for establishing and maintaining disclosure controls and
procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and
internal control over financial reporting (as defined in Exchange Act
Rules 13a-15(f) and 15d-15(f)) for the registrant and
have:
|
|
a)
|
designed
such disclosure controls and procedures, or caused such disclosure
controls and procedures to be designed under our supervision, to ensure
that material information relating to the registrant, including its
consolidated subsidiaries, is made known to us by others within those
entities, particularly during the period in which this report is being
prepared;
|
|
b)
|
designed
such internal control over financial reporting, or caused such internal
control over financial reporting to be designed under our supervision, to
provide reasonable assurance regarding the reliability of financial
reporting and the preparation of financial statements for external
purposes in accordance with generally accepted accounting
principals;
|
|
c)
|
evaluated
the effectiveness of the registrant's disclosure controls and procedures
and presented in this report our conclusions about the effectiveness of
the disclosure controls and procedures, as of the end of the period
covered by this report based upon such evaluation;
and
|
|
d)
|
disclosed
in this report any change in the registrant’s internal control over
financial reporting that occurred during the registrant’s most recent
fiscal quarter (the registrant’s fourth fiscal quarter in the case of an
annual report) that has materially affected, or is reasonably likely to
materially affect, the registrant’s internal control over financial
reporting; and
|
5.
|
I
have disclosed, based on our most recent evaluation of internal control
over financial reporting, to the registrant's auditors and the audit
committee of the registrant's board of directors (or persons performing
the equivalent functions):
|
|
a)
|
all
significant deficiencies and material weaknesses in the design or
operation of internal control over financial reporting which are
reasonably likely to adversely affect the registrant’s ability to record,
process, summarize and report financial information;
and
|
|
b)
|
any
fraud, whether or not material, that involves management or other
employees who have a significant role in the registrant's internal control
over financial reporting.
|
Date:
March 30, 2008
|
/s/ John P.
Broderick
|
|
John
P. Broderick
|
|
Chief
Executive Officer
|
Exhibit
31.2
CERTIFICATIONS
I, John
P. Broderick, certify that:
1.
|
I
have reviewed this Annual Report on Form 10-K of Cicero Inc., formerly
Level 8 Systems, Inc.;
|
2.
|
Based
on my knowledge, this report does not contain any untrue statement of a
material fact or omit to state a material fact necessary to make the
statements made, in light of the circumstances under which such statements
were made, not misleading with respect to the period covered by this
report;
|
3.
|
Based
on my knowledge, the financial statements, and other financial information
included in this report, fairly present in all material respects the
financial condition, results of operations and cash flows of the
registrant as of, and for, the periods presented in this
report;
|
4.
|
I
am responsible for establishing and maintaining disclosure controls and
procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and
internal control over financial reporting (as defined in Exchange Act
Rules 13a-15(f) and 15d-15(f)) for the registrant and
have:
|
|
a)
|
designed
such disclosure controls and procedures, or caused such disclosure
controls and procedures to be designed under our supervision, to ensure
that material information relating to the registrant, including its
consolidated subsidiaries, is made known to us by others within those
entities, particularly during the period in which this report is being
prepared;
|
|
b)
|
designed
such internal control over financial reporting, or caused such internal
control over financial reporting to be designed under our supervision, to
provide reasonable assurance regarding the reliability of financial
reporting and the preparation of financial statements for external
purposes in accordance with generally accepted accounting
principals;
|
|
c)
|
evaluated
the effectiveness of the registrant's disclosure controls and procedures
and presented in this report our conclusions about the effectiveness of
the disclosure controls and procedures, as of the end of the period
covered by this report based upon such evaluation;
and
|
|
d)
|
disclosed
in this report any change in the registrant’s internal control over
financial reporting that occurred during the registrant’s most recent
fiscal quarter (the registrant’s fourth fiscal quarter in the case of an
annual report) that has materially affected, or is reasonably likely to
materially affect, the registrant’s internal control over financial
reporting; and
|
5.
|
I
have disclosed, based on our most recent evaluation of internal control
over financial reporting, to the registrant's auditors and the audit
committee of the registrant's board of directors (or persons performing
the equivalent functions):
|
|
a)
|
all
significant deficiencies and material weaknesses in the design or
operation of internal control over financial reporting which are
reasonably likely to adversely affect the registrant’s ability to record,
process, summarize and report financial information;
and
|
|
b)
|
any
fraud, whether or not material, that involves management or other
employees who have a significant role in the registrant's internal control
over financial reporting.
|
Date:
March 30, 2008
|
/s/ John P.
Broderick
|
|
John
P. Broderick
|
|
Chief
Financial Officer
|
CERTIFICATION
PURSUANT TO
SECTION 906 OF THE
SARBANES-OXLEY ACT OF 2002
(18
U.S.C.SECTION 1350)
In
connection with the accompanying Annual Report of Cicero Inc., formerly Level 8
Systems, Inc. (the “Company”) on Form 10-K for the fiscal year ended December
31, 2007 as filed with the Security Exchange Commission on the date hereof (the
“Report”), I, John P. Broderick, Chief Executive and Financial Officer of the
Company, certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002, that to my
knowledge:
|
(1)
|
The
Report fully complies with the requirements of Section 13(a) or 15(d) of
the Securities Exchange Act of 1934;
and
|
|
(2)
|
The
information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the Company
for the periods presented in the
Report.
|
|
By:
|
/s/ John P.
Broderick
|
|
John
P. Broderick
|
|
Chief
Executive and Financial Officer
|
|
(Principal
Financial and Accounting Officer)
|
|
March
30, 2008
|